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Abstract 
 
Neuropeptides are evolutionarily ancient mediators of neuronal signalling that 
regulate a diverse range of physiological processes and behaviours. Recent advances 
in comparative genomics/transcriptomics are providing opportunities to analyse 
neuropeptide systems in a wider range of phyla. The echinoderms (e.g. starfish, sea 
urchins and sea cucumbers) are of particular interest in this respect because as 
deuterostomian invertebrates they occupy an intermediate position in animal 
phylogeny, bridging model protostomian invertebrates (e.g. Drosophila) to the 
vertebrates. Herein, the common European starfish Asterias rubens has been 
established as a model system for neuropeptide research. 
Generation and analysis of a neural transcriptome dataset from A. rubens has 
enabled the identification of thirty-five novel neuropeptide precursors and a number 
of candidate receptors. Interestingly, precursors of two kisspeptin-type peptides (the 
first identified in a non-chordate species), a melanin-concentrating hormone-type 
peptide (the first identified outside of the vertebrates) and two tachykinin-type 
peptides (the first identified in an ambulacrarian species) were identified. Discovery 
of this repertoire of neuropeptide precursors has provided the foundation for a 
comprehensive analysis of the physiological functions of neuropeptides in starfish. 
Investigation of the physiological roles of two neuropeptides – a 
vasopressin/oxytocin-type peptide (“asterotocin”) and an NG peptide 
(“NGFFYamide”) – has revealed roles in the remarkable process of extraoral feeding 
in starfish. Discovery of neuropeptides that trigger cardiac stomach eversion 
(asterotocin) and retraction (NGFFYamide) provides a novel insight into the neural 
regulation of starfish feeding and a rationale for chemically based strategies to 
control starfish that feed on economically important shellfish or protected marine 
fauna. 
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Finally, characterisation of the receptor for the NG peptide NGFFFamide in 
the sea urchin Strongylocentrotus purpuratus has unified a bilaterian neuropeptide 
family that includes neuropeptide-S-type peptides in tetrapod vertebrates, NG 
peptides in deuterostomian invertebrates and crustacean cardioactive peptide-type 
peptides in protostomian invertebrates. 
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1. General introduction 
 
1.1. Neuropeptides 
 
Neuropeptides can be defined as short polypeptides (typically 5-50 amino acids in 
length) that are produced and released by neurons through the regulated secretory 
pathway (RSP) – these short polypeptides act on receptor proteins to regulate a 
diverse range of physiological processes and behaviours. Neuropeptides represent the 
largest class of signalling molecules in the nervous system; the mammalian genome 
encodes almost 70 “classic” neuropeptide precursors (Burbach, 2012). Thus, 
neuropeptides regulate an equally large and diverse range of physiological processes 
and behaviours, from the role of substance P in nociception (Zubrzycka and Janecka, 
2000) to the role of oxytocin (OT) in reproduction (Gimpl and Fahrenholz, 2001). 
Neuropeptides can be pleiotropic; for example, neuropeptide-Y (NPY) has roles in 
regulating anxiety, feeding and in cardiovascular function (Thorsell and Heilig, 
2002). However, the definition of a neuropeptide is not completely restrictive; 
neuropeptides can also be produced and released by non-neuronal cell types. One 
such example is mammalian somatostatin (SMS), which is also secreted by the gut 
(Pradayrol et al., 1978). Moreover, there are a number of other neuronal signalling 
molecules that are not considered classic neuropeptides but are considered 
neuropeptides in the broader perspective. These include peptide hormones, growth 
factors, granins and chemokines (Burbach, 2012). 
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1.1.1. Neuropeptide structural characteristics 
 
Neuropeptides are derived from larger precursor proteins (or pre-prohormones) that 
are directly encoded in the genome. These larger precursor proteins are comprised of 
an N-terminal signal peptide and one or more bioactive neuropeptides that are 
usually flanked by dibasic/monobasic cleavage sites (Fig. 1.1) (Steiner, 1998). 
Bioactive neuropeptides may then undergo a number of post-translational 
modifications, which are often crucial for receptor binding and biological activity 
(Bennett et al., 1993). 
The N-terminal signal peptide (typically 20-30 amino acids in length) has a 
tripartite structure consisting of a positively charged region (n-region), a 
hydrophobic core (h-region) and an uncharged but polar region (c-region) (von 
Heijne, 1985). The signal peptide is required for directing proteins into the lumen of 
the endoplasmic reticulum (ER) in the RSP (Rapoport et al., 1996; Zheng and 
Gierasch, 1996). Subsequently, the signal peptide is cleaved during passage from the 
ER membrane into the Golgi network at a consensus cleavage site in the c-region by 
an extracellular signal peptidase (von Heijne, 1985).  
Bioactive neuropeptides are typically flanked by cleavage sites, which are 
recognised by pro-hormone convertase cleaving enzymes (Steiner, 1998). In 
vertebrates, cleavage most often occurs at dibasic cleavage sites comprised of the 
basic amino acids lysine (K) and arginine (R), whilst cleavage can also occur at 
monobasic cleavage sites (Devi, 1991; Rholam et al., 1995; Rouille et al., 1995; 
Seidah and Chretien, 1999). Importantly, cleavage site rules have also been proposed 
for insect neuropeptides, expanding our knowledge on neuropeptide prediction in 
non-vertebrate species (Veenstra, 2000). 
Upon cleavage by pro-hormone convertases, neuropeptides are often 
subjected to post-translation modifications. The most common post-translational 
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modification is C-terminal amidation, which is often crucial for receptor binding and 
the biological activity of the secreted neuropeptide (Bennett et al., 1993). C-terminal 
amidation is catalysed by peptidyl-aminotransferase using a C-terminal glycine (G) 
residue as an amide donor for the preceding amino acid (Eipper et al., 1993). Other 
post-translational modifications contributing to biological activity include but are not 
limited to serine (S) phosphorylation (e.g. gastrin) (Varro and Dockray, 1993), N-
linked acetylation (e.g. α-melanocyte-stimulating hormone (α-MSH)) (Dores et al., 
1991), tyrosine (Y) sulfation (e.g. cholecystokinin (CCK)) (Mutt and Jorpes, 1968) 
and conversion of an N-terminal glutamine (Q) residue to a pyroglutamate (pQ) (e.g. 
thyrotropin-releasing hormone (TRH)) (Boler et al., 1969).  
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Fig. 1.1. Processing and modification of a neuropeptide precursor. A signal 
peptidase cleaves the signal peptide from a pre-prohormone to give rise to a pro-
hormone. A pro-hormone convertase cleaves at dibasic/monobasic cleavage sites to 
give rise to a peptide hormone (neuropeptide). A carboxypeptidase and 
aminopeptidase cleave basic residues at the C-terminal and N-terminal respectively, 
giving rise to a bioactive peptide hormone. The peptide hormone can then undergo a 
number of potential post-translational modifications. For example, amidation is 
catalysed by peptidyl-aminotransferase, which uses a C-terminal glycine (G) residue 
as an amide donor for the preceding amino acid. The signal peptide is represented in 
blue, a neuropeptide is represented in red, a C-terminal glycine (G) residue is 
represented in orange and dibasic/monobasic cleavage sites are represented in green. 
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1.1.2. Neuropeptide release 
Classic neuropeptides are produced and released by neurons via the RSP (Rapoport 
et al., 1996; Zheng and Gierasch, 1996). Neuropeptides are synthesised in the rough 
ER and are sorted in the trans-Golgi network into dense-core vesicles (DCVs) (Fig. 
1.2) (Mains and Eipper, 1999). In DCVs, activation of proteolytic enzymes result in 
the processing of the neuropeptide precursor into one or more bioactive 
neuropeptides, which are released from the neuron via exocytosis at sites distant 
from the cell body (Fig. 1.2) (Brownstein et al., 1980; Lang et al., 1997; Tooze and 
Huttner, 1990).  
However, in comparison to the release of neurotransmitters in small synaptic 
vesicles (Sudhof, 2012), far less is known about the release of neuropeptides. This is 
in part due to the small and slow nature of neuropeptide release, which makes 
electrophysiological studies more difficult (van den Pol, 2012). The release of 
neuropeptides from DCVs has been most extensively studied for the mammalian 
neurohypophyseal peptides vasopressin (VP) and OT, in which the presence of large 
DCVs (LDCVs) with high and measurable amounts of peptide has provided a 
suitable model system (van den Pol, 2012). In VP and OT release, the amount of 
neuropeptide released per spike increases with spike frequency (Dreifuss et al., 1971; 
Gainer et al., 1986). This has been shown to be due to an increase in cytoplasmic 
calcium (Ca2+) in axon terminals, which is key to increasing the likelihood of LDCV 
exocytosis (Bondy et al., 1987; Jackson et al., 1991; Muschol and Salzberg, 2000). 
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Fig. 1.2. Neuropeptide biosynthesis, processing and storage. Neuropeptide 
precursors are synthesised on ribosomes in the rough endoplasmic reticulum (ER) 
and processed through the Golgi apparatus. Neuropeptides are packaged into dense 
core vesicles (DCVs) or large dense core vesicles (LDCVs), which are axonally 
transported to the site of release. Neuropeptides are then released through the process 
of exocytosis. Figure from Mains and Eipper, 1999. 
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1.2. G-protein coupled receptors (GPCRs)  
 
Neuropeptides, with a few notable exceptions including insulin-like (INSL) peptides 
that signal through tyrosine kinase receptors (RTKs), bind to and activate G-protein 
coupled receptors (GPCRs). GPCRs are a large and diverse family of membrane-
bound receptors comprised of an extracellular N-terminus, seven-transmembrane 
spanning α-helices, an intracellular C-terminus and three inter-helical loops on each 
side of the membrane. GPCRs are classified into five families – rhodopsin, secretin, 
glutamate, adhesion and frizzled/taste-2 (Fredriksson et al., 2003). GPCRs bind a 
diverse range of ligands including photons, organic odorants, nucleotides, peptides, 
lipids and proteins (Bockaert and Pin, 1999). Furthermore, GPCRs represent a major 
target for drug discovery, with pharmaceuticals developed for a range of human 
diseases (Drews, 2000; Hopkins and Groom, 2002; Howard et al., 2001). 
GPCRs function through intracellular heterotrimeric G-proteins, functioning 
as molecular switches linking ligand binding to intracellular signal transduction 
pathways. However, despite the large and diverse nature of the GPCR superfamily, 
there are relatively few G-proteins in comparison (Downes and Gautam, 1999). 
Heterotrimeric G-proteins are comprised of three subunits – an α-, β- and γ-subunit – 
divided into four main classes based on α-subunit specificity (Gαs, Gαi, Gαq and 
Gα12) (Simon et al., 1991). Upon ligand binding, GPCRs undergo a conformational 
change to allow for G-protein binding and subsequent activation. The Gα-subunit 
cycles from an inactive guanosine diphosphate (GDP)-bound form to an active 
guanosine triphosphate (GTP)-bound form, which destabilises the Gα/GPCR 
complex to allow for the Gβ/Gγ dimer to interact with downstream effector proteins 
(Oldham and Hamm, 2008). 
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GPCRs activated by neuropeptides belong to three families/classes – the 
rhodopsin-β, rhodopsin-γ and secretin families (Fredriksson et al., 2003). The 
rhodopsin-β family in humans comprises a total of thirty-six receptors including the 
tachykinin (TK) receptors, CCK receptors, TRH receptors, gonadotropin-releasing 
hormone (GnRH) receptors and vasopressin/oxytocin (VP/OT)-type receptors 
(Fredriksson et al., 2003). The rhodopsin-γ family comprises three branches – the 
SOG (somatostatin, opioid and galanin-type) receptor cluster, the melanin-
concentrating hormone (MCH) receptor cluster and the chemokine receptor cluster 
(Fredriksson et al., 2003). The secretin family comprises receptors including the 
calcitonin (CT) receptor, corticotropin-releasing hormone (CRH) receptors, the 
glucagon receptor, the gastric inhibitory polypeptide (GIP) receptor and the 
parathyroid hormone (PTH) receptors. The secretin family bind large peptide ligands 
and are characterised by an extracellular N-terminus between 60-80 amino acids in 
length comprising conserved disulphide bridges, which are crucial for ligand binding 
(Fredriksson et al., 2003). 
 
1.3. Bilaterian neuropeptide signalling systems 
 
1.3.1. The Bilateria 
The Bilateria (animals with bilateral symmetry) are comprised of two super-phyla – 
the protostomes and the deuterostomes (Fig. 1.3). The protostomes (from Greek 
meaning “mouth first”) comprise the lophotrochozoans (e.g. molluscs and annelids) 
and the ecdysozoans (e.g. arthropods and nematodes). The deuterostomes (from 
Greek meaning “second mouth”) comprise the chordates (comprising vertebrates, 
cephalochordates and urochordates), the hemichordates (e.g. acorn worms), the 
echinoderms (e.g. starfish, sea urchins and sea cucumbers) and the xenacoelomorphs 
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(e.g. ciliated marine worms). The cnidarians, comprising hydrozoans (e.g. Hydra), 
cubozoans (e.g. comb jellyfish), scyphozoans (e.g. real jellyfish) and anthozoans 
(e.g. sea anemones and corals), are basal to the bilaterians in animal phylogeny (Fig. 
1.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3. The Bilateria. A simplified phylogenetic tree based upon the findings of 
Philippe et al., 2011 and Telford et al., 2006. The bilaterians are comprised of two 
super-phyla – the protostomes (lophotrochozoans and ecdysozoans) and the 
deuterostomes (vertebrates, urochordates, cephalochordates, hemichordates, 
echinoderms and xenacoelomorphs). The cnidarians are basal to the bilaterians.  
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1.3.2. The Bilateria: providing insights into the evolutionarily ancient origins of 
neuropeptide signalling systems 
 
Neuropeptide signalling systems are key components of nervous systems in both the 
bilaterians (Jekely, 2013; Mirabeau and Joly, 2013) and the primitive cnidarians 
(Grimmelikhuijzen et al., 2004). Neuropeptides can be found in highly conserved 
families and can therefore be readily identified in evolutionary distant animals within 
the animal kingdom. One such example is the VP/OT-type neuropeptide signalling 
system; the mature peptide comprises a characteristic disulphide bridge between 
positions 1 and 6 crucial for bioactivity (Hruby et al., 1990; Sawyer, 1977) whilst the 
C-terminal region of the precursor contains a highly conserved neurophysin domain 
(comprising fourteen cysteine (C) residues) required for sorting in the RSP (de Bree, 
2000; de Bree and Burbach, 1998).  
However, such high sequence conservation is relatively uncommon and 
therefore establishing evolutionary relationships between neuropeptide signalling 
systems in evolutionarily distant phyla has historically proved difficult. 
Neuropeptides are highly diverse and are typically comprised of relatively short 
stretches of amino acids with relatively few conserved residues. Neuropeptides are 
also often repetitive, with the number and length of bioactive neuropeptides often 
changing through evolutionary time, providing difficulties for multiple alignment-
based molecular phylogeny analyses (Jekely, 2013).  
Recent advances in comparative genomics/transcriptomics has transformed 
our understanding of neuropeptide diversity and its functional significance across the 
animal kingdom. The increasing availability of genomic/transcriptomic sequence 
data has meant that neuropeptides from evolutionarily distant phyla have been shown 
to be orthologous and of an ancestral bilaterian origin (Jekely, 2013; Mirabeau and 
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Joly, 2013). However, what is the importance of understanding whether, for 
example, an arthropod neuropeptide is related to a vertebrate neuropeptide?  
Firstly, understanding the evolutionary relatedness of neuropeptides allows us 
to gain novel insights into neuropeptide function. For example, the sequencing of the 
genome of the fruit fly Drosophila melanogaster has led to the identification of a 
number of neuropeptide signalling systems (Brody and Cravchik, 2000; Hewes and 
Taghert, 2001; Vanden Broeck, 2001) that have provided important insights into the 
evolutionarily ancient roles of neuropeptide families. One such example is 
neuropeptide-F (NPF), which has been shown to regulate processes including 
foraging, feeding, alcohol sensitivity and aggression in D. melanogaster (Nässel and 
Wegener, 2011). Interestingly, it has been shown that NPF is related to NPY, which 
has been shown to regulate a range of processes including appetite and food 
consumption in vertebrates (Beck, 2006). It therefore appears that the NPF/NPY 
signalling system may have an evolutionarily ancient role in regulating feeding 
behaviours in the bilaterians.  
Secondly, understanding the evolutionary relatedness of neuropeptides also 
allows for synergistic exchange of knowledge and resources between various fields 
of research. Key examples illustrating this have come from the genome of the 
nematode Caenorhabditis elegans; neuropeptides including adipokinetic hormone 
(AKH), pyrokinin (PK) and sulfakinin (SK) have been shown to be orthologous to 
vertebrate GnRH, neuromedin U (NMU) and CKK respectively through the 
identification of receptors that bind these neuropeptides (Janssen et al., 2008; 
Lindemans et al., 2011; Lindemans et al., 2009). 
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Finally, understanding the evolutionary relatedness of neuropeptides, both 
within and between different phyla, may provide pathways to pharmaceutical 
(Torres-Lugo and Peppas, 2000) and agrochemical (Bendena, 2010) discovery by 
informing development of synthetic non-peptidic receptor agonists and antagonists.  
 
1.4. The echinoderms 
 
The echinoderms (Phylum: Echinodermata) are marine animals, which, together with 
the hemichordates and the xenocoelomorphs, form a sister clade to the chordates 
(Bourlat et al., 2006; Bromham and Degnan, 1999; Philippe et al., 2011). The 
echinoderms comprise five extant classes – the echinoids (e.g. sea urchins), the 
holothurians (e.g. sea cucumbers), the asteroids (e.g. starfish), the ophiuroids (e.g. 
brittle stars) and the crinoids (e.g. feather stars and sea lilies) (Fig. 1.4.). The 
echinoids and holothurians form the echinozoan clade; the asteroids and ophiuroids 
form the asterozoan clade, whilst the crinoids are basal to the echinozoan and the 
asterozoan clades (O'Hara et al., 2014; Telford et al., 2014).  
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Fig. 1.4. The echinoderms. A simplified phylogenetic tree based upon the findings 
of O’Hara et al., 2014 and Telford et al., 2014. The holothurians (e.g. sea cucumbers) 
and echinoids (e.g. sea urchins) form the echinozoan clade. The ophiuroids (e.g. 
brittle stars) and asteroids (e.g. starfish) form the asterozoan clade. The crinoids (e.g. 
feather stars and sea lilies) are found basal to the echinozoan and asterozoan clades. 
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1.4.1. The echinoderms: a model system for neuropeptide research  
 
The echinoderms provide a number of advantages as a model system for 
neuropeptide research over classic and long-standing model organisms including the 
fruit fly D. melanogaster and the nematode C. elegans, which continue to yield 
important insights into neuropeptide function in invertebrate species (Beets et al., 
2012; Taghert and Nitabach, 2012). The echinoderms are of interest due to their 
phylogenetic position as a sister clade to the chordates; analysis of echinoderms 
therefore provides a basis for identifying synapomorphies shared within the 
deuterostome clade as well as factors that differentiate the echinoderms from the 
chordates. Moreover, the echinoderms provide a unique context for investigating the 
structure, function and evolution of neuropeptide signalling systems. The 
echinoderms possess a pentaradial morphological organisation along with the ability 
to autotomise, regenerate and rapidly and reversibly change the mechanical state of 
their body wall (Byrne, 2001; Patruno et al., 2001; Thorndyke et al., 2001; Wilkie, 
2001; Wilkie, 2005).  
Recent advances in comparative genomics/transcriptomics has transformed 
our knowledge and understanding of neuropeptide diversity across the animal 
kingdom. In 2006, the genome of the sea urchin Strongylocentrotus purpuratus was 
sequenced (Sodergren et al., 2006). The sea urchin genome project led to the 
identification of approximately 23,300 genes, with representatives of nearly all 
vertebrate gene families (Sodergren et al., 2006). Historically, the sea urchin has 
been an important model organism in developmental and systems biology. However, 
the sea urchin genome project has also allowed exploration into numerous regulatory 
networks including the defensome, adhesome, biomineralisation and the nervous 
system (Sodergren et al., 2006).  
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Analysis of the genome of the sea urchin S. purpuratus has resulted in the 
identification of a number of neuropeptide precursors (a SALMFamide precursor, a 
NGFFFamide precursor and a vasotocin-like precursor) and thirty-seven candidate 
neuropeptide receptors (Burke et al., 2006; Sodergren et al., 2006). Subsequently, 
analysis of 2026 expressed sequence tags (ESTs) from an S. purpuratus radial nerve 
cDNA library has led to the identification of twenty additional neuropeptide 
precursors (Rowe and Elphick, 2012), whilst a more recent analysis of sea urchin 
genome data has led to the identification of numerous additional neuropeptide 
precursors (Jekely, 2013; Mirabeau and Joly, 2013).  
To date, investigation into the physiological functions of this repertoire of 
neuropeptides is limited. However, a VP/OT-type peptide (“echinotocin”) has been 
shown to cause contraction of in vitro oesophagus and tube foot preparations from 
the sea urchin species Echinus esculentus (Elphick and Rowe, 2009). Importantly, 
transcriptome sequence data has also been obtained for a species belonging to 
another class of echinoderm in the echinozoan clade – a holothurian – the sea 
cucumber Apostichopus japonicus (Du et al., 2012). This has led to the identification 
of seventeen neuropeptide precursors and a number of candidate receptors (Rowe et 
al., 2014). However, when this study commenced, there was no publicly available 
transcriptome sequence data available for an asteroid, ophiuroid or crinoid species –
generation and analysis of sequence data from these echinoderm classes would 
provide an opportunity to generate new insights into the evolution and diversity of 
neuropeptide signalling systems across the echinoderms. 
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S. purpuratus Ref(s) A. japonicus Ref(s) 
- - Stichopin, GN-19, GLRFA a, h 
NGFFFamide e NGIWYamide a, h 
Echinotocin e  - 
F-type SALMFamide e F-type SALMFamide b, h 
Spnp1 (L-type SALMFamide) f Ajnp1 (L-type SALMFamide) i 
Spnp2 (GnRHP) g - - 
Spnp3 (TRHLP) g Ajnp3 (TRHLP) l 
Spnp4 (CTLPP) g Ajnp4 (CTLPP) l 
Spnp5 (ANPP) g Ajnp5 (ANPP) l 
Spnp6 (PPLNP1) g - - 
Spnp7 (PPLNP2) g Ajnp7 (PPLNP2) l 
Spnp9 g Ajnp9 l 
Spnp16 g Ajnp16 l 
Spnp8, Spnp10-15, Spnp17-20 g - - 
SpLQLP j AjLQLP l 
SpCRHLP k AjCRHLP l 
 SpGPA2 l AjGPA2 l 
SpBALP d, j AjBALP l 
SpBBLP d AjBBLP l 
  
Table 1. Neuropeptide and polypeptide hormone precursors identified in S. 
purpuratus and A. japonicus. BALP, bursicon-α like precursor; BBLP, bursicon-β 
like precursor; CRHLP, corticotropin-releasing hormone-like precursor; CTLPP, 
calcitonin-like precursor; GnRHP, gonadotropin-releasing hormone-type precursor; 
GPA2, glycoprotein α-2-type precursor; LQLP, luqin-like precursor; PPLNP, pedal 
peptide-like precursor; TRHLP, thyrotropin-releasing hormone-like precursor. a, 
Iwakoshi et al., 1995; b, Ohtani et al., 1999; c, Elphick and Thorndyke, 2005; d, 
Burke et al., 2006; e, Elphick and Rowe, 2009; f, Rowe and Elphick, 2010; g, Rowe 
and Elphick, 2012; h, Elphick, 2012; i, Elphick et al., 2013; j, Jekely, 2013; k, 
Mirabeau and Joly, 2013; l, Rowe et al., 2014. Table adapted from Rowe et al., 2014. 
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1.5. The common European starfish A. rubens 
 
The common European starfish Asterias rubens (Class: Asteroidea) is found 
throughout the coasts of the UK and through much of coastal Europe. However, the 
species also occurs in deeper waters off the northern coast of North America. Starfish 
reproduce by the process of free-spawning with gametes released into the 
environment from the gonads, which are located in pairs in each arm of the animal. 
In A. rubens, gonadal growth occurs through the autumn and winter, with gonadal 
size and oocyte diameter peaking in early spring prior to spawning (Barker and 
Nichols, 1983). A. rubens, whilst differing in shape and morphology from many of 
the approximate 1500 living species of asteroid, possesses a common external and 
internal anatomy to other starfish species with few exceptions (Ruppert et al., 2004). 
 
1.5.1. A. rubens external anatomy 
 
Many starfish species possess a striking pentaradial body plan with five arms (or 
rays) emanating from a central disk region (Fig. 1.5). However, some starfish species 
may possess more than five arms emanating from the central disk (e.g. the common 
sun star Crossaster papposus) (Ruppert et al., 2004). The spiny upper surface of the 
starfish is called the aboral surface, whilst the bottom surface is called the oral 
surface. The aboral surface contains structures including the anus, a madreporite that 
controls entry of seawater into the water vascular system, small jaw-like structures 
called pedicellariae that prevent colonisation of microorganisms and papulae for 
respiratory function (Cobb, 1978). The oral surface contains the mouth of the 
starfish, with an ambulacral groove extending radially from the mouth down each 
arm (Ruppert et al., 2004). The ambulacrum contains two to four rows of tubular 
projections termed tube feet, which drive the processes of locomotion, attachment 
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and feeding (Hennebert, 2010). The external anatomy of the starfish is supported by 
a body wall comprising an epidermal layer, a dermal layer (in which calcite ossicles 
are embedded) forming the endoskeleton, two layers of longitudinal and circular 
muscle and an inner coelomic epithelium (O'Neill, 1989).  
 
1.5.2. A. rubens internal anatomy 
 
The internal anatomy of starfish is comprised of a number of structures that form 
internal systems including a decentralised nervous system, a water vascular system, a 
digestive system and a haemal system.  
 The decentralised nervous system is comprised of five radial nerve cords 
located in each arm that extend outwards along the ambulacra and connect to a 
circumoral nerve ring. The circumoral nerve ring is located in the central disk region 
surrounding the mouth and is attached to and innervates the peristomial epidermis 
(Moore and Thorndyke, 1993). The circumoral nerve ring and radial nerve cord 
comprise an ectoneural and a hyponeural region (Cobb, 1970). The ectoneural nerve 
plexus is both sensory and motor in function, whilst the hyponeural nerve plexus is 
motor in function (Cobb, 1987; Moore and Thorndyke, 1993; von Hehn, 1970). 
The tube foot driven processes of locomotion, attachment and feeding in 
addition to processes including respiration are powered by a water vascular system 
(Nichols, 1966; Nichols, 1972). The calcareous madreporite allows the movement of 
seawater into a single axial canal termed the stone canal and through to the ring canal 
located around the mouth of the starfish, which contains Tiedemann’s bodies with a 
coelomocyte-like function (Holm et al., 2008). Pentamerous radial canals extend into 
each arm with perpendicular lateral canals allowing the movement of seawater into 
the tube feet, with ampullae acting as valves to power the tube feet. 
Perhaps one of the most recognisable internal systems of the starfish is the 
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digestive system. Feeding in starfish species including A. rubens is a remarkable 
process by which the cardiac stomach is everted through the mouth over the 
digestible parts of the prey (e.g. mussels) through the relaxation of intrinsic muscles 
and extrinsic stomach retractor strands (Anderson, 1954). The eversion of the cardiac 
stomach enables starfish to feed on relatively large prey, with prey tissue partially 
digested externally. The cardiac stomach is then retracted through the contraction of 
intrinsic muscles and extrinsic stomach retractor strands (Basch, 1956; Burnett and 
Anderson, 1955) allowing the transport of partially digested tissue into the pyloric 
stomach, which, via pyloric ducts, is connected to a pair of pyloric caecae in each 
arm. From the pyloric stomach, a short tubular intestine joins to a rectum lined with 
out-pockets termed rectal caecae (Ruppert et al., 2004). The rectum opens at an anus 
in the centre of the aboral central disk (Ruppert et al., 2004).  
The digestive system is linked to a haemal system, to allow for the transport 
and storage of nutrients from the pyloric caecae (Cuenot, 1948; Ruppert et al., 2004). 
The haemal system is comprised of three radial sets of vessels each consisting of a 
haemal ring in the disc and five radial vessels (Ruppert et al., 2004). The three 
haemal rings are the hyponeural haemal ring, the gastric haemal ring and the genital 
haemal ring, each connected by an axial sinus located in the coelomic cavity 
(Beijnink and Voogt, 1986; Broertjes and Posthuma, 1978). The heart is located on 
top of the axial sinus, above the three haemal rings and to one side of the 
madreporite (Ruppert et al., 2004). 
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Fig. 1.5. Diagram of a dissected starfish displaying the main anatomical 
features, with a particular focus on the digestive system. The digestive system 
comprises a cardiac stomach (with eversion and retraction controlled by retractor 
strands), a pyloric stomach, pyloric ducts, pyloric caecae, rectal caecae and an anus. 
The water vascular system comprises a madreporite, ampullae, ambulacral plate and 
tube feet. Also shown are ossicles (components of the body wall) and gonads 
(components of the reproductive system). Figure adapted from Brusca and Brusca, 
2003. 
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1.5.3. A. rubens: a model system for neuropeptide research 
 
The starfish A. rubens has been used as a model system for neuropeptide research for 
over twenty-five years – this was pioneered by the detection of FMRFamide-like 
immunoreactivity in the radial nerve and circumoral nerve ring in A. rubens (Elphick 
et al., 1989). This led to an effort to purify and identify peptides responsible for 
FMRF-like immunoreactivity in A. rubens, which resulted in the discovery of the 
first neuropeptides to be identified in an echinoderm species – the SALMFamides S1 
(GFNSALMF-NH2) and S2 (SGPYSFNSGLTF-NH2) (Elphick et al., 1991a; Elphick 
et al., 1991b). Investigation into the distribution of S1 and S2 in A. rubens using 
immunocytochemistry (ICC) revealed expression in the nervous system and 
neuromuscular organs, including the digestive system, tube feet and apical muscle 
(Elphick et al., 1995; Newman et al., 1995a; Newman et al., 1995b). Subsequently, 
investigation into the pharmacological actions of S1 and S2 revealed that they cause 
relaxation of cardiac stomach, tube foot and apical muscle preparations in vitro 
(Elphick et al., 1995; Melarange and Elphick, 2003; Melarange et al., 1999) and 
cause cardiac stomach eversion in vivo (Elphick et al., 1995; Melarange et al., 1999). 
In addition to providing pioneering insights into neuropeptide signalling 
systems in the echinoderms, A. rubens provides a number of further advantages as a 
model echinoderm system for neuropeptide research. Unlike other echinoderm 
species such as the sea urchin S. purpuratus, the starfish A. rubens is a common and 
easily obtained species in the UK and throughout much of coastal Europe, whilst A. 
rubens is also found in deeper waters off the northern coast of North America. Other 
closely related species of the genus Asterias also occur globally – Asterias forbesi is 
found along the Atlantic coast of the USA whilst Asterias amurensis is found along 
the coasts of Japan, China, Korea and Russia. Moreover, analysis of neuropeptide 
systems in A. rubens is important from an economical and environmental 
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perspective. Starfish species feed on economically important shellfish (e.g. mussels) 
harvested as foodstuffs (Agüera et al., 2012; Dare, 1982; Dolmer, 1998; Magnesen 
and Redmond, 2012). Importantly, the crown-of-thorns starfish Acanthaster planci 
feeds of reef building corals with periodic increases causing destruction of Pacific 
reef tracts (De'ath et al., 2012; Kayal et al., 2012; Timmers et al., 2012). 
Identification of neuropeptides that trigger cardiac stomach eversion (e.g. the 
SALMFamides S1 and S2) or retraction may therefore provide a basis for the 
development of non-peptidic antagonists that mimic or block the effects of 
endogenous neuropeptides, which could be used for chemical control of starfish 
species. 
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1.6. Aims and objectives 
 
The aims and objectives of this thesis are represented in the proceeding results 
chapters: 
 
(1) Identification of transcripts encoding neuropeptide precursors and 
neuropeptide receptors in the starfish A. rubens 
The primary aim of the work reported in this this chapter is to sequence and 
assemble a neural transcriptome of the starfish A. rubens and utilise the 
transcriptome dataset to establish the species as a model system for neuropeptide 
research. This will provide a foundation to (i) investigate the evolutionary origins of 
neuropeptide signalling systems from the common ancestor of the Bilateria and (ii) 
investigate the physiological functions of neuropeptide signalling systems in (a) a 
starfish species, (b) an echinoderm species and even in (c) an ambulacrarian and (d) 
a non-chordate species, in many cases, for the very first time.  
 
(2) Discovery and functional characterisation of a novel vasopressin/oxytocin 
(VP/OT)-type neuropeptide (“asterotocin”) in the starfish A. rubens 
The aim of the work reported in this chapter is to investigate the physiological 
function of a VP/OT-type peptide (“asterotocin”) identified through the sequencing 
of a neural transcriptome of the starfish A. rubens. The sequence of the asterotocin 
precursor will be confirmed through cloning and sequencing, with the sequence of 
the asterotocin peptide and potential post-translational modifications confirmed 
through mass spectrometry. The physiological role(s) of asterotocin will be 
investigated utilising both in vitro and in vivo assays and the expression of 
asterotocin mRNA will be investigated through mRNA in situ hybridisation (ISH). 
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(3) Discovery and functional characterisation of a novel neurophysin-associated 
neuropeptide (“NGFFYamide”) in the starfish A. rubens 
The aim of the work reported in this chapter is to investigate the physiological 
function of an NG peptide (“NGFFYamide”) identified through the sequencing of a 
neural transcriptome of the starfish A. rubens. The sequence of the NGFFYamide 
precursor will be confirmed through cloning and sequencing, with the sequence of 
the NGFFYamide peptide and potential post-translational modifications confirmed 
through mass spectrometry. The physiological role(s) of NGFFYamide will be 
investigated utilising both in vitro and in vivo assays and the expression of 
NGFFYamide mRNA will be investigated through mRNA ISH. 
 
(4) Discovery of the NGFFFamide receptor in the sea urchin S. purpuratus unites 
a bilaterian neuropeptide family 
The primary aim of the work reported in this chapter is to clone, sequence and 
pharmacologically characterise the receptor for the NG peptide NGFFFamide in the 
sea urchin S. purpuratus. The candidate NGFFFamide receptor is orthologous to 
neuropeptide-S (NPS)-type receptors in the tetrapod vertebrates and crustacean 
cardioactive peptide (CCAP)-type receptors in the protostomian invertebrates. Thus, 
characterisation of the NGFFFamide receptor will unify a bilaterian neuropeptide 
family that includes NPS-type peptides in vertebrates, NG peptides in 
deuterostomian invertebrates and CCAP-type peptides in protostomian invertebrates. 
The secondary aim of this chapter is to identify NG peptide precursors and candidate 
NPS/CCAP-type receptors utilising recently available genome/transcriptome data 
from a number of echinoderm species. In combination, these data will provide a 
foundation to pharmacologically characterise NG peptide receptors across the 
echinoderms. 
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2.  Identification of transcripts encoding neuropeptide precursors and 
neuropeptide receptors in the starfish A. rubens 
  
2.1. General introduction 
 
Neuropeptides are evolutionarily ancient mediators of neuronal signalling that 
regulate a diverse range of physiological processes and behaviours across the animal 
kingdom. Previous phylogenetic studies aiming to understand the relationships of 
neuropeptide signalling systems outside of the vertebrates has been confined to 
analysing genome data from chordates including the urochordate Ciona intestinalis 
(Kamesh et al., 2008) and the cephalochordate Branchiostoma floridae (Nordstrom 
et al., 2008) and ecdysozoans including the fruit fly Drosophila melanogaster 
(Hewes and Taghert, 2001) and the nematode Caenorhabditis elegans (Nathoo et al., 
2001).  
However, recent advances in comparative genomics/transcriptomics has 
transformed our understanding of neuropeptide diversity across the animal kingdom, 
with a number of neuropeptide signalling systems having been recently traced back 
to the common ancestor of the Bilateria (Jekely, 2013; Mirabeau and Joly, 2013). 
The key to this approach has been the analysis of sequence data from a wider range 
of phyla across the animal kingdom; recent phylogenetic studies have utilised 
genome data from the urochordates (Dehal et al., 2002), cephalochordates (Putnam et 
al., 2008), hemichordates, echinoderms (Sodergren et al., 2006), lophotrochozoans 
(Simakov et al., 2013) and ecdysozoans (Adams et al., 2000; Colbourne et al., 2011; 
Richards et al., 2008) to provide important evidence for the evolutionarily ancient 
origins of a number of neuropeptide signalling systems (Jekely, 2013; Mirabeau and 
Joly, 2013).  
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2.1.1. The Ambulacraria 
 
The echinoderms (e.g. starfish, sea urchins, sea cucumbers) and the hemichordates 
(e.g. acorn worms) form the ambulacrarians (Telford, 2006). The ambulacrarians are 
deuterostomian invertebrates and therefore occupy an intermediate position in animal 
phylogeny, bridging model protostomian invertebrates (e.g. Drosophila and C. 
elegans) to the vertebrates. Both Drosophila and C. elegans belong to the 
ecdysozoan clade and are therefore not representative of invertebrates as a whole. 
Therefore, the investigation of genome/transcriptome data available for the 
ambulacrarians has been crucial in providing novel insights into the evolutionarily 
ancient origins of neuropeptide signalling systems.  
 
2.1.2. Ambulacrarian neuropeptide signalling systems: the hemichordates 
 
The generation and analysis of genome data from the hemichordate Saccoglossus 
kowalevskii has recently proved invaluable in identifying neuropeptide signalling 
systems of a bilaterian origin (Jekely, 2013; Mirabeau and Joly, 2013). For example, 
the identification of an orexin (OX)-type precursor in S. kowalevskii has unified a 
bilaterian neuropeptide family that is comprised of OX-type precursors in the 
deuterostomes and allatotropin (AT)-type precursors in the protostomes. OX’s are 
hypothalamic neuropeptides that were first discovered as regulators of feeding 
behaviour (de Lecea et al., 1998; Sakurai et al., 1998) and have subsequently been 
implicated as key regulators in the processes of sleep and wakefulness in mammals 
(Sakurai, 2007). AT was first isolated through its regulatory function in stimulating 
the synthesis and secretion of juvenile hormone (JH) from the corpora allata and has 
subsequently been implicated in regulating cardioacceleration and the inhibition of 
active ion transport in the midgut of the tobacco hornworm Manduca sexta (Kataoka 
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et al., 1989; Veenstra et al., 1994). It had been shown that OX and AT share 
orthologous receptors (Vuerinckx et al., 2011; Yamanaka et al., 2008). However, 
homology could not be deduced based on neuropeptide sequences but were deduced 
on the presence of conserved domains in the neuropeptide precursor proteins 
(Mirabeau and Joly, 2013). In this regard, hemichordate genome data was utilised to 
identify conserved “cryptic” domains outside of peptide regions in the S. kowalevskii 
OX precursor and all protostomian AT precursors – this was not seen previously as 
the cryptic domain appears to have been lost in the chordates. This suggests that the 
OX and AT neuropeptide signalling systems are orthologous and can be traced back 
to the common ancestor of the Bilateria (Mirabeau and Joly, 2013).!!
2.1.3. Ambulacrarian neuropeptide signalling systems: the echinoderms 
The generation and analysis of genome/transcriptome data from the sea urchin S. 
purpuratus (Burke et al., 2006; Rowe and Elphick, 2012) and transcriptome data 
from the sea cucumber Apostichopus japonicus (Rowe et al., 2014) have also 
recently proved invaluable in identifying neuropeptide signalling systems of a 
bilaterian origin. One such example is the identification of a thyrotropin-releasing 
hormone (TRH)-like precursor in S. purpuratus; this was the first TRH-like 
precursor to be identified in an invertebrate species and therefore allowed the 
neuropeptide signalling system to be traced back at least as far as the common 
ancestor of the deuterostomes (Rowe and Elphick, 2012).  
The availability of genome/transcriptome data has also allowed for functional 
studies into the roles of novel neuropeptides in the echinoderms. For example, the 
identification of a vasopressin/oxytocin (VP/OT)-type peptide (“echinotocin”) in S. 
purpuratus has shown that echinotocin causes contraction of in vitro tube foot and 
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oesophagus preparations from the sea urchin species Echinus esculentus (Elphick 
and Rowe, 2009). 
 In addition to sequence data for an echinoid species (S. purpuratus) and a 
holothurian species (A. japonicus), the genome of an asteroid – the starfish species 
Patiria miniata – has also been sequenced and has been made publically available 
(http://www.echinobase.org/Echinobase/pm). The utilisation of P. miniata genome 
data has, for example, provided interesting insights into the evolution and diversity 
of the SALMFamide family of neuropeptides (Elphick et al., 2013). 
 
2.1.4. A. rubens: a model system for neuropeptide research 
 
The importance of analysing and utilising genome/transcriptome data in the 
echinoderms has been highlighted by studies in the echinoid S. purpuratus, the 
holothurian A. japonicus and the asteroid P. miniata. However, the aim of this thesis 
is to utilise the common European starfish and asteroid Asterias rubens as a model 
system for neuropeptide research. A. rubens has a number of advantages over P. 
miniata as a model system for neuropeptide research. A. rubens has been utilised as a 
model system for over twenty-five years, with the SALMFamides S1 (GFNSALMF-
NH2) and S2 (SGPYSFNSGLTF-NH2) the first neuropeptides to be identified in an 
echinoderm species (Elphick et al., 1991a; Elphick et al., 1991b); the identification 
of S1 and S2 has subsequently allowed for the investigation of the physiological 
function of S1 and S2 in this species (Elphick et al., 1995; Melarange and Elphick, 
2003; Melarange et al., 1999). A. rubens is also a common and easily obtained 
species in the UK and throughout much of coastal Europe and deeper waters off the 
northern coast of North America, whilst P. miniata is found along the Pacific coast 
from Alaska to Mexico. 
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2.1.5. Aims and objectives 
 
The aim of this chapter is to sequence and assemble a neural transcriptome of the 
starfish A. rubens to provide an opportunity to: 
 
(1) Identify novel neuropeptide precursors and candidate receptors. 
(2) Investigate the evolutionary origins of neuropeptide signalling systems from the 
common ancestor of the Bilateria. 
(3) Provide an opportunity to investigate the physiological functions of 
neuropeptides in (a) a starfish species, (b) an echinoderm species and even in (c) an 
ambulacrarian and (d) a non-chordate species, in many cases, for the very first time.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! 60 
2.2. Methods 
 
2.2.1. Animal collection 
 
Specimens of A. rubens were collected at low tide from the Thanet coast (Kent, UK) 
and transported to Queen Mary University of London (QMUL). Specimens of A. 
rubens were then maintained in a seawater aquarium at approximately 11 °C and fed 
with the bivalve mollusc Mytilus edulis. 
 
2.2.2. RNA isolation 
 
Radial nerve cords approximating 30 mg of tissue were dissected from a single male 
adult specimen and used for total RNA isolation using the SV Total RNA Isolation 
Kit (Promega). Total RNA was then transported to the Barts and the London 
Genome Centre in preparation for Illumina Hi-Seq. 
 
2.2.3. Illumina Hi-Seq 
 
Library preparation was performed using the TruSeq RNA Sample Preparation Kit 
v.2 (Illumina) at the Barts and the London Genome Centre. Transcriptome 
sequencing was performed on an Illumina HiSeq platform at the National Institute 
for Medical Research, with cBot used to generate clusters. 
 
 
 
 
 
 
! 61 
2.2.4. Transcriptome assembly 
Raw sequence data was assembled using SOAPdenovo-Trans v.1.0 
(http://soap.genomics.org.cn/SOAPdenovo-Trans.html), a short-read assembly 
method developed by the Beijing Genomics Institute (Li et al., 2008a). Contigs were 
assembled from reads with an overlap greater than 31 bp, which were then mapped 
back to the raw reads. The 326,816 contigs generated (with 16,316 over 1000 bp) 
were then set up for BLAST analysis using SequenceServer software 
(http://www.sequenceserver.com/), which is freely available to academic users 
(Priyam et al., in prep). 
 
2.2.5. Bioinformatic identification of novel neuropeptide/peptide hormone 
precursors  
 
To search for transcripts encoding putative neuropeptide or peptide hormone 
precursor proteins in the starfish A. rubens, a number of approaches were used: 
 
(1) Sequences of neuropeptide or peptide hormone precursors identified in the sea 
urchin S. purpuratus (Burke et al., 2006; Elphick and Rowe, 2009; Elphick and 
Thorndyke, 2005; Jekely, 2013; Mirabeau and Joly, 2013; Rowe and Elphick, 2012), 
the sea cucumber A. japonicus (Rowe et al., 2014) and the starfish species Asterina 
pectinifera (Mita et al., 2009) were submitted individually as queries in tBLASTn 
searches of the contig database with the BLAST parameter expect (e)-value set to 
1000. Contigs identified as encoding putative precursors were analysed after 
translation of their full length DNA sequence into a protein sequence using the 
ExPASy Translate tool (http://web.expasy.org/translate/). Proteins were assessed as 
potential precursors of secreted bioactive peptides by investigating: (i) the presence 
of a putative N-terminal signal peptide sequence using the SignalP 3.0 online server 
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(Bendtsen et al., 2004), (ii) the presence of putative dibasic/monobasic cleavage sites 
flanking putative bioactive peptide(s), with reference to known consensus cleavage 
motifs (Liu et al., 2006; Seidah and Chretien, 1999; Veenstra, 2000) and (iii) the 
presence, in some cases, of C-terminal glycine (G) residues that are putative 
substrates for amidation. 
 
(2) A list of open reading frames (ORFs) generated from transcriptome assembly 
were analysed using a hidden Markov model (HMM), in which the scores used to 
rank precursor candidates are the expected density of cleavage inside a precursor 
(Mirabeau et al., 2007). The top 500 candidate sequences were then screened for the 
presence of an N-terminal signal peptide and short sequences flanked by dibasic 
cleavage sites and a C-terminal glycine (G) residue indicative of C-terminal 
amidation. 
 
(3) A list of ORFs generated from transcriptome assembly were also analysed using 
the novel neuropeptide prediction tool NPsearch 
(https://rubygems.org/gems/NpSearch). NPsearch utilises the common characteristics 
of neuropeptides including the presence of an N-terminal signal peptide and short 
sequences flanked by dibasic cleavage sites and a C-terminal glycine (G) residue 
indicative of C-terminal amidation. 
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2.2.6. Multiple sequence alignments  
 
Multiple sequence alignments of putative neuropeptides and/or selected regions of 
neuropeptide precursors were performed using ClustalX v.2.1 with a default colour 
scheme (Table 2) (Larkin et al., 2007). An asterisk denotes a single, fully conserved 
amino acid residue, a colon denotes strong conservation between groups of amino 
acid residues (≥ 0.5 Gonnet PAM 250 matrix) and a full stop denotes weak 
conservation between groups of amino acid residues (≤ 0.5 Gonnet PAM 250 matrix) 
(Gonnet et al., 1992). Multiple sequence alignments were performed using sequences 
from the starfish A. rubens and representative species from the vertebrates (e.g. 
Homo sapiens and Takifugu rubripes), the urochordates (e.g. C. intestinalis) the 
cephalochordates (e.g. B. floridae), the hemichordates (e.g. S. kowalevskii), 
echinoderms (e.g. S. purpuratus), the lophotrochozoans (e.g. Capitella telata, Lottia 
gigantea and Aplysia californica) and the ecdysozoans (e.g. D. melanogaster and 
Daphnia pulex) (Mirabeau and Joly, 2013). 
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Residue Colour Threshold/residue group 
A, I, L, M, F, W, V Blue (+60 % WLVIMAFCHP) 
R, K Red (+60 % KR) (+80 % KRQ) 
N Blue (+50 % N) (+ 85 % NY) 
C Green (+ 60 % WLVIMAFCHP) 
C Pink (100 % C) 
Q Green (+60 % KR) (+50 % QE) (+85 % QEKR) 
E Magenta (+60 % KR) (+50 % QE) (+85 % EQD) 
D Magenta (+60 % KR) (+85 % KRQ) (+50 % ED) 
G Orange (0 % G) 
H, Y Cyan (+60 % WLVIMAFCHP)  
(+85 % WYACPQ FHILMV) 
P Yellow (+0 % P) 
S, T Green (+60 % WLVIMAFCHP)  
(+50 % TS) (+85 % ST) 
 
Table 2. ClustalX v.2.1 default colour scheme. In ClustalX v.2.1 multiple sequence 
alignments, amino acid residues are assigned a colour if the residue meets a specified 
criteria for the residue type. These specified criteria are represented as (+X %, xy) 
where X is the minimum percentage for a specified residue type represented as x or 
y.  
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2.2.7. Bioinformatic identification of candidate neuropeptide/peptide hormone 
receptors 
 
To search for transcripts encoding candidate neuropeptide or peptide hormone 
receptors in the starfish A. rubens, sequences of neuropeptide or peptide hormone 
receptors identified in the sea urchin S. purpuratus (Burke et al., 2006; Jekely, 2013; 
Mirabeau and Joly, 2013) (or other representative bilaterian species if a receptor is 
absent in S. purpuratus) (Jekely, 2013; Mirabeau and Joly, 2013) were submitted 
individually as queries in tBLASTn searches of the contig database with the BLAST 
parameter e-value set to 1000. Contigs identified as encoding putative precursors 
were analysed after translation of their full length DNA sequence into protein 
sequence using the ExPASy Translate tool (http://web.expasy.org/translate/). The 
protein sequences were then analysed for the presence of seven transmembrane 
domains using GPCRHMM (http://gpcrhmm.sbc.su.se). Subsequently, the protein 
sequences were submitted individually in tBLASTn searches of The National Centre 
for Biotechnology Information (NCBI) databases 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to determine sequence similarity to known 
neuropeptide or peptide hormone receptors.  
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2.2.8. Neighbour joining (NJ) trees  
 
Multiple sequence alignments of candidate A. rubens neuropeptide receptors with 
other bilaterian neuropeptide receptors were performed using ClustalW2 (Larkin et 
al., 2007). Neighbour joining (NJ) trees were constructed using MEGA v.6.06 
(http://www.megasoftware.net) using bootstrapping (with 1000 bootstrap 
replications), a Poisson substitution model and uniform rates. Representative H. 
sapiens secretin-type neuropeptide receptors were used as an outgroup for rhodopsin 
β/γ-type NJ trees, whilst representative H. sapiens rhodopsin β-type neuropeptide 
receptors were used as an outgroup for secretin-type NJ trees (Mirabeau and Joly, 
2013). NJ trees were annotated using the program FigTree v.1.4.2 
(http://tree.bio.ed.ac.uk/software/figtree/).  
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2.3. Results and Discussion 
 
The generation and analysis of a neural transcriptome of the starfish A. rubens has 
led to the identification of thirty-five novel neuropeptide precursors and a number of 
candidate receptors (Fig. A1-3). These neuropeptide precursors are reported in four 
groups – precursors of neuropeptides that have previously been biochemically 
identified (see chapter 2.3.1), precursors of neuropeptides that belong to bilaterian 
neuropeptide families (see chapter 2.3.2.), precursors of neuropeptides and peptide 
hormones that comprise multiple cysteine (C) residues (see chapter 2.3.3.) and 
precursors of putative neuropeptides that do not share sequence similarity with any 
known bilaterian neuropeptide and peptide hormone families (see chapter 2.3.4.). 
These neuropeptide precursors, and potential candidate receptors, are discussed one-
by-one (or in groups). 
 
2.3.1. Precursors of neuropeptides that have been identified previously in A. 
rubens – the SALMFamides S1 and S2 
 
The SALMFamides S1 (GFNSALMF-NH2) and S2 (SGPYSFNSGLTF-NH2) were 
the first neuropeptides to be identified in the echinoderms and were isolated from the 
starfish species A. rubens and A. forbesi (Elphick et al., 1991a; Elphick et al., 
1991b). However, until now, the neuropeptide precursor(s) from which S1 and S2 
are derived from in A. rubens were unknown. 
The A. rubens L-type SALMFamide precursor is a 210-residue precursor 
protein comprising a predicted 23-residue N-terminal signal peptide and seven 
putative L-type SALMFamide-type peptides with the motif S/TxLxF/Y-NH2 (where 
x is variable) bounded by dibasic cleavage sites (KR/RR) (Fig. 2.1A; Fig. S1). These 
include single copies of the L-type peptide sequences PAGASAFHSALSYG 
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(residues 67-80), AYHSALPFG (residues 94-102), AYHTGLPFG (residues 111-
119), GFNSALMFG (or S1) (residues 136-144), LHSALPFG (residues 147-154), 
GYHSALPFG (residues 157-165) and GYHSGLPFG (residues 181-189) 
respectively. The presence of C-terminal glycine (G) residues on each of these 
peptide sequences is indicative of post-translational modifications giving rise to C-
terminal amide groups on the mature peptides (e.g. PAGASAFHSALSY-NH2).  
The A. rubens F-type SALMFamide precursor is a 234-residue precursor 
protein comprising a predicted 24-residue N-terminal signal peptide, seven putative 
F-type SALMFamide-type peptides with the motif F/YxF/Y-NH2 (where x is 
variable) and one putative L-type SALMFamide-type peptide (or S2) bounded by 
dibasic cleavage sites (KR/RR) (Fig. 2.1B; Fig. S2). These include single copies of 
the F-type peptide sequences QQSDREREVEAAQTQFYPYG (residues 64-83), 
TDPRKASGGFTFG (residues 86-98), NIFGSYDFG (residues 161-169), 
AYGNNFSFG (residues 172-180), GMGVSSFSFG (residues 183-192), 
AFGDFSFG (residues 209-216), NNGLSSFTFG (residues 219-228) and one copy of 
the L-type peptide sequence SGPYSFNSGLTFG (or S2) (residues 141-153) 
respectively. The presence of C-terminal glycine (G) residues on each of these 
peptide sequences is indicative of post-translational modifications giving rise to C-
terminal amide groups on the mature peptides (e.g. TDPRKASGGFTF-NH2). It 
should also be noted that the presence of an N-terminal glutamine (Q) residue on the 
F-type polypeptide sequence QQSDREREVEAAQTQFYPY-NH2 may be indicative 
of a post-translational modification, giving rise to an N-terminal pyro-glutaminyl 
(pQ) residue (pQQSDREREVEAAQTQFYPY-NH2).  
The discovery of the A. rubens L-type and F-type SALMFamide precursors 
has revealed that both S1 (GFNSALMF-NH2) and S2 (SGPYSFNSGLTF-NH2) are 
derived from different precursor proteins and provides further evidence that putative 
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L-type and F-type SALMFamide neuropeptides can also be derived from the same 
precursor protein (Elphick et al., 2013). In this regard, both SALMFamide precursors 
in A. rubens are similar to the orthologous SALMFamide precursors that have 
recently identified in the genome of the starfish species P. miniata (Elphick et al., 
2013).  
 
(A) L-type SALMFamide precursor 
 
MKGQHLLAVAVVVVAGSFGIIEAYSPFGGYNRAPFDNVWVRADSMARGGSTGEDEAN
EQRMTGAKRPAGASAFHSALSYGKRGDDDSAEVERRAYHSALPFGKRTPIEKRAYHT
GLPFGKRDDEAAEQDAMMERRGFNSALMFGKRLHSALPFGKRGYHSALPFGKRLDTT
DEGDIIERRGYHSGLPFGKRATDDEAVNDILDQLRSEEN 
 
 
(B) F-type SALMFamide precursor 
 
MMVRFVALLGAVSLLVCQSAGLDAADVEEQDEFNKPYAPDSSYADLNALLGNNVPSL
HSASKRQQSDREREVEAAQTQFYPYGRRTDPRKASGGFTFGKRGQYFIPIPYEKREM
DEVNPYSVAKRDDELTGLEEYQASKRSGPYSFNSGLTFGKREPEKRNIFGSYDFGKR
AYGNNFSFGKRGMGVSSFSFGKRSGLEGEQMMPEDKRAFGDFSFGKRNNGLSSFTFG
KREGER 
 
Fig. 2.1. A. rubens SALMFamide precursors. (A) L-type SALMFamide precursor. 
(B) F-type SALMFamide precursor. N-terminal signal peptides are represented in 
blue, putative SALMFamide neuropeptides are represented in red, C-terminal 
glycine (G) residues are represented in orange and dibasic cleavage sites are 
represented in green.  
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SALMFamide precursors have also been identified in other echinoderm 
classes (Fig. 2.2). The sea urchin S. purpuratus (Class: Echinoidea) has two 
precursors – an L-type SALMFamide precursor containing two putative L-type 
SALMFamides and an F-type SALMFamide precursor containing seven putative F-
type SALMFamides (Elphick and Thorndyke, 2005; Rowe and Elphick, 2010). 
Similarly, the sea cucumber A. japonicus (Class: Holothuroidea) has two precursors 
– an L-type SALMFamide precursor containing three putative L-type SALMFamides 
and an F-type SALMFamide precursor containing five putative F-type 
SALMFamides and three putative L-type SALMFamides (Elphick et al., 2013).  
However, until recently, it was not known whether the occurrence of an L-
type and largely F-type SALMFamide precursor was an ancestral feature of the 
SALMFamide neuropeptide family. The generation and analysis of transcriptome 
data from the brittle star Ophionotus victoriae (Class: Ophiuroidea) and the feather 
star Antedon mediterranea (Class: Crinoidea) has shed light on this issue (Fig. 2.2) 
(Elphick et al., 2015). Similarly to the echinoids, holothurians and asteroids, the 
ophiuroid O. victoriae has two SALMFamide precursors – an L-type SALMFamide 
precursor containing two putative L-type SALMFamides and a putative F-type 
SALMFamide and an F-type SALMFamide precursor containing eleven putative F-
type SALMFamides and a putative L-type SALMFamide. However, interestingly, in 
the crinoid A. mediterranea, only one SALMFamide precursor has been identified 
containing six putative L-type SALMFamides and six putative F-type 
SALMFamides. It has therefore been proposed that there was a single SALMFamide 
gene encoding both L-type and F-type SALMFamides before a duplication in a 
common ancestor of the echinozoans and asterozoans giving rise to an L-type 
SALMFamide precursor and an F-type SALMFamide precursor respectively 
(Elphick et al., 2015). 
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Fig. 2.2. The SALMFamide neuropeptide family. A phylogenetic schematic of the 
SALMFamide precursors across the echinoderms is shown. In an ancestral 
SALMFamide-type precursor in crinoids, the majority of the putative peptides have 
an FxLamide or an LxLamide-type motif and there is only one L-type SALMFamide 
and one F-type SALMFamide. However, as a consequence of specialisation 
following a predicted duplication of the ancestral-type precursor in the common 
ancestor of the echinozoans and asterozoans, two types of SALMFamide precursor 
have evolved – one that is predominantly comprised of L-type SALMFamides and 
another that is exclusively or predominantly comprised of F-type SALMFamides. 
Signal peptides are represented in blue. L-type SALMFamides with a C-terminal 
LxFamide motif or with an L-type-like motif (e.g. IxFamide) are represented in red. 
F-type SALMFamides with an FxFamide motif or with an F-type-like motif (e.g. 
YxFamide) are represented in yellow. SALMFamides with an FxLamide-type motif 
are represented in orange and SALMFamides with an LxLamide motif are 
represented in dark red. Peptides that do not conform to any of the four color-coded 
categories are represented in white. Dibasic or monobasic cleavage sites are 
represented in green. An asterisk denotes the position of S1 in the L-type precursor, 
whilst a double asterisk denotes the position of S2 in the F-type precursor in the 
starfish A. rubens. A.jap = Apostichopus japonicus; A.med = Antedon mediterranea; 
A.rub = Asterias rubens; O.vic = Ophionotus victoriae; S.pur = Strongylocentrotus 
purpuratus. Figure adapted from Elphick et al., 2015. 
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The physiological roles of the SALMFamide neuropeptides S1 and S2 in the 
starfish A. rubens have been previously investigated and have revealed a function in 
muscle relaxation both in vitro and in vivo (Elphick and Melarange, 2001; Elphick et 
al., 1995; Melarange and Elphick, 2003; Melarange and Elphick, 2003; Melarange et 
al., 1999). In this regard, S1 and S2 cause dose-dependent relaxation of cardiac 
stomach preparations in vitro (Melarange et al., 1999) whilst injection of S1 or S2 
triggers cardiac stomach eversion in vivo (Elphick et al., 1995; Melarange et al., 
1999).  
Interestingly, S2 is approximately ten times more potent than S1 in cardiac 
stomach relaxation in vitro (Elphick and Melarange, 2001; Melarange and Elphick, 
2003; Melarange and Elphick, 2003) whilst S2 is also more potent in inducing 
relaxation of tube feet and apical muscle preparations in vitro (Melarange and 
Elphick, 2003). It has been shown that the C-terminal regions of S1 and S2 are key to 
the differing potencies of both peptides (Otara et al., 2014). However, the discovery 
of the L-type and F-type SALMFamide precursors and fifteen putative 
SALMFamides has provided added complexity to previous functional studies. For 
example, it has recently been shown that the L-type SALMFamides AYHSALPF-
NH2 and GYHSGLPF-NH2 bind copper (Cu2+) and nickel (Ni2+) and generate metal-
linked dimers to form ternary complexes with LHSALPF-NH2 (Jones et al., 2016). It 
has therefore been suggested that the formation of these ternary complexes may 
protect the SALMFamides from degradation from aminopeptidases during the 
process of extra-oral feeding in starfish (Jones et al., 2016). Thus, the discovery of a 
total of fifteen putative SALMFamides has provided new opportunities to investigate 
SALMFamide function and could provide a good model system for experimental 
analysis of the physiological significance of neuropeptide “cocktails” derived from 
the same precursor protein (Elphick et al., 2013). 
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To date, the relationship of echinoderm SALMFamide neuropeptides with 
neuropeptides that have been identified in other phyla remains unknown. Insights 
into orthologous neuropeptides in other phyla could be obtained through 
characterisation of the receptor(s) that mediate the effects of the SALMFamides.  
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2.3.2. Precursors of neuropeptides that belong to bilaterian neuropeptide 
families 
 
Neuropeptide and peptide hormone precursors that have previously been identified as 
being of an ancestral bilaterian origin have been identified in the neural 
transcriptome of the starfish A. rubens (Table 3). In some cases, these novel 
neuropeptide and peptide hormone precursors have been identified in an echinoderm, 
an ambulacrarian and a non-chordate species for the very first time and will be 
discussed on a one-by-one basis (or in groups). 
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A. rubens 
precursor 
Precursor family Key peptide/precursor characteristics 
Asterotocin VP/OT-type Peptide: Single peptide with conserved C residues (positions 1/6); C-terminal amidation 
Precursor: C-terminal neurophysin domain 
NGFFYamide NG peptide Peptides: Multiple peptides with NG motif; C-terminal amidation 
Precursor: C-terminal neurophysin domain 
ArGnRHP1-2 GnRH/AKH-type Single peptide with N-terminal pQ residue; C-terminal amidated P motif 
 
ArTRHLP TRH-like Multiple peptides with an N-terminal pQxP motif (x aromatic residue); C-terminal amidation 
ArTKLP TK-like Single/multiple peptide(s) with amidated C-terminal pentapeptide motifs FxGLM-NH2 (vertebrates) or FxGxR-NH2 (invertebrates) 
ArCCKLP CCK/SK-like Single/multiple peptide(s) with amidated C-terminal octapeptide motif DYMGWMDF-NH2 (CCK) or heptapeptide motif 
DYGHMRF-NH2 (SK) 
ArOXLP1-2 OX/AT-like Single peptide located after signal peptide with conserved C residues; C-terminal amidation 
ArLQLP LQ-like Peptide: Single peptide with amidated C-terminal RF-NH2 (lophotrochozoans) or RY-NH2 motif (ecdysozoans) 
Precursor: C-terminal domain with two C residues separated by a 10-residue sequence 
ArKPLP KP-like Single/multiple peptide(s) with amidated C-terminal LxF-NH2 motif 
ArSMSLP SMS/AST-C-like Single peptide with two conserved C residues located at N-terminus of precursor 
ArMCHLP MCH-like Single peptide with two conserved C residues located at N-terminus of precursor 
ArCTLPP CT/DH31-like Single peptide with two conserved C residues; C-terminal amidated P motif 
ArCRHLP CRH/DH44/ELH-like Single/multiple peptide(s) with C-terminal amidated I/L motif 
ArPDFLP PDF-like Single/multiple peptide(s) with C-terminal amidated V/A motif 
ArPPLNP1 PP/orcokinin-like Multiple peptides with SGFx motif (x hydrophobic residue)  
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Table 3. Summary of key peptide/precursor characteristics of bilaterian 
neuropeptide precursor families. CCK/SK, cholecystokinin/sulphakinin; 
CRH/DH44/ELH, corticotropin-releasing hormone/diuretic hormone-44/ egg-laying 
hormone; CT/DH31, calcitonin/diuretic hormone-31; GnRH/AKH, gonadotropin-
releasing hormone/adipokinetic hormone; KP, kisspeptin; LQ, luqin; MCH, melanin-
concentrating hormone; OX/AT, orexin/allatotropin; PDF, pigment-dispersing factor; 
PP, pedal peptide; SMS/AST-C, somatostatin/allatostatin-C; TK, tachykinin; TRH, 
thyrotropin-releasing hormone; VP/OT, vasopressin/oxytocin. Note that the table is 
not exhaustive and additional similarities and differences between 
neuropeptides/precursors are expanded on in the respective sub-headings. 
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2.3.2.1. VP/OT-type precursor (“asterotocin” precursor) 
 
The A. rubens VP/OT-type precursor (“asterotocin” precursor) is a 147-residue 
precursor protein comprising a predicted 23-residue N-terminal signal peptide, one 
copy of the putative neuropeptide CLVQDCPEGG (“asterotocin”) (residues 24-33) 
bounded by a dibasic cleavage site (KR) and a neurophysin domain (residues 44-
121) containing a characteristic fourteen conserved cysteine (C) residues (Fig. 2.3; 
Fig. S3). The presence of a C-terminal glycine (G) residue is indicative of a post-
translational modification, giving rise to a C-terminal amide group on the mature 
peptide (CLVQDCPEG-NH2). It is noteworthy that asterotocin contains two cysteine 
(C) residues (residues 24 and 29), which are likely to form a disulphide bridge in 
accordance with VP/OT-type peptides in other phyla (de Bree and Burbach, 1998; 
Light and Du Vigneaud, 1958). Importantly, a candidate VP/OT-type receptor has 
also been identified in A. rubens (Fig. 3.4; Fig. A5L; Fig. S4). A detailed 
characterisation and discussion of the VP/OT-type neuropeptide signalling system is 
presented in chapter 3. 
 
Vasopressin/oxytocin (VP/OT)-type precursor (“asterotocin” precursor) 
 
MGMKSMVALWTGVLVALWVQSQACLVQDCPEGGKRSSYNTIRQCLSCGPGGLGQCVG
SAICCGNTFGCFLGTKETFVCREESQLSTPCEVVGETCESITDGKCVSNGFCCNERS
CSLDVACRETDTEQRDLKNRLKERLLDALLRQP 
 
Fig. 2.3. A. rubens asterotocin precursor. An N-terminal signal peptide is 
represented in blue, the putative asterotocin neuropeptide (with cysteine (C) residues 
underlined) is represented red, a C-terminal glycine (G) residue is represented in 
orange and a dibasic cleavage site is represented in green. A neurophysin domain 
characteristic of VP/OT-type peptide precursors is represented purple, with a 
characteristic fourteen cysteine (C) residues underlined. 
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2.3.2.2. NGFFYamide precursor 
 
The A. rubens NGFFYamide precursor is a 240-residue precursor protein comprising 
a predicted 23-residue N-terminal signal peptide, two copies of the putative 
neuropeptide NGFFYG (“NGFFYamide”) (residues 124-130 and 132-137 
respectively) bounded by dibasic cleavage sites (KR) and a neurophysin domain 
(residues 153-232) containing a characteristic fourteen cysteine (C) residues (Fig. 
2.4; Fig. S5). The presence of C-terminal glycine (G) residues on each of these 
sequences is indicative of post-translational modifications giving rise to a C-terminal 
amide group on the mature peptide (NGFFY-NH2). Importantly, a candidate NG 
peptide receptor has also been identified in A. rubens (Fig. 5.6C; Fig. A5F; Fig. S6). 
A detailed characterisation and discussion of the NG peptide signalling system is 
presented in chapter 4. 
 
 
NGFFYamide precursor 
 
MTMGSRSLLVTIVITVVIPSIWAGAIAGAQTQKIRRESRESGKYWPNSVGISDQQLR
QLLAHSLADSYSTSGASHIRGGDGDAGYIYDSRDQVDDTGTNEEEGERVIGSEVTSR
DSNPGTSKRNGFFYGKRNGFFYGKRSASTPGNANEVTQCIPCGPQNNGQCVMFGTCC
SYELGGCFFLTEEALPCVTSKSSSLCELSGLPCGDEGYGRCVADSVCCLPQEGSCHI
NAECGGKMTFQ 
 
Fig. 2.4. A. rubens NGFFYamide precursor. An N-terminal signal peptide is 
represented in blue, putative NGFFYamide neuropeptides are represented in red, C-
terminal glycine (G) residues are represented in orange and dibasic cleavage sites are 
represented in green. A neurophysin domain characteristic of NG peptide precursors 
is represented in purple, with a characteristic fourteen cysteine (C) residues 
underlined. 
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2.3.2.3. GnRH-type precursor 1 (ArGnRHP1) 
 
The A. rubens gonadotropin-releasing hormone (GnRH)-type precursor 1 
(ArGnRHP1) is a 121-residue precursor protein comprising a predicted 27-residue 
N-terminal signal peptide followed by a putative GnRH-type neuropeptide with the 
predicted peptide sequence QIHYKNPGWGPG (residues 28-40) termed ArGnRH 
followed by a dibasic cleavage site (KR) (Fig. 2.5A; Fig. S7). The presence of an N-
terminal glutamine (Q) residue and a C-terminal glycine (G) residue are indicative of 
post-translational modifications giving rise to an N-terminal pyro-glutaminyl (pQ) 
residue and a C-terminal amide group on the mature peptide (pQIHYKNPGWGP-
NH2); this would be consistent with the occurrence of these post-translational 
modifications in GnRH-type peptides that have been identified in other species 
(Roch et al., 2011). 
GnRH-type peptides are a family of neuropeptides with a widespread 
phylogenetic distribution indicative of an ancestral bilaterian origin (Jekely, 2013; 
Mirabeau and Joly, 2013). GnRH was first discovered in mammals as a reproductive 
regulator through its stimulatory effect on the release of the gonadotropins 
luteinising hormone (LH) and follicle-stimulating hormone (FSH) from the anterior 
pituitary gland (Kah et al., 2007). GnRH-type peptides have subsequently been 
identified in other vertebrates (Guilgur et al., 2006; Kavanaugh et al., 2008; Kim et 
al., 2011; Morgan and Millar, 2004), deuterostomian invertebrates including 
urochordates (Gorbman and Sower, 2003; Tsai, 2006), the cephalochordate B. 
floridae (Roch et al., 2014), the hemichordate S. kowalevskii (Mirabeau and Joly, 
2013) and the echinoderm S. purpuratus (Rowe and Elphick, 2012). GnRH-type 
peptides have also been identified in the lophotrochozoans including a number of 
molluscs (Di Cristo et al., 2009; Iwakoshi et al., 2002; Tsai and Zhang, 2008; Zhang 
et al., 2000a) and annelids (Roch et al., 2011; Tsai and Zhang, 2008; Veenstra, 
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2011).  
GnRH-type peptides have been found to be orthologous to adipokinetic 
hormone (AKH) and corazonin-type peptides identified in the ecdysozoans including 
a number of arthropods and nematodes (Lindemans et al., 2009; Lindemans et al., 
2011). AKH was first discovered on account of its synthesis in the corpora cardiaca, 
which is considered the functional equivalent of the pituitary gland in vertebrates 
(O'Shea and Rayne, 1992). AKH has been shown to be involved in mobilising 
energy from the fat body during flight and locomotion in insects (Gade, 2004). More 
recently, however, AKH-type peptides have also been shown to have a central role in 
regulating fertility in the nematode C. elegans, which is indicative of GnRH/AKH-
type peptides having an evolutionarily ancient role in regulating reproductive 
processes (Lindemans et al., 2009). However, whilst insect AKH has not yet been 
implicated with a role in reproductive functions, AKH-like expression has been 
detected in reproductive organs in various insect species including the female 
mosquito Anopheles gambiae (Kaufmann and Brown, 2006) and the fall armyworm 
Spodoptera frugiperda (Abdel-Latief and Hoffmann, 2007).  
It is important to consider ArGnRHP1 in relation to GnRH-type 
precursors/peptides identified in other phyla (Fig. 2.5B). The presence of a single 
GnRH-type peptide located directly after the N-terminal signal peptide in 
ArGnRHP1 is a conserved feature of all GnRH-type precursors. Moreover, the 
presence of an N-terminal pyro-glutaminyl (pQ) residue and C-terminal amide group 
in the peptide is also a feature of all known GnRH-type peptides. However, there are 
a few exceptions, including AKH-type peptides in C. elegans (Lindemans et al., 
2009) and insects (e.g. S. frugiperda) (Abdel-Latief and Hoffmann, 2007), which 
does contain a C-terminal amide group (Lindemans et al., 2011).  
It is also important to consider ArGnRHP1 in relation to GnRH-type 
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precursors/peptides identified in other echinoderm species (Fig. 2.5B). ArGnRHP is 
only the second member of the GnRH-type neuropeptide family to be identified in an 
echinoderm after the identification of Spnp2 (SpGnRHP) in the sea urchin S. 
purpuratus (Roch et al., 2011; Rowe and Elphick, 2012). To date, a GnRH-type 
precursor has not been identified in a transcriptome dataset from the sea cucumber A. 
japonicus (Rowe et al., 2014). Interestingly, whilst GnRH-type peptides derived 
from ArGnRHP1 and SpGnRHP (pQVHHRFSGWRPG-NH2) have all the 
characteristics of GnRH-type peptides identified in other phyla, SpGnRH also has an 
F (S/T) signature characteristic of protostomian GnRH-type peptides as opposed to 
chordate GnRH-type peptides (Lindemans et al., 2011).  
To date, the physiological function of GnRH-type peptides in the 
echinoderms is currently unknown. To this extent, investigation would be facilitated 
by the identification of receptors that mediate the effects of GnRH-type peptides. In 
this regard, candidate GnRH-type receptors have been identified in the sea urchin S. 
purpuratus (Burke et al., 2006). Importantly, however, two candidate GnRH-type 
receptors have also been identified in the starfish A. rubens and may facilitate 
investigation into the physiological functions of GnRH-type peptides in an 
echinoderm species (Fig. A5B-C; Fig. S9-10). 
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(A) Gonadotropin-releasing hormone (GnRH)-type precursor 1 (ArGnRHP1) 
 
MADMRMLTLTSVLVSLLFMAEIQRCQGQIHYKNPGWGPGGKRSSHMTGSNVLRKRHW
RVESDQMGTDSMQKERNLIMLQEIAKSLAKQLVVPTSEDDTVLDQLTVDQWRQEADE
INDNGWN 
 
(B) GnRH-type neuropeptide multiple sequence alignments 
                               * 
A.rub -----QI-HYKNP---GWGPGG    22
S.pur -----QV-HHRFS---GWRPGG    22
S.kow ----QAQPHFSLKDRYRWKPG-    22
B.flo QILCARAFTYTH----TW--G-    22
H.sap1 -----Q--HWSY----GLRPGG    22
H.sap2 -----Q--HWSH----GWFPGG    22
C.tel -----QAYHFSH----GWFPG-    22
A.cal -----QNYHFSN----GWYAG-    22
D.mel_CORZ -----QTFQYSR----GWTNG-    22
D.mel_AKH ----QCQLTFSP----DW--G-    22
 
 
Fig. 2.5. A. rubens GnRH-type precursor 1 (ArGnRHP1). (A) Sequence of 
ArGnRHP1. An N-terminal signal peptide is represented in blue, a putative GnRH-
type neuropeptide is represented in red, a C-terminal glycine (G) residue is 
represented in orange and a dibasic cleavage site is represented in green. (B) 
ClustalX v.2.1 multiple sequence alignment of putative GnRH-type neuropeptides 
derived from precursors of representative species across the Bilateria. A.cal, Aplysia 
californica GnRH-type precursor [GI: 325296898]; A.rub, Asterias rubens GnRH-
type precursor; B.flo, Branchiostoma floridae GnRH-type precursor [GI: 
568818760]; C.tel, Capitella teleta GnRH-type precursor [GI: 161294493]; 
D.mel_AKH, Drosophila melanogaster adipokinetic hormone (AKH) precursor [GI: 
281365621]; D.mel_CORZ, Drosophila melanogaster corazonin (CORZ) precursor 
[GI: 386765761]; H.sap1, Homo sapiens GnRH1 [GI: 133908609]; H.sap2, Homo 
sapiens GnRH2  [GI: 109731929]; S.kow, Saccoglossus kowalevskii GnRH-type 
precursor [GI: 585702722]; S.pur, Strongylocentrotus purpuratus GnRH-type 
precursor [GI: 390361802]. 
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2.3.2.4. GnRH-type precursor 2 (ArGnRHP2) 
 
The A. rubens gonadotropin-releasing hormone (GnRH)-type precursor 2 
(ArGnRHP2) is a 99-residue precursor protein comprising a predicted 23-residue N-
terminal signal peptide and a putative GnRH-type peptide sequence 
(HNTFTMGGQNRWKAGG) termed ArGnRH2 followed by a dibasic cleavage site 
(KR) (Fig. 2.6A; Fig. S8). The presence of a C-terminal glycine (G) residue is 
indicative of a post-translational modification giving rise to a C-terminal amide 
group on the mature peptide (HNTFTMGGQNRWKAG-NH2). However, the 
absence of an N-terminal pyroglutamate (pQ) residue is not consistent with GnRH-
type peptides that have been identified in other species (Roch et al., 2011). 
ArGnRHP2 was identified through sequence similarity with Spnp12 in the 
sea urchin S. purpuratus (Rowe and Elphick, 2012). However, upon the discovery of 
ArGnRH2 and alignments with ArGnRHP and Spnp2 (SpGnRHP), it is likely that 
Spnp12 is a GnRH-type neuropeptide precursor comprising a putative GnRH-type 
neuropeptide (HNTFSFKGRSRYFP-NH2) (Fig. 2.6B). ArGnRHP2 and Spnp12 
(SpGnRHP2) share superficial sequence similarity with GnRH-type peptides in the 
putative neuropeptide region comprising an F (S/T) signature characteristic of 
protostomian GnRH-type peptides as opposed to chordate GnRH-type peptides 
(Lindemans et al., 2011). Significantly, both ArGnRHP2 and Spnp12 (SpGnRHP2) 
have a highly conserved C-terminal domain, providing further evidence that the 
precursors are orthologous and belong to a family of GnRH-type neuropeptide 
precursors (Fig. 2.6B). The presence of two GnRH-type neuropeptides in both the 
starfish A. rubens and the sea urchin S. purpuratus add further complexity to the 
evolutionary origins of a neuropeptide signalling system that comprises GnRH-type, 
AKH-type and corazonin-type peptides. Accordingly, the gene duplications that gave 
rise to this diverse family of neuropeptides remains unclear (Roch et al., 2014). 
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As described previously, the physiological function of GnRH-type peptides in 
the echinoderms is currently unknown. However, the discovery of two GnRH-type 
peptides and two candidate GnRH-type receptors in the starfish A. rubens may 
facilitate investigation into the physiological functions of GnRH-type peptides in an 
echinoderm species (Fig. A5B-C; Fig. S9-10). 
 
(A) Gonadotropin-releasing hormone (GnRH)-type precursor 2 (ArGnRHP2) 
 
MGSYSVTATIYLALVLGSLVCSAHNTFTMGGQNRWKAGGKRSAPAGRPQQTFLDPSS
FSEDQQGETTITLREMLVDMRDYCSFLLKLLDNVRLPQTERK 
 
(B) GnRH-type neuropeptide/precursor multiple sequence alignment 
(i) 
             :  .   *   : .* 
A.rub_GnRH QIHYKNPG---WGPGG    13
S.pur_GnRH QVHHRFSG---WRPGG    13
A.rub_GnRH2 HNTFTMGGQNRWKAGG    16
S.pur_GnRH2 HNTFSFKGRSRYFPG-    15 
(ii) 
 
             :* :: :      *:         *: :     :            
A.rub_GnRH MLQEIAKSLAKQ-LVVPTSEDDTVLDQLT--VDQWRQEN-------
S.pur_GnRH ILGDLRRAANRMRLLQLFNLSKTRLNDLNDATSNEPVYGDYLGTGL
A.rub_GnRH2 MLVDM-RDYCSF-LLK-------LLDNVR--LPQ------------
S.pur_GnRH2 MLTEL-RGYCDF-LLK-------LLDGVRPDLPQQRK---------  
Fig. 2.6. A. rubens GnRH-type precursor 2 (ArGnRHP2). (A) Sequence of 
ArGnRHP2. An N-terminal signal peptide is represented in blue, a putative GnRH-
type neuropeptide is represented in red, a C-terminal glycine (G) residue is 
represented in orange and a dibasic cleavage site is represented in green. (B) 
ClustalX v.2.1 multiple sequence alignment of (i) putative GnRH-type neuropeptides 
and (ii) a C-terminal domain of GnRH-type precursors in the starfish A. rubens and 
the sea urchin S. purpuratus. A.rub_GnRH, Asterias rubens GnRH-type precursor; 
A.rub_GnRH2, Asterias rubens GnRH-type precursor 2; S.pur_GnRH, 
Strongylocentrotus purpuratus GnRH-type precursor [GI: 390361802]; 
S.pur_GnRH2, Strongylocentrotus purpuratus GnRH-type precursor 2 [GI: 
109403263]. 
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2.3.2.5. TRH-like precursor (ArTRHLP) 
 
The A. rubens thyrotropin-releasing hormone (TRH)-like precursor (ArTRHLP) is a 
240-residue precursor protein comprising a predicted 23-residue N-terminal signal 
peptide and thirteen putative TRH-type peptides bounded by dibasic cleavage sites 
(KR/RR) (Fig. 2.7A; Fig. S11). These include a single copy of the polypeptide 
sequence QYPGGAPIGLDG (residues 58-69) and twelve copies of the polypeptide 
sequence QWYTG. The presence of an N-terminal glutamine (Q) residue and a C-
terminal glycine (G) residue on these polypeptide sequences are indicative of post-
translational modifications giving rise to a N-terminal pyro-glutaminyl (pQ) residue 
and a C-terminal amide group on the mature peptides (e.g. pQWYT-NH2) based on 
the structure of TRH in mammals (pQHP-NH2). Moreover, the occurrence of 
multiple copies of this peptide is consistent with the organisation of TRH-like 
precursors in vertebrates (Richter et al., 1984; Lechan et al., 1986). 
TRH-type peptides are a family of neuropeptides with a widespread 
phylogenetic distribution indicative of an ancestral bilaterian origin (Jekely, 2013; 
Mirabeau and Joly, 2013). TRH is a hypothalamic peptide that stimulates the release 
of thyroid stimulating hormone (TSH) and prolactin from the anterior pituitary gland 
in vertebrates. In mammals, TRH stimulates release of TSH from the pituitary gland 
triggering release of thyroid hormones (T3 and T4) that stimulate metabolism in cells 
throughout the body and promote growth and development (Lovejoy, 2005). 
Moreover, TRH also acts as a neurotransmitter or neuromodulator in many other 
regions of the brain (Breese et al., 1981; Shibusawa et al., 2008). In amphibians and 
fish, however, TRH stimulates the release of pituitary growth hormone and prolactin 
but has little or no effect on the secretion of TSH (Galas et al., 2009). Thus, the role 
of TRH as a regulator of TSH release in mammals does not apply to all vertebrate 
species. TRH-type peptides have also been identified in a number of deuterostomian 
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invertebrates including the cephalochordate B. floridae (Jekely, 2013) and the 
echinoderm species S. purpuratus (Rowe and Elphick, 2012) and A. japonicus (Rowe 
et al., 2014). To date, TRH-like peptides have not been identified in the protostomes. 
However, orthologues of vertebrate TRH receptors have been identified in the 
ecdysozoans and lophotrochozoans (Jekely, 2013; Mirabeau and Joly, 2013). Thus, 
the evolutionary origin of the TRH-like neuropeptide signalling system can be traced 
back to the common ancestor of the bilaterians. 
It is important to consider ArTRHLP in relation to TRH-like 
precursors/peptides identified in other phyla (Fig. 2.7B). The discovery of ArTRH 
suggests that the presence of an N-terminal pyro-glutaminyl (pQ) residue and C-
terminal amide group is likely to be an ancestral feature of deuterostomian TRH-type 
peptides. However, it is unclear whether TRH-type peptides would have been 
tetrapeptides; TRH-type peptides in the vertebrates (pQHP-NH2) and the 
cephalochordate B. floridae (pQSP-NH2) are tripeptides (Jekely, 2013). Further 
insights will be provided if TRH-type peptides are identified in the hemichordates 
(e.g. S. kowalevskii), the sister phylum to the echinoderms (Rowe et al., 2014).  
It is also important to consider ArTRHLP in relation to TRH-like 
precursors/peptides identified in other echinoderm species (Fig. 2.7B). ArTRHLP is 
the third member of the TRH-like neuropeptide family to be identified in an 
echinoderm after the identification of Spnp3 (SpTRHLP) in the sea urchin S. 
purpuratus (Rowe and Elphick, 2012) and Ajnp3 (AjTRHLP) in the sea cucumber A. 
japonicus (Rowe et al., 2014). Interestingly, the most abundant putative TRH-type 
peptide derived from SpTRHLP (pQYPG-NH2) conforms to the pQxP motif 
characteristic of the human TRH peptide (pQHP-NH2). However, the most abundant 
putative TRH-type peptides derived from both ArTRHLP (pQWYT-NH2) and 
AjTRHLP (pQYFA-NH2) do not share the pQxP motif found in vertebrate TRH. 
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However, these putative TRH-type peptides do contain an aromatic residue (tyrosine 
(Y); phenylalanine (F) or tryptophan (W)) in position 2 and a cyclic residue (proline 
(P)) in position 3, which is characteristic of vertebrate TRH-type peptides. 
To date, the physiological functions of TRH-type peptides in invertebrate 
species and specifically in the echinoderms are currently unknown. To this extent, 
investigation would be facilitated by the identification of receptors that mediate the 
effects of TRH-type peptides. In this regard, a candidate TRH-like receptor has been 
identified in the sea urchin S. purpuratus (Burke et al., 2006). However, to date, a 
candidate TRH-like receptor has not been identified in the starfish A. rubens. 
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(A) Thyrotropin-releasing hormone (TRH)-like precursor (ArTRHLP) 
 
MSVTRNSGFLLVTLLFTWVVCRAELADFVENAEVAKEVSNEIEGVEAEQWQRDEDKR
QYPGGAPIGLDGKRQWYTGKRQWYTGKRDAEDSPALLAENDKRQWYTGKRSGNEEQQ
PDEANKRQWYTGKRQWYTGKRGDEDRVLDDDAVNSLKRQWYTGKRQWYTGKRSGVEQ
ADDGDLEQQYNKRQWYTGKRADDLADAADLEKRQWYTGKRQWYTGKRSDSEDEKRQW
YTGKRQWYTGRR 
 
(B) TRH-type neuropeptide multiple sequence alignments 
                *               
A.rub1 -----QYPG-GAPIGLDG---    21
A.rub2 -----QWYT-G----------    21
S.pur1 -----QFVG-GELIPS-PEL-    21
S.pur2 -----QFVG-GEALEQESNIN    21
S.pur3 -----QYPG-G----------    21
S.pur4 -----QFPA-G----------    21
S.pur5 -----QFPG-G----------    21
S.pur6 -----QWPG-G----------    21
S.pur7 -----QWPE-V----------    21
S.kow1 ---GEQPPEKG----------    21
S.kow2 SVLSEQPPGKG----------    21
S.kow3 SFPGEQPPGKG----------    21
S.kow4 SFLGEQPPGKG----------    21
B.flo1 -----QSP--G----------    21
B.flo2 -----QHP--G----------    21
H.sap -----QHP--G----------    21 
Fig. 2.7. A. rubens TRH-like precursor (ArTRHLP). (A) Sequence of 
ArTRHLPP. An N-terminal signal peptide is represented in blue, putative TRH-type 
neuropeptides are represented in red, C-terminal glycine (G) residues are represented 
in orange and dibasic cleavage sites are represented in green. (B) ClustalX v.2.1 
multiple sequence alignment of putative TRH-type neuropeptides derived from 
precursors of representative species across the Bilateria. A.rub, Asterias rubens 
TRH-like precursor; B.flo, Branchiostoma floridae TRH-like precursor [GI: 
260784028]; H.sap, Homo sapiens TRH-like precursor [GI: 485464565]; S.kow, 
Saccoglossus kowalevskii TRH-like precursor [GI: 187216047]; S.pur, 
Strongylocentrotus purpuratus TRH-like precursor [GI: 109402869]. 
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2.3.2.6. TK-like precursor (ArTKLP) 
 
The A. rubens tachykinin (TK)-like precursor (ArTKLP) is a 199-residue precursor 
protein comprising a predicted 31-residue N-terminal signal peptide and two putative 
TK-type peptides (Fig. 2.8A; Fig. S12). These include the polypeptide sequences 
QLWANQQSGLFG (residues 132-143) termed ArTK1 and GGGVPHVFQSGGIFG 
(residues 173-187) termed ArTK2 bounded by dibasic (KR) and monobasic (R) 
cleavage sites. The presence of an N-terminal glutamine (Q) residue on ArkTK1 and 
a C-terminal glycine (G) residue on both ArTK1 and ArtK2 is indicative of post-
translational modifications giving rise to an N-terminal pyro-glutaminyl (pQ) residue 
and C-terminal amide groups on the mature peptides (e.g. pQLWANQQSGLFG-
NH2).  
TK-type peptides are a family of neuropeptides with a widespread 
phylogenetic distribution indicative of an ancestral bilaterian origin (Jekely, 2013; 
Mirabeau and Joly, 2013). The first TK-type peptide to be discovered was substance 
P (Chang and Leeman, 1970; Studer et al., 1973; von Euler and Gaddum, 1931) 
before the subsequent discovery of neurokinin A (NKA) and neurokinin B (NKB) in 
mammals (Kangawa et al., 1983; Kimura et al., 1983; Nawa et al., 1984). More 
recently, endokinins and hemokinins have been identified as additional mammalian 
members of the TK-like neuropeptide family (Kurtz et al., 2002; Page et al., 2003; 
Zhang et al., 2000b). TK-type peptides have been implicated as neurotransmitters, 
neuromodulators and neurohormones in both the central and peripheral nervous 
system in relation to regulating intestinal motility (Shimizu et al., 2008), smooth 
muscle contraction (Kovac et al., 2006) and cardiovascular function (Walsh and 
McWilliams, 2006). TK-type peptides have been identified in a number of 
vertebrates (Severini et al., 2002) and have subsequently been identified in 
deuterostomian invertebrates including the urochordates (Satake et al., 2004) but had 
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not previously been identified in the ambulacrarians. TK-type peptides have also 
been identified in the lophotrochozoans including a number of molluscs (Kanda et 
al., 2003) and annelids (Ikeda et al., 1993; Kawada et al., 1999) and in the 
ecdysozoans including a number of arthropods (Christie et al., 1997; Nieto et al., 
1998; Siviter et al., 2000; Veelaert et al., 1999) and nematodes (Nathoo et al., 2001).  
It is important to consider ArTKLP in relation to TK-like precursors/peptides 
identified in other phyla (Fig. 2.8B). ArTKLP is the first member of the TK-like 
neuropeptide family to be identified in the ambulacrarians and specifically in an 
echinoderm species, with TK-type peptides so far not identified in the sea urchin S. 
purpuratus (Burke et al., 2006; Rowe and Elphick, 2012) or the sea cucumber A. 
japonicus (Rowe et al., 2014). Vertebrate TK-type peptides share the conserved C-
terminal pentapeptide motif FxGLM-NH2. Most invertebrate TK-type peptides, on 
the other hand, share the conserved C-terminal pentapeptide motif FxGxR-NH2, with 
a few exceptions including the yellow fever mosquito Aedes aegypti and the octopus 
species Eledone moschata and Octopus vulgaris, which have vertebrate-type C-
terminal pentapeptide motifs (Champagne and Ribeiro, 1994; Van Loy et al., 2010). 
ArTKLP contains two TK-type peptides with the C-terminal pentapeptide motifs 
QSGLF-NH2 and QSGGIF-NH2, respectively, which share the common motif GxF-
NH2, with x representing a hydrophobic residue. This motif shares more sequence 
similarity with the vertebrate GLM-NH2 motif in comparison to the invertebrate 
GxR-NH2 motif, with regards to the presence of hydrophobic residues. Identification 
of TK-type peptides in other ambulacrarian species would provide further insights 
into ancestral features of deuterostomian TK-type peptides.  
To date, with no TK-type peptide previously identified, the physiological 
function of TK-type peptides in the echinoderms is currently unknown. To this 
extent, investigation would be facilitated by the identification of receptors that 
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mediate the effects of TK-type peptides. In this regard, candidate TK-like receptors 
have been identified in S. purpuratus (Burke et al., 2006). Importantly, two candidate 
TK-like receptors have also been identified in the starfish A. rubens and may 
facilitate investigation into the physiological functions of TK-type peptides in an 
echinoderm species (Fig. A5J-K; Fig. S13-14).  
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(A) Tachykinin (TK)-like precursor (ArTKLP) 
 
MLLAMAPNGEMMTRFLLAAHFLLLAVSIVNARVYFNGEDETKSGLLELSEYGENEKV
DGTEDVDGQQVEDRQWKGEDQWKSGLYAAQRSLQSYPNTAKRSWPQTGMYNKQSTNW
LRALAQEPRWHSAMAKRQLWANQQSGLFGKREADMERTLPAWNVKRSAEEREFARQS
RGGGVPHVFQSGGIFGKRSSDDWAKRYE 
 
 
(B) TK-type neuropeptide multiple sequence alignments 
                         .  *
A.rub1 QLWAN------QQSGLFG    12
A.rub2 QSRGGGVPHVFQSGGIFG    18
C.int --HVR------HFYGLMG    10
H.sap_SubP RPKPQ------QFFGLMG    12
H.sap_NKA -GKAS------QFFGLMG    11
H.sap_NKB -DMHD------FFVGLMG    11
C.tel -LSRG-------FYAARG    10
L.gig1 HPNFG-------FMGSRG    11
L.gig2 QRTFG-------FVGTRG    11
D.mel APTSS-------FIGMRG    11
       1 ---QLWANQQS
2 GGGVPHVFQSG
 --- HVRHFY
H.sap_SubP ---RPKPQQFFGLMG
H.sap_NKA ----GKASQFFGLMG
H.sap_NKB ----DMHDFFVGLMG
C.tel -----LSRGFYAARG
1 ----HPNFGFM S
L gig2 ----QRTFGFV T
D.mel ----APTSSFIGMRG
 
 
Fig. 2.8. A. rubens TK-like precursor (ArTKLP). (A) Sequence of ArTKLP. An 
N-terminal signal peptide is represented in blue, putative TK-type neuropeptides are 
represented in red, C-terminal glycine (G) residues are represented in orange and 
dibasic/monobasic cleavage sites are represented in green. (B) ClustalX v.2.1 
multiple sequence alignment of putative TK-type neuropeptides derived from 
precursors of representative species across the Bilateria. A.rub, Asterias rubens TK-
like precursor; C.int, Ciona intestinalis TK-like precursor [GI: 74136064]; C.tel, 
Capitella teleta TK-like precursor [GI: 161289578]; D.mel, Drosophila 
melanogaster TK-like precursor [GI: 442618676]; H.sap_SubP, Homo sapiens β-
prepro TK precursor [GI: 29482]; H.sap_NKA, Homo sapiens TK4 precursor [GI: 
117938255]; H.sap_NKB, Homo sapiens neurokinin β precursor [GI: 48146502]; 
L.gig1, Lottia gigantea TK-like precursor 1 [GI: 676441944]; L.gig2, Lottia gigantea 
TK-like precursor 2 [GI: 163525452]. 
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2.3.2.7. CCK-like precursor (ArCCKLP) 
 
The A. rubens cholecystokinin (CCK)-like precursor (ArCCKLP) is a 163-residue 
precursor protein comprising a predicted 22-residue N-terminal signal peptide and 
two putative CCK-type peptides (Fig. 2.9A; Fig. S15). These include the 
polypeptide sequences RQSKVDDYGHGLFWG (residues 103-117) termed 
ArCCK1 and GGDDQYGFGLFFG (residues 139-151) termed ArCCK2 bounded by 
dibasic cleavage sites (KR). In ArCCK1, the presence of a tyrosine (Y) residue is 
indicative of a post-translational modification giving rise to a O-sulphated tyrosine 
(Y) residue,!based the occurrence of this post-translational modification in CCK-type 
peptides in vertebrates (Mutt and Jorpes, 1968). The presence of a C-terminal glycine 
(G) residue is indicative of a post-translational modification giving rise to a C-
terminal amide group on the mature peptide (RQSKVDDYGHGLFW-NH2), 
consistent with C-terminal amidation of CCK/gastrin-type peptides in vertebrates 
(Dockray et al., 1978). However, there is the possibility that the secreted bioactive 
peptide is formed between residues 102-117 due to the presence of a putative dibasic 
cleavage site (RK) at residues 100 and 101 (RRQSKVDDYGHGLFW-NH2) or a 14-
residue polypeptide formed between residues 104-117 due to the presence of a 
putative dibasic cleavage (RR) site at residues 100 and 101 (QSKVDDYGHGLFW-
NH2). In the latter, the presence of an N-terminal glutamine (Q) residue may be 
indicative of a post-translational modification giving rise to an N-terminal pyro-
glutaminyl (pQ) residue on the mature peptide (pQSKVDDYGHGLFW-NH2). 
Likewise, in ArCCK2, the presence of a tyrosine (Y) residue and C-terminal 
phenylalanine (F) and glycine (G) residues are indicative of post-translational 
modifications giving rise to an O-sulphated tyrosine (Y) residue and a C-terminal 
amide group on the mature peptide respectively (GGDDQYGFGLFF-NH2). 
CCK-type peptides are a family of neuropeptides with a widespread 
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phylogenetic distribution indicative of an ancestral bilaterian origin (Hewes and 
Taghert, 2001; Janssen et al., 2008; Jekely, 2013; Mirabeau and Joly, 2013). CCK is 
structurally and functionally related to gastrin; both peptides are characterised by the 
C-terminal tetrapeptide WMDF-NH2, which has been shown to be necessary for 
biological activity and is suggestive of a common evolutionary origin (Dockray, 
1977; Johnsen, 1998; Larsson and Rehfeld, 1977). CCK has numerous regulatory 
functions in both the gastrointestinal system and in the brain of mammals. In the 
gastrointestinal system, CCK/gastrin have been implicated in functions including gut 
development, gallbladder contraction, gastrointestinal motility and pancreatic 
secretion of digestive enzymes (Guilloteau et al., 2006). In the brain, CCK/gastrin 
have been implicated in learning and memory, angiogenesis, nociception and 
regulating food intake (Dufresne et al., 2006; Johnsen, 1998; Konturek et al., 2003). 
CCK-type peptides have subsequently been identified in other vertebrates (Johnsen, 
1998) and deuterostomian invertebrates including the urochordate C. intestinalis 
(Johnsen and Rehfeld, 1990), the hemichordate S. kowalevskii (Mirabeau and Joly, 
2013) and the echinoderm S. purpuratus (Mirabeau and Joly, 2013). Interestingly, 
however, CCK-type peptides and receptors appear to have been lost in the 
cephalochordate B. floridae (Mirabeau and Joly, 2013).  
CCK-type peptides have been found to be orthologous to sulfakinin (SK)-
type peptides (Schoofs and Nachman, 2006; Schoofs et al., 2013). SK was first 
isolated from head extracts of the Madeira cockroach Leucophaea maderae and 
displays myotropic activity on the hindgut (Nachman et al., 1986a; Nachman et al., 
1986b). SK-type peptides have been implicated in numerous regulatory functions in 
multiple insect species including myotropic effects on the hindgut and foregut 
(Maestro et al., 2001), heart (Nichols et al., 2009) and body wall muscles (Chen et 
al., 2012). SK-type peptides have also been shown to involved in regulating food 
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intake in multiple insect species, including the desert locust Schistocerca gregaria 
(Wei et al., 2000) and regulating digestive enzyme release in the beetle 
Rhynchophorus ferrugineus (Nachman et al., 1997) and the moth Opisina arenosella 
(Harshini et al., 2002). SK-type peptides are characterised by the C-terminal 
heptapeptide DYGHMRF-NH2, which is often sulphated at the tyrosine (Y) residue 
(Schoofs et al., 2013). SK-type peptides have been identified in the ecdysozoans 
including in a number of arthropods (Schoofs et al., 2013) and nematodes (Janssen et 
al., 2008) and in the lophotrochozoans (Mirabeau and Joly, 2013). It would therefore 
appear that the CCK/gastrin/SK-like neuropeptide system can be traced back to the 
common ancestor of the bilaterians and is likely to have an ancient role in regulating 
physiological processes in the gastrointestinal system.  
It is important to consider ArCCKLP in relation to CCK/gastrin/SK-like 
precursors/peptides identified in other phyla (Fig. 2.9B). Most vertebrate CCK-type 
peptides typically share the conserved C-terminal octapeptide motif DYMGWMDF-
NH2. Most SK-type peptides, on the other hand, typically share the conserved C-
terminal heptapeptide motif DYGHMRF-NH2. ArCCKLP contains two CCK-type 
peptides with the C-terminal octapeptide motifs DYGHGLFW-NH2 and 
(R)QYGFGLFF-NH2, respectively, which share the common motif x1YGx2GLFx3-
NH2, with x3 representing a shared hydrophobic residue. This motif shares sequence 
similarity with both the vertebrate and SK-type motifs, including the likely presence 
of a conserved O-sulphated tyrosine (Y) residue and an amidated phenylalanine (F) 
residue (with the exception of ArCCK1, which has a tryptophan (W) residue). 
It is also important to consider ArCCKLP in relation to CCK/gastrin-like 
precursors/peptides identified in other echinoderm species (Fig. 2.9B). ArCCKLP is 
only the second member of the CCK-like neuropeptide family to be identified in an 
echinoderm after the identification of a CCK-like precursor (SpCCKLP) in the sea 
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urchin S. purpuratus (Mirabeau and Joly, 2013). To date, a CCK-like precursor has 
not been identified in a transcriptome dataset from the sea cucumber A. japonicus 
(Rowe et al., 2014). SpCCKLP has two CCK-type peptides with the C-terminal 
octapeptides DYGHGMFF-NH2 and DYNWGMWF-NH2, respectively, which share 
the common motif DYx1x2Gx3F-NH2, with x3 representing a shared hydrophobic 
residue. This motif shares similarity with the ArCCKLP motif, including the 
presence of a conserved glycine (G) residue in comparison to the vertebrate and SK-
type motifs respectively. 
To date, the physiological function of CCK-type peptides in the echinoderms 
is currently unknown. To this extent, investigation would be facilitated by the 
identification of receptors that mediate the effects of CCK-type peptides. In this 
regard, a candidate CCK-like receptor has been identified in the sea urchin S. 
purpuratus (Burke et al., 2006). Importantly, a candidate CCK-like receptor has also 
been identified in the starfish A. rubens and this may facilitate investigation into the 
physiological functions of CCK-type peptides in an echinoderm species (Fig. A5A; 
Fig. S16). 
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(A) Cholecystokinin (CCK)-like precursor (ArCCKLP) 
 
MSSWLTVAIATVTCLLLSPITCLPLHDVADGKERRELLHSTWLDPSGSTGQGTEELA
ETSKRLLGDNNRDSGIIDLLVALRDTNTNPRDLYLHGNTETARKRRQSKVDDYGHGL
FWGKRGSNWSDHGVRAMTDKDTKRGGDDQYGFGLFFGKRNEEDYEDFTL 
 
(B) CCK-like neuropeptide multiple sequence alignments 
                       .     : 
A.rub1 -RQSKVD-DYGHGL-FWG    18
A.rub2 ---GGDD-QYGFGL-FFG    18
S.pur1 --------DYGHGM-FFG    18
S.pur2 -----PD-DYNWGM-WFG    18
S.pur3 ---DKAD-LYGWGG-FFG    18
S.kow1 --EAGKS-DYGWGM-MFG    18
S.kow2 ------D-HYGWMN--F-    18
S.kow3 ------D-YYGWMN--F-    18
C.int ------N-YYGWMD--FG    18
H.sap_CCK-8 ------D-YMGWMD--FG    18
H.sap_Gast-6 ---------YGWMD--FG    18
C.tel -----YD-AFGLGG-RFG    18
L.gig1 --QGAWDYDYGLGGGRFG    18
L.gig2 ----SYD-DYGIGGGRFG    18
D.mel_SK GGDDQFD-DYGHMR--FG    18 
Fig. 2.9. A. rubens CCK-like precursor (ArCCKLP). (A) Sequence of ArCCKLP. 
An N-terminal signal peptide is represented in blue, putative CCK-type 
neuropeptides are represented in red, C-terminal glycine (G) residues are represented 
in orange and dibasic cleavage sites are represented in green. (B) ClustalX v.2.1 
multiple sequence alignment of putative CCK-type neuropeptides derived from 
precursors of representative species across the Bilateria. A.rub, Asterias rubens 
CCK-like precursor; C.int, Ciona intestinalis CCK-like precursor [GI: 10799472]; 
C.tel, Capitella teleta CCK-like precursor [GI: 161296032]; D.mel_SK, Drosophila 
melanogaster sulfakinin (SK) precursor [GI: 386765036]; H.sap_CCK-8, Homo 
sapiens CCK-8 precursor [GI: 30582820]; H.sap_Gast-6, Homo sapiens gastrin 
precursor [GI: 47481291]; L.gig1, Lottia gigantea CCK-like precursor 1 [GI: 
161296032]; L.gig2, Lottia gigantea CCK-like precursor 2 [GI: 52414496]; S.kow1, 
Saccoglossus kowalevskii CCK-like precursor 1 [GI: 585688033]; S.kow2, 
Saccoglossus kowalevskii CCK-like precursor 2 [GI: 187061456]; S.pur, 
Strongylocentrotus purpuratus CCK-like precursor [GI: 390355380]. 
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2.3.2.8. OX-like precursors (ArOXLP1-2) 
 
The A. rubens orexin (OX)-like precursor 1 (ArOXLP1) is a 112-residue precursor 
protein comprising a predicted 24-residue N-terminal signal peptide followed by a 
putative OX-type peptide with the predicted polypeptide sequence 
SNADSACCARTFRCNLRSDCTCMVREILCRDPSEGMLNSG (residues 25-64) 
termed ArOX1 bounded by a dibasic cleavage site (KR) (Fig. 2.10A; Fig. S17). The 
presence of a C-terminal glycine (G) residue is indicative of a post-translational 
modification giving rise to a C-terminal amide group on the mature peptide 
(SNADSACCARTFRCNLRSDCTCMVREILCRDPSEGMLNS-NH2). It is 
noteworthy that this putative OX-type peptide contains six cysteine (C) residues 
(residues 31, 32, 38, 44, 46 and 53), which are likely to form up to three disulphide 
bridges in accordance with OX-type peptides in vertebrates that form two disulphide 
bridges (Sakurai et al., 1998).  
The A. rubens OX-like precursor 2 (ArOXLP2) is a 161-residue precursor 
protein comprising a predicted 26-residue N-terminal signal peptide followed by a 
putative OX-type peptide with the predicted polypeptide sequence 
NACCRGTCHDIPPGCNCPYKSYLCGELNALTMG (residues 27-59) termed 
ArOX2 bounded by a dibasic cleavage site (KR) (Fig. 2.10B; Fig. S18). The 
presence of a C-terminal glycine (G) residue is indicative of a post-translational 
modification giving rise to a C-terminal amide group on the mature peptide 
(NACCRGTCHDIPPGCNCPYKSYLCGELNALTMG-NH2). It is noteworthy that 
this putative OX-type peptide contains six cysteine (C) residues (residues 29, 30, 34, 
41, 43 and 50), which are likely to form up to three disulphide bridges in accordance 
with OX-type peptides in vertebrates that form two disulphide bridges (Sakurai et al., 
1998).  
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OX-type peptides are a family of neuropeptides with a widespread 
phylogenetic distribution indicative of an ancestral bilaterian origin (Jekely, 2013; 
Mirabeau and Joly, 2013). The OX’s are hypothalamic neuropeptides that were first 
discovered as regulators of feeding behaviour in mammals (de Lecea et al., 1998; 
Sakurai et al., 1998). However, OX’s have subsequently been implicated as key 
regulators of the processes of sleep and wakefulness in mammals (Sakurai, 2007). 
Similarly, OX’s have also been shown to regulate feeding behaviour and the 
processes of sleep and wakefulness in teleost fish (Matsuda et al., 2012). OX-type 
peptides have subsequently been identified in a number of deuterostomian 
invertebrates including the cephalochordate B. floridae (Jekely, 2013; Mirabeau and 
Joly, 2013), the hemichordate S. kowalevskii (Jekely, 2013; Mirabeau and Joly, 
2013) and the echinoderm S. purpuratus (Jekely, 2013; Mirabeau and Joly, 2013).  
OX-type peptides have recently been found to be orthologous to allatotropin 
(AT)-type peptides based on receptor orthology (Jekely, 2013; Mirabeau and Joly, 
2013). AT was first isolated through its regulatory function in stimulating the 
synthesis and secretion of juvenile hormone (JH) from the corpora allata and has 
subsequently been implicated in regulating cardioacceleration and the inhibition of 
active ion transport in the midgut of the tobacco hornworm M. sexta (Kataoka et al., 
1989; Veenstra et al., 1994). AT-type peptides have therefore been identified in the 
ecdysozoans (Elekonich and Horodyski, 2003; Weaver and Audsley, 2009) and in 
the lophotrochozoans including molluscs (Harada et al., 1993; Li et al., 1993; 
Veenstra, 2010) and annelids (Ukena et al., 1995; Veenstra, 2011). Interestingly, 
however, OX-type peptides and receptors appear to have been lost in the nematode 
C. elegans (Jekely, 2013; Mirabeau and Joly, 2013). 
It is important to consider ArOXLP1 and ArOXLP2 in relation to OX-like 
precursors/peptides identified in other phyla (Fig. 2.10C). OX-type peptides are 
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highly conserved in the vertebrates with two OX-type peptides (termed OX-A and 
OX-B) encoded in tandem on one OX-like precursor protein (Tsujino and Sakurai, 
2009). However, two separate OX-like precursors have been identified in the starfish 
A. rubens, which is consistent with other OX-like precursors in the ambulacrarians 
(Jekely, 2013; Mirabeau and Joly, 2013). OX-A in vertebrates has an N-terminal 
pyro-glutaminyl (pQ) residue and four cysteine (C) residues, which has been shown 
to form two disulphide bridges (Sakurai et al., 1998). ArOX1 and ArOX2 have six 
cysteine (C) residues suggesting the presence of three disulphide bridges; however, 
both ArOX1 and ArOX2 do not contain an N-terminal pyro-glutaminyl (pQ) residue. 
Interestingly, however, only one OX-like precursor has been identified in the 
hemichordate S. kowalevskii (Jekely, 2013; Mirabeau and Joly, 2013). The S. 
kowalevskii OX-like precursor contains one OX-type peptide with an N-terminal 
pyro-glutaminyl (pQ) residue and has six cysteine (C) residues suggesting the 
presence of three disulphide bridges. Thus, the S. kowalevskii OX-type peptide 
shares features of both OX-A and ArOX1 and ArOX2, consistent with the 
phylogenetic position of the hemichordates as a sister group to the echinoderms. 
Furthermore, these findings indicate that the occurrence of six cysteine (C) residues 
may be a characteristic of OX-type peptides in the ambulacrarians.  
It is also important to consider ArOXLP1 and ArOXLP2 in relation to OX-
like precursors/peptides identified in other echinoderm species (Fig. 2.10C). 
ArOXLP1 and ArOXLP2 are only the second members of the OX-like neuropeptide 
family to be identified in an echinoderm after the identification of two OX-like 
precursors (SpOXLP1-2) in the sea urchin S. purpuratus (Jekely, 2013; Mirabeau 
and Joly, 2013). Similarly to the starfish A. rubens, there are two OX-like precursors 
each containing one OX-type peptide in the sea urchin S. purpuratus; both OX-type 
peptides have six cysteine (C) residues suggesting the presence of three disulphide 
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bridges. Interestingly, however, the OX-type peptide derived from SpOXLP1 has a 
putative N-terminal pyro-glutaminyl (pQ) residue, which is consistent with 
vertebrate OX-A and an OX-type peptide in the hemichordate S. kowalevskii. 
To date, the physiological function of OX-type peptides in invertebrate 
species is not particularly well understood and in the echinoderms is currently 
unknown. To this extent, investigation would be facilitated by the identification of 
receptors that mediate the effects of OX-type peptides. In this regard, two candidate 
OX-like receptors have been identified in the sea urchin S. purpuratus (Burke et al., 
2006). Importantly, three candidate OX-like receptors have also been identified in 
the starfish A. rubens and this may facilitate investigation into the physiological 
functions of OX-type peptides in an echinoderm species  (Fig. A5G-I; Fig. S19-21). 
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(A) Orexin (OX)-like precursor 1 (ArOXLP1) 
 
MMTRSYLVLCCLVIWAFLATGTLPSNADSACCARTFRCNLRSDCTCMVREILCRDPS
EGMLNSGKRSPPSDRQQQQLNVLESSGYHANPRMMPSSSKYRRALPLATMNEDFL 
 
(B) OX-like precursor 2 (ArOXLP2) 
 
MRTTTLFVIQTVVVIGYFTCSSTAAANACCRGTCHDIPPGCNCPYKSYLCGELNALT
MGKRKADDTSYLLTQEQETQQQNQQRRTQQTQPWVDRQPDDDRIVDVLNNLLKLFKE
THQGDQDGFDLQDQSDDWEPVTSSRKQQSENAHNVYRHQPLFSADIL 
 
 
(C) OX-like neuropeptide multiple sequence alignments 
                                               .    *
A.rub1 SNADSACCARTFRCNLRSDCTCMVREILCRD--PSEGMLNSG    40
A.rub2 ----NACCR-GTCHDIPPGCNCPYKSYLCG----ELNALTMG    33
S.pur1 ---QSPCCRRAKGCSFPPGCHCPLKMSFCGD--PSRGLQIVG    37
S.pur2 ---DRACCKRTVGCNLRSDCTCRIREITCTD--PSLGLQNYG    37
S.kow ---QPQCCR-GVGCKIPPNCKCPFQSIICDN--PTKNVLTAG    36
B.flo1 ---FPRCCW-------RRTCNCPHFRRLFGPRNHGHGILTVG    32
B.flo2 --QKPACCE-------SGSCICPYVSRLHSPGNHGYGILTTG    33
H.sap_OXA -QPLPDCCR-------QKTCSCRLYELLHGAGNHAAGILTLG    34
H.sap_OXB -RSGPPGLQ-------G-----RLQRLLQASGNHAAGILTMG    29 
 
Fig. 2.10. A. rubens OX-like precursors. (A) Sequence of ArOXLP1. (B) Sequence 
of ArOXLP2. N-terminal signal peptides are represented in blue, putative OX-type 
neuropeptides (with cysteine (C) residues underlined) are represented in red, C-
terminal glycine (G) residues are represented in orange and dibasic cleavage sites are 
represented in green. (C) ClustalX v.2.1 multiple sequence alignment of putative 
OX-type neuropeptides derived from precursors of representative species across the 
Bilateria. A.rub1, Asterias rubens OX-like precursor 1; A.rub2, Asterias rubens OX-
like precursor 2; B.flo1, Branchiostoma floridae OX-like precursor 1 [GI: 
260807454]; B.flo2, Branchiostoma floridae OX-like precursor 2 [GI: 260780718]; 
H.sap_OXA-B, Homo sapiens OX (hypocretin) precursor [GI: 4557634]; S.kow, 
Saccoglossus kowalevskii OX-like precursor [GI: 585662697]; S.pur1, 
Strongylocentrotus purpuratus OX-like precursor 1  [GI: 346420309]; S.pur2, 
Strongylocentrotus purpuratus OX-like precursor 2 [GI: 346419879]. 
 
 
 
 
 
 
 
! 104 
2.3.2.9. LQ-like precursor (ArLQLP) 
 
The A. rubens luqin (LQ)-like precursor (ArLQLP) is a 106-residue precursor protein 
comprising a predicted 44-residue N-terminal signal peptide followed by a putative 
LQ-type peptide with the predicted peptide sequence EEKTRFPKFMRWG (residues 
45-57) termed ArLQ bounded by a dibasic cleavage site (KR) (Fig. 2.11A; Fig. 
S22). The presence of a C-terminal glycine (G) residue is indicative of a post-
translational modification giving rise to a C-terminal amide group on the mature 
peptide (EEKTRFPKFMRW-NH2).  
LQ-type peptides are a family of neuropeptides with a phylogenetic 
distribution recently attributed to be indicative of an ancestral bilaterian origin 
(Jekely, 2013; Mirabeau and Joly, 2013). LQ was first identified in the California sea 
slug Aplysia californica and named on account of the expression of its precursor 
protein in the dorsal left upper quadrant (LUQ) cells of the abdominal ganglion 
(Aloyz and DesGroseillers, 1995). Prior to the discovery of LQ in A. californica, a 
closely related neuropeptide termed Achatina cardioexcitatory peptide-1 (or ACEP-
1) was isolated from the African giant snail Achatina fulica on account of its 
excitatory effect on the heart and other muscles (Fujimoto et al., 1990). 
Subsequently, a closely related peptide termed Lymnaea cardioexcitatory peptide (or 
LyCEP) that also has a cardioexcitatory effect was isolated from the pond snail 
Lymnaea stagnalis (Tensen et al., 1998). LQ-type peptides have also been identified 
in a number of lophotrochozoans including other molluscs (Veenstra, 2010) and 
annelids (Veenstra, 2011) and have recently been identified as orthologous to the 
RYamides identified in the ecdysozoans, including a number of arthropods and 
nematodes (Jekely, 2013; Mirabeau and Joly, 2013). LQ-type peptides have also 
been identified in a number of deuterostomian invertebrates including the 
hemichordate S. kowalevskii and the echinoderm species S. purpuratus (Jekely, 
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2013; Mirabeau and Joly, 2013) and A. japonicus (Rowe et al., 2014). Interestingly, 
however, LQ-type peptides or receptors have not yet been identified in the chordates, 
suggesting that the LQ-like neuropeptide signalling system may have been lost in the 
chordate lineage.  
It is important to consider ArLQLP in relation to LQ-like precursors/peptides 
identified in other phyla (Fig. 2.11B). ArLQLP (EEKTRFPKFMRW-NH2) contains 
one LQ-type peptide, similar to the LQ-type peptides in the lophotrochozoans and S. 
kowalevskii, as opposed to the RYamide-type peptides in the ecdysozoans that are 
repetitive, which is likely a derived feature (Jekely, 2013). ArLQ has a C-terminal 
RW-NH2 motif, which shares the common second hydrophobic residue with both the 
RF-NH2 motif in the lophotrochozoans and the RY-NH2 motif in the ecdysozoans. 
Moreover, the presence of two cysteine (C) residues typically separated by a 10-
residue polypeptide sequence in the C-terminal region of the ArLQLP precursor 
appears to be a conserved feature of all LQ-like precursors (Fig. 2.11B) (Jekely, 
2013; Mirabeau and Joly, 2013). 
It is also important to consider ArLQLP in relation to LQ-like 
precursors/peptides identified in other echinoderm species (Fig. 2.11B). Comparison 
of ArLQ (EEKTRFPKFMRW-NH2) with LQ-type peptides in the sea urchin S. 
purpuratus (PHKFMRW-NH2) and the sea cucumber A. japonicus (PYKFMRW-
NH2) reveals high sequence similarity, sharing the C-terminal KFMRW-NH2 motif. 
Moreover, similarly to LQ-type peptides in the echinoderm species S. purpuratus 
and A. japonicus, ArLQLP has two cysteine (C) residues separated by a 10-residue 
polypeptide sequence in the C-terminal region of the precursor.  
To date, the physiological function of LQ-type peptides in the echinoderms is 
currently unknown. To this extent, investigation would be facilitated by the 
identification of receptors that mediate the effects of LQ-type peptides. In this 
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regard, two candidate LQ-like receptors orthologous to the LyCEP receptor (Tensen 
et al., 1998) have been identified in the sea urchin S. purpuratus (Jekely, 2013; 
Mirabeau and Joly, 2013). Similarly, an ortholog of the LyCEP receptor has also 
been identified in the sea cucumber A. japonicus (Rowe et al., 2014). Importantly, 
two candidate LyCEP-type receptors have been identified here in the starfish A. 
rubens and this may facilitate investigation into the physiological functions of LQ-
type peptides in an echinoderm species  (Fig. A5D-E; Fig. S23-24). 
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(A) Luqin (LQ)-like precursor (ArLQP) 
 
MTNRTAQEQCTRAGSICPSIIRFSAWLLLTILVAQVLLGTTAKAEEKTRFPKFMRWG
KRYSPDYVVMDDNELKDEMKLPVFGNGEVLCKNVASGGLYRCGKVPATA 
 
(B) LQ-type neuropeptide/precursor multiple sequence alignments 
(i) 
                    :    *:*
A.rub EEKTRFP-KFM---RWG
S.pur ------PHKFM---RWG
S.kow -EG---SNTFL---RWG
C.tel ------QFAWRPQGRFG
L.gig ------APQWRPQGRFG
D.pul1 -----NPERFFIGSRYG
D.pul2 -------QTFFTNGRYG
D.mel1 -----N-EHFFLGSRYG
D.mel2 -------PVFFVASRYG  
(ii) 
                        *
A.rub VLCKNVASGGLYRC    14
S.pur ILCKHIAAGGLYKC    14
S.kow VYCRRFQKGGLYRC    14
C.tel AICINAGTKGYYKC    14
L.gig RLCSESGLENVPRC    14
D.pul LECNPIGIEQLYHC    14
D.mel ---KRSG-K--YLC     8 
 
Fig. 2.11. A. rubens LQ-like precursor (ArLQP). (A) Sequence of ArLQP. An N-
terminal signal peptide is represented in blue, a putative LQ-type neuropeptide is 
represented in red, a C-terminal glycine (G) residue is represented in green and 
dibasic/monobasic cleavage sites are represented in green. (B) ClustalX v.2.1 
multiple sequence alignment of (i) putative LQ-type neuropeptides and (ii) a C-
terminal domain of LQ-like precursors of representative species across the Bilateria. 
A.rub, Asterias rubens LQ-like precursor; C.tel, Capitella teleta LQ-like precursor 
[GI: 161280144]; D.mel, Drosophila melanogaster RY-amide precursor [GI: 
442634438]; D.pul, Daphnia pulex LQ-like precursor [JGI: 251691]; L.gig, Lottia 
gigantea LQ-like precursor [GI: 163510328]; S.kow, Saccoglossus kowalevskii LQ-
like precursor [GI: 585716464]; S.pur, Strongylocentrotus purpuratus LQ-like 
precursor [GI: 390331828]. 
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2.3.2.10. KP-like precursor (ArKPLP) 
 
The A. rubens kisspeptin (KP)-like precursor (ArKPLP) is a 149-residue precursor 
protein comprising a predicted 24-residue N-terminal signal peptide and two putative 
KP-type peptides (Fig. 2.12A; Fig. S25). These include the peptide sequences 
SGRCRSGTKCIMRGPNPNTASRVLPFG (residues 87-113) termed ArKP1 and 
GRGPPKNSRARGGRTLLPFG (residues 127-146) termed ArKP2 bounded by 
dibasic cleavage sites (KR). The presence of C-terminal glycine (G) residues on each 
of these sequences are indicative of post-translational modifications giving rise to a 
C-terminal amide group on the mature peptides (e.g. GRGPPKNSRARGGRTLLPF-
NH2). It is noteworthy that ArKP1 contains two cysteine (C) residues (residues 90 
and 96), which suggest the presence of a disulphide bridge in the mature peptide.  
KP-type peptides are a family of neuropeptides with a phylogenetic 
distribution recently attributed to be indicative of an ancestral bilaterian origin 
(Jekely, 2013; Mirabeau and Joly, 2013). KP (or KiSS1) is a hypothalamic peptide 
that was originally discovered in humans as a metastasis-suppressor gene (Harms et 
al., 2003; Lee et al., 1996). However, subsequently, KP has been shown to have a 
key role in reproductive functions in the hypothalamic-pituitary axis in mammals 
(Oakley et al., 2009). KP has been shown to regulate the activity of GnRH neurons 
both directly (Colledge, 2009) and indirectly (Pielecka-Fortuna et al., 2008; Zhang et 
al., 2008) whilst KP has also been shown to act directly on gonadotropes (Richard et 
al., 2009). Similarly, non-mammalian vertebrate KP-type peptides have also been 
implicated in the regulation of reproductive function in various fish (Elizur, 2009; 
Oakley et al., 2009; Zohar et al., 2010). However, KP expression outside of the 
hypothalamic-pituitary axis has also been shown in mammals. For example, KP is 
expressed in the hippocampus and has been implicated with various neurological 
processes including cognition and neurogenesis (Arai, 2009). KP-type peptides have 
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subsequently been identified in a number of deuterostomian invertebrates including 
the cephalochordate B. floridae (Mirabeau and Joly, 2013) and, recently, in the 
echinoderm S. purpuratus (Elphick and Mirabeau, unpublished data). Interestingly, 
there has been a large expansion of KP-like receptors in the cephalochordate B. 
floridae and in the ambulacrarians (Mirabeau and Joly, 2013). KP-like receptors 
have also been identified in the lophotrochozoa but, to date, a KP-type peptide has 
yet to be identified. However, KP-type peptides and receptors appear to have been 
lost in lineages leading to the urochordates and the ecdysozoans (Mirabeau and Joly, 
2013).  
It is important to consider ArKPLP in relation to KP-like precursors/peptides 
identified in other phyla (Fig. 2.12B). ArKPLP contains two KP-type peptides – 
ArKP1 (SGRCRSGTKCIMRGPNPNTASRVLPF-NH2) and ArKP2 
(GRGPPKNSRARGGRTLLPF-NH2) –  whilst vertebrate KP-like precursors contain 
one KP-type peptide. ArKP1 and ArKP2 share the common C-terminal motif LxF-
NH2, which is a characteristic feature of KP-type peptides. However, ArKP1 has two 
cysteine (C) residues, suggesting the presence of a disulphide bridge or a 
homodimeric protein formed by up to two intermolecular disulphide bridges, which 
is not a feature of KP-type peptides in other phyla.  
It is also important to consider ArKPLP in relation to KP-like 
precursors/peptides identified in other echinoderms (Fig. 2.12B). ArKPLP is only the 
second KP-like precursor to be identified in the ambulacrarians and specifically in an 
echinoderm after the identification of a KP-like precursor (SpKPLP) in the sea 
urchin S. purpuratus (Elphick and Mirabeau, unpublished data). SpKPLP has two 
KP-type peptides – SpKP1 (SRCRGRQCRNVGGLNPNANLRPLPF-NH2) and 
SpKP2 (GRTKNRIRERVPHFLPF-NH2). Both SpKP1 and SpKP2 (like ArKP1 and 
ArKP2) share the common C-terminal motif LxF-NH2 characteristic of KP-type 
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peptides. Moreover, and similarly to ArKP1, SpKP1 also has two cysteine (C) 
residues suggesting the presence of a disulphide bridge, or a homodimeric protein 
formed by up to two intermolecular disulphide bridges – this may be a characteristic 
feature of KP-type peptides in the echinoderms.  
To date, the physiological function of KP-type peptides in invertebrate 
species is unknown. Therefore, the discovery of ArKPLP (and SpKPLP) are 
important findings. Investigation of the physiological roles of KP-type peptides in 
the echinoderms would be facilitated by the identification of receptors that mediate 
their effects. In this regard, four candidate KP-like receptors have been identified in 
the sea urchin S. purpuratus (Mirabeau and Joly, 2013). Importantly, nine candidate 
KP-like receptors have also been identified in the starfish A. rubens, which confirms 
a large expansion of KP-like receptors in the ambulacrarians and may facilitate 
investigation into the physiological functions of KP-type peptides in an echinoderm 
species  (Fig. A6A-I; Fig. S26-34). 
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(A) Kisspeptin (KP)-like precursor (ArKPLP) 
 
MEWFTKCCLLVILAVCFGSSFVLGDGRNLQGYNGDLYNGEFENEEGTEALRNIIGQI
IDDVDAKNNIRTAILEDTLEHAQYEPDKRSGRCRSGTKCIMRGPNPNTASRVLPFGK
REDDSPNKLARRGRGPPKNSRARGGRTLLPFGKRR 
 
 
(B) KP-type neuropeptide multiple sequence alignments 
                                             *
A.rub1 -----SGRCRSGTKCIMRGP---NPNTASRVLPFG    27
A.rub2 ------GRG------PPKNS--RARGGR-TLLPFG    20
S.pur1 ------SRCRG---RQCRNVGGLNPNANLRPLPFG    26
S.pur2 ------GR--------TKN---RIRERVPHFLPFG    18
S.kow1 -----------------SPS---RQNPASRQAAFG    15
S.kow2 -FDINDKLEFYGLGRMVRGT---WPPPASSRTAFG    31
B.flo1 TEVSTSHTARSGWEYENEPP---EYNPNSWSV-FG    31
B.flo2 ------TEIDDEEVVDSADPDRVQYNPNAWSR-FG    28
B.flo3 --------SGGAWVADTNMD---DISPNMFSL-HG    23
B.flo4 ----------------ARKP----PNMNAWGQPWG    15
H.sap -----------------DLP---NYNWNSFGLRFG    15 
Fig. 2.12. A. rubens KP-like precursor (ArKPLP). (A) Sequence of ArKPLP. An 
N-terminal signal peptide is represented in blue, putative KP-type neuropeptides 
(with cysteine (C) residues underlined) are represented in red, C-terminal glycine (G) 
residues are represented in orange and dibasic cleavage sites are represented in 
green. (B) ClustalX v.2.1 multiple sequence alignment of putative KP-type 
neuropeptides derived from precursors of representative species across the Bilateria. 
A.rub, Asterias rubens KP-like precursor; B.flo1, Branchiostoma floridae KP-like 
precursor 1 [GI: 260826607]; B.flo2, Branchiostoma floridae KP-like precursor 2 
[GI: 260827077]; B.flo3, Branchiostoma floridae KP-like precursor 3 [GI: 
260826605]; B.flo4, Branchiostoma floridae KP-like precursor 4 [GI: 260793233]; 
H.sap, Homo sapiens KiSS-1 metastasis-suppressor precursor [GI: 21950713]; 
S.kow, Saccoglossus kowalevskii KP-like precursor [GI: 187123982]; S.pur, 
Strongylocentrotus purpuratus KP-like precursor [GI: 374768013]. 
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2.3.2.11. SMS-like precursor (ArSMSLP) 
 
The A. rubens somatostatin (SMS)-like precursor (ArSMSLP) is a 132-residue 
precursor protein comprising a predicted 24-residue N-terminal signal peptide and a 
putative SMS-type peptide with the predicted polypeptide sequence 
KCIGRFQPFSMPC (residues 120-132) termed ArSMS bounded by a dibasic 
cleavage site (KR) (Fig. 2.13A; Fig. S35). It is noteworthy that this putative SMS-
type peptide contains two cysteine (C) residues, which may form an intramolecular 
disulphide bridge in accordance with SMS-type peptides (Rivier et al., 1975). 
ArSMSLP was identified through sequence similarity with Spnp19 in the sea urchin 
S. purpuratus (Rowe and Elphick, 2012). However, upon the discovery of ArSMSLP 
and alignments with SMS-like precursors (Fig. 2.13B), it is likely that Spnp19 is a 
SMS-like precursor comprising a putative SMS-type peptide with the predicted 
polypeptide sequence GKCMGRFGPYMLNC, bounded by a monobasic (R) and 
dibasic cleavage site (KR). 
SMS-type peptides are a family of neuropeptides with a phylogenetic 
distribution recently attributed to be indicative of an ancestral bilaterian origin 
(Jekely, 2013; Mirabeau and Joly, 2013; Veenstra, 2009). SMS was first 
characterised from the sheep hypothalamus (Brazeau et al., 1973) and was initially 
described as a neuroendocrine peptide regulating pituitary hormone release 
(Epelbaum, 1986; Fodor et al., 2005). An SMS-related peptide was subsequently 
discovered in H. sapiens termed cortistatin (de Lecea et al., 1997) and has been 
shown to be present throughout tetrapod vertebrates (Tostivint et al., 2008). 
Interestingly, however, additional SMS-type precursors termed SMS 3–6 are also 
present in teleost fish (Liu et al., 2010). SMS-type peptides have subsequently been 
implicated in a number of physiological functions including neuromodulation, motor 
activity, sensory processing and cognition (Viollet et al., 2008). SMS-type peptides 
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have been identified in other vertebrates (Ocampo Daza et al., 2012) and a candidate 
SMS-type peptide has recently been identified in the cephalochordate B. floridae, 
revealing that SMS-type peptides occur throughout the chordates (Mirabeau and 
Joly, 2013). 
SMS-type peptides have recently been found to be orthologous to allatostatin-
C (AST-C) (Jekely, 2013; Mirabeau and Joly, 2013; Veenstra, 2009). AST’s are a 
family of peptides that inhibit JH biosynthesis in the corpora allata. AST’s were first 
isolated from the cockroach Diploptera punctata and these were termed AST-A 
(Pratt et al., 1991; Pratt et al., 1989; Woodhead et al., 1989). Neuropeptides with 
allastatic activity identified from the cricket Gryllus bimaculatus were subsequently 
termed AST-B (Lorenz et al., 1995) and from the tobacco hornworm M. sexta were 
subsequently termed AST-C despite structural differences to AST-A-type peptides 
(Kramer et al., 1991). AST-C-type peptides have been identified in a number of 
arthropods including numerous insect species (Li et al., 2006; Li et al., 2008b; Price 
et al., 2002; Williamson et al., 2001) and also in the tick Ixodes scapularis (Veenstra, 
2009). Interestingly, it has recently been reported that these species also have 
precursors comprising a second AST-C-type peptide termed AST-CC (Veenstra, 
2009).  
It is important to consider ArSMSLP in relation to SMS-like 
precursors/peptides that have been identified in other phyla (Fig. 2.13B). It is likely 
that Spnp19 identified in the sea urchin S. purpuratus (Rowe and Elphick, 2012) is in 
fact an SMS-like precursor based on the discovery of ArSMS and further support 
from neuropeptide alignments. ArSMSLP comprises a putative 13-residue SMS-type 
peptide (KCIGRFQPFSMPC) sharing high sequence similarity with the putative 14-
residue SMS-type peptide (GKCMGRFGPYMLNC) derived from Spnp19 (Rowe 
and Elphick, 2012). Both ArSMS and the SMS-type peptide derived from Spnp19 
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have a GRF motif and two cysteine (C) residues, which is a characteristic of 
SMS/cortistatin-type peptides in the vertebrates. However, the SMS precursor in H. 
sapiens contains two biologically active SMS peptides derived from differential 
cleavage of the SMS precursor – the 14-residue SMS-14 and the 28-residue SMS-28 
(Pradayrol et al., 1980). 
To date, the physiological roles of SMS-type peptides in deuterostomian 
invertebrates and more specifically in the echinoderms are currently unknown. To 
this extent, investigation would be facilitated by identification of receptors that 
mediate the effects of SMS-type peptides. Importantly, three candidate SMS-like 
receptors have been identified in the starfish A. rubens and may facilitate 
investigation into the physiological functions of SMS-type peptides in an echinoderm 
species  (Fig. A6L-N; Fig. S36-38). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! 115 
(A) Somatostatin (SMS)-like precursor (ArSMSLP) 
 
MRFCCVVVVLPLICVLAGCLVAHAAPRRGGGGNSDPRWKRNFSPPGMQSSGGSYNKG
DLVERILNRLQERLLGKVDLSQTNTWHGNQSPKELDLQRYSDQEDEFIDDDDEVPNR
PAIKRKCIGRFQPFSMPC 
 
 
(B) SMS-type neuropeptide multiple sequence alignments 
               *   :         *
A.rub ---KCIGRFQP---FSMPC    13
S.pur --GKCMGRFGP---YMLNC    14
B.flo -AKGCARFYWKMPATAMSC    18
H.sap_SMS --AGCKNFFWK---TFTSC    14
H.sap_CORT DRMPCRNFFWK---TFSSC    16
 
 
Fig. 2.13. A. rubens SMS-like precursor (ArSMSLP). (A) Sequence of ArSMSLP. 
An N-terminal signal peptide is represented in blue, a putative SMS-type 
neuropeptide (with cysteine (C) residues underlined) is represented in red and a 
dibasic cleavage site is represented in green. (B) ClustalX v.2.1 multiple sequence 
alignment of putative SMS-type neuropeptides derived from precursors of 
representative species across the Bilateria. A.rub, Asterias rubens SMS-like 
precursor; B.flo, Branchiostoma floridae SMS-like precursor [JGI: 72051]; 
H.sap_CORT, Homo sapiens cortistatin (CORT) precursor [GI: 110645815]; 
H.sap_SMS, Homo sapiens SMS precursor [GI: 21619155]; S.pur, 
Strongylocentrotus purpuratus SMS-like precursor [GI: 390344260]. 
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2.3.2.12. MCH-like precursor (ArMCHLP) 
 
The A. rubens melanin-concentrating hormone (MCH)-like precursor (ArMCHLP) is 
an 88-residue precursor protein comprising a predicted 24-residue N-terminal signal 
peptide and a putative MCH-type peptide with the predicted polypeptide sequence 
DRPNRREVTYCMDWIHNTWRPCRGRKAG (residues 61-88) termed ArMCH 
bounded by a dibasic cleavage site (KR) (Fig. 2.14A; Fig. S39). However, there is 
the possibility that ArMCH is a polypeptide sequence formed between residues 66-
84 due to the presence of a putative dibasic cleavage site (RR) at residues 65 and 66 
(EVTYCMDWIHNTWRPCRGRKAG) whilst the presence of a putative dibasic 
cleavage site (RK) at residues 85 and 86 may give rise to a version of both peptides 
in which the presence of a C-terminal glycine (G) residue on ArMCH is indicative of 
a post-translational modification giving rise to a C-terminal amide group on the 
mature peptide (EVTYCMDWIHNTWRPCRGRKA-NH2). It is noteworthy that this 
putative MCH-type peptide contains two cysteine (C) residues, which may form an 
intramolecular disulphide bridge in accordance with other MCH-type peptides (Lebl 
et al., 1988). ArMCHLP was identified through sequence similarity with Spnp14 in 
the sea urchin S. purpuratus (Rowe and Elphick, 2012). However, upon the 
discovery of ArMCHLP and alignment with MCH-like precursors (Fig. 2.14B), it is 
likely that Spnp14 is a MCH-like precursor comprising a putative MCH-type 
neuropeptide with the predicted polypeptide sequence 
SRSGRKLRFCMDVIRNTWRLCRNTRSN, bounded by dibasic cleavage sites 
(KR). 
MCH-type peptides are a family of neuropeptides with a phylogenetic 
distribution attributed to be indicative of a chordate origin (Jekely, 2013; Kawauchi, 
2006; Kawauchi and Baker, 2004; Mirabeau and Joly, 2013). MCH was first 
identified in the chum salmon Oncorhynchus keta on account of its physiological 
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function of inducing body colour change (Kawauchi et al., 1983; Kawazoe et al., 
1987). MCH-type peptides have subsequently been identified throughout the 
vertebrates (Nahon, 1994). However, to date, MCH-type peptides have not been 
identified outside of the vertebrates although MCH-like receptors have been 
identified in the cephalochordate B. floridae (Jekely, 2013) and in the hemichordate 
S. kowalevskii, in which there has been a large expansion (Mirabeau and Joly, 2013). 
It is important to consider ArMCHLP in relation to MCH-like 
precursors/peptides identified in other phyla (Fig. 2.14B). ArMCHLP is the first 
member of the MCH-like neuropeptide family to be identified outside of the 
vertebrates. However, it is likely that Spnp14 previously identified in the sea urchin 
S. purpuratus (Rowe and Elphick, 2012) is also MCH-like based on the discovery of 
ArMCHLP and further support from neuropeptide alignments. Vertebrate MCH-type 
peptides have a characteristic cyclic structure due to the presence of two cysteine (C) 
residues that form an intramolecular disulphide bridge (Lebl et al., 1988). ArMCH 
and the MCH-type peptide derived from Spnp14 also have two cysteine (C) residues 
that are indicative of an intramolecular disulphide bridge. However, unlike vertebrate 
MCH-type peptides, ArMCH also has a C-terminal glycine (G) residue indicative of 
a post-translational modification giving rise to a C-terminal amide group on the 
mature peptide.  
To date, the physiological function of MCH-type peptides outside of the 
vertebrates and specifically in the echinoderms is currently unknown. To this extent, 
investigation would be facilitated by identification of receptors that mediate the 
effects of MCH-type peptides. Importantly, two candidate MCH-like receptors have 
been identified in the starfish A. rubens and this may facilitate investigation into the 
physiological functions of MCH-type peptides in an echinoderm species  (Fig. A6J-
K; Fig. S40-41). 
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(A) Melanin-concentrating hormone (MCH)-like precursor (ArMCHLP) 
 
MRPHVVLFACLAVPCLLLAQIVSCAPVYDGNNQIQPFDTDDWTGGDALGDQDFMMET
EKRDRPNRREVTYCMDWIHNTWRPCRGRKAG 
 
(B) MCH-type neuropeptide multiple sequence alignments 
              .   :  *:    ..:: *      
A.rub DRPNRREVTYCMDWIHNTWRPCRGRKAG    28
S.pur SRSGRK-LRFCMDVIRNTWRLCRNTRSN    27
S.kow -R-GRKVLQVCIDWKKKTWKWCYFDL--    24
T.rub -NADLDILLRCM--VGRVYRPCWEVE--    23
H.sap ---DFD-MLRCM--LGRVYRPCWQV---    19 
 
Fig. 2.14. A. rubens MCH-like precursor (ArMCHLP). (A) Sequence of 
ArMCHLP. An N-terminal signal peptide is represented in blue, a putative MCH-
type neuropeptide (with cysteine (C) residues underlined) is represented in red and a 
dibasic cleavage site is represented in green. (B) ClustalX v.2.1 multiple sequence 
alignment of putative MCH-type neuropeptides derived from precursors of 
representative species across the Bilateria. A.rub, Asterias rubens MCH-like 
precursor; H.sap, Homo sapiens MCH precursor [GI: 187445]; S.kow, Saccoglossus 
kowalevskii MCH-like precursor [GI: 187231810]; S.pur, Strongylocentrotus 
purpuratus MCH-like precursor [GI: 109402760]; T.rub, Takifugu rubripes MCH 
precursor [GI: 410918650]. 
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2.3.2.13. CT-like precursor (ArCTLPP) 
 
The A. rubens calcitonin (CT)-like precursor (ArCTLPP) is a 114-residue precursor 
protein comprising a predicted 21-residue N-terminal signal peptide and a 40-residue 
putative CT-type neuropeptide with the predicted polypeptide sequence 
NGESRGCSGFGGCGVLTIGHNAAMRMLAESNSPFGASGPG (residues 61-100) 
termed ArCT bounded by dibasic cleavage sites (KR) (Fig. 2.15A; Fig. S42). The 
presence of a C-terminal glycine (G) residue is indicative of post-translational 
modification giving rise to a C-terminal amide group on the mature polypeptide 
(NGESRGCSGFGGCGVLTIGHNAAMRMLAESNSPFGASGP-NH2). It is 
noteworthy that this putative CT-type neuropeptide contains two cysteine (C) 
residues (residues 67 and 73), which are likely to form a disulphide bridge in 
accordance with CT/CT-gene related peptide (CGRP)-type peptides in other phyla. 
CT was first discovered in mammals as a peptide that is released from 
parafollicular cells of the thyroid gland and inhibits intestinal calcium ion (Ca2+) 
absorption and inhibits osteoclast activity in bones (Wendelaar Bonga and Pang, 
1991). CT is encoded by a gene that also encodes CGRP, with alternative splicing 
giving rise to either prepro-CT (exons 1, 2, 3 and 4) or prepro-CGRP (exons 1, 2, 3, 
5 and 6) (Amara et al., 1982). Thus, whilst the CT/CGRP gene encodes both CT and 
CGRP, mRNA transcripts encoding both peptides in tandem are not generated 
(Strand, 1999). 
CT-type peptides have subsequently been identified in other vertebrates 
(Ogoshi et al., 2006) and deuterostomian invertebrates including urochordates 
(Sekiguchi et al., 2009), the cephalochordate B. floridae (Mirabeau and Joly, 2013), 
the hemichordate S. kowalevskii (Mirabeau and Joly, 2013) and the echinoderm 
species S. purpuratus (Rowe and Elphick, 2012) and A. japonicus (Rowe et al., 
2014). In the protostomes, the first CT-type peptide to be discovered was diuretic 
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hormone (DH31) in the cockroach Diploptera punctata (Furuya et al., 2000). 
Subsequently, DH31-type peptides have been identified in other ecdysozoans 
including a number of arthropod species (Furuya et al., 2000) and nematodes 
(Mirabeau and Joly, 2013) and also in the lophotrochozoans (Mirabeau and Joly, 
2013). Thus, CT/DH31-type peptides are a family of neuropeptides with a 
widespread phylogenetic distribution indicative of an origin that dates back to the 
common ancestor of the Bilateria (Jekely, 2013; Mirabeau and Joly, 2013).  
It is important to consider ArCTLPP in relation to CT/DH31-like 
precursors/peptides identified in other phyla (Fig. 2.15B). ArCT contains a C-
terminal amidated proline (P) motif, which appears to be a conserved feature of CT-
type peptides, with the exception of CGRP. It would therefore appear that the C-
terminal region of invertebrate CT-type peptides are more CT-like than CGRP-like. 
ArCT also has two cysteine (C) residues, which are likely to form a disulphide 
bridge in the N-terminal of the putative CT-type peptide. This feature is comparable 
to CT/CGRP-type peptides identified throughout the vertebrates (Ogoshi et al., 2006). 
It should be noted, however, that CT/CGRP-type peptides identified in other 
invertebrate species do not share this feature. For example, DH31-type peptides 
identified in the arthropods do not have these two cysteine (C) residues (Furuya et 
al., 2000). Identification of a CT-type peptide in the urochordate C. intestinalis with 
two cysteine (C) residues indicated at the time of discovery that this feature may be a 
unique characteristic of CT/CGRP-type peptides in chordates (Sekiguchi et al., 
2009). However, there are two genes encoding CT-type peptides in the annelid 
Capitella teleta, one comprising a CT-type peptide with two N-terminal cysteine (C) 
residues and one comprising a DH31-type peptide without two N-terminal cysteine 
(C) residues (Mirabeau and Joly, 2013; Veenstra, 2011). It therefore appears that 
there may have been an ancient duplication of a CT-like gene, with one copy 
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retaining the N-terminal cysteine (C) residues and the other copy losing the N-
terminal cysteine (C) residues in the protostomian lineage before subsequent loss of 
the CT-type peptide and retention of the DH31-type peptide in the arthropod lineage 
(Rowe et al., 2014).  
It is also important to consider ArCTLPP in relation to CT-like 
precursors/peptides identified in other echinoderm species (Fig. 2.15B). ArCTLPP is 
the third member of the CT-like neuropeptide family to be identified in an 
echinoderm after the identification of Spnp4 (SpCTLPP) in the sea urchin S. 
purpuratus (Rowe and Elphick, 2012) and Ajnp4 (AjCTLPP) in the sea cucumber A. 
japonicus (Rowe et al., 2014). ArCTLPP, along with SpCTLPP, contains a single 
CT-type peptide. Interestingly, AjCTLPP is the first CT-like precursor that 
comprises two CT-type peptides in tandem (Rowe et al., 2014). However, a CT-like 
precursor comprising two CT-type peptides has also been identified in S. kowalevskii 
(Freeman et al., 2008; Mirabeau and Joly, 2013; Rowe et al., 2014) suggesting that 
independent intragenic duplication events may have given rise to genes encoding two 
CT-type peptides in both the vertebrate lineage, the hemichordate lineage and in the 
holothurian lineage.  
To date, the physiological function of CT-type peptides in the echinoderms is 
currently unknown. To this extent, investigation would be facilitated by the 
identification of receptors that mediate the effects of CT-type peptides. In this regard, 
a candidate CT-like receptor has been identified in the sea urchin S. purpuratus 
(Burke et al., 2006) but not in the sea cucumber A. japonicus (Rowe et al., 2014). 
Importantly, a candidate CT-like receptor has also been identified in the starfish A. 
rubens and may facilitate investigation into the physiological functions of CT-type 
peptides in an echinoderm species  (Fig. A4A; Fig. S43). 
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(A) Calcitonin (CT)-like precursor (ArCTLPP) 
 
MKPTTVLTLAVFCTLYTIITAASISRDDDMFDVTGDDLRQLAKKVDTYARNNEIQSL
LKRNGESRGCSGFGGCGVLTIGHNAAMRMLAESNSPFGASGPGKRRRSVDAVANQEA 
 
(B) CT-type neuropeptide multiple sequence alignments 
                          *                                *
A.rub NGESRGCS-GFGG-CGVLTIGHNAAMRML-----AESNS-PFGASGPG    40
S.pur ---SKGCG-SFSG-CMQMEVAKNRVAALL-----RNSNAHLFGLNGPG    38
S.kow GRGTSACG-GFAT-CKQLEYGR--KYATS-----KADLS-HFGATSPG    38
B.flo1 --GKIACK---TAWCMNNRLSH--NLSSL-----DNPTD--TGVGAPG    34
B.flo2 -----DCS---TLTCFNQKLAH--ELAMD-----NQRTDTANPYS-PG    32
B.flo3 -----KCE---SGTCVQMHLADRLRLGLG-----HNMFTNTGPES-PG    34
B.flo4 ------NN---ESTCQTYLLKV---RKFT-----REFIHHAAGPGEPG    31
H.sap_Calc ------CG--NLSTCMLGTYTQ--DFNKF-----HTFPQTAIGVGAPG    33
H.sap_CGRP1 -----ACD---TATCVTHRLAG--LLSRSGGVVKNNFVPTNVGSKAFG    38
C.tel -----TCQFNLGGHCATESAAS--VADHW-----HYLNS---PLS-PG    32
L.gig1 -----SCSLRLGGMCLTENLNA--AANQY-----EYLSS---GLS-PG    32
L.gig2 -----SCNLNLGFHCQTDEYSS--IADMY-----DFLQS---ALS-PG    32 
Fig. 2.15. A. rubens CT-like precursor (ArCTLPP). (A) Sequence of ArCTLPP. 
An N-terminal signal peptide is represented in blue, a putative CT-type neuropeptide 
(with cysteine (C) residues underlined) is represented in red, a C-terminal glycine 
(G) residue is represented in orange and dibasic cleavage sites are represented in 
green. (B) ClustalX v.2.1 multiple sequence alignment of putative CT-type 
neuropeptides derived from precursors of representative species across the Bilateria. 
A.rub, Asterias rubens CT-like precursor; B.flo1, Branchiostoma floridae CT-like 
precursor 1 [GI: 260826569]; B.flo2, Branchiostoma floridae CT-like precursor 2 
[GI: 260826567]; B.flo3, Branchiostoma floridae CT-like precursor 3 [GI: 
260826573]; Bflo4, Branchiostoma floridae CT-like precursor 4  [GI: 260812099]; 
H.sap_Calc, Homo sapiens CT precursor [GI: 179819]; H.sap_CGRP1, Homo 
sapiens CT-related polypeptide α [GI: 269784661]; C.tel, Capitella teleta CT-like 
precursor [GI: 161220966]; L.gig1, Lottia gigantea CT-like precursor 1 [GI: 
163526287]; L.gig2, Lottia gigantea CT-like precursor 2 [GI: 676481265]; S.kow, 
Saccoglossus kowalevskii CT-like precursor [GI: 187217193]; S.pur, 
Strongylocentrotus purpuratus CT-like precursor [GI: 115767208]. 
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2.3.2.14. CRH-like precursor (ArCRHLP) 
 
The A. rubens corticotropin-releasing hormone (CRH)-like precursor (ArCRHLP) is 
a 130-residue precursor protein comprising a predicted 28-residue N-terminal signal 
peptide and a putative CRH-type peptide with the predicted polypeptide sequence 
QGLSVSPIFPIQRIRLNAIERDRQDQVDQAEANQGLFQIAG (residues 87-127) 
termed ArCRH bounded by dibasic cleavage sites (KR/RK) (Fig. 2.16A; Fig. S44). 
The presence of an N-terminal glutamine (Q) residue and a C-terminal glycine (G) 
residue is indicative of post-translational modifications giving rise to an N-terminal 
pyro-glutaminyl (pQ) residue and a C-terminal amide group on the mature peptide. 
CRH-type peptides are a family of neuropeptides with a phylogenetic 
distribution indicative of an ancestral bilaterian origin (Jekely, 2013; Mirabeau and 
Joly, 2013). CRH is a hypothalamic neurohormone that stimulates release of 
adrenocorticotropic hormone (ACTH) in response to stress in mammals (Lovejoy, 
2005). CRH-type peptides have been identified in other vertebrates (Lovejoy and 
Balment, 1999) and deuterostomian invertebrates including urochordates (Lovejoy 
and Barsyte-Lovejoy, 2010), the cephalochordate B. floridae (Mirabeau and Joly, 
2013) and the hemichordate S. kowalevskii (Jekely, 2013; Mirabeau and Joly, 2013). 
However, whilst it has been proposed that CRH-type peptides have been identified in 
the echinoderm species S. purpuratus (Jekely, 2013; Mirabeau and Joly, 2013) and 
A. japonicus (Rowe et al., 2014), ArCRHLP is likely to be the first true precursor 
comprising a CRH-type peptide to be identified in an echinoderm species. 
CRH-type peptides have been found to be orthologous to diuretic hormone 
DH44 identified in insects and to egg-laying hormone (ELH) identified in molluscs 
(Jekely, 2013; Lovejoy and Jahan, 2006; Mirabeau and Joly, 2013). DH44 was first 
identified in the fruit fly D. melanogaster and has been implicated in stimulating 
fluid secretion by Malpighian tubules through elevated cyclic adenosine 
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monophosphate (cAMP) levels (Cabrero et al., 2002). DH44-type peptides have 
subsequently been identified in a number of insect species but have yet to be 
identified in nematodes (Jekely, 2013; Mirabeau and Joly, 2013). ELH was first 
characterised in the mollusc A. californica (Scheller et al., 1983) and has 
subsequently been implicated in coordinating the process of egg-laying in Aplysia 
species (Conn and Kaczmarek, 1989). ELH-type peptides have also been identified 
in other molluscan species and in the annelids, where evidence of roles in promoting 
gamete release has been obtained (Salzet et al., 1997; Vreugdenhil et al., 1988). 
It is important to consider ArCRHLP in relation to CRH-like precursors that 
have previously been identified in other echinoderms and CRH/DH44/EHL-like 
precursors identified in other phyla (Fig. 2.16B). CRH-like precursors containing 
two putative CRH-type peptides separated by an acidic spacer have recently been 
identified in the sea urchin S. purpuratus (Jekely, 2013; Mirabeau and Joly, 2013) 
and the sea cucumber A. japonicus (Rowe et al., 2014). It had been hypothesised that 
the occurrence of two CRH-type peptides in the echinoderms was likely a 
consequence of intragenic duplication in the echinoderm lineage with CRH/DH44-
like precursors in other phyla containing only one CRH-type peptide (Rowe et al., 
2014). However, upon the discovery of ArCRHLP, it appears that both of the CRH-
like precursors identified in the echinoderm species S. purpuratus (Jekely, 2013) and 
A. japonicus (Rowe et al., 2014) are in fact PDF-like precursors based on 
neuropeptide alignments (see chapter 2.3.2.15). Further support of this notion is the 
presence of two PDF-type peptides in these echinoderm precursors, which is 
consistent with the presence of two PDF-type peptides in PDF-like precursors 
identified in other phyla. In accordance with CRH/DH44-like precursors identified in 
other phyla, ArCRHLP has only one CRH-type peptide, which opposes the 
hypothesis of an intragenic duplication in the echinoderm lineage (Rowe et al., 
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2014). 
To date, the physiological function of CRH-type peptides in the echinoderms 
is currently unknown. However, it has been proposed that CRH-type peptides may be 
involved in regulating the release of TSH-type hormones in the echinoderms by 
virtue of non-mammalian vertebrate CRH triggering the release of TSH (Rowe et al., 
2014). To this extent, investigation would be facilitated by identification of receptors 
that mediate the effects of CRH-type peptides. In this regard, a candidate CRH-like 
receptor orthologous to mammalian CRHR1 and CRHR2 (Lovejoy, 2005) has been 
identified in the sea urchin S. purpuratus (Mirabeau and Joly, 2013). Similarly, an 
orthologue of mammalian CRHR1 and CRHR2 has also been identified in the sea 
cucumber A. japonicus (Rowe et al., 2014). Importantly, two candidate CRH-like 
receptors have been identified in the starfish A. rubens and this may facilitate 
investigation into the physiological functions of CRH-type peptides in an 
echinoderm species (Fig. A4B-C; Fig. S45-46). 
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(A) Corticotropin-releasing hormone (CRH)-like precursor (ArCRHLP) 
 
MNDLQRLILLVSLGTFALLLCLPACTEAQPLGLFKFEYDDLLDPSFEADDPRNPRRL
SRQQILRRLNDLAMSRSGSGPGYTIPRKRQGLSVSPIFPIQRIRLNAIERDRQDQVD
QAEANQGLFQIAGRKR 
 
(B) CRH-type neuropeptide multiple sequence alignments 
                                           *                        :    *
A.rub -----------------QGLSVSPIFPIQRIRLNAIERDRQDQ-----VDQAEANQGLFQIAG
S.kow --------------NPTSGHSIGLSLDIIRDRLEKAESERMQQEKQSDINRYRQNTELMTGLG
B.flo ---------------NPPHVAMDISTMLLGELLGAGGDGERAT--------TDHNIDLFRQAG
H.sap_CRH --------------SEEPPISLDLTFHLLREVLEMARAEQLAQQ----AHSNRKLMEI---IG
C.tel1 ----------------SSPLSFGTDIDAISTMLASRRMGKHGR-------MRSVRHRLA-ALG
C.tel2 MMDLAKYGMPLKQAALQNDVRESLDDRILRGMLLRQNAQEFKTK----SRQGKVMQKLF-GIG
C.tel3 -------------EPTQAQMNVQLELHVLRNMLRSQERRPLSSD----PTEAKSMNKLF-GIG
C.tel4 --------------VPKPLMLVDITPDLLRAMLYRQQRQRMAAK----IRPQEPKSDLR-FIG
L.gig1 -----------------SRLSINQELKSLANLLVLRENKRRE------AQKTKLRSKLL-SIG
L.gig2 ----------------AGRLSINGALSSLADLLVS-ENQRRDR-----LESMELRQRLQ-YLG  
Fig. 2.16. A. rubens CRH-like precursor (ArCRHLP). (A) Sequence of 
ArCRHLP. An N-terminal signal peptide is represented in blue, a putative CRH-type 
neuropeptide is represented in red, a C-terminal glycine (G) residue is represented in 
orange and dibasic cleavage sites are represented in green. (B) ClustalX v.2.1 
multiple sequence alignment of putative CRH-type neuropeptides derived from 
precursors of representative species across the Bilateria. A.rub, Asterias rubens 
CRH-like precursor; B.flo, Branchiostoma floridae CRH-like precursor [GI: 
260786674]; C.tel1, Capitella teleta CRH-like precursor 1 [GI: 161303031]; C.tel2, 
Capitella teleta CRH-like precursor 2 [JGI: 190906]; C.tel3, Capitella teleta CRH-
like precursor 3 [JGI: 190906]; C.tel4, Capitella teleta CRH-like precursor 4 [JGI: 
194553]; H.sap_CRH, Homo sapiens CRH precursor [GI: 30583744]; L.gig1, Lottia 
gigantea CRH-like precursor 1  [GI: 676493124]; L.gig2, Lottia gigantea CRH-like 
precursor 2 [GI: 163524672]; S.kow, Saccoglossus kowalevskii CRH-like precursor 1 
[GI: 281433636]. 
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2.3.2.15. PDF-like precursor (ArPDFLP) 
 
The A. rubens pigment-dispersing factor (PDF)-like precursor (ArPDFLP) is a 104-
residue precursor protein comprising a predicted 22-residue N-terminal signal 
peptide and two putative PDF-type peptides with the predicted polypeptide 
sequences LGDNDFFQATYNDAQARQRQRVLQSYLDDRMASVG (residues 31-
65) termed ArPDF1 and NFDEDVYHQEGLDNEFVRRLMAKYFDGVA (residues 
73-101) termed ArPDF2 bounded by dibasic cleavage sites (KR/RR) (Fig. 2.17A; 
Fig. S47). The presence of a C-terminal glycine (G) residue on ArPDF1 is indicative 
of a post-translational modification giving rise to a C-terminal amide group on the 
mature peptide (LGDNDFFQATYNDAQARQRQRVLQSYLDDRMASV-NH2). 
PDF-type peptides are a family of neuropeptides with a phylogenetic 
distribution recently attributed to be indicative of an ancestral bilaterian origin 
(Jekely, 2013; Mirabeau and Joly, 2013). The insect PDF-type peptides are 
orthologous to the crustacean pigment-dispersing hormone (PDH) family (Rao and 
Riehm, 1993) and have been implicated in regulating circadian rhythms in insects 
(Bahn et al., 2009; Lee et al., 2009). PDF-type peptides have subsequently been 
identified in a number of ecdysozoans including other arthropods (Rao and Riehm, 
1993) and nematodes (Janssen et al., 2009) and in lophotrochozoans including 
molluscs (Veenstra, 2010) and annelids (Veenstra, 2011). In the deuterostomes, a 
candidate PDF-type peptide has been identified in the hemichordate S. kowalevskii 
(Mirabeau and Joly, 2013). However, PDF-type peptides have not been identified in 
the vertebrates, the cephalochordate B. floridae or, until now, an echinoderm species. 
Moreover, PDF-like receptors have been identified in the ambulacrarians suggesting 
that the PDF-like neuropeptide signalling system can be traced back to the common 
ancestor of the bilaterians (Jekely, 2013; Mirabeau and Joly, 2013).  
It is important to consider ArPDFLP in relation to PDF-like 
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precursors/peptides that have been identified in other phyla (Fig. 2.17B). It can be 
postulated that precursors previously identified in the sea urchin S. purpuratus 
(Jekely, 2013; Mirabeau and Joly, 2013) and in the sea cucumber A. japonicus 
(Rowe et al., 2014) as CRH-like are in fact PDF-like based on the discovery of 
ArCRHLP and further support from neuropeptide alignments (Fig. 2.16B; Fig. 
2.17B). ArPDFLP has two PDF-type peptides – termed ArPDF1 and ArPDF2 – with 
ArPDF1 having a C-terminal glycine (G) residue indicative of C-terminal amidation. 
Similarly, PDF-like precursors in S. purpuratus and in the sea cucumber A. japonicus 
also have two PDF-type peptides. However, both of the PDF-type peptides in S. 
purpuratus (SpPDF1 and SpPDF2) have a C-terminal glycine (G) residue indicative 
of C-terminal amidation, whilst only one of the PDF-type peptides in A. japonicus 
(AjPDF2) has a C-terminal glycine (G) residue indicative of C-terminal amidation. 
Similarly, PDF-like precursors identified in other phyla also have two PDF-type 
peptides, with C-terminal amidation on one or both of these PDF-type peptides 
(Jekely, 2013; Mirabeau and Joly, 2013). Further support of the notion that 
ArPDFLP is orthologous to the S. purpuratus and A. japonicus PDF-like precursors 
previously thought to be CRH-like is the conservation of an N-terminal NDF motif 
common to ArPDF1, SpPDF1 and AjPDF1. Interestingly, ArPDF2 contains an N-
terminal NFD motif suggesting that the presence of two PDF-type peptides could be 
due to an intragenic duplication. However, it is not clear whether this intragenic 
duplication occurred in the common ancestor of the bilaterians or whether this 
intragenic duplication occurred in the echinoderm lineage due to a noticeable 
difference between PDF-type peptide length in other phyla compared to a similar 
PDF-type peptide length in the echinoderms. 
To date, the physiological function of PDF-type peptides in the 
deuterostomes and specifically in the echinoderms is currently unknown. To this 
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extent, investigation would be facilitated by identification of receptors that mediate 
the effects of PDF-type peptides. In this regard, a candidate PDF-like receptor has 
been identified in the sea urchin S. purpuratus (Jekely, 2013; Mirabeau and Joly, 
2013). Importantly, two candidate PDF-like receptors have been identified in the 
starfish A. rubens and this may facilitate investigation into the physiological 
functions of PDF-type peptides in an echinoderm species (Fig. A5D-E; Fig. S48-49). 
 
(A) Pigment-dispersing factor (PDF)-like precursor (ArPDFLP) 
 
MTQLTLLAVCGSVLLLVGLTHCTDEQREKRLGDNDFFQATYNDAQARQRQRVLQSYL
DDRMASVGKRDGLKRNFDEDVYHQEGLDNEFVRRLMAKYFDGVARRR  
 
 
(B) PDF-type neuropeptide multiple sequence alignments 
 
                           :      .    :   :  ..
A.rub1 -LGDNDFFQATYND-AQARQRQRVLQSYLDDRMASVG    35
A.rub2 NFDEDVY--------HQEGLDNEFVRRLMAKYFDGVA    29
S.pur1 -IADNDFAAMRHQERSNSMRRTRLLQA-MNEMLAKAG    35
S.pur2 SLAQNDYMMVR-----QDLANGRLYRSLMDRMLSEAG    32
C.tel ----------------NSGMLDAVIN--MP-DLFKAG    18
L.gig ----------------NAGTVDHLLN--FP-DL-SVG    17
D.mel ----------------NSELINSLLS--LPKNMNDAG    19 
Fig. 2.17. A. rubens PDF-like precursor (ArPDFLP). (A) Sequence of ArPDFLP. 
An N-terminal signal peptide is represented in blue, putative PDF-type neuropeptides 
are represented in red, a C-terminal glycine (G) residue is represented in orange and 
dibasic cleavage sites are represented in green. (B) ClustalX v.2.1 multiple sequence 
alignment of putative PDF-type neuropeptides derived from precursors of 
representative species across the Bilateria. A.rub, Asterias rubens PDF-like 
precursor; C.tel, Capitella teleta PDF-like precursor [JGI: 204689]; D.mel, 
Drosophila melanogaster PDF-like precursor [GI: 281362639]; L.gig, Lottia 
gigantea cerebrin precursor [GI: 676458325]; S.pur, Strongylocentrotus purpuratus 
PDF-like precursor [GI: 115899431]. 
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2.3.2.16. PP/orcokinin-like precursor 1 (ArPPLNP1) 
 
The A. rubens pedal peptide (PP)/orcokinin-like neuropeptide precursor (ArPPLNP1) 
is a partial 325-residue precursor protein comprising a predicted 31-residue N-
terminal signal peptide and seven putative PP/orcokinin-type neuropeptides (Fig. 
2.18A; Fig. S50). These include single copies of the polypeptide sequences 
GRTNMYGSSQLSRLSSGFN (residues 101-155) termed ArPPLNP1a, 
GRSSFAGSSRLTNLGSGFT (residues 142-160) termed ArPPLNP1b, 
GRSSFTGSSRLTNLASGFN (residues 176-194) termed ArPPLNP1c, 
GRSAFSGSRGLTNLASGFN (residues 211-229) termed ArPPLNP1d, 
GRSSFAGVSGLTHLGSGFN (residues 238-256) termed ArPPLNP1e, 
GRSAFSGSKGLTNLASGFN (residues 273-291) termed ArPPLNP1f and a single 
copy of the partial polypeptide sequence GRTSLSGSSGLTHLSSG (residues 309-
325) termed ArPPLNP1g bounded by dibasic cleavage sites (KR/KK). 
PP/orcokinin-type peptides are a family of neuropeptides with a phylogenetic 
distribution recently attributed to be indicative of an ancestral bilaterian origin 
(Rowe and Elphick, 2012). PP was first discovered in the mollusc A. californica as a 
peptide that causes contraction of pedal muscles (Hall and Lloyd, 1990; Lloyd and 
Connolly, 1989) and has subsequently been shown to cause beating of cilia 
associated with the pedal sole (Longley and Peterman, 2013). PP-type peptides were 
thought to be unique to the lophotrochozoans, with identification of PPs in molluscs 
and annelids (Conzelmann et al., 2011; Veenstra, 2011). However, the recent 
discovery of Spnp6 (SpPPLNP1) and Spnp7 (SpPPLNP2) in the sea urchin S. 
purpuratus (Rowe and Elphick, 2012) and Ajnp7 (AjPPLNP2) in the sea cucumber A. 
japonicus (Rowe et al., 2014) has shown that PPs are of an ancestral bilaterian origin. 
PPs have also subsequently been identified in the ecdysozoans including in the 
nematode C. elegans (Rowe and Elphick, 2012). 
! 131 
PPs have been found to be orthologous to orcokinin-type peptides identified 
in the arthropods (Rowe and Elphick, 2012). Orcokinin was first isolated from 
abdominal nerve cord extracts of the crayfish Orconectus limosus on account of its 
function of stimulating hindgut myoactivity (Stangier et al., 1992). Orcokinin-type 
peptides have subsequently been identified in a number of arthropods and attributed 
with a range of physiological functions including the stimulation of the prothoracic 
gland and the regulation of ecdysteroidogenesis in the silk moth Bombyx mori 
(Yamanaka et al., 2011) and regulation of circadian and seasonal physiology in the 
cockroach Leucophaea maderae (Hofer and Homberg, 2006; Soehler et al., 2011; 
Wei and Stengl, 2011). It would therefore appear that the PP/orcokinin-like 
neuropeptide signalling system could be traced back to the common ancestor of the 
bilaterians. Interestingly, however, PP/orcokinin-type peptides have not yet been 
identified in the vertebrates, suggesting that the PP/orcokinin-like neuropeptide 
signalling system may have been lost in the vertebrate lineage. 
It is important to consider ArPPLNP1 in relation to PP/orcokinin-like 
precursors/peptides identified in other phyla (Fig. 2.18B). PP/orcokinin-like 
precursors in other phyla comprise multiple copies of PP/orcokinin-type peptides. 
Similarly, ArPPLNP1 contains seven putative PPs. However, unlike in other phyla, 
including in the mollusc A. californica comprising four PP-like precursors (Moroz et 
al., 2006), only one PP-like precursor has been identified thus far in the starfish A. 
rubens. There appears to be little sequence similarity between PPs derived from 
ArPPLNP1 and PP/orcokinin-type peptides in other phyla. However, each of the PPs 
derived from ArPPLNP1 excluding ArPPLN1g, which may be a partial sequence, 
include a C-terminal SGFx (x is a hydrophobic residue) motif common to PP in the 
mollusc A. californica. Moreover, PPs derived from ArPPLNP1 and PP from the 
mollusc A. californica has a characteristic distribution of hydrophobic and 
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hydrophilic residues throughout each of the respective peptides. 
It is also important to consider ArPPLNP1 in relation to PP-like 
precursors/peptides identified in other echinoderm species (Fig. 2.18B). ArPPLNP1 
is the fourth member of the PP-like neuropeptide family to be identified in an 
echinoderm after the identification of SpPPLNP1 and SpPPLNP2 in the sea urchin S. 
purpuratus (Rowe and Elphick, 2012) and AjPPLNP2 in the sea cucumber A. 
japonicus (Rowe et al., 2014). It appears that ArPPLNP1 shares the highest sequence 
similarity with SpPPLNP1 and SpPPLNP2, which also contain a C-terminal SGFx 
motif common to PP in the mollusc A. californica. Interestingly, however, each of 
the PPs derived from AjPPLNP2 do not have the C-terminal SGFx motif but have a 
C-terminal glycine (G) residue indicative of C-terminal amidation, which is atypical 
to the majority of PP/orcokinin-type peptides identified in other phyla to date. 
However, two PPs derived from SpPPLNP1 also have C-terminal glycine (G) 
residues indicative of C-terminal amidation. 
To date, the physiological function of PP/orcokinin-type peptides in the 
echinoderms is currently unknown with preliminary pharmacological investigations 
of synthetic SpPPLN1c in the sea urchin species E. esculentus not revealing any 
myoactive effects on the contractile activity of tube foot or oesophagus preparations 
in vitro (Rowe and Elphick, 2012). Identification of candidate PP/orcokinin-like 
peptide receptors in the echinoderm species S. purpuratus, A. japonicus or A. rubens 
may facilitate investigation into the physiological functions of PP’s in an echinoderm 
species. However, to date, no PP/orcokinin-like receptors have been identified or 
characterised throughout the bilaterians. 
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(A) Partial (3’) pedal peptide (PP)/orcokinin-like precursor 1 (ArPPLNP1) 
 
MARCGGETPRALRTWWLVGLFCLALSLVCQAEIEANDVELVPEPEETKANEILLEEL
RDELFNELLQELEDEVAKGLTPEGRDLFHKRLTSLNSEWRAKRGRTNMYGSSQLSRL
SSGFNKRTLTDDESALEDLLDDAEVKRGRSSFAGSSRLTNLGSGFTKKSDPGVWLDS
EDKRGRSSFTGSSRLTNLASGFNKRDEDAYLLDDFLSKRGRSAFSGSRGLTNLASGF
NKREEAVKRGRSSFAGVSGLTHLGSGFNKRGDFLEDVYANEDKRGRSAFSGSKGLTN
LASGFNKRSDGDQSLWEENDVKRGRTSLSGSSGLTHLSSG 
 
 
(B) PP-type neuropeptide multiple sequence alignments 
                       . .:       
A.rub SAFSGSRGLTNLASGFN------    23
S.pur1 -GF-NSGAMEPLGAGFF------    23
S.pur2 --F-GSGSLEPMSSGFY------    23
C.tel -AFDQIGGLSNFG-GFD------    23
L.gig -------PMDSLASGLVG-----    23
A.cal -PLDSVYGTHGMS-GFA------    23
D.mel ----NFDEIDKASASFSILNQLV    23 
Fig. 2.18. A. rubens partial (3’) PP/orcokinin-like precursor (ArPPLNP1). (A) 
Sequence of ArPPLNP1. An N-terminal signal peptide is represented in blue, 
putative PP-type neuropeptides are represented in red and dibasic cleavage sites are 
represented in green. (B) ClustalX v.2.1 multiple sequence alignment of putative PP-
type neuropeptides derived from precursors of representative species across the 
Bilateria.  A.cal, Aplysia californica PP precursor-1 [GI: 325297152]; A.rub, Asterias 
rubens PP/orcokinin-like precursor; C.tel, Capitella teleta orcokinin precursor [GI: 
161190484]; D.mel, Drosophila melanogaster orcokinin precursor [GI: 442624594]; 
L.gig, Lottia gigantea orcokinin precursor [GI: 163527842]; S.pur1, 
Strongylocentrotus purpuratus PP/orcokinin-like precursor 1 [GI: 390335272]; 
S.pur2, Strongylocentrotus purpuratus PP/orcokinin-like precursor 2 [GI: 
390352581]. 
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2.3.3. Precursors of neuropeptides and peptide hormones that contain multiple 
cysteine (C) residues 
 
Transcripts encoding neuropeptide and peptide hormone precursors that contain 
multiple cysteine (C) residues and disulphide bridges have been identified by 
analysis of the neural transcriptome of the starfish A. rubens (Table 4). These 
precursors will be discussed in groups or on a one-by-one basis (or in groups). 
 
 
A. rubens 
precursor 
 
Precursor family 
 
Key peptide/precursor characteristics 
 
ArGPA2-1-2 
 
GPA2-type 
 
Subunit with ten conserved C residues 
 
ArGPB5-1-3 
 
GPB5-type 
 
Subunit with multiple conserved C residues 
ArBALPP/ 
ArBBLPP 
 
Bursicon-like 
 
Subunit(s) with eleven conserved C residues 
 
ArGSSLP 
 
GSS-like 
 
A-chain with four conserved C residues; B-chain with 
two conserved C residues 
 
ArRLP 
 
Relaxin/INSL-like 
 
A-chain with four conserved C residues; B-chain with 
two conserved C residues 
 
ArIGF1-2 
 
IGF-like 
 
A-E domain structure; A-chain with four conserved C 
residues; B-chain with two conserved C residues 
 
Table 4. Summary of key peptide/precursor characteristics of 
neuropeptides/peptide hormones with multiple cysteine (C) residues. GPA2, 
glycoprotein hormone α-2; GPB5, glycoprotein hormone β-5; GSS, gonad-
stimulating substance; IGF, insulin-like growth factor; INSL, insulin. Note that the 
table is not exhaustive and additional similarities and differences between 
neuropeptides/precursors are expanded on in the respective sub-headings. 
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2.3.3.1. GPA2/5-type precursors (ArGPA2-1-2 and ArGPB5-1-3)  
 
The A. rubens glycoprotein hormone α-2 (GPA2)-type precursor 1 (ArGPA2-1) is a 
135-residue precursor protein comprising a predicted 24-residue N-terminal signal 
peptide followed by a 111-residue polypeptide sequence sharing sequence similarity 
with GPA2 subunits (Fig. 2.19A; Fig. S51). A second GPA2-type precursor 
(ArGPA2-2) was identified as a 130-residue precursor protein comprising a predicted 
28-residue N-terminal signal peptide followed by a 102-residue polypeptide 
sequence sharing sequence similarity with GPA2 subunits (Fig. 2.19B; Fig. S52). It 
is noteworthy that both ArGPA2-1 and ArGPA-2 contain ten cysteine (C) residues, 
which are likely to form five disulphide bridges in accordance with glycoprotein 
hormone subunits in other phyla (Fig. 2.21) (Lovejoy, 2005).  
The A. rubens glycoprotein hormone β-5 (GPB5)-type precursor 1 (ArGPB5-
1) is a 136-residue precursor protein comprising a predicted 24-residue N-terminal 
signal peptide followed by a 112-residue polypeptide sequence sharing sequence 
similarity with GPB5 subunits (Fig. 2.19C; Fig. S53). A second GPB5-type 
precursor (ArGPB5-2) is a 141-residue precursor protein comprising a predicted 31-
residue N-terminal signal peptide followed by a 110-residue polypeptide sequence 
sharing sequence similarity with GPB5 subunits (Fig. 2.19D; Fig. S54). A third 
GPB5-type precursor (ArGPB5-3) is a 130-residue precursor protein comprising a 
predicted 30-residue N-terminal signal peptide followed by a 100-residue 
polypeptide sequence sharing sequence similarity with GPB5 subunits (Fig. 2.19E; 
Fig. S55). It is noteworthy that ArGPB5-1 contains eight cysteine (C) residues whilst 
both ArGPB5-2 and ArGPB5-3 contain ten cysteine (C) residues, which are likely to 
form four or five disulphide bridges, respectively, in accordance with glycoprotein 
hormone subunits in other phyla (Fig. 2.21) (Lovejoy, 2005).  
The glycoprotein hormones are a family of cysteine (C)-rich polypeptide 
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hormones with a phylogenetic distribution indicative of an evolutionary ancestry that 
dates back to the common ancestor the Bilateria (Park et al., 2005). The prototypical 
members of the glycoprotein hormone family are the mammalian gonadotropins LH, 
FSH, choriogonadotropin (CG) and TSH (Pierce and Parsons, 1981). The 
gonadotropins are heterodimeric glycoproteins comprising a common α-subunit and 
a unique β-subunit, which is crucial for receptor specificity. The α-subunit has ten 
cysteine (C) residues forming five disulphide bridges whilst the β-subunit has twelve 
cysteine (C) residues forming six disulphide bridges, with the formation of α/β 
dimers necessary for biological activity (Lovejoy, 2005). The α-subunit is common 
to the α/β dimer within a species whilst the β-subunit determines hormone 
specificity (Fiddes and Goodman, 1979; Fiddes and Goodman, 1980). 
Sequencing of the human genome revealed a novel member of the 
glycoprotein hormone family member, which is now known as thyrostimulin (Hsu et 
al., 2002). Thyrostimulin is a heterodimeric glycoprotein comprising an α-subunit 
termed GPA2 and a β-subunit termed GPB5 and it acts as a ligand for TSH receptors 
(Nakabayashi et al., 2002). GPA2 and GPB5-type subunits have subsequently been 
identified in a number of vertebrates (Hsu et al., 2002) and in deuterostomian 
invertebrates including urochordates (Campbell et al., 2004; Dos Santos et al., 2009), 
the cephalochordate B. floridae (Holland et al., 2008), the hemichordate S. 
kowalevskii (Dos Santos et al., 2009) and the echinoderm species S. purpuratus 
(Burke et al., 2006) and A. japonicus (Rowe et al., 2014). GPA2 and GPB5-type 
subunits have also been identified in ecdysozoans including arthropods (Sudo et al., 
2005) and nematodes (Park et al., 2005) and in lophotrochozoans including molluscs 
(Veenstra, 2010) and annelids (Veenstra, 2011). Thus, the phylogenetic distribution 
of GPA2 and GPB5-type subunits is indicative of these subunits being of an 
ancestral bilaterian origin, with the α- and β-subunits of vertebrate LH, FSH, CG and 
! 137 
TSH evolving from GPA2 and GPB5-type subunits, respectively, in the vertebrate 
lineage (Sower et al., 2009).  
To date, the physiological function of GPA2 and GPB5-type subunits in 
invertebrate species is not particularly well understood although it has been 
hypothesised that these peptide hormones may modulate ion and osmotic balance in 
insects (Sellami et al., 2011). The physiological function of GPA2 and GPB5-type 
subunits in the echinoderms is currently unknown. To this extent, investigation 
would be facilitated by the identification of receptors that mediate the effects of 
GPA2 and GPB5-type subunits. In this regard, a candidate receptor orthologous to 
DLGR1 identified in D. melanogaster (Sudo et al., 2005) has been identified in the 
sea urchin S. purpuratus. Importantly, a candidate receptor has also been identified 
in the starfish A. rubens and this may facilitate investigation into the physiological 
functions of GPA2 and GPB5-type subunits in an echinoderm species (Fig. A7A; 
Fig. S56). 
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(A) Glycoprotein hormone α-2-type precursor 1 (ArGPA2-1) 
MQWCKVVLTLMSLSVCLCSLFATAQQRPYWERSGCHLVGYSTLVQIPGCHKTRVDMN
ACRGYCVTYTLLSTFNQIVSNNIRYSSRGTCCAIGDTHDVIVILACENNEQKSVTYK
SAASCSCTLCTQEDASQLNNV 
 
(B) Glycoprotein hormone α-2-type precursor 2 (ArGPA2-2) 
 
MTMKVSVTFIYVACTAALLILVSSPVKGAWEPTAGCHLVGYRKEVRVPGCHIEYVKM
NACRGYCMTYSFLSDTATLERSGGTQLFTSHGSCCSITSTHDVHITLQCENNQVYKD
TFKSAKTCSCALCSTQ 
 
(C) Glycoprotein hormone β-5-type precursor 1 (ArGPB5-1) 
 
MDQGAAYTSIVMVTLVMMWACALAINPVTTTNCYVHTAMKHLVEKPGCRPHELVVFG
CWGRCDTNEVPSLDPPFVEAYHPVCTLTNYEDVKVKLPDCDPEVDPTYTYQSALSCG
CANIDDSSTKYSYRPDYFVSEK 
 
(D) Glycoprotein hormone β-5-type precursor 2 (ArGPB5-2) 
 
MFFKCQARHRWTATFLPLFALALLIGTIVEGARYQKQSMPFLDVSCRVREYTKYEAK
LPGCMDEVVPARGCYGRCQSFEVPVLLPPHKASSHKMCLVEEIELRSVELSDCLPGV
NRTFVYQSAVRCRCKKCIESNTFCARN 
 
(E) Glycoprotein hormone β-5-type precursor 3 (ArGPB5-3) 
 
MMATRRLTAVQNLAIFGFVVLVLSATLCTSQGLSCLPRQYIKYDAVKPGCRTQRITI
YGCFGRCHTSEIPKLLPPYKESNHAMCSYGQTESRVILLDDCDPGVDPTFQYEDALS
CACKKCEPWNTFCQGF 
 
 
Fig. 2.19. A. rubens GPA2-type and GPB5-type precursors. (A) Glycoprotein 
hormone α-2-type precursor 1 (ArGPA2-1). (B) GPA2-type precursor 2 (ArGPA2-
2). (C) Glycoprotein hormone β-5-type precursor 1 (ArGPB5-1) (D) GPB5-type 
precursor 2 (ArGPB5-2). (E) GPB5-type precursor 3 (ArGPB5-3). N-terminal signal 
peptides are represented in blue and putative GPA2-type and GPB5-type subunits are 
represented in red (with cysteine (C) residues underlined). 
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2.3.3.2. Bursicon α/β-like precursors (ArBALP and ArBBLP) 
 
The A. rubens bursicon-α-like hormone precursor (ArBALP) is a 139-residue 
precursor protein comprising a predicted 35-residue N-terminal signal peptide 
followed by a 104-residue polypeptide sequence comprising eleven cysteine (C) 
residues, sharing sequence similarity with bursicon-α type subunits (Fig. 2.20A; Fig. 
S57). The A. rubens bursicon-β-like hormone precursor (ArBBLP) is a 142-residue 
precursor protein comprising a predicted 30-residue N-terminal signal peptide 
followed by a 112-residue polypeptide sequence comprising eleven cysteine (C) 
residues, sharing sequence similarity with bursicon-β-type subunits (Fig. 2.20B; Fig. 
S58). It is noteworthy that both ArBALP and ArBBLP contain eleven cysteine (C) 
residues, sharing sequence similarity with bursicon-type subunits (Fig. 2.21). 
The bursicons, belonging to the glycoprotein hormone protein family (see 
chapter 2.3.3.1), are a family of polypeptide hormones with a phylogenetic 
distribution indicative of an ancestral bilaterian origin. Bursicon was originally 
discovered in insects on account of its effect in cuticular tanning (Fraenkel et al., 
1966) and has subsequently been shown to be a heterodimeric protein formed by the 
subunits bursicon-α and bursicon-β encoded by separate precursors (Luo et al., 
2005). Bursicon-type subunits have subsequently been identified in the ecdysozoans 
including arthropods (Van Loy et al., 2007) and have been shown to function in 
cuticle hardening and ecdysis in crustacean species (Chung et al., 2012; Webster et 
al., 2013; Wilcockson and Webster, 2008). Bursicon subunits have also been 
identified in the lophotrochozoans including molluscs (Veenstra, 2010) and annelids 
(Veenstra, 2011) and have also recently been identified in a number of 
deuterostomian invertebrates including the echinoderm species S. purpuratus (Burke 
et al., 2006), A. japonicus (Rowe et al., 2014) and now A. rubens, indicative of the 
bursicon-type peptide hormone system being of an ancestral bilaterian origin. 
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To date, the physiological function of bursicons in non-arthropod species is 
not particularly well understood and in the echinoderms is currently unknown. To 
this extent, investigation would be facilitated by the identification of receptors that 
mediate the effects of bursicons. In this regard, two candidate bursicon-like receptors 
orthologous to bursicon-like receptors in Drosophila and other insects (Bai and Palli, 
2010; Baker and Truman, 2002) and leucine-rich repeat containing GPCRs in 
vertebrates (LGR4-6) (Deng et al., 2013) have been identified in the sea urchin S. 
purpuratus; however, to date, no bursicon-like receptors have been identified in the 
sea cucumber A. japonicus (Rowe et al., 2014). Importantly, a candidate bursicon-
like receptor has been identified in the starfish A. rubens and this may facilitate 
investigation into the physiological functions of bursicons in an echinoderm species 
(Fig. A7B; Fig. S59). 
 
(A) Bursicon α-like precursor (ArBALP) 
 
MDSHHRNTGTASATVVVKCALIAILLLGVISQCSAVCRRQPLIHSIVHEGCQTKRLR
TFGCRGTCNSYSRVSPTDYTQMERSCQCCQESQHVVGFVELNCPSLSPPTQIVEFRH
VRSCSCRPCNSVSGVPRVTRLEDLE 
 
(B) Bursicon β-like precursor (ArBBLP) 
 
MAPMQHHHHLAAIFIFSVLSMCLLPDLVQAVRRGPAGTCEVGISFITVEEEFESSDG
GSVISCTGTTTVNQCEGECVTTSTPSVTEPTGYSKICKCCREQSLRPKQVMLSDCYD
SAGNAITGQQYPVYVPEPASCSCQKCSR 
 
Fig. 2.20. A. rubens bursicon-type precursors. (A) Bursicon α-like precursor 
(ArBALP). (B) Bursicon β-like precursor (ArBBLP). N-terminal signal peptides are 
represented in blue and putative bursicon-type subunits are represented in red (with 
cysteine (C) residues underlined).  
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              *      * * * :         *        *          * *    
A.rub_GPA2_1 GCHCHMNACRGYCVTYTLLSRGTCCAIVIVILACENVTYKSAASCSCTLCT    51
A.rub_GPA2_2 GCHCHMNACRGYCMTYSFLSHGSCCSIVHITLQCENDTFKSAKTCSCALCS    51
A.rub_GPB5_1 NCYCRVFGCWGRCDTN-EVAYHPVCTLKVKLPDCDPYTYQSALSCGCANID    50
A.rub_GPB5_2 SCRCMARGCYGRCQSF-EVSSHKMCLVSVELSDCLPFVYQSAVRCRCKKCI    50
A.rub_GPB5_3 SCLCRIYGCFGRCHTS-EISNHAMCSYVILLDDCDPFQYEDALSCACKKCE    50
A.rub_BursA VCRCQTFGCRGTCNSYSRVRSCQCCQELN----CPSVEFRHVRSCSCRPCN    47
A.rub_BursB -CECVN-QCEGECVTTSTPKICKCCREQVMLSDCYDVYVPEPASCSCQKCS    49
H.sap_GPA2 -CHTCAQACVGHCESSAFPSVSQCCTIVKVQLQCVG--IFTARACQCDMC-    47
H_sap_GPB5 GCACRTDACWGRCETW-EKAHHRVCTYTVKLPNCAPYTYPVAIRCDCGACS    50
H.sap_FSHB ECRCITTWCAGYCYTRDLVKIQKTCTFTVRVPGCAHYTYPVATQCHCGKCD    51
H.sap_CGB GCPCITTICAGYCPT--MTRVQVVCNYSIRLPGCPRVSYAVALSCQCALCR    49
H.sap_LSHB GCPCITTICAGYCPT--MMRVQVVCTYSIRLPGCPRVSFPVALSCRCGPCR    49
H.sap_TSHB ECACLTTICAGYCMTRDINLSQDVCTYTVEIPGCPLFSYPVALSCKCGKCN    51
D.mel_GPA2 GCHCVTNACRGFCESFSVPSVGQCCNMIQRRVLCIEVTFNSALSCSCYHCK    51
D.mel_GPB5 GCHLQVWSCWGRCDSS-EISFHPVCVHVAILKNCHPYQYMEAVNCHCQTCS    50
D.mel_BursA DCQCVSFACVGRCASYIQVRSCMCCQEACSL-FCPKVLTKAPLECMCRPCT    50
D.mel_BursB NCECVN-KCEGLCNSQVQPKECYCCREVITLTHCYDIRLREPTECKCFKCG    50 
Fig. 2.21. Conservation of bursicon-like, GPA2-type and GPB5-type subunits in 
representative phyla and species across the animal kingdom. ClustalX v.2.1 
multiple sequence alignment of putative bursicon-like, GPA2-type and GPB5-type 
subunits derived from precursors of representative species across the Bilateria.  
A.rub_GPA2_1, Asterias rubens GPA2-type precursor 1; A.rub_GPA2_2, Asterias 
rubens GPA2-type precursor 2; A.rub_GPB5_1, Asterias rubens GPB5-type 
precursor 1; A.rub_GPB5_2, Asterias rubens GPB5-type precursor 2; 
A.rub_GPB5_3, Asterias rubens GPB5-type precursor 3; A.rub_BursA, Asterias 
rubens bursicon α-type precursor; A.rub_BursB, Asterias rubens bursicon β-type 
precursor; D.mel_GPA2, Drosophila melanogaster GPA2 precursor [GI: 
320546230]; D.mel_TSHB, Drosophila melanogaster glycoprotein hormone β-
subunit-related precursor [GI: 21427595]; D.mel_BursA, Drosophila melanogaster 
bursicon-α precursor [GI: 665394724]; D.mel_BursB, Drosophila melanogaster 
bursicon-β precursor [GI: 62392020]; H.sap_GPA2, Homo sapiens GPA2 precursor 
[GI: 189491650]; H.sap_GPB5, Homo sapiens GPB5 precursor [GI: 21427593]; 
H.sap_FSHB, Homo sapiens follicle-stimulating hormone (FSH) β-precursor [GI: 
124014246]; H.sap_CGB7, Homo sapiens chorionic gonadotropin (CG) β-
polypeptide-7 precursor [GI: 15451749]; H.sap_LSHB,  Homo sapiens luteinising 
hormone (LH) β-precursor [GI: 15431286]; H.sap_TSHB, Homo sapiens thyroid 
stimulating hormone (TSH) β-precursor [GI: 47479817]. !!
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2.3.3.3. GSS-like precursor (ArGSSLP) 
 
The A. rubens gonad-stimulating substance (GSS)-like precursor (ArGSSLP) is a 
109-residue precursor protein comprising a predicted 26-residue N-terminal signal 
peptide and two putative gonad-stimulating substance (GSS)-like peptides (Fig. 
2.22; Fig. S60). These include the polypeptide sequences 
AEKYCDEDFHMAVYRTCTEH (residues 27-46) termed the Ar B-chain and 
PETYVGMGSYCCLVGCTRDQLSQVC (residues 85-109) termed the Ar A-chain 
separated by a connecting peptide (C-peptide) (residues 49-82). It is noteworthy that 
the Ar B-chain contains two cysteine (C) residues (residues 31 and 43) and the Ar A-
chain contains four cysteine (C) residues (residues 95, 96, 100 and 109), which are 
likely to form disulphide bridges and a peptide heterodimer between both chains, 
based on previous structural characterisation of GSS in the starfish species A. 
pectinifera (Mita et al., 2009). 
GSS was first discovered on account of inducing gamete release in the 
starfish A. rubens (Chaet and McConnaughy, 1959) and was identified as a peptide 
hormone (Kanatani et al., 1971; Kanatani and Shirai, 1970) before subsequent 
purification in the starfish species A. pectinifera (Mita et al., 2009). GSS has been 
shown to induce oocyte maturation and ovulation and is thus functionally analogous 
the vertebrate gonadotropin LH (Mita et al., 2009). However, subsequently, GSS has 
been identified as a member of the insulin/insulin-like growth factor (IGF)/relaxin 
superfamily (Mita, 2013a). The insulin/IGF/relaxin superfamily is divided into two 
distinct sub-classes: the insulin/IGF sub-class and the relaxin/insulin-like (INSL) 
sub-class, with GSS belonging to the relaxin/INSL sub-class (Mita et al., 2009).  
It is important to consider ArGSSLP in relation to the GSS precursor 
identified in A. pectinifera (Mita et al., 2009). ArGSSLP and the GSS precursor in A. 
pectinifera both have an A-chain and a B-chain linked by a connecting C-peptide 
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organised in the same manner as in relaxin/INSL-like peptide hormones. The A-
chains both comprise the cysteine motif CCxxxCxxxxxxxxC, characteristic of the 
insulin/IGF/relaxin superfamily. However, the final residue in the A-chain is a 
cysteine (C) residue, indicative of the relaxin/INSL sub-class as opposed to the 
insulin/IGF sub-class, which have an asparagine (N) residue after this residue (Mita, 
2013a). Similarly, the B-chains both have the cysteine motif CxxxxxxxxxxxC, which 
is also characteristic of the insulin/IGF/relaxin superfamily. It could therefore be 
predicted that the A-chain and B-chain of ArGSSLP would form a peptide 
heterodimer through disulphide bonds, consistent with the structural properties of 
GSS in A. pectinifera (Mita et al., 2009). 
 
Gonad-stimulating substance (GSS)-like precursor (ArGSSLP) 
 
MANYRLILEATCLLVLLINTALYAEAAEKYCDEDFHMAVYRTCTEHKRSGRSAFSLN
DFFRSNSKRTAGSPRPDDDFFLTMQKRPETYVGMGSYCCLVGCTRDQLSQVC 
 
Fig. 2.22. A. rubens GSS-like precursor (ArGSSLP). An N-terminal signal peptide 
is represented in blue, putative GSS-like neuropeptides (with cysteine (C) residues 
underlined) are represented red, a putative C-peptide is represented in black and 
dibasic cleavage sites are represented in green. 
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2.3.3.4. Relaxin-like precursor (ArRLP) 
 
The A. rubens relaxin-like precursor (ArRLP) is a 119-residue precursor protein 
comprising a predicted 30-residue N-terminal signal peptide and two putative 
relaxin-like peptides (Fig. 2.23; Fig. S61). These include the polypeptide sequences 
RSDHASVKHFCGLEFSYAVVTACGEA (residues 31-56) termed the Ar B-chain 
and QDYQGMATYCCTNGCTISQLTNSGIC (residues 94-119) termed the Ar A-
chain separated by a C-peptide (residues 59-91). The presence of an N-terminal 
glutamine (Q) residue in the Ar B-chain is indicative of a post-translational 
modification giving rise to an N-terminal pyro-glutaminyl (pQ) residue 
(pQDYQGMATYCCTNGCTISQLTNSGIC). It is noteworthy that the Ar B-chain 
contains two cysteine (C) residues (residues 41 and 53) and the Ar A-chain contains 
four cysteine (C) residues (residues 103, 104, 108 and 119), which are likely to form 
disulphide bridges and a peptide heterodimer between both chains based on the 
presence of this feature in the insulin and the relaxin-like peptide hormone family 
(Wilkinson et al., 2005). 
It is important to consider ArRLP in relation to insulin/IGF/relaxin 
superfamily precursors identified in other echinoderm species. ArRLP is only the 
third insulin/IGF/relaxin superfamily precursor to be identified in an echinoderm 
after the identification of SpIGF1 and SpIGF2 in the sea urchin S. purpuratus (Burke 
et al., 2006). SpIGF1 has characteristics of the both the insulin/IGF and relaxin/INSL 
sub-classes, with the presence of dibasic cleavage sites at the N-terminal and C-
terminal of the A-chain and B-chain indicative of cleavage of the C-peptide (Burke 
et al., 2006). However, the presence of a C-chain and D-chain is indicative of the 
insulin/IGF-subclass (Burke et al., 2006). SpIGF2 also has characteristics of the 
insulin/IGF sub-class, with no dibasic cleavage sites present at the N-terminal and C-
terminal of the A-chain and B-chain indicative of a lack of cleavage of the C-peptide 
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(Burke et al., 2006; Lapraz et al., 2006). However, unlike SpIGF1 and SpIGF2, it 
appears that ArRLP has characteristics of the relaxin/INSL sub-class with the 
presence of dibasic cleavage sites at the N-terminal and C-terminal of the A-chain 
and B-chain indicative of cleavage of the C-peptide (Burke et al., 2006). Moreover, 
ArRLP does not contain a D-domain and E-domain indicative of the insulin/IGF sub-
class. However, similar to GSS, the relaxin/INSL-like peptide derived from ArRLP 
does not have the relaxin-specific receptor-binding motif RxxxRxxI/V characteristic 
of the vertebrate relaxin-like peptides (Bullesbach and Schwabe, 2000).  
Interestingly, four orthologous relaxin/INSL genes are present in teleost fish 
and mammals (Good-Avila et al., 2009; Wilkinson and Bathgate, 2007). It has 
therefore been suggested that these vertebrate relaxin/INSL genes are a result of 
whole genome duplication (WGD) during the evolution of vertebrates from an 
invertebrate ancestor (Hoffmann and Opazo, 2011; Yegorov and Good, 2012). More 
specifically, it has been suggested that the relaxin/INSL genes are products of an 
ancestral system that originally consisted of three genes (two of which trace their 
origins back to the invertebrates) before subsequent diversification of the system 
through WGD (Yegorov and Good, 2012). Thus, it can be hypothesised that both 
ArGSSLP and ArRLP represent the ancient invertebrate orthologues of the vertebrate 
relaxin/INSL family.  
 To date, the physiological function of GSS has been well studied in A. 
pectinifera but not much is known about the function of relaxin/INSL-like peptide 
hormones in the echinoderms. To this extent, investigation would be facilitated by 
the identification of receptors that mediate the effects of GSS and relaxin/INSL-like 
peptide hormones. However, despite some understanding of the GSS signal 
transduction pathway (Mita, 2013a; Mita, 2013b), the identity of the GSS receptor 
remains unknown. It can be hypothesised that GSS and relaxin/INSL-like peptide 
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hormones bind to relaxin-like receptors. However, the A-chains and B-chains 
derived from both ArGSSLP and ArRLP do not contain the vertebrate relaxin-
specific receptor-binding motif RxxxRxxI/V (Bullesbach and Schwabe, 2000). 
Further studies would therefore be necessary to identify the receptors that mediate 
the effects of GSS and relaxin/INSL-like peptide hormones in starfish and other 
echinoderm species. 
 
Relaxin-like precursor (ArRLP) 
 
MTSCSHQMLALLSAVYILIFFLGGLPAVHARSDHASVKHFCGLEFSYAVVTACGEAK
RSIRSAPFFDMFPVFKSPERIPADFDDSSMIHVRKRQDYQGMATYCCTNGCTISQLT
NSGIC 
 
Fig. 2.23. A. rubens relaxin-like precursor (ArRLP). An N-terminal signal peptide 
is represented in blue, putative relaxin-like neuropeptides (with cysteine (C) residues 
underlined) are represented in red, a putative C-peptide is represented in black and 
dibasic cleavage sites are represented in green. 
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2.3.3.5. IGF-like precursors (ArIGF1-2) 
 
The A. rubens insulin-like growth factor 1 precursor (ArIGF1) is a 355-residue 
precursor protein comprising a predicted 27-residue N-terminal signal peptide and 
characteristic polypeptide A-E domains found in IGF-like precursors (Fig. 2.24A; 
Fig. S62) (Reinecke and Collet, 1998). It is noteworthy that the B-domain contains 
two cysteine (C) residues (residues 32 and 44) and the A-domain contains four 
cysteine (C) residues (residues 91, 92, 96 and 105), which are likely to form 
disulphide bridges and a peptide heterodimer between both domains based on the 
presence of this feature in the relaxin/INSL-like peptide hormone family. ArIGF1 
has dibasic cleavage sites at the C-terminal and N-terminal of the B-domain (residues 
28-55) and A-domain (residues 83-106) respectively, which would allow for the 
removal of the intervening C-peptide (residues 58-80) as in the relaxin/INSL-like 
peptide hormone family. However, the ArIGF1 A-domain extends to the D-domain 
(residues 107-133) and E-domain (residues 134-355), a feature found in IGF-like 
precursors (Reinecke and Collet, 1998). 
The A. rubens IGF 2 precursor (ArIGF2) is a 343-residue precursor protein 
comprising a predicted 22-residue N-terminal signal peptide and characteristic 
polypeptide A-E domains found in IGF-like precursors (with no D-domain detected) 
(Fig. 2.24B; Fig. S63) (Reinecke and Collet, 1998). It is noteworthy that the B-
domain contains two cysteine (C) residues (residues 41 and 53) and the A-domain 
contains four cysteine (C) residues (residues 66, 67, 71 and 80), which are likely to 
form disulphide bridges and a peptide heterodimer between both domains based on 
the presence of this feature in the relaxin/INSL-like peptide hormone family. 
However, unlike vertebrate insulin and relaxin, ArIGF2 does not contain dibasic 
cleavage sites at the C-terminal and N-terminal of the B-domain (residues 23-46) and 
A-domain (residues 61-81) respectively, indicating that the intervening C-peptide 
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(residues 47-80) is not processed for removal. Moreover, the ArIGF2 A-domain 
extends to the E-domain (residues 82-343), a feature also found in IGF-like 
precursors (Reinecke and Collet, 1998). 
It is important to consider ArIGF1 and ArIGF2 in relation to IGF-like 
precursors identified and subsequently characterised in the sea urchin S. purpuratus 
(Burke et al., 2006; Perillo and Arnone, 2014). ArIGF1 and SpIGF1 both have an A-
E domain organisation as found in IGF-like precursors and are more relaxin/INSL-
like in relation to potential removal of the C-peptide. ArIGF2 and SpIGF2 both have 
a similar A-E domain organisation (with no D-domain detected) and are more IGF-
like in relation to the C-peptide (Reinecke and Collet, 1998). Both the ArIGF1/2 A-
domains have the cysteine motif CCxxxCxxxxxxxxC, characteristic of the 
insulin/IGF/relaxin superfamily. Similarly, the B-domains both have the cysteine 
motif CxxxxxxxxxxxC, characteristic of the insulin/IGF/relaxin superfamily. 
Importantly, two disulphide bridges connecting the B-domain and A-domain and a 
single intra-disulphide bridge associated to the A-domain have been identified in 
SpIGF1 and SpIGF2 (Perillo and Arnone, 2014) suggesting that this is a feature of 
ArIGF1 and ArIGF2. However, it has been suggested that the lack of conservation in 
the C-E domains suggests that these domains are not involved in a conserved 
function and that their role may be species-specific (Perillo and Arnone, 2014). 
To date, the physiological function of IGF-like peptides in non-chordate 
deuterostomes and in particular echinoderms has not been extensively studied. 
However, it has previously been shown that mammalian insulin stimulates growth of 
the sea urchin embryo and that IGFs may be expressed in the sea urchin larval gut 
(de Pablo et al., 1988) and adult starfish gut (Wilson and Falkmer, 1965) suggesting 
a role in the feeding process. Moreover, microarray data confirm expression in the 
sea urchin embryo (Samanta et al., 2006). The identification of SpIGF1 and SpIGF2 
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in the sea urchin S. purpuratus has made it possible to investigate the roles of IGFs 
in the echinoderms (Burke et al., 2006). It has recently been shown that SpIGF1 is 
expressed in both the stomach and intestine of feeding larva with differential 
expression dependent on nutrient availability, suggesting a role for SpIGF1 in the 
feeding process (Perillo and Arnone, 2014). Moreover, it has been shown that 
SpIGF2 is expressed in the gastrula foregut, whilst a putative IGF-like receptor 
(SpInsr) is expressed in the mesodermal cells at the tip of the archenteron (Perillo 
and Arnone, 2014). Taken together, this suggests a role for SpIGF2 as a growth 
signal to stimulate coelomic pouch development (Perillo and Arnone, 2014). The 
discovery of ArIGF1 and ArIGF2 will facilitate investigation into the physiological 
functions of IGF-like peptides in a starfish species for the first time. 
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(A) Insulin-like growth factor 1-like precursor (ArIGF1) 
!
MFRNTSTMRALLLLDVIFVALVLPITAWPKICGEQLVETVSLVCSTRGFYSHRDSKR
DVEVFQNERAAKSFLGSRIGSRQRRRTGRIATECCDRICSFDIVESYCNPWPVAIES
RDPPLSPVAPGRVREDKSADVDYMYNPDVVDVEEANSVIQREEDLIDDIETQEQEIE
QDEEQNMQTLPEEDAEDTDIREPEDVEESFPVPVPTKKRRKVEGRRSKESKNKGGKS
EGKNKKRSGSREGGRSSRRSRGKSSRSKKQRDGRERSKRWEGLDTSHPVKEPTARSV
LGRVDTRPFRNFLYNRYTVDEKRDTERESYRAVAPLTGYNSHRGGSQPDNHPTLAAL
YNLAVKLAKGLQH 
 
(B) Insulin-like growth factor 2-like precursor (ArIGF2) 
 
MNQYQLIVLFEVLAHASMLNYASPVQLCGRELTETLRSICGDRGYYSPGQSFSRRAP
THDGIATRCCQSLCESSILETYCNLPAPPSQTQPSTAAPTTTTKMAPLTEDRRTKDV
VVDYSDQLATEGSQMSRVDGVLTHDTVTNRSKTTTESNEGSYDNEEGAPYDKPDDSS
PSERGESIQDEDNEVNKPEPNNIRDNSKERGRNRTHKGVSSERRANNSRRRGLSSER
RGSSSSRREEKLRRRRQRHRERELREQRKQSNSKRKSKGDKKDHSVAATTPLAVQER
PLKNGGRNSTSGEHSSVNGTETDTAGAGSPEVKKDDLITTITAVLSDMIGFQPDNGN
R 
 
Fig. 2.24. A. rubens IGF-like precursors. (A) Insulin-like growth factor 1-like 
precursor (ArIGF1). (B) IGF 2-like precursor (ArIGF2). N-terminal signal peptides 
are represented in blue, putative B-domains and A-domains (with cysteine (C) 
residues underlined) are represented in red, putative C-peptides are represented in 
black, a putative D-domain is represented in olive, putative E-domains are 
represented in maroon and dibasic cleavage sites are represented in green. 
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             *.  :       *     **   *    :     *
A.rub_IGF1 ICGEQLVETVSLVCSIATECCDRICSFDIVE--SYC    36
A.rub_IGF2 LCGRELTETLRSICGIATRCCQSLCESSILE--TYC    36
A.rub_GSS YCDEDFHMAVYRTCGMGSYCCLVGCTRDQLS--QVC    36
A.rub_Rel FCGLEFSYAVVTACGMATYCCTNGCTISQLTNSGIC    36
H.sap_INS LCGSHLVEALYLVCGIVEQCCTSICSLYQLE--NYC    36
H.sap_IGF1 LCGAELVDALQFVCGIVDECCFRSCDLRRLE--MYC    36
H.sap_Rel1 LCGRELVRAQIAICGMFEKCCLIGCTKRSLA--KYC    36
H.sap_Rel2 LCGRELVRAQIAICGMANKCCHVGCTKRSLA--RFC    36
H.sap_Rel3 LCGREFIRAVIFTCGGSSSCCKWGCSKSEIS--SLC    36
D.mel_INSL1 LCGPALSDAMDVVC-VYDECCVKTCSYLELA--IYC    36
D.mel_INSL2 LCSEKLNEVLSMVCEIVERCCKKSCDMKALR--EYC    36
D.mel_INSL3 LCGRKLPETLSKLC-VFDECCLKSCTMDEVL--RYC    36
D.mel_INSL4 MCGEALIQALDVIC-HE--CCKEGCTYDDIL--DYC    36
D.mel_INSL5 ACGPALMDMLRVAC-VVDSCC-RSCSFSTLR--AYC    36
D.mel_INSL6 MCSTGLSDVIQKIC-VTDLCCKSGCTYRELL--QYC    36 
 
Fig. 2.25. Conservation of insulin/IGF/relaxin-like peptide hormones in 
representative phyla and species across the Bilateria. ClustalX v.2.1 multiple 
sequence alignment of putative insulin/IGF/relaxin-like peptide hormones derived 
from precursors of representative species across the Bilateria. A.rub_IGF1, Asterias 
rubens insulin-like growth factor (IGF1) precursor 1; A.rub_IGF2, Asterias rubens 
IGF precursor 2; A.rub_GSS, Asterias rubens GSS precursor; A.rub_Rel, Asterias 
rubens relaxin-like precursor; D.mel_INSL1, Drosophila melanogaster insulin-like 
(INSL) peptide precursor 1 [GI: 317423340]; D.mel_INSL2, Drosophila 
melanogaster INSL peptide precursor 2 [GI: 442631434]; D.mel_INSL3, Drosophila 
melanogaster INSL peptide precursor 3 [GI: 221331056]; D.mel_INSL4, Drosophila 
melanogaster INSL peptide precursor 4 [GI: 442631435]; D.mel_INSL5, Drosophila 
melanogaster INSL peptide precursor 5 [GI: 320545737]; D.mel_INSL6, Drosophila 
melanogaster INSL peptide precursor 6 [GI: 442614930]; H.sap_INS, Homo sapiens 
insulin precursor [GI: 186429]; H.sap_IGF1, Homo sapiens IGF precursor [GI: 
49456676]; H.sap_Rel1, Homo sapiens relaxin-1 precursor [GI: 35932]; H.sap_Rel2, 
Homo sapiens relaxin-2 precursor [GI: 35926]; H.sap_Rel3, Homo sapiens relaxin-3 
precursor [GI: 17484095]. 
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2.3.4. Precursors of putative neuropeptides that appear to be unrelated to 
known bilaterian neuropeptide families 
 
Neuropeptide precursors previously identified in the sea urchin S. purpuratus (Rowe 
and Elphick, 2012) that are not known to be of a bilaterian origin were used for 
BLAST analysis of the neural transcriptome of the starfish A. rubens. Homologues of 
five neuropeptide precursors previously identified in S. purpuratus are discussed 
below (Table 5). However, homologues of nine sea urchin neuropeptide precursors 
(Spnp6-9, Spnp10, Spnp13, Spnp16-17 and Spnp20) were not identified in A. rubens. 
It could be possible that these neuropeptide precursors are unique to S. purpuratus. 
However, identification of Ajnp7, Ajnp9 and Ajnp16 in the sea cucumber A. 
japonicus (Rowe et al., 2014) suggests that it is likely that homologues for at least 
some of these neuropeptide precursors exist in other echinoderms but may be too 
divergent to be found by BLAST analysis.  
 
 
A. rubens 
precursor 
 
Precursor family 
 
Key peptide/precursor characteristics 
 
ArANPP 
 
AN-type 
 
Multiple peptides with an N-terminal AN motif 
 
Arnp11 
 
11-type 
 
Single/multiple peptide(s) with six conserved C 
residues 
 
Arnp15a-b 
 
15-type 
 
Single/multiple peptide(s) with six conserved C 
residues 
 
Arnp18 
 
18-type 
 
Single/multiple peptide(s) with eight conserved C 
residues 
 
Table 5. Summary of key peptide/precursor characteristics of non-bilaterian 
neuropeptide precursor families. Note that the table is not exhaustive and 
additional similarities and differences between neuropeptides/precursors are 
expanded on in the respective sub-headings. 
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2.3.4.1. AN peptide-type precursor (ArANPP) 
 
The. A. rubens AN peptide-type precursor (ArANPP) is a 274-residue precursor 
protein comprising a predicted 24-residue N-terminal signal peptide and six putative 
neuropeptides with an N-terminal dipeptide alanine-asparagine (AN) motif (Fig 
2.26; Fig. S64). These include two copies of the polypeptide sequence 
ANYHARGGKPRGGF (residues 179-192 and 219-232) termed ArANP1 and single 
copies of the polypeptide sequences ANHYASGRQRTRGKAGY (residues 56-72) 
termed ArANP2, ANYRASVSRGG (residues 95-105) termed ArANP3, 
ANYRATMNGG (residues 134-143) termed ArANP4 and ANYHASRGRQRGNG 
(residues 258-271) termed ArANP5 bounded by dibasic cleavage sites (KR/RR). The 
presence of a C-terminal glycine (G) residue on ArANP3-5 are indicative of post-
translational modifications giving rise to C-terminal amide groups on the mature 
peptides (e.g. ANYRASVSRG-NH2) based on the presence of C-terminal amidation 
in SpANP1, SpANP2 and SpANP3 derived from Spnp5 (SpANPP) in the sea urchin 
S. purpuratus (Menschaert et al., 2010; Rowe and Elphick, 2012). 
The AN-peptides are a family of peptides that to date have only been 
identified in the echinoderms (Rowe et al., 2014; Rowe and Elphick, 2012). The AN-
peptides do not appear to share any sequence similarities with neuropeptides 
identified in other phyla. It has previously been hypothesised that the presence of a 
putative amidated C-terminal lysine (K) residue in SpANP1, SpANP3 and SpANP5 
and the presence of a putative amidated C-terminal arginine (R) residue in AjANP2 
derived from Ajnp5 (AjANPP) in the sea cucumber A. japonicus suggests that 
amidated basic residues may be important structural features of the AN-peptides 
(Rowe et al., 2014). Interestingly, the feature of basic residue amidation is indicative 
of potential relationships with neuropeptides that have been discovered in the TK 
family of neuropeptides. However, the identification of a putative TK-like precursor 
! 154 
in A. rubens (see chapter 2.3.2.6) means that AN-type peptides are unlikely to be 
candidate members of the TK-like neuropeptide family and these similarities are 
likely due to convergence.  
However, despite the relationship of AN-type peptides with peptides in other 
phyla being currently unclear, it is important to consider ArANPP in relation to AN-
type precursors/peptides identified in other echinoderm species. ArANPP is the third 
member of the AN-type neuropeptide family to be identified after the identification 
of Spnp5 (SpANPP) in the sea urchin S. purpuratus (Rowe and Elphick, 2012) and 
Ajnp5 (AjANPP) in the sea cucumber A. japonicus (Rowe et al., 2014). ArANPP, 
along with SpANPP and AjANPP, contain multiple copies of putative peptides with 
an N-terminal dipeptide AN motif. ArANPP comprises six putative AN-type 
peptides, SpANPP comprises thirteen putative AN-type peptides whilst AjANPP 
comprises only three putative AN-type peptides. However, this could be in part due 
to the AjANPP sequence being a partial sequence (Rowe et al., 2014). It should also 
be noted that these putative AN-type peptides could be amidated or non-amidated at 
the C-terminal; ArANPP contains putative AN-type peptides both with and without a 
C-terminal glycine (G) residue as a substrate for amidation. However, AN-type 
peptides derived from both SpANPP and AjANPP all contain a C-terminal glycine 
(G) residue as substrates for amidation, with the exception of SpANP5 (Rowe and 
Elphick, 2012). Importantly, C-terminal amidation has been shown for SpANP1, 
SpANP2 and SpANP3 derived from SpANPP (Menschaert et al., 2010; Rowe and 
Elphick, 2012). 
To date, the physiological functions of the AN-type peptides in the 
echinoderms is currently unknown; preliminary pharmacological investigations of 
synthetic SpANP2 on in vitro tube foot and oesophagus preparations from the sea 
urchin species E. esculentus have not revealed any myoactive effects of the peptide 
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(Rowe and Elphick, 2012).  
 
AN peptide-type precursor (ArANPP) 
 
MARLDLILLLLSVVVAAVVLQCRADDENTDGQGAADVDEVLKQLYAEDENDDDKRAN
HYASGRQRTRGKAGYRRVTKSDMDAVAGLEDMDEEKRANYRASVSRGGKKGFRRYTK
SDGDEEEIPELEEMDEEKRANYRATMNGGRKPHRFNRFTKADGDGEEEEGPEDLEGE
DIDEDKRANYHARGGKPRGGFRRYTKSDEDQDAMEQAPAEEMDEDKRANYHARGGKP
RGGFRRYTKSDEDLAMGEAAADELDEEKRANYHASRGRQRGNGRRN 
 
Fig. 2.26. A. rubens AN peptide-type precursor (ArANPP). An N-terminal signal 
peptide is represented in blue, putative AN-type neuropeptides are represented in red, 
C-terminal glycine (G) residues are represented in orange and dibasic cleavage sites 
are represented in green. 
 
2.3.4.2. Arnp11 
 
Arnp11 is a 103-residue precursor protein comprising a 21-residue N-terminal signal 
peptide followed by an 82-residue polypeptide sequence (residues 22-103) that 
contains a dibasic cleavage site (RR) at residues 45 and 46 (Fig. 2.27; Fig. S65). The 
N-terminal region of the protein (residues 22-44) contains six acidic amino acid 
residues, which indicates that this part of the protein may function as an acidic spacer 
peptide. It can be proposed that it is the 57-residue polypeptide formed by residues 
47-103 that may be a secreted bioactive neuropeptide. However, there is the 
possibility that the secreted bioactive neuropeptide is a 54-residue polypeptide 
formed between residues 50-103 due to the presence of a putative dibasic cleavage 
site (RK) at residues 48 and 49. It is noteworthy that the 57-residue polypeptide 
includes six cysteine (C) residues located at positions 54, 58, 61, 72, 76 and 97, 
suggesting the presence of up to three potential disulphide bridges that would confer 
tertiary structure on the polypeptide. However, alternatively, a homodimeric protein 
could be formed by up to six intermolecular disulphide bridges. It should also be 
noted, however, that the 57-residue polypeptide also includes potential monobasic 
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cleavage sites (R/K), so there remains the possibility it is cleaved into two or more 
bioactive neuropeptides.  
Arnp11 was identified through sequence similarity with Spnp11 in the sea 
urchin S. purpuratus (Rowe and Elphick, 2012). Spnp11 comprises a putative 54-
residue polypeptide, which shares high sequence similarity with the putative 57-
residue polypeptide in Arnp11, including the presence of six cysteine (C) residues. 
However, the putative bioactive neuropeptides derived from both Arnp11 and 
Spnp11 do not share any apparent sequence similarity with neuropeptides or peptide 
hormones identified in any other phyla. However, neuropeptides of a similar size and 
with six cysteine (C) residues have been identified in other animals. For example, 
moult-inhibiting hormone (MIH) is a 78-residue neuropeptide in the crustacean 
Carcinus maenas with six cysteine (C) residues that form three intramolecular 
disulphide bridges (Webster, 1991).  
 
Arnp11 
 
MRTALVTFLAMLLVGDLIVSALPIDNEQDSDPIFDHLYTRNIVERRSRKDLTKCISE
CVSCAKYAGLYADKCVRGCSSKTSGKGIINKTEFDAWSACEQFLHR 
 
Fig. 2.27. A. rubens Arnp11 precursor. An N-terminal signal peptide is represented 
in blue, a putative neuropeptide (with cysteine (C) residues underlined) is 
represented in red and a dibasic cleavage site is green. 
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2.3.4.3. Arnp15a-b 
 
Arnp15a is a 111-residue protein comprising a predicted 19-residue N-terminal 
signal peptide followed by a 92-residue polypeptide sequence (residues 20-111) that 
contains a dibasic cleavage site (KR) at residues 54 and 55 (Fig. 2.28A; Fig. S66). 
The N-terminal region of the protein (residues 12-53) contains eight acidic amino 
acid residues, indicating that this part of the protein may function as an acidic spacer 
peptide. It can be proposed that is the 53-residue polypeptide formed by residues 56-
108 that may be a secreted bioactive neuropeptide. The presence of a C-terminal 
glycine (G) residue is indicative of a post-translational modification, giving rise to a 
C-terminal amide group on the mature peptide. However, the N-terminal region of 
the protein (residues 12-53) contains a potential dibasic cleavage (KR) site at 
residues 39 and 40, so there remains the possibility that the precursor forms two or 
more secreted bioactive neuropeptides. The presence of six cysteine (C) residues in 
the 53-residue polypeptide suggests that there may be up to three intramolecular 
disulphide bridges. Alternatively, a homodimeric protein could be formed by up to 
six intermolecular disulphide bridges.  
Arnp15b is a 111-residue protein comprising a predicted 25-residue N-
terminal signal peptide followed by an 86-residue polypeptide sequence (residues 26-
111) that contains a dibasic cleavage site (KR) at residues 63 and 64 (Fig. 2.28B; 
Fig. S67). The N-terminal region of the protein (residues 26-62) contains six acidic 
amino acid residues, indicating that this part of the protein may function as an acidic 
spacer peptide. It can be proposed that is the 47-residue polypeptide formed by 
residues 65-111 that may be a secreted bioactive neuropeptide. However, the N-
terminal region of the protein (residues 26-62) contains a potential dibasic cleavage 
site (KR) at residues 39 and 40, so there remains the possibility that the precursor 
forms two or more secreted bioactive neuropeptides. The presence of six cysteine (C) 
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residues in the 47-residue polypeptide suggests that there may be up to three 
intramolecular disulphide bridges. Alternatively a homodimeric protein could be 
formed by up to six intermolecular disulphide bridges.  
Arnp15a-b were identified through sequence similarity with Spnp15 in the 
sea urchin S. purpuratus (Rowe and Elphick, 2012). Spnp15 contains a putative 40-
residue bioactive neuropeptide, which shares high sequence similarity with the 
putative bioactive neuropeptides in Arnp15a-b, including the presence of six cysteine 
(C) residues. However, these peptides derived from both Arnp15a-b and Spnp15 do 
not exhibit any apparent sequence similarity with neuropeptides identified in any 
other phyla. However, neuropeptides of a similar size and with six cysteine (C) 
residues have been identified in other animals including the 28-residue neuropeptide 
trissin in the fruit fly D. melanogaster with six cysteine (C) residues that form three 
intramolecular disulphide bridges (Ida et al., 2011).  
 
(A) Arnp15a 
 
MKSILCICAIALLVEVVIGAPFAEMAGDMSDEDSQLFSKRVRDIISPLSHDLDKRKA
NLCAMDCFSCFKMIRNVSPDQCVTGCQKKSISDGSYSYDRMWNRCSSYLTGRRR 
 
(B) Arnp15b 
 
MSASTITTLLLSLAALSVFLPNASAEWSPDNDNNNDHKRAQMSAHDWLNSLLAGNDV
GHAKTKRIAKACAIDCLNCGMMFQVQAYSQGDCLTACQNDDNHRDPSCHEHITM 
 
Fig. 2.28. A. rubens Arnp15a-b precursors. (A) Arnp15a. (B) Arnp15b. N-terminal 
signal peptides are represented in blue, putative neuropeptides (with cysteine (C) 
residues underlined) are represented in red, C-terminal glycine (G) residues are 
represented in orange and dibasic/tribasic cleavage sites are represented in green. 
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2.3.4.4. Arnp18 
 
Arnp18 is a 113-residue precursor protein comprising a predicted 27-residue N-
terminal signal peptide followed by an 86-residue polypeptide sequence (residues 28-
113) that contains a dibasic cleavage sites (KR) at residues 36 and 37 (Fig. 2.29; Fig. 
S68). It can be proposed that it is the 76-residue polypeptide formed by residues 38-
113 that may be a secreted bioactive neuropeptide. It is noteworthy that this putative 
76-residue polypeptide contains eight cysteine (C) residues, which may form up to 
four intramolecular disulphide bridges. Alternatively, a homodimeric protein could 
be formed by up to eight intermolecular disulphide bridges.  
Arnp18 was identified through sequence similarity with Spnp18 in the sea 
urchin S. purpuratus (Rowe and Elphick, 2012). Spnp18 contains a putative 70-
residue bioactive neuropeptide, which shares high sequence similarity with the 
putative 76-residue bioactive neuropeptide in Arnp18, including the presence of 
eight cysteine (C) residues. However, these peptides derived from both Arnp18 and 
Spnp18 do not share any apparent sequence similarity with neuropeptides or peptide 
hormones identified in any other phyla. However, neuropeptides of a similar size and 
with eight cysteine (C) residues have been identified in other animals including the 
anti-gonadotropic peptide schistosomin in the pond snail L. stagnalis thought to 
contain four intramolecular disulphide bridges (Hordijk et al., 1991). 
 
Arnp18 
 
MQSSTVVTLATCLIIATIVTESASALAFQGSQDRAKRLFWVDKKSVNEDTTVCVRAS
SADDIAECFITECIKHQINCEMICGSDSEPCHSLCKAKKSDCAINCLEREQQSMSQ 
 
Fig. 2.29. A. rubens Arnp18 precursor. An N-terminal signal peptide is represented 
in blue, a putative neuropeptide (with cysteine (C) residues underlined) is 
represented in red and a dibasic cleavage site is represented in green. 
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2.4. General discussion 
 
Herein, the identification of a repertoire of novel neuropeptide precursors and a 
number of candidate receptors in the starfish A. rubens has provided a foundation to 
investigate the physiological functions of neuropeptide signalling systems in an 
echinoderm species, in many cases, for the very first time. Utilisation of this 
transcriptome dataset has been highlighted by the identification of the VP/OT-type 
peptide asterotocin and the NG peptide NGFFYamide, for which the physiological 
roles of these peptides has been investigated (see chapters 3 and 4). However, 
before undertaking further functional studies on other putative neuropeptides, it will 
be important to confirm these sequences through cloning and sequencing and 
potential post-translational modifications through the use of mass spectrometry (see 
chapters 3 and 4).  
The identification of novel neuropeptide precursors in the starfish A. rubens 
has also provided important insights into the evolutionary origins of a number of 
neuropeptide families. As an echinoderm species, A. rubens is a deuterostomian 
invertebrate and therefore occupies an intermediate position in animal phylogeny, 
bridging model protostomian invertebrates (e.g. Drosophila and C. elegans) to 
vertebrates to provide important insights into neuropeptide diversity and its 
functional significance across the animal kingdom. Amongst these novel 
neuropeptide precursors, and perhaps most interestingly from an evolutionary 
perspective, precursors comprising two KP-type peptides (the first identified in a 
non-chordate species), a MCH-type peptide (the first identified outside of the 
vertebrates) and two TK-type peptides (the first identified in an ambulacrarian 
species) have been discovered. Thus, the identification of neuropeptide precursors in 
A. rubens has provided important new insights into the evolutionarily ancient origins 
of neuropeptide signalling systems. 
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It is important, however, to note that the list of neuropeptide precursors 
identified here in the starfish A. rubens is unlikely to be exhaustive. Neuropeptides 
are typically comprised of relatively short stretches of amino acids with relatively 
few conserved residues, with the number and length of repetitive bioactive 
neuropeptides often changing through evolution. Therefore, neuropeptide precursors 
can often be too divergent to be identified through BLAST analysis alone. For 
example, it would be reasonable to expect to find homologues of the neuropeptide 
precursors Spnp7/Ajnp7, Spnp9/Ajnp9 and Spnp17/Ajnp17 in A. rubens, which have 
been identified in the sea urchin S. purpuratus (Rowe and Elphick, 2012) and the sea 
cucumber A. japonicus  (Rowe et al., 2014) respectively.  
However, attempts at providing a more comprehensive insight into the 
complement of neuropeptide precursors in a transcriptome dataset are being 
provided. For example, a number of novel neuropeptide precursors have been 
identified in the starfish A. rubens using the neuropeptide prediction tool termed 
NPsearch (https://rubygems.org/gems/NpSearch), which utilises common 
characteristics of neuropeptides and their precursors to identify novel sequences 
computationally. The development of computational tools that allow the 
identification of novel neuropeptide precursors will be vital in providing a 
comprehensive list of sequences present in a given transcriptome dataset.  
The starfish species A. rubens has been used as a model system for 
neuropeptide research for over twenty-five years, pioneered by the discovery of the 
first neuropeptides to be identified in an echinoderm – the SALMFamides S1 and S2 
(Elphick et al., 1991a; Elphick et al., 1991b). Now, in a post-genomic and 
transcriptomic era, the generation of a neural transcriptome dataset has revitalised the 
use of A. rubens as a model system for neuropeptide research in the echinoderms and 
has begun to provide important insights into neuropeptide function and evolution 
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(see chapters 3 and 4) and will provide the basis to provide further insights into a 
number of other novel neuropeptide signalling systems. 
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3. Discovery and functional characterisation of a novel vasopressin/oxytocin 
(VP/OT)-type neuropeptide (“asterotocin”) in the starfish A. rubens  
 
3.1. Introduction 
 
Vasopressin (VP) and oxytocin (OT) are highly related and evolutionarily conserved 
neurohypophyseal peptides with a plethora of known physiological functions in 
mammals and other vertebrates. VP (CYFQNCPRG-NH2) has been classically 
viewed as regulating vasoconstriction and osmoregulation (Henderson and Byron, 
2007; McCormick and Bradshaw, 2006), whilst OT (CYIQNCPLG-NH2) has been 
viewed as a reproductive hormone involved in uterine contraction and the 
stimulation of lactation (Gimpl and Fahrenholz, 2001).  
VP/OT-type peptides are also found outside of the vertebrates and have a 
widespread phylogenetic distribution indicative of an ancestry that dates back to at 
least as far as the common ancestor of the Bilateria (Jekely, 2013; Mirabeau and 
Joly, 2013; Stafflinger et al., 2008; van Kesteren et al., 1995). Thus, VP/OT-type 
peptides have been identified in vertebrates (Hoyle, 1999; Urano et al., 1992), 
protostomian invertebrates (Beets et al., 2012; Cruz et al., 1987; Garrison et al., 
2012; Jekely, 2013; Mirabeau and Joly, 2013; Proux et al., 1987; Reich, 1992; van 
Kesteren et al., 1992) and recently in a number of deuterostomian invertebrates 
(Elphick and Rowe, 2009; Jekely, 2013; Kawada et al., 2008; Mirabeau and Joly, 
2013; Ukena et al., 2008).  
VP/OT-type peptides are highly conserved across the Bilateria (Fig. 3.1). All 
known members of the VP/OT neuropeptide family have two conserved cysteine (C) 
residues in positions 1 and 6 of the mature neuropeptide that have been shown to 
form a disulphide bridge and confer a cyclic conformation that is important for 
biological activity (Hruby et al., 1990; Sawyer, 1977). VP/OT-type peptides have 
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hydrophobic residues in positions 2 and 3 of the mature neuropeptide, whilst other 
conserved features include a proline (P) residue in position 7 (exceptions include the 
urochordate Ciona intestinalis and the hemichordate Saccoglossus kowalevskii) and a 
C-terminal glycine (G) residue in position 9, which is usually a substrate for C-
terminal amidation (exceptions include the urochordate C. intestinalis and the 
nematode Caenorhabditis elegans). 
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             * : .*.      
H.sap_VP CYFQNCP-RG--G
H.sap_OT CYIQNCP-LG--G
T.rub_VP CYIQNCP-RG--G
T.rub_OT CYISNCP-IG--G
C.int_VP/OT CFFRDCSNMDWYR
B.flo_VP/OT CYIINCP-RG--G
S.kow_VP/OT CFISDCA-RG--G
S.pur_VP/OT CFISNCP-KG--G
C.tel_VP/OT CFIRNCP-IG--G
L.gig_VP/OT CFIRNCP-TG--G
D.pul_VP/OT CFITNCP-PG--G
T.cas_VP/OT CLITNCP-RG--G
C.ele_VP/OT CFLNSCP-YRRYG
 
Fig. 3.1. Conservation of VP/OT-type peptides in representative phyla and 
species across the Bilateria. ClustalX v.2.1 multiple sequence alignment of putative 
VP/OT-type neuropeptides derived from precursors of representative species across 
the Bilateria. B.flo_VP/OT, Branchiostoma floridae VP/OT-type precursor [GI: 
260828088]; C.ele_VP/OT, Caenorhabditis elegans VP/OT-type precursor [GI: 
86564869]; C.int_VP/OT, Ciona intestinalis VP/OT-type precursor [GI: 209529695]; 
C.tel_VP/OT, Capitella teleta VP/OT-type precursor [JGI: 173251]; D.pul_VP/OT, 
Daphnia pulex VP/OT-type precursor [GI: 321460843]; H.sap_OT, Homo sapiens 
OT precursor [GI: 189410]; H.sap_VP, Homo sapiens VP precursor [GI: 340298]; 
L.gig_VP/OT, Lottia gigantea VP/OT-type precursor [GI: 676470613]; 
S.kow_VP/OT, Saccoglossus kowalevskii VP/OT-type precursor [GI: 187155721]; 
S.pur_VP/OT, Strongylocentrotus purpuratus VP/OT-type precursor [GI: 
390337108]; T.cas_VP/OT, Tribolium castaneum VP/OT-type precursor [GI: 
145651811]; T.rub_OT, Takifugu rubripes OT precursor [GI: 410922774]; 
T.rub_VP, Takifugu rubripes VP-type precursor [GI: 410922770]. 
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3.1.1. VP/OT-type neuropeptide function in the vertebrates 
 
VP and OT regulate a range of physiological processes in mammals and other 
vertebrates. In addition to the classic peripheral functions of VP in regulating 
vasoconstriction, osmoregulation (Henderson and Byron, 2007; McCormick and 
Bradshaw, 2006) and liver glycogenolysis (Eugenin et al., 1998; Michell et al., 1979) 
and OT in regulating reproductive processes (Gimpl and Fahrenholz, 2001), VP and 
OT have also been implicated with various central neuromodulatory functions.  
VP and OT have been shown to have important roles in complex social 
cognition and behaviours including maternal-infant bonding and aggression (Broad 
et al., 2006; Caldwell et al., 2008; Donaldson and Young, 2008) in addition to pair 
bonding and attachment, which has been particularly well studied in vole species 
(Carter, 2014; Carter et al., 1995; Cho et al., 1999; Donaldson and Young, 2008; 
Insel and Young, 2001; Winslow et al., 1993; Young and Wang, 2004). These 
findings have stimulated a resurgence in interest in both VP and OT with respect to 
understanding human social behaviour. For example, VP and OT have recently been 
implicated in modulating social behaviour with respect to understanding autism, 
social anxiety disorder, borderline personality disorder and schizophrenia (McCall 
and Singer, 2012; Meyer-Lindenberg et al., 2011).  
 
3.1.2. VP/OT-type neuropeptide function across the animal kingdom 
 
Recent advances in comparative genomics/transcriptomics have provided new 
opportunities to discover neuropeptide signalling systems in a wider range of phyla 
and species across the animal kingdom. Despite the identification and 
characterisation of VP/OT-type neuropeptide signalling systems outside of the 
vertebrates, studies on the physiological roles that VP/OT-type peptides cover is 
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more limited. However, functional data has begun to provide important insights into 
the physiological roles of VP/OT-type peptides in these species and has provided 
insights into the evolutionarily ancient roles of the VP/OT-type neuropeptide 
signalling system in the common ancestor of the Bilateria. 
 
3.1.2.1. VP/OT-type peptides in the deuterostomes 
 
In the deuterostomian branch of the animal kingdom, recent genome/transcriptome 
sequencing has permitted the identification of VP/OT-type neuropeptide signalling 
systems in the urochordates, cephalochordates, hemichordates and the echinoderms. 
In the urochordates, VP/OT-type peptides have been identified in species including 
Styela plicata (Ukena et al., 2008), C. intestinalis (Kawada et al., 2008) and Ciona 
savignyi (Kawada et al., 2008). Functional studies in the urochordate S. plicata have 
revealed that Styela OT-related peptide (SOP) (CYISDCPNSRFWST-NH2) causes 
contraction of in vitro inhalant and exhalant siphon preparations, suggesting that 
SOP has an osmoregulatory role in preventing the influx of a low concentration of 
seawater into the body (Ukena et al., 2008). VP/OT-type peptides have also been 
identified in the cephalochordate B. floridae (Elphick, 2010; Gwee et al., 2009) and 
the hemichordate S. kowalevskii (Elphick, 2010). However, to date, there is no 
functional data on the role of VP/OT-type peptides in these species. In the 
echinoderms, a VP/OT-type peptide (“echinotocin”) has been identified in the sea 
urchin Strongylocentrotus purpuratus (Elphick and Rowe, 2009). Functional studies 
have revealed that echinotocin (CFISNCPKG-NH2) causes contraction of in vitro 
tube foot and oesophagus preparations from the sea urchin species Echinus 
esculentus, suggesting that echinotocin may have an osmoregulatory role through the 
retraction of tube feet to reduce water influx in hypo-osmotic conditions (Elphick 
and Rowe, 2009). Taken together with the role of VP in vertebrates, data from the 
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urochordate S. plicata and the echinoderm S. purpuratus suggest that the VP/OT-
type peptides may have an evolutionarily ancient role in osmoregulation (Elphick 
and Rowe, 2009). 
 
3.1.2.2. VP/OT-type peptides in the protostomes 
 
In the protostomian branch of the animal kingdom, recent genome/transcriptome 
sequencing has permitted the identification of VP/OT-type neuropeptide signalling 
systems across the lophotrochozoans including the mollusc Lottia gigantea 
(Veenstra, 2010) and the annelid Capitella teleta (Veenstra, 2011) and across the 
ecdysozoans including the arthropod Tribolium castaneum (Stafflinger et al., 2008) 
and the nematode C. elegans (Beets et al., 2012; Garrison et al., 2012). In 
comparison to the deuterostomian invertebrates, there have been more functional 
studies performed on the role of VP/OT-type peptides in the protostomian 
invertebrates. For example, functional studies in the mollusc Lymnaea stagnalis have 
revealed that Lys-conopressin (CFIRNCPKG-NH2) induces the contraction of male 
copulatory organs (van Kesteren et al., 1995) and regulates glycogen metabolism 
(Geraerts, 1992; van Kesteren et al., 1995). Functional studies in the annelid 
Whitmania pigra have revealed that both annetocin (CFVRNCPTG-NH2) and Lys-
conopressin induce egg-laying-like behaviours and changes body weight as a 
measure of water balance, suggesting that both peptides have both reproductive and 
osmoregulatory functions respectively (Fujino et al., 1999; Oumi et al., 1996). 
Functional studies in the arthropod T. castaneum have revealed that an arginine VP-
like peptide (AVPL) (CLITNCPRG-NH2) has diuretic activity and acts indirectly to 
affect Malpighian tubule function, indicating that AVPL is involved in the regulation 
of water homeostasis in insects (Aikins et al., 2008). However, perhaps the most 
exciting breakthrough into the role of VP/OT-type peptides has come from recent 
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behavioural genetic studies in the nematode C. elegans in which central 
neuromodulatory functions of VP/OT-type peptides have been investigated. It has 
been shown that nematocin (CFLNSCPYRRY-NH2) is involved in neuromodulation 
of male mating circuits and experience driven salt chemotaxis, a form of gustatory 
associative learning (Beets et al., 2012; Beets et al., 2013). It has therefore has been 
suggested that VP/OT-type peptides may in fact be ancient neuromodulators of 
neuronal circuits involved in associative learning (Beets et al., 2012; Beets et al., 
2013). Taken together, functional data from the deuterostomes and the protostomes 
suggest that VP/OT-type peptides may have had an evolutionarily ancient role in 
both reproductive and osmoregulatory processes, whilst data from C. elegans has 
provided insights into potential roles in associative learning (Beets et al., 2012; Beets 
et al., 2013). 
 
3.1.3. Investigating VP/OT-type peptides in A. rubens 
 
The sequencing of the genome of the sea urchin S. purpuratus (Sodergren et al., 
2006) led to the discovery of echinotocin, the first VP/OT-type peptide to be 
identified in an echinoderm species (Elphick and Rowe, 2009). However, despite 
echinotocin being shown to cause contraction of in vitro tube foot and oesophagus 
preparations in the sea urchin species E. esculentus, relatively little is known about 
the array of functions that echinotocin may cover in the sea urchin (Elphick and 
Rowe, 2009).  
The VP/OT-type peptide (“asterotocin”) in the common European starfish 
Asterias rubens (see chapter 2.3.2.1) is only the second VP/OT-type peptide to be 
identified in an echinoderm species and has provided further opportunities to 
investigate the function of VP/OT-type peptides in the echinoderms. The 
echinoderms provide a unique context for investigating the structure, function and 
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evolution of neuropeptide signalling systems; echinoderms possess a pentaradial 
morphological organisation along with the ability to autotomise, regenerate and 
rapidly and reversibly change the mechanical state of their body wall (Byrne, 2001; 
Patruno et al., 2001; Thorndyke et al., 2001; Wilkie, 2001; Wilkie, 2005). Moreover, 
as deuterostomian invertebrates, the echinoderms occupy an intermediate position in 
animal phylogeny, bridging model protostomian invertebrates (e.g. Drosophila and 
C. elegans) to the vertebrates. Therefore, investigating the function of asterotocin in 
A. rubens may provide important insights on neuropeptide diversity and its 
functional significance across the animal kingdom. 
 
3.1.4. Aims and objectives  
 
Herein, the analysis of neural transcriptome data from the starfish A. rubens has led 
to the discovery of a precursor protein that gives rise to a VP/OT-type peptide that 
has been termed “asterotocin” (see chapter 2.3.2.1). The discovery of the asterotocin 
precursor has provided an opportunity to: 
 
(1) Confirm the sequence of the asterotocin precursor by cDNA cloning and 
sequencing. 
(2) Determine the structure of the asterotocin peptide through the use of mass 
spectrometric methods. 
(3) Investigate the expression of the asterotocin precursor in the starfish A. rubens 
using mRNA in situ hybridisation (mRNA ISH). 
(4) Investigate the physiological functions of asterotocin in the starfish A. rubens 
using in vivo and in vitro pharmacological techniques. 
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3.2. Methods 
 
3.2.1. Bioinformatic identification of the asterotocin precursor and a candidate 
asterotocin receptor in A. rubens 
 
To search for a transcript encoding a VP/OT-type neuropeptide precursor in the 
starfish A. rubens, the sea urchin S. purpuratus VP/OT-type neuropeptide precursor 
(“echinotocin” precursor) protein sequence (Elphick and Rowe, 2009) was submitted 
as a query in a tBLASTn search of the A. rubens neural transcriptome using 
SequenceServer software (http://www.sequenceserver.com/) (Priyam et al., in prep). 
The protein sequence encoded by the top-hit (expect (e)-value) transcript was then 
analysed for the presence of an N-terminal signal peptide as predicted by SignalP 3.0 
(Bendtsen et al., 2004), a VP/OT-type peptide flanked by dibasic/monobasic 
cleavage sites and a C-terminal neurophysin domain, which is characterised by the 
presence of fourteen cysteine (C) residues (de Bree, 2000; de Bree and Burbach, 
1998). Subsequently, the protein sequence was submitted in a tBLASTn search of 
The National Centre for Biotechnology Information (NCBI) database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to determine sequence similarity to known 
neuropeptide or peptide hormone precursors.  
To search for a transcript encoding a candidate VP/OT-type receptor in the 
starfish A. rubens, the sea urchin S. purpuratus candidate echinotocin receptor 
protein sequence (Burke et al., 2006; Elphick and Rowe, 2009) was submitted as a 
query in a tBLASTn search of the A. rubens neural transcriptome using 
SequenceServer software (http://www.sequenceserver.com/) (Priyam et al., in prep). 
The protein encoded by the top-hit (e-value) transcript was then analysed for seven 
transmembrane domains characteristic of GPCRs using GPCRHMM 
(http://gpcrhmm.sbc.su.se).! Subsequently, the protein sequence was submitted in a 
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tBLASTn search of The National Centre for Biotechnology Information (NCBI) 
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to determine sequence similarity to 
known neuropeptide or peptide hormone receptors. 
 
3.2.2. Cloning and sequencing of the asterotocin precursor  
 
Total RNA generated from the same specimen of A. rubens used for Illumina Hi-Seq 
(see chapter 2.2.2) was used to generate cDNA using the Quantitect Reverse 
Transcription Kit (QIAgen). Asterotocin precursor cDNA containing the entire 
coding region was amplified by PCR using Phusion High-Fidelity PCR Master Mix 
(NEB) and the oligos:  5’-ACACAGTACTACGATCAG-3’ and 5’-
GTCACAAGTGACCATATC-3’. The PCR product was gel-extracted and purified 
using the QIAquick Gel Extraction Kit (QIAgen) before being blunt-end cloned into 
a pBluescript SKII (+) vector (Agilent Technologies) cut with the EcoRV-HF (NEB) 
restriction endonuclease. Two clones were sequenced from both the T3 and T7 
sequencing primer sites for sequence confirmation (Eurofins). A plasmid maxiprep 
was subsequently performed using the QIAgen Plasmid Maxi Kit (QIAgen). 
 
3.2.3. Mass spectrometric confirmation of asterotocin 
 
Radial nerve cords were dissected from five adult specimens of A. rubens using a 
method described previously (Chaet, 1964). Neuropeptides were then extracted in 1 
ml of 80 % acetone on ice (Elphick et al., 1991a). Acetone was subsequently 
removed by evaporation using nitrogen, with the aqueous fraction centrifuged at 
11,300 g in a MiniSpin® microcentrifuge (Eppendorf) for 10 minutes and the 
remaining supernatant stored at −80 °C. Prior to mass spectrometry (MS), the extract 
was thawed (with an aliquot diluted 10-fold with 0.1 % aqueous formic acid) and 
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filtered through a 0.22 µm Costar® Spin-X® centrifuge tube filter (Sigma-Aldrich) to 
remove particulates. The extract was analysed by nanoflow liquid chromatography 
(LC) with electrospray ionisation (ESI) quadrupole time-of-flight tandem MS (nano 
LC-ESI-MS/MS) using a nanoAcquity ultra performance LC (UPLC) system 
coupled to a Synapt® G2 High-Definition Mass SpectrometerTM (HDMS) (Waters 
Corporation) and MassLynx v.4.1 SCN 908 software (Waters Corporation). The 
mobile phases used for the chromatographic separation were 0.1 % aqueous formic 
acid (termed mobile phase A) and 0.1 % formic acid in acetonitrile (termed mobile 
phase B). An aliquot containing 15 µl of the A. rubens radial nerve cord extract was 
applied to a Symmetry C18® trapping column (180 µm x 20 mm, 5 µm particle size, 
100 Å pore size) (Waters Corporation) using 99.9 % mobile phase A at a flow rate of 
10 µl min−1 for 3 minutes, after which the fluidic flow path included the HSS T3 
analytical capillary column (75 µm x 150 mm, 1.8 µm particle size, 100 Å pore size) 
(Waters Corporation). A linear gradient of 5–40 % mobile phase B over 105 minutes 
was utilised with a total run time of 120 minutes. The nanoflow ESI source 
conditions utilised a 3.5 kV capillary voltage, 25 V sample cone voltage and an 80 
°C source temperature. The instrument was operated in resolution mode (~ 20,000 
measured at full width and half height). A data-dependent acquisition was performed 
that would trigger an MS/MS scan on any singly charged peptide having a 
mass/charge (m/z) ratio of 960.3919, or a doubly charged peptide of m/z 480.6999, 
with a tolerance of 100 mDa allowed on the precursor m/z. MS/MS spectra, obtained 
from data-dependent acquisition, were processed using MassLynx v.4.1 SCN 908 
software (Waters Corporation). Spectra were combined and processed using the 
MaxEnt 3 algorithm to generate singly charged, monoisotopic spectra for 
interpretation and manual validation.  
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3.2.4. Localisation of the asterotocin precursor in A. rubens using mRNA in situ 
hybridisation (mRNA ISH) 
 
3.2.4.1. Probe synthesis  
 
A total of 5 µg of maxipreped pBluescript SKII (+) vector containing the asterotocin 
precursor cDNA was linearised using either the restriction endonuclease SacI (NEB) 
(for sense probe) or KpnI (NEB) (for anti-sense probe) at approximately 3 hours at 
37 °C. Linearised cDNA was cleaned using a phenol-chloroform (Sigma-Aldrich) 
and chloroform-isomylalcohol (Sigma-Aldrich) extraction. Asterotocin precursor 
cDNA was precipitated using 1/10 volume of 3 M sodium acetate and 2.5 volumes of 
100 % ethanol at -80 °C for approximately 30 minutes before being vortexed for 30 
minutes at 4 °C. The supernatant was then removed and the pellet was washed with 
70 % ice-cold ethanol before air drying for approximately 1 hour and re-suspending 
in 12 µl autoclaved water. RNA probes were then synthesised using 2 µl digoxygenin 
nucleotide triphosphate (DIG-NTP) mix (Roche), 4 µl 5x transcription buffer (NEB), 
2 µl 0.2 M dithiothreitol (DTT) (Promega) and 0.5 µl placental ribonuclease inhibitor 
(10 U/µl) (Promega) using 0.5 µl T7 polymerase (50 U/µl) (NEB) with 1 µg of SacI 
linearised cDNA (for sense probe) or 0.5 µl T3 polymerase (50 U/µl) (NEB) with 1 
µg KpnI linearised cDNA (for anti-sense probe) in a 20 µl reaction for approximately 
3 hours at 37 °C. Template DNA was then digested with RNase free DNase (NEB) 
for approximately 30 minutes at 37 °C. RNA probes were stored in 25% 
formaldehyde (FA) / 2x saline-sodium citrate (SSC) at -20 °C for long-term storage. 
 !!!
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3.2.4.2. Tissue fixation 
 
Small adult specimens of A. rubens were fixed in 4 % paraformaldehyde (PFA) in 
phosphate-buffered saline (PBS) overnight at 4 °C. Specimens were washed in PBS 
for approximately 10 minutes. A. rubens arms were dissected and placed in Morse’s 
solution (10 % sodium citrate; 20 % formic acid in autoclaved water) for 
approximately 3 hours, whilst the central disk region was placed in Morse’s solution 
for approximately 8 hours, with the Morse’s solution changed approximately every 
2-3 hours. A. rubens arms and central disk region were then washed in autoclaved 
water before being placed sequentially in 50 % ethanol, 70 % ethanol, 90 % ethanol 
and 100 % ethanol (x3) for approximately 30 minutes. A. rubens arms and central 
disk region were then placed in xylene solution for 5 minutes and then subsequently 
for 8 minutes. A. rubens arms and central disk region were then placed in melted 
filtered wax for approximately 1 hour (x3) to remove xylene before leaving 
overnight to solidify.  
 
3.2.4.3. Tissue sectioning 
 
A series of adjacent 14 µm sections of A. rubens arms and central disk (from at least 
three individual animals) were prepared on a RM 2145 microtome (Leica). Sections 
were collected on poly-L-lysine coated slides (VWR) covered with autoclaved water 
on a hot plate. Slides were left to dry for approximately 20 minutes before removing 
excess autoclaved water and leaving to completely dry overnight before proceeding 
with probe hybridisation and immunodetection.  
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3.2.4.4. Probe hybridisation and immunodetection  
 
Slides were placed at 60 °C for approximately 1 hour to allow excess wax to melt 
before leaving to cool at room temperature for approximately 15 minutes. Slides 
were then placed in xylene solution for 7 minutes (x3) and then sequentially in 100 
% ethanol (x2), 90 % ethanol, 70 % ethanol, 50 % ethanol, 30 % ethanol and then in 
PBS (x2) for 7 minutes respectively. Slides were then post-fixed in 4 % PFA/PBS for 
20 minutes before washing with PBS/Tween 0.1 % for 5 minutes (x3) and 
subsequent treatment with 20 mg/ml proteinase K (QIAgen) (50 mM Tris-HCl [pH 
7.5]; 6.25 mM EDTA in autoclaved water) at 37 °C for 12 minutes. Slides were then 
post-fixed in 4 % PFA/PBS for 5 minutes before washing with PBS/Tween 0.1 % for 
5 minutes (x3) and then acetylated (1.325 % triethanolamine [pH 7-8]; 0.25 % acetic 
anhydride; 0.175 % HCl in autoclaved water) with stirring for 10 minutes. Slides 
were washed in PBS/0.1 % Tween-20 for 5 minutes (x2) and in 5x SSC for 5 
minutes. Slides were then dried and placed in a humidified chamber containing 5x 
SSC and covered with hybridisation buffer (50 % formamide; 5x SSC; 500 µg/ml 
yeast; 50 µg/ml heparin; 0.1 % Tween-20 in autoclaved water) at room temperature 
for approximately 2 hours. Asterotocin precursor sense and asterotocin precursor 
anti-sense probes (800 ng/ml) were denatured in 100 µl of hybridisation buffer at 80 
°C for 2 minutes and placed on ice before adding remaining hybridisation buffer to a 
total of 100 µl per slide. Slides were sealed with parafilm and placed in a humidified 
chamber containing 5x SSC at 65 °C overnight. 
 Parafilm was removed from slides by gentle shaking in 5x SSC heated to 65 
°C and then washed in 0.2x SSC at 65 °C for 40 minutes (x2). Slides were then 
washed in 0.2x SSC at room temperature for 10 minutes and equilibrated in buffer 
B1 (10 mM Tris-HCl [pH 7.5]; 150 mM NaCl in autoclaved water) for 10 minutes. 
Slides were covered in buffer B1/5 % goat serum and placed in a humidified 
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chamber containing autoclaved water at room temperature for approximately 2 
hours. Slides were then dried and covered in an alkaline phosphatase (AP)-
conjugated anti-DIG antibody (1:3000; Roche) in buffer B1/ 2.5 % goat serum at 4 
°C overnight. Slides were washed in buffer B1 for 5 minutes (x3) and then 
equilibrated in buffer B3 (100 mM Tris-HCl [pH 9.5]; 100 mM NaCl; 50 mM MgCl2 
in autoclaved water) for 10 minutes. Slides were then covered in buffer B3/0.1 % 
Tween-20 with nitro-blue tetrazolium chloride (NBT) (75 mg/ml in 70 % 
dimethylformamide) and 5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt 
(BCIP) substrate solution (50 mg/ml BCIP in autoclaved water) until desired staining 
was achieved. The staining reaction was stopped by rinsing slides in autoclaved 
water for 5 minutes (x3). Slides were then dried on a hot plate for approximately 45 
minutes before rinsing for 10 seconds in 100 % ethanol (x2) and Histo-Clear 
(Natural Diagnostics) for 7 minutes (x2). Slides were finally mounted in Histo-
Mount solution (Natural Diagnostics) for long-term storage.  
 Images were captured using a DMRA2 light microscope (Leica) with a 
MicroPublisher 5.0 Real-Time Viewing (RTV) digital colour camera (QImaging) 
and by utilising Volocity® v.5.3.1 image analysis software (PerkinElmer). 
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3.2.5. Analysis of the in vivo effects of asterotocin in A. rubens 
 
Hamilton 75N 5 µl syringes (Sigma-Aldrich) were used to inject synthetic 
asterotocin (CLVQDCPEG-NH2) (Peptide Protein Research Ltd.) at a range of 
concentrations into the perivisceral coelom of animals at two sites in the aboral body 
wall of the arms proximal to the junctions with the central disk region. Eversion of 
the cardiac stomach was observed in several animals. Subsequently, a total of thirty 
specimens of A. rubens were individually placed in a glass tank containing seawater. 
Animals were injected with 10 µl of 10 µmol l−1 synthetic asterotocin (a 
concentration selected based on preliminary observations) and video recorded for 
15 minutes. A number of animals were first injected with 10 µl autoclaved water 
(control) and video recorded for 15 minutes to ensure cardiac stomach eversion was 
not due to injection alone. Care was taken to inject test agents into the perivisceral 
coelom and not into the cardiac stomach. Static images from video recordings of five 
animals in which the cardiac stomach was visible for the duration of the experiment 
were captured at 1-minute intervals from the time of injection. Then the two-
dimensional area of everted cardiac stomach was measured from the images using 
ImageJ software (http://rsb.info.nih.gov/ij/) and normalised as a percentage of the 
area of the central disk of the animal. 
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3.2.6. Analysis of the in vitro effects of asterotocin on cardiac stomach 
preparations from A. rubens 
 
Informed by the in vivo effect of synthetic asterotocin triggering cardiac stomach 
eversion, experiments were performed to investigate the in vitro effects of 
asterotocin on dissected cardiac stomach preparations. Cardiac stomachs were 
dissected from specimens of A. rubens and set up in a 20 ml organ bath maintained at 
11 °C, as described previously (Fig. 3.2) (Elphick et al., 1995; Melarange et al., 
1999). The organ bath contained artificial seawater supplemented with 30 mM 
potassium chloride (KCl) to maintain the cardiac stomach in a contracted state to 
allow for expected muscle relaxation to be recorded. Stock solutions of synthetic 
asterotocin (CLVQDCPEG-NH2) (Peptide Protein Research Ltd.) were prepared in 
autoclaved water and then added to the organ bath to achieve final concentrations 
ranging from 30 pmol l–1 to 1 µmol l−1 upon the cardiac stomach maintaining a 
stabilised state. Cardiac stomach relaxation was recorded using an isotonic 
transducer (Harvard Apparatus) linked to a Goerz SE 120 chart recorder 
(Recorderlab). The preparation was subsequently washed with artificial seawater 
containing 30 mM KCl between different concentrations to allow the cardiac 
stomach preparation to return to a stabilised state. 
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tube foot and apical muscle preparations (Melarange and Elphick,
2003; Melarange et al., 1999). When tested at the same concentra-
tion the magnitude of the relaxing effect of S2 on the three prepara-
tions was found to be significantly larger than the relaxing effect of
S1 (Melarange and Elphick, 2003; Melarange et al., 1999). Further-
more, dose–response data obtained for cardiac stomach and tube
foot preparations have revealed that S2 is an order of magnitude
more potent than S1 (Fig. 1C) (Elphick and Melarange, 2001; Otara
et al., 2014).
Feeding in A. rubens and many other starfish species is accom-
plished by eversion of the cardiac stomach over the digestible parts
of prey (e.g., mussels, for A. rubens). Discovery of the relaxing effect
of S1 and S2 on cardiac stomach preparations in vitro provided a
rationale for investigating if this effect of S1 and S2 causes cardiac
stomach eversion in vivo. Injection of 100 ll of 1 mM S2 was found
to cause cardiac stomach eversion within 5 min in 57% of tests,
whereas injection of 100 ll of 1 mM S1 caused cardiac stomach
eversion within 5 min in only 11% of tests (Melarange et al.,
1999). Thus, the effectiveness of S1 and S2 in triggering cardiac
stomach eversion in vivo correlates with the potency of these pep-
tides in vitro. Furthermore, the discovery that SALMFamides trigger
cardiac stomach eversion in A. rubens provided the first insight on
neurochemical mechanisms underlying the unusual extraoral
feeding behaviour of starfish. Recently, a neuropeptide that trig-
gers cardiac stomach contraction in vitro and cardiac stomach
retraction in vivo has been identified as the pentapeptide NGFFYa-
mide (Semmens et al., 2013). Thus, counteracting neuropeptide
systems appear to be involved in controlling the process of cardiac
stomach eversion and retraction in starfish.
The pharmacological actions of SALMFamides have also been
investigated as potential regulators of hormone release in the star-
fish A. pectinifera. Gamete release in starfish is triggered by gonad-
stimulating substance (GSS), a neurohormone that is present in
starfish radial nerve cords and that is related to the mammalian
hormone relaxin (Mita et al., 2009). Release of GSS from radial
nerve cords can be triggered in vitro by KCl-induced depolarisation
and S1 causes dose-dependent inhibition of KCl-induced GSS re-
lease (Mita et al., 2004). Thus, S1 may act as a neurotransmitter
in the radial nerve cords of starfish that inhibits release of GSS. This
is interesting because it suggests a potentially important role for
SALMFamides as regulators of reproductive physiology in starfish.
Furthermore, the detection of S1-ir in the gonads of A. pectinifera
suggests that SALMFamides may regulate reproductive processes
peripherally as well as centrally (Mita et al., 2004).
2.6. Investigation of a structural basis for the differing potency of S1
and S2 in starfish
Recently, a structural basis for the difference in the potency of
S1 and S2 as muscle relaxants in the starfish A. rubens has been
investigated (Otara et al., 2014). The most striking difference be-
tween S1 and S2 is that S1 is an octapeptide (GFNSALMFamide)
whereas S2 is a dodecapeptide (SGPYSFNSGLTFamide), with four
additional N-terminal residues (SGPY). It was hypothesised, there-
fore, that the presence of these four residues may account for S2’s
greater potency compared to S1. Synthesis of an N-terminally trun-
cated analog of S2 (short S2 or SS2; SFNSGLTFamide) enabled
experimental testing of this hypothesis. However, the results
Fig. 1. SALMFamide expression and action in starfish. (A) S2-immunoreactivity in the cardiac stomach of Asterias rubens, localised in mucosal cell bodies (arrow) and their
processes in the underlying basiepithelial nerve plexus (asterisk). (B) The cardiac stomach of A. rubens. (i) Dissected animal showing cardiac stomach in situ. (ii) Isolated
cardiac stomach in vitro. (iii) Diagram showing how cardiac stomach contractility is recorded in vitro; (a) oral opening; (b) oesophagus; (c) intrinsic retractor strands; (d)
aboral part of cardiac stomach; (e) nodule; (f) extrinsic retractor strand; and (g) ambulacrum. Scale bar, 0.5 cm. (C) Graph comparing the dose-dependent relaxing effect of S1
and S2 on in vitro cardiac stomach preparations from A. rubens; S2 is approximately ten times more potent than S1. (D) Representative traces showing the relaxing effect of S2
(0.01–10 lM) on an in vitro cardiac stomach preparation from A. rubens. (A is from Newman et al. (1995b); (B) is from Elphick et al. (1995); (C) is from Elphick and Melarange
(2001); and (D) is from Melarange et al. (1999)).
4 M.R. Elphick / General and Comparative Endocrinology xxx (2014) xxx–xxx
Please cite this article in press as: Elphick, M.R. SALMFamide salmagundi: The biology of a neuropeptide family in echinoderms. Gen. Comp. Endocrinol.
(2014), http://dx.doi.org/10.1016/j.ygcen.2014.02.012
 
 
Fig. 3.2. Cardiac stomach assay. (i) Dissected specimen of A. rubens showing 
cardiac stomach in situ. (ii) An isolated A. rubens cardiac stomach in vitro. (iii) 
Illustration representing in vitro assay to measure cardiac stomach myoactivity. 
Cardiac stomach is tied to a force transducer and placed in an organ bath before 
addition of synthetic peptide to measure potential contraction and/or relaxation. a, 
oral opening; b, oesophagus; c, intrinsic retractor strands; d, aboral part of cardiac 
stomach; e, nodule; f, extrinsic retractor strand; g, ambulacrum. Scale bars, 0.5 c . 
Figure from Elphick et al., 1995 and Elphick, 2014. 
 
 
! 181 
3.3. Results 
 
3.3.1. Bioinformatic identification and cloning of the asterotocin precursor and 
identification of a candidate VP/OT-type receptor in A. rubens 
 
In BLAST analysis of the A. rubens neural transcriptome data using the sea urchin S. 
purpuratus echinotocin precursor as a query, the top-hit (e-value: 1e-17) was contig 
1119045 (2209 bp), which encodes a 147-residue protein termed the asterotocin 
precursor. The sequence of the asterotocin precursor has been confirmed by cDNA 
cloning and sequencing (Fig. 3.3). The precursor protein comprises a 23-residue N-
terminal signal peptide (residues 1-23) followed by a 9-residue putative VP/OT-type 
peptide (CLVQDCPEGG) (residues 24-33), with the C-terminal glycine (G) residue 
predicted to be subject to amidation (asterotocin; CLVQDCPEG-NH2). The 
asterotocin precursor also has a 78-residue C-terminal neurophysin domain 
comprising fourteen conserved cysteine (C) residues that are characteristic of 
VP/OT-type precursors (residues 44-121).  
In BLAST analysis of the A. rubens neural transcriptome data using the sea 
urchin S. purpuratus VP/OT-type receptor as a query, the top-hit (e-value: 1e-114) 
was contig 1122053 (2710 bp), which encodes a 428-residue protein (Fig. 3.4; Fig. 
A5L; Fig. S4). The 428-residue protein contains seven transmembrane domains 
characteristic of GPCRs, with phylogenetic analyses revealing that the GPCR is a 
VP/OT-type receptor (Fig. A2). 
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1    ac 
3    acagtactacgatcagcagacgagattgagggacgatcgctggtttttttgcgagagtac 
63   gcgattgataacgacttcatcatcaattggctcagatacgtttattgaataacctgttgt 
123  gaagagaaaagttgtccaaggatattccacagaacttccgtccggtggacgatgggcatg 
                                                         M  G  M    3  
183  aagtcaatggtggcgctgtggactggggtactggtcgcactgtgggttcaaagtcaagca 
      K  S  M  V  A  L  W  T  G  V  L  V  A  L  W  V  Q  S  Q  A   23  
243  tgtttagttcaagactgtccggaaggaggaaagaggtccagttataacacaatcagacag 
      C  L  V  Q  D  C  P  E  G  G  K  R  S  S  Y  N  T  I  R  Q   43  
303  tgcctatcctgcggccctggtggtttgggacaatgtgtaggttcagctatatgctgcggc 
      C  L  S  C  G  P  G  G  L  G  Q  C  V  G  S  A  I  C  C  G   63  
363  aatactttcggctgttttctcgggacaaaagaaaccttcgtgtgcagagaagaaagtcag 
      N  T  F  G  C  F  L  G  T  K  E  T  F  V  C  R  E  E  S  Q   83  
423  ctctccacaccttgtgaggttgttggagagacatgtgaatctattactgacgggaaatgt 
      L  S  T  P  C  E  V  V  G  E  T  C  E  S  I  T  D  G  K  C  103  
483  gtttcaaacggcttctgttgcaatgagagaagctgctctttagacgtagcgtgcagagaa 
      V  S  N  G  F  C  C  N  E  R  S  C  S  L  D  V  A  C  R  E  123  
543  accgatacagaacagagagacctcaaaaacagactcaaagagaggcttctggacgccctc 
      T  D  T  E  Q  R  D  L  K  N  R  L  K  E  R  L  L  D  A  L  143  
603  ttgcgtcaaccatgaacccagttaccactccctcaactttgttgataattttcacccaca 
      L  R  Q  P  *                                               147 
663  atgcaatgtgatatggtcacttgtgac 
 
Fig. 3.3. A. rubens asterotocin precursor cDNA sequence. The nucleotide 
sequence (lowercase, 689 bases) encoding the asterotocin precursor protein 
(uppercase, 147 amino acid residues) is shown. Primers used for cloning the 
asterotocin precursor cDNA are represented in bold and underlined text. The 
predicted signal peptide is represented in blue, putative asterotocin peptide is 
represented in red, a C-terminal glycine (G) residue that is a putative substrate for 
amidation is represented in orange and a putative dibasic cleavage site (KR) is 
represented in green. The C-terminal region of the precursor comprises a 
neurophysin domain (with fourteen characteristic cysteine (C) residues underlined), 
which is represented in purple. The asterisk shows the position of the stop codon. 
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1    atgacgccctcgcaggttttgacaactcgagtaccagtcgtggcaaccgatacaaaggaa 
      M  T  P  S  Q  V  L  T  T  R  V  P  V  V  A  T  D  T  K  E   20    
61   agtaatatatcacaagagggcgctgcgacgtatgggcttatgacaacgtcaacaccatac 
      S  N  I  S  Q  E  G  A  A  T  Y  G  L  M  T  T  S  T  P  Y   40  
121  catcctaccagagacaaccaactcgcaatagtggagatcctaatcacagcttctatattt 
      H  P  T  R  D  N  Q  L  A  I  V  E  I  L  I  T  A  S  I  F   60  
181  gtactggcaatcgttggtaataccattgtcattgcagttctctggcgtagacgcaagagc 
      V  L  A  I  V  G  N  T  I  V  I  A  V  L  W  R  R  R  K  S   80  
241  ctgtcgcgtatgcactattttatcatacacctttgcgtagcggatctgactgtagctttc 
      L  S  R  M  H  Y  F  I  I  H  L  C  V  A  D  L  T  V  A  F  100  
301  ttatacaccttgccacagatgttatgggatattacgtacaagttctacgccccggatgtt 
      L  Y  T  L  P  Q  M  L  W  D  I  T  Y  K  F  Y  A  P  D  V  120  
361  gtctgcaggcttgtcaagtattttcaactgttccctgtctatctatccacgtatatcctg 
      V  C  R  L  V  K  Y  F  Q  L  F  P  V  Y  L  S  T  Y  I  L  140  
421  gtgatgactgcaatagacaggtaccttgctatttgccaccctctaatgggtctgcgacgt 
      V  M  T  A  I  D  R  Y  L  A  I  C  H  P  L  M  G  L  R  R  160  
481  aaccaaacgtttcgcatgcgcgttatggtgctcatagcatggggaatagctgtggtatgc 
      N  Q  T  F  R  M  R  V  M  V  L  I  A  W  G  I  A  V  V  C  180  
541  agtttgccccagttggctgttttcaaactgaaaaatcgcaccccgaactcacatcaagag 
      S  L  P  Q  L  A  V  F  K  L  K  N  R  T  P  N  S  H  Q  E  200  
601  tggatggattgccgagctaactttcaaaacagcgcaggggtgaaggcttacatcaccttc 
      W  M  D  C  R  A  N  F  Q  N  S  A  G  V  K  A  Y  I  T  F  220  
661  ttcaccatggctatctacgtcatacccagcctgattctggctgccatgtacggtatgatc 
      F  T  M  A  I  Y  V  I  P  S  L  I  L  A  A  M  Y  G  M  I  240  
721  tgcctcaccgtctggaagaacatgggcaagaattacaagtcgtctgacaccaagacgccg 
      C  L  T  V  W  K  N  M  G  K  N  Y  K  S  S  D  T  K  T  P  260  
781  cagcaaccagcaccgcagaaagagaataacaactgggaggacgacgagacggacaaactg 
      Q  Q  P  A  P  Q  K  E  N  N  N  W  E  D  D  E  T  D  K  L  280  
841  aatccagaccatgttgagatgcaacaaccaacggtcaccaagaaggagtccagccagaaa 
      N  P  D  H  V  E  M  Q  Q  P  T  V  T  K  K  E  S  S  Q  K  300  
901  acgcaggtccaataccgacgtcacggggcggccggtaaggtgtcacgtgcgaagatcaag 
      T  Q  V  Q  Y  R  R  H  G  A  A  G  K  V  S  R  A  K  I  K  320  
961  acggtcaagatgacgctgactatagtaaccgtctatgtggtcacgtgggctccattcttc 
      T  V  K  M  T  L  T  I  V  T  V  Y  V  V  T  W  A  P  F  F  340  
1021 gttgcgcaaatgttgtcagtgtggacaacagttcaatttgactctttgttctttgccatt 
      V  A  Q  M  L  S  V  W  T  T  V  Q  F  D  S  L  F  F  A  I  360  
1081 gcgctcctgctgaccagtctgacgagctgcatcaacccctggatttacttcgcattctcc 
      A  L  L  L  T  S  L  T  S  C  I  N  P  W  I  Y  F  A  F  S  380  
1141 agcaacgccgggcgagatatcaaacagacctttggctgtttgaaagtttcacggcaagat 
      S  N  A  G  R  D  I  K  Q  T  F  G  C  L  K  V  S  R  Q  D  400  
1201 aatggtcttgcttccgataagactcaccacgacgaaacttcgagtcgtttcgtgtctaca 
      N  G  L  A  S  D  K  T  H  H  D  E  T  S  S  R  F  V  S  T  420  
1261 actggcactgcttccgctcacatgtag 
      T  G  T  A  S  A  H  M  *                                   438 
 
Fig. 3.4. A. rubens VP/OT-type receptor. The nucleotide sequence (lowercase, 
1287 bases) encoding the receptor protein (uppercase, 438 amino acid residues) is 
shown. The asterisk shows the position of the stop codon. Predicted transmembrane 
domains are highlighted in grey. 
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3.3.2. Mass spectrometric confirmation of the structure of asterotocin 
 
In order to perform both in vivo and in vitro functional studies, it is important to 
confirm the sequence and structure of the putative asterotocin peptide. Cloning and 
sequencing of the asterotocin precursor confirmed the presence of one copy of a 
VP/OT-type peptide (“asterotocin”) with the sequence CLVQDCPEGG (Fig. 3.3). 
However, it is important to confirm whether the asterotocin peptide has a disulphide 
bridge between the cysteine (C) residues in positions 1 and 6 and whether the C-
terminal glycine (G) residue is converted to an amide group. Nano LC-ESI-MS/MS 
using synthetic asterotocin as a standard was implemented, resulting in the peptide 
eluting at a retention time of 29.35 minutes with the singly charged species observed 
at a m/z of 960.39 (Fig. 3.5A). Subsequent analysis of the A. rubens radial nerve 
cord extract under identical conditions revealed that a single charged peptide with an 
m/z of 960.39 eluted at the same retention time to synthetic asterotocin (Fig. 3.5B). 
Both peptides were subjected to MS/MS during the experiment and the resulting 
deconvoluted, singly charged, monoisotopic spectra were compared, confirming the 
presence of asterotocin in the radial nerve cord extract (Fig. 3.5A-B).  
 
 
 
 
 
 
 
 
 
 
! 185 
(A) 
 
 
 
 
(B) 
 
 
 
Fig. 3.5. Mass spectrometric confirmation that asterotocin is present in the 
radial nerve cord of A. rubens. (A) MS/MS spectrum of synthetic asterotocin 
peptide. (B) MS/MS spectrum of asterotocin in an acetone extract of radial nerve 
cords of A. rubens. The deconvoluted, monoisotopic, singly charged spectrum 
derived from MS/MS data is shown, with the asterotocin peptide ion annotated 
(960.39).  
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3.3.3. Expression profile of asterotocin mRNA in A. rubens 
 
Serial sections were taken through the central disk and one arm of the starfish A. 
rubens to allow for visualisation of the expression of asterotocin precursor mRNA 
(or “asterotocin mRNA” for brevity) (Fig. 3.6). Expression of asterotocin mRNA 
was observed in the radial nerve cord, circumoral nerve ring, marginal nerve, tube 
feet, cardiac stomach, pyloric stomach, pyloric ducts, body wall and pedicellariae, 
which will be discussed on a one-by-one basis. Note that expression of asterotocin 
mRNA was not detected in control experiments utilising an asterotocin mRNA sense 
probe to detect non-specific binding (an example is provided in Fig. 3.7). 
 
 
Fig. 3.6. Diagram of a transverse section of an arm of A. rubens. Ampulla (am); 
apical muscle (AM); basal nerve ring (BNR); body wall (BW); coelomic nerve 
plexus (CNP); ectoneural nerve plexus (ec); hyponeural nerve plexus (hy); 
longitudinal nerve (LN); marginal nerve (MN); ossicle (os); papulae (pap); 
pedicellariae (ped); radial nerve cord (RNC); radial perihaemal canal (RPC); sub-
epithelial nerve plexus (SNP); tube feet (TF). Figure adapted from Moore and 
Thorndyke, 1993. 
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Fig. 4. Diagrammatic representation of a transverse section taken 
through the arm of Asterias showing the position of the radial nerve 
ord (RNC), tube feet (TF) and apical muscle (AMS); pedicellariae 
(PED); body wall (Bid/); coelomic nerve plexus (CNP); marginal 
nerve (MN); hyponeural nerve plexus (H Y); ectoneural nerve plexus 
(EC); radial perihaemal canal (RPC); longitudinal nerve (LN); basal 
nerve ring (BNR); sub-epithelial nerve plexus (SNP); ampulla 
(AM); ossicle (OS); papulae (P) 
sense organ (Smith 1937). The nerve cord is bounded 
orally by a layer of cuticle that separates it from the 
external environment, and aborally by the coelomic epi- 
thelium and perihaemal canal (Fig. 4). 
ICC revealed the presence of S1 in both ectoneural 
and hyponeural elements of the nerve cord; it was associ- 
ated with axons and epithelial cell bodies (Fig. 5A,B). The 
majority of the ectoneural immunoreactive cell bodies 
were bipolar, with fibres extending into the cuticle layer 
in one direction and ramifying through the neuropile in 
the other (Fig. 5C). The nerve fibres were particularly 
concentrated in the lateral borders of the cord mainly in 
a longitudinal orientation. Occasionally, however, later- 
ally oriented axons were also observed, especially at the 
edges of the nerve cord supplying the innervation to the 
tube feet (Fig. 6A) and the marginal nerves (Fig. 6B). 
S1 immunoreactivity associated with the hyponeural 
cell bodies revealed an interesting pattern of staining, 
with the cell bodies grouped at regular intervals in a gan- 
glionated fashion, on alternate sides of the nerve cord 
(Figs. 5A, 6C). The majority of the nerve fibres in the 
hyponeural region emerged from monopolar cell bodies, 
(Fig. 5B) and extended laterally, possibly innervating the 
inter-ambulacral muscles (Fig. 6E). 
S1 immunoreactivity in the optic cushion is confined 
to the ectoneural nerve plexus (Fig. 6F) and is associated 
with bipolar cell bodies and axons (Fig. 6D). The hy- 
poneural nerve plexus is restricted to the nerve cord 
proper. 
Tube feet and marginal nerves 
The tube feet are situated in the ambulacral groove and 
are an integral part of the water vascular system, being 
functionally involved in a variety of behaviours including 
locomotion, feeding and monitoring environmental 
change. They are connected to the RNC by the outer 
cuticle layer and the underlying sub-epithelial ectoneural 
nerve plexus, which is continuous with the ectoneural 
nerve plexus of the radial nerve. The nerve plexus is 
situated amongst epithelial cells and supporting fibres, 
and is separated from the longitudinally oriented retrac- 
tor muscle fibres by a region of connective tissue. 
Ciliated coelomic epithelial cells line the tube foot lumen 
(Fig. 4). 
S1 immunoreactivity was present extensively in axons 
of the sub-epithelial nerve plexus and basal nerve ring 
(Fig. 7A) and was associated with the single longitudinal 
nerve that comprised a local thickening of the sub-epithe- 
lial plexus (Fig. 7A,B). Epithelial cell bodies were evident 
in the proximal region of the tube foot near to its connec- 
tions with the RNC (Fig. 6E). The majority of the inner- 
vation was supplied from the ectoneural region of the 
RNC, with the marginal nerves believed to innervate the 
outer row of tube feet (Fig. 6B; Cu6not 1948). 
The marginal nerves are continuous with the extensive 
skin plexus (Figs. 4, 7D) which supplies part of the papu- 
lae innervation (Fig. 7C), whilst providing the only inner- 
vation to the pedicellariae (Fig. 7D; Roberts and Camp- 
bell 1988). 
Apical muscle 
This structure comprises a muscular thickening located 
aborally on the inside of the dorsal body wall (Fig. 4). It 
is believed to be involved in arm flexion during locomo- 
tion and feeding (O'Neill 1989). At the point where the 
arm joins the disc, the apical muscle is straddled by a 
band of circular sub-epidermal muscle, viz. the aboral 
autotomy plane, a predetermined point at which the arm 
always breaks during autotomy (Wilkie et al. 1990). 
The apical muscle is bounded orally by a single layer 
of ciliated coelomic epithelial cells and an overlying nerve 
plexus that appears to be continuous with the visceral 
innervation of the gut. Aboral to the nerve plexus is a 
region of longitudinal muscle separated from a deeper 
circular muscle layer by a band of connective tissue 
(Figs. 8; 9A). 
S 1 immunoreactivity is associated extensively with the 
coelomic nerve plexus supplied by bipolar epithelial cell 
bodies (Fig. 9B). Fibres from the nerve plexus ramify ex- 
tensively throughout the overlying longitudinal muscle 
layer as far as the connective tissue boundary; no fibres 
have been found to cross this barrier (Fig. 9A). S1 im- 
munoreactivity is also present in the deeper circular mus- 
cle layer (Fig. 9A). Some sections have revealed that S1 
immunoreactive neurones from this circular muscle layer 
penetrate between the aboral body wall ossicles, with fi- 
bres occasionally being associated with the calcite tissue 
itself (Fig. 9C). The area between the ossicles comprises 
reticular muscle and supporting connective tissue that is 
believed to realign the ossicles (O'Neill 1989). 
Sl immunostaining of the apical muscle has suggested 
for the first time that the coelomic nerve plexus is contin- 
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3.3.3.1. Radial nerve cord and circumoral nerve ring  
 
The decentralised nervous system of the starfish A. rubens is comprised of five radial 
nerve cords, located in each arm between ambulacral ossicles, which connect to the 
circumoral nerve ring. The circumoral nerve ring is located in the central disk region 
surrounding the mouth and is attached to and innervates the peristomal epidermis 
(Moore and Thorndyke, 1993). The circumoral nerve ring and radial nerve cords 
comprise an ectoneural and a hyponeural region separated by a thin band of 
connective tissue (Cobb, 1970). The ectoneural nerve plexus is both sensory and 
motor in function, whilst the hyponeural nerve plexus is solely motor in function, 
innervating the tube feet and body wall muscles (Cobb, 1987; Moore and Thorndyke, 
1993; von Hehn, 1970). 
 In transverse sections of the arm, expression of asterotocin mRNA was 
observed in the ectoneural region of the radial nerve cord but not in the hyponeural 
region (Fig. 3.8.A-B). The labelled cell bodies were located uniformally along the 
length of the radial nerve cord in the epithelium of the ectoneural nerve plexus (Fig. 
3.8.A-B). Asterotocin mRNA expression was also present in cell bodies located in 
the lateral branches of the ectoneural region of the radial nerve cord (Fig. 3.8D). In 
sections through the central disk, expression of asterotocin mRNA was also observed 
in the ectoneural region of the circumoral nerve ring (Fig. 3.8C), consistent with the 
expression pattern observed in the ectoneural region of the radial nerve cord. 
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Fig. 3.7. Control experiment for asterotocin mRNA expression in the radial 
nerve cord in A. rubens. Transverse section through an arm of A. rubens displaying 
the radial nerve cord. Asterotocin mRNA expression was not detected in the radial 
nerve cord utilising an asterotocin mRNA sense probe to detect non-specific binding. 
ec = ectoneural; hy = hyponeural. 
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Fig. 3.8. Asterotocin mRNA expression in the radial nerve cord, lateral 
branches of the radial nerve cord and circumoral nerve ring in A. rubens. (A-B) 
Transverse section through an arm of A. rubens displaying the radial nerve cord at 
two magnifications. Asterotocin mRNA expression was detected in the epithelium of 
the ectoneural nerve plexus of the radial nerve cord. (C) Transverse section through 
the central disk of A. rubens displaying the circumoral nerve ring. Asterotocin 
mRNA expression was detected in the ectoneural region of the circumoral nerve 
ring. (D) Transverse section through an arm of A. rubens displaying the lateral 
branches of the radial nerve cord. Asterotocin mRNA expression was detected in the 
ectoneural region of the lateral branches of the radial nerve cord. CONR = 
circumoral nerve ring; ec = ectoneural; hy = hyponeural; lat = lateral branch of 
radial nerve cord; RNC = radial nerve cord.  
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3.3.3.2. Tube feet and marginal nerve 
 
Four rows of tube feet are located in the ambulacral groove, with a pair of rows of 
tube feet on either side of the radial nerve cord. The epidermis of the tube feet, with 
an underlying sub-epithelial nerve plexus, is continuous with the ectoneural region of 
the radial nerve cord (Moore and Thorndyke, 1993). The sub-epithelial nerve plexus 
is separated from longitudinally oriented retractor muscle fibres by a thin layer of 
connective tissue (Moore and Thorndyke, 1993). The sub-epithelial nerve plexus 
approaches the adhesive region of the tube foot (sucker) in a circular orientation and 
branches and thickens to form the basal nerve ring at the distal end of the tube foot 
stem (Newman et al., 1995a). The outer row of tube feet are innervated by a 
thickening of the body wall sub-epithelial nerve plexus called the marginal nerve, 
which is continuous with the extensive skin plexus (Moore and Thorndyke, 1993).  
 In transverse sections through the arm and central disk, expression of 
asterotocin mRNA was observed in cells located in the adhesive region of tube feet 
suckers (Fig. 3.9A-B). However, expression of asterotocin mRNA was not observed 
in the basal nerve ring or the sub-epithelial nerve plexus. Asterotocin mRNA 
expression was also detected in the marginal nerve, which innervates the outer row 
of tube feet (Fig. 3.9C-D). 
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Fig. 3.9. Asterotocin mRNA expression in the tube feet and marginal nerve in A. 
rubens. (A-B) Transverse section through an arm of A. rubens displaying tube feet at 
two magnifications. Asterotocin mRNA expression was detected in the nerve plexus 
in the adhesive region of the tube foot sucker. (C-D) Transverse section through a 
single arm of A. rubens displaying a marginal nerve supplying innervation to a tube 
foot at two magnifications. Asterotocin mRNA expression was detected in the 
marginal nerve. ad = adhesive region of tube foot; MN marginal nerve; TF = tube 
foot.  
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3.3.3.3. Digestive system 
 
In the digestive system of the starfish A. rubens, the mouth is located at the centre of 
the disk on the oral side of the animal, surrounded by a muscular peristomal 
membrane. The mouth opens into a short oesophagus leading to the cardiac stomach 
(Ruppert et al., 2004). The cardiac stomach is an extensively folded structure that 
occupies a large proportion of the central disk and is connected aborally to a smaller 
pyloric stomach. A short duct, termed the pyloric duct, connects the pyloric stomach 
to a pair of digestive glands (pyloric caecae) in each arm. The aboral side of the 
pyloric stomach is connected to the anus by short tubular intestine (rectum), which 
has diverticulae known as rectal caecae (Ruppert et al., 2004).  
The gut is comprised of a single layer of ciliated peritoneal epithelial cells, 
with two thin layers of longitudinal and circular muscle (comprising the visceral 
muscle layer) associated innervation beneath (Fig. 3.10) (Moore and Thorndyke, 
1993). The visceral muscle layer is separated from the basiepithelial nerve plexus 
and adjacent epithelial cells lining the lumen of the gut by a continuous layer of 
connective tissue (Moore and Thorndyke, 1993). The majority of cells lining the 
lumen of the gut are ciliated, allowing the movement of partially digested material 
from the cardiac stomach through to the pyloric caeca. However, other cell types 
lining the lumen of the gut include mucosal goblet cells and granular secretory cells 
(Moore and Thorndyke, 1993). 
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Fig. 3.10. Diagram of the anatomy of the gut of A. rubens. Basiepithelial nerve 
plexus (BNP); coelomic epithelium (CE); connective tissue (con); lumen (lu); 
mucosa (mu); visceral muscle layer (VML); visceral nerve plexus (VNP). Figure 
adapted from Moore and Thorndyke, 1993. 
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Fig. 10. Diagram showing the general anatomy of the gut of Aster# 
as rubens. Lumen (LU); mucosa (MU); basiepitheliat nerve plexus 
(BNP); connective tissue (C7); visceral nerve plexus (VNP); visceral 
mu cle layer (VML); oelomic epithelium (CE)
ach. A short duct leads from the pyloric stomach into the 
pyloric caeca, where nutrients are stored and absorbed. A 
short intestine bearing two rectal caeca opens up into the 
anus from the aboral wall of the pyloric stomach. 
The tissues are bounded by a single layer of ciliated 
peritoneal epithelial cells, beneath which are two thin 
layers of longitudinal and circular muscle with their asso- 
ciated innervation. A continuous layer of connective tis- 
sue separates the muscle from the main nerve plexus and 
adjacent tall ciliated epithelial cells that line the lumen of 
the gut. The majority of these cells are ciliated, producing 
the currents that propel food particles from the cardiac 
stomach through to the pyloric caeca. Other cell popula- 
tions include mucous goblet cells and granular secretory 
cells (Fig. 10). 
Whole-mounts of the digestive system revealed $1 im- 
munostaining as a complex network of varicose fibres, 
together with numerous cell bodies (Fig. l lA). Many of 
the nerve fibres in the oesophagus were oriented perpen- 
dicular to the mouth opening (Fig. llB), whereas in the 
other tissues, the pattern was less ordered, with the fibres 
forming a meshwork (Fig. 11C). 
The oesophagus is attached to the peristomal mem- 
brane and is lightly grooved. St immunoreactivity in tis- 
sue sections is associated with the nerve plexus and nu- 
merous mucosal cell bodies (Fig. l iD). 
Whilst feeding, Asterias rubens everts the cardiac 
stomach through the mouth, after which the stomach is 
retracted back into the disc by contraction of the intrinsic 
and extrinsic retractor muscles. Unlike the oesophagus, 
the stomach is extensively pouched and folded producing 
a large surface area for digestion. S1 immunoreactivity is 
evident both in the nerve plexus and mucosal cell bodies, 
with the nerve plexus becoming thickened at the point 
where the intrinsic retractor muscles insert (Fig. 11E; An- 
derson 1954). As with the cardiac stomach, S1 im- 
munoreactivity in the pyloric stomach is also associated 
with axons in the nerve plexus and mucosal cell bodies 
(Fig. 1 IF). 
The pyloric caeca (which receive partially digested 
material from the pyloric stomach) comprise absorptive, 
secretory and storage cells. Histologically, this tissue is 
similar to the other regions, although the pattern of S1 
immunostaining is slightly different, with immunoreac- 
tive nerve fibres in amongst the visceral muscle layers and 
in association with the nerve plexus and mucosal cell 
bodies (Fig. 12A, B). A small amount of S1 immunoreac- 
tivity is also associated with the nerve plexus and cell 
bodies of the rectal caeca. 
No S1 immunoreactivity was detected in either the 
male or female gonads. Pre-absorbed controls carried out 
with the native peptide resulted in S1 immunostaining 
being effectively abolished (Fig. 12C,D). Pre-absorption 
with thyroglobulin, FMRFamide and FLRFamide had 
no significant effect, whereas $2 and LPLRFamide re- 
duced but did not abolish the immunostaining. The min- 
imal reduction of immunostaining noticed with $2 pre- 
absorption was evenly distributed throughout all the tis- 
sues and was considered to be attributable to the com- 
mon C-terminal F-amide. Comparison of the results fol- 
lowing the use of normal BLIV antiserum and that pre- 
absorbed with $2 showed no detectable difference in the 
distribution of immunoreactivity. Thus, we were con- 
vinced that BLIV revealed authentic S1 localization. 
D i s c u s s i o n  
The Echinodermata are the only deuterostome inverte- 
brate phylum, a feature that allies them to the Urochor- 
data, which are invertebrate deuterostomian members of 
the phylum Chordata. This feature combined with their 
radial symmetry secondarily derived from bilateral an- 
cestors, an internal skeleton of articulating calcite ossi- 
cles and possession of a true coelom make them a fasci- 
nating and evolutionary significant group of animals. 
The SALMFamides (S1 and $2) are the first neu- 
ropeptides to be isolated and fully characterized from 
this phylum. They have been identified from extracts of 
RNC from A. rubens and A. forbesii (Elphick et al. 
1991a,b). RIA has demonstrated an abundance of $1 in 
the nervous system of A. rubens (Moore et al. 1991). Here, 
specific antisera have been used to map the distribution 
of S1 at the light-microscopical level. This is the first time 
that a fully sequenced, native echinoderm neuropeptide 
has been demonstrated immunocytochemically. 
The adult echinoderm nervous system comprises five 
RNCs and a central CONR. Both structures consist of an 
oral ectodermal motor and sensory nerve plexus (the ec- 
toneural) and an aboral mesodermal motor plexus (the 
hyponeural). Initially, it was believed that the nerve ring 
acted as a "brain" controlling the arms via centres at the 
junction of each RNC with the nerve ring (Smith 1945; 
Kerkut 1955). This idea of cephalization has been largely 
discredited following the suggestion that these "centres', 
if present, are more functional than histological (Smith 
1950). Instead, the nerve ring is believed to act as a link 
between the arms, all of which can control whole animal 
behaviour (Cobb and Moore 1989). 
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In sections through the central disk, expression of asterotocin mRNA was 
observed in the cardiac stomach (Fig. 3.11) with sparser expression detected in the 
pyloric stomach and very sparse expression detected in the pyloric ducts (Fig. 3.12A-
B and Fig. 3.12D). However, expression of asterotocin mRNA was not observed in 
the peristomial epithelium, oesophagus, pyloric caecae (Fig. 3.12C), rectum, rectal 
caecae (Fig. 3.12A) or retractor strands. Labelled cell bodies appear to be more 
densely concentrated in the aboral region as opposed to the oral region of the cardiac 
stomach, which is densely packed with granular secretory cells (Fig. 3.11). In both 
the aboral and oral regions of the cardiac stomach, however, labelled cell bodies are 
largely concentrated in the basiepithelial nerve plexus (Fig 3.11). Labelled cell 
bodies are also located in the mucosal layer, with very sparse expression in the 
visceral muscle layer (Fig. 3.11). In the pyloric stomach, labelled cell bodies are 
sparsely located in the basiepithelial nerve plexus but are absent from the mucosal 
and visceral muscle layers (Fig. 3.12B). In the pyloric ducts, cell bodies are sparsely 
located in the basiepithelial nerve plexus and the mucosal layer but are absent from 
the visceral muscle layer (Fig. 3.12D). !
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Fig. 3.11. Asterotocin mRNA expression in the cardiac stomach of A. rubens. (A) 
Transverse section through the central disk of A. rubens displaying the oral and 
aboral regions of the cardiac stomach.  (B) Transverse section through the central 
disk of A. rubens displaying the aboral region of the cardiac stomach. Asterotocin 
mRNA expression was detected in the basiepithelial nerve plexus, with sparse 
expression in the mucosal layer. (C) Transverse section through the central disk of A. 
rubens displaying an oral region of the cardiac stomach. Asterotocin mRNA 
expression was detected in the basiepithelial nerve plexus, with sparse expression in 
the mucosal layer and the visceral muscle layer. (D) Transverse section through the 
central disk of A. rubens displaying the aboral region of the cardiac stomach. 
Asterotocin mRNA expression was detected in the basiepithelial nerve plexus, with 
sparse expression in the mucosal layer and visceral muscle layer. ab = aboral 
cardiac stomach; BNP = basiepithelial nerve plexus; mu = mucosal layer; or = oral 
cardiac stomach; VML = visceral muscle layer.  
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Fig. 3.12. Asterotocin mRNA expression in regions of the digestive system in A. 
rubens. (A) Transverse section through the central disk of A. rubens displaying the 
pyloric stomach and rectal caecae. Asterotocin mRNA expression was detected in the 
basiepithelial nerve plexus and mucosal layer of the pyloric stomach. (B) Transverse 
section through the central disk of A. rubens displaying the pyloric stomach. 
Asterotocin mRNA expression was detected in the basiepithelial nerve plexus and 
mucosal layer of the pyloric stomach. (C) Transverse section through the central disk 
of A. rubens displaying pyloric caecae. Asterotocin mRNA expression was not 
detected in the pyloric caecae. (D) Transverse section through the central disk of A. 
rubens displaying a pyloric duct. Asterotocin mRNA expression was detected in the 
basiepithelial nerve plexus and mucosal layer of the pyloric duct. AM = apical 
muscle; BNP = basiepithelial nerve plexus; CS = cardiac stomach; mu = mucosal 
layer; PC = pyloric caecae; PD = pyloric duct; PS = pyloric stomach; RC = rectal 
caecae.  
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3.3.3.4. Body wall and pedicellariae  
 
The starfish body wall comprises an epidermal layer, a dermal layer in which calcite 
ossicles are embedded, two layers of longitudinal and circular muscle forming the 
visceral muscle layer and an inner coelomic epithelium (O'Neill, 1989). The dermal 
layer is packed with fibres comprised of collagen fibrils forming an orthogonal array 
(Motokawa, 2011; O'Neill, 1989). In between these collagen fibrils, juxtaligamental 
cells controlling the mechanical properties of connective tissue are found 
(Motokawa, 2011; Wilkie, 2005). The expression of asterotocin mRNA was 
observed in cell bodies in the epidermal layer of the body wall (Fig. 3.13A). 
However, asterotocin mRNA was not observed in the dermal layer or in the inner 
coelomic epithelium (Fig. 3.13A). 
 The pedicellariae are small jaw-like structures present on the aboral surface 
that are primarily used to prevent colonisation of microorganisms (Roberts and 
Campbell, 1988). The pedicellariae consist of a short stalk surpassed by small 
ossicles, which together form the characteristic jaw-like structure (Moore and 
Thorndyke, 1993). The expression of asterotocin mRNA was observed in cell bodies 
in the epidermal layer of the pedicellariae, which lines both inside and outside of the 
jaw (Fig. 3.13B). 
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Fig. 3.13. Asterotocin mRNA expression in the body wall and pedicellariae in A. 
rubens. (A) Transverse section through the central disk of A. rubens displaying the 
body wall. Asterotocin mRNA expression was detected in cell bodies in the 
epidermal layer of the body wall. (B) Transverse section through the central disk of 
A. rubens displaying a single pedicellariae. Asterotocin mRNA expression was 
detected in cell bodies in the epidermal layer of the pedicellariae. BW = body wall; 
ep = epidermal layer; ped = pedicellariae.  
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3.3.4. Asterotocin causes cardiac stomach eversion in vivo 
 
In order to determine whether synthetic asterotocin (CLVQDCPEG-NH2) has an 
observable effect on any physiological processes in vivo, asterotocin was injected 
into the perivisceral coelom of the central disk region of the starfish A. rubens. 
Injections of the SALMFamides S1 (GFNSALMF-NH2) and S2 (SGPYSFNSGLTF-
NH2) have previously been shown to trigger cardiac stomach eversion in the starfish 
A. rubens (Elphick et al., 1995; Melarange et al., 1999). Interestingly, in the in vivo 
assay, injection of asterotocin (10 µl of 10 µmol l−1) into the perivisceral coelom also 
triggered eversion of the cardiac stomach. Informed by this initial observation, 
injection experiments were performed on a total of thirty specimens in order to 
determine whether the effect of asterotocin (10 µl of 10 µmol l−1) on cardiac stomach 
eversion was repeatable. Asterotocin triggered cardiac stomach eversion in 17/30 
experiments with variability in the rate and extent of eversion (Fig. 3.14). Fig. 3.14B 
shows data from five experiments in which the cardiac stomach could be monitored 
for the full duration of the experiment, with the mean area of cardiac stomach 
everted at 1-minute intervals during a 15 minute recording period following peptide 
injection at time 0 (T0) expressed as a percentage of the area everted in relation to the 
central disk area. Importantly, in control experiments in which starfish were injected 
with autoclaved water, no eversion of the cardiac stomach was observed. It should 
also be noted that in a number of specimens, postural changes including the thinning 
of arms, curling of arms and tube foot extension could be observed (Fig. 3.15). 
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Fig. 3.14. Asterotocin triggers cardiac stomach eversion in A. rubens. 
(A) Photographs from a representative experiment showing that injection of synthetic 
asterotocin (10 µl of 10 µmol l−1) causes cardiac stomach eversion. At time 0 (T0), no 
cardiac stomach eversion can be seen. At 7.5 minutes and 15 minutes after injection 
of asterotocin, cardiac stomach eversion is observed (outline of cardiac stomach 
marked by white dots). (B) Graph showing that injection of synthetic asterotocin 
(10 µl of 10 µmol l−1) causes cardiac stomach eversion. The area of cardiac stomach 
everted (in 2D) at each time point (0-15 minutes) is normalised to the area of central 
disk, with means (± s.e.m.) from five experiments shown. 
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Fig. 3.15. Representative example of postural changes in the starfish A. rubens 
following injection of synthetic asterotocin. Following injection of synthetic 
asterotocin (10 µl of 10 µmol l−1), in addition to cardiac stomach eversion (not 
shown), postural changes including the thinning of arms, curling of arms and tube 
foot extension was observed.  
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3.3.5. Asterotocin causes cardiac stomach relaxation in vitro 
 
In order to determine whether the effect of synthetic asterotocin on cardiac stomach 
eversion in vivo (Fig. 3.14) correlates with an effect on cardiac stomach relaxation in 
vitro, an in vitro assay previously used to show that the SALMFamides S1 and S2 
cause cardiac stomach relaxation was implemented (Fig. 3.2) (Elphick and 
Melarange, 1998; Elphick et al., 1995; Melarange et al., 1999). In the in vitro assay, 
the addition of asterotocin to cardiac stomach preparations revealed that it caused 
dose-dependent relaxation at concentrations ranging from 30 pmol l–1 to 1 µmol l−1 
(Fig. 3.16); this is consistent with the effects of asterotocin on cardiac stomach 
eversion in vivo. A total of sixteen adult specimens were analysed, with the maximal 
efficacy of asterotocin observed at 100 nmol l−1 (Fig. 3.16).  !
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Fig. 3.16. Asterotocin is a potent stimulator of cardiac stomach relaxation in A. 
rubens. (A) Representative recordings from a single cardiac stomach preparation 
showing the dose-dependent effect of synthetic asterotocin (30 pmol l–1 to 
1 µmol l−1). The application of asterotocin (upward-pointing arrowheads) causes 
cardiac stomach relaxation in a typical time-frame of 1-2 minutes, whilst the effect of 
asterotocin is reversed by washing (downward-pointing arrowheads). (B) Graph 
showing the dose-dependent effects of synthetic asterotocin (30 pmol l–1 to 
1 µmol l−1). The effects of asterotocin are normalised to the maximal effect observed 
with asterotocin in each experiment, with mean values (± s.e.m.) from sixteen 
experiments shown. 
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3.4. Discussion 
 
3.4.1. Discovery of asterotocin, a VP/OT-type peptide in A. rubens 
The asterotocin precursor in the starfish A. rubens is only the second VP/OT-type 
precursor to be discovered in an echinoderm species after the discovery of the 
echinotocin precursor in the sea urchin S. purpuratus (Elphick and Rowe, 2009). The 
asterotocin precursor contains an N-terminal signal peptide, one copy of the 
sequence CLVQDCPEGG flanked by a dibasic cleavage site (KR) and a C-terminal 
neurophysin domain (Fig. 3.3). Importantly, mass spectrometry has confirmed that 
the C-terminal glycine (G) residue of asterotocin is converted to an amide group 
(CLVQDCPEG-NH2) (Fig. 3.5). In addition to the presence of a C-terminal amide 
group, comparison of asterotocin with other VP/OT-type peptides in phyla across the 
animal kingdom reveals interesting similarities and differences. Asterotocin, as with 
all known members of the VP/OT neuropeptide family, comprises two conserved 
cysteine (C) residues in positions 1 and 6 of the mature neuropeptide that has been 
shown to form a disulphide bridge and confer a cyclic conformation that is important 
for biological activity (Hruby et al., 1990; Sawyer, 1977). Importantly, the presence 
of this disulphide bridge has also been confirmed by mass spectrometry (Fig. 3.5). 
Asterotocin has a leucine (L) and a valine (V) residue in positions 2 and 3 of the 
mature neuropeptide, respectively, which is consistent with the occurrence of 
hydrophobic residues in these positions in other members of the VP/OT neuropeptide 
family. Moreover, asterotocin has an aspartic acid (D) residue in position 5 of the 
mature neuropeptide similar to two VP/OT-type peptides identified in the 
urochordates C. intestinalis and S. plicata (Kawada et al., 2008; Ukena et al., 2008) 
and in the nematode C. elegans (Beets et al., 2012; Garrison et al., 2012). 
Asterotocin also has a proline (P) residue in position 7 along with a C-terminal 
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glycine (G) residue in position 9, which undergoes C-terminal amidation as with all 
other known VP/OT-type peptides.  
Interestingly, asterotocin is the first VP/OT-type peptide with an acidic 
residue in position 8 of the mature neuropeptide, as opposed to a basic or neutral 
residue (Fig. 3.1; Fig. 3.3). Interestingly, the amino acid residue in position 8 of 
vertebrate VP (CYFQNCPRG-NH2) and OT (CYIQNCPLG-NH2) is the amino acid 
residue in which both peptides are structurally and functionally distinguished through 
binding to their respective receptors. This can also be seen in the mollusc L. 
stagnalis, where Lys-conopressin (CFIRNCPKG-NH2) activates two VP/OT-type 
receptors with differential expression patterns in the brain and peripheral 
reproductive structures – L. stagnalis conopressin receptor 1 (LSCPR1) and LSCPR2 
(van Kesteren and Geraerts, 1998; van Kesteren et al., 1995; van Kesteren et al., 
1996). Interestingly, LSCPR2 is maximally activated by Lys-conopressin and the 
OT-like analogue Ile-conopressin (differing only via the amino acid residue at 
position 8), whilst LSCPR1 is only maximally activated by Lys-conopressin with Ile-
conopressin approximately ten-times less potent (van Kesteren et al., 1995). 
However, to date, only one candidate VP/OT-type receptor has been identified in the 
starfish A. rubens (Fig. 3.4; Fig. A5L; Fig. S4) and in other echinoderms, including 
the sea urchin S. purpuratus in line with the presence of one VP/OT-type peptide 
(Elphick and Rowe, 2009). The functional significance of the acidic residue in 
position 8 of the mature neuropeptide remains to be explored. 
 
3.4.2. Cardiac stomach eversion and retraction in A. rubens 
 
To date, a number of neuropeptidergic and non-neuropeptidergic mediators of 
cardiac stomach eversion and cardiac stomach retraction, crucial to the remarkable 
extraoral feeding process in starfish, have been identified. In terms of cardiac 
! 212 
stomach eversion, it has been found that the gaseous signalling molecule nitric oxide 
(NO) (Elphick and Melarange, 1998) and the SALMFamide neuropeptides S1 
(GFNSALMF-NH2) and S2 (SGPYSFNSGLTF-NH2) (Elphick et al., 1991a) cause 
relaxation of in vitro cardiac stomach preparations from the A. rubens (Elphick and 
Melarange, 1998; Elphick et al., 1995; Melarange et al., 1999). Immunocytochemical 
studies have also revealed that NO synthase (NOS), S1 and S2 are present in the 
innervation of the cardiac stomach in starfish (Martínez et al., 1994; Newman et al., 
1995a; Newman et al., 1995b). Together, these data indicate that NO and the 
SALMFamides may mediate neural control of cardiac stomach relaxation (Elphick 
and Melarange, 2001). Further evidence in support of the role of S1 and S2 in 
cardiac stomach eversion is the observation that injection of both synthetic peptides 
can trigger cardiac stomach eversion when injected into the perivisceral coelom of 
the starfish A. rubens (Melarange et al., 1999). In terms of cardiac stomach 
retraction, it has been found that the neurotransmitter acetylcholine (ACh) causes 
contraction of extrinsic stomach retractor strands (Basch, 1956; Burnett and 
Anderson, 1955) and contraction of in vitro cardiac stomach preparations from A. 
rubens (Elphick et al., 1995) and it is also therefore likely that ACh mediates neural 
control of cardiac stomach retraction in vivo (Elphick et al., 1995). 
 
3.4.3. Asterotocin: a regulator of cardiac stomach eversion  
 
Investigation into the in vivo effects of asterotocin revealed that it also triggers 
cardiac stomach eversion in the starfish A. rubens (Fig. 3.14). However, it is 
important to note that only a total of 17/30 animals responded to injection of 
asterotocin with eversion of the cardiac stomach. This could be in part due to the 
relative nature of access of the peptide to muscles in the cardiac stomach via 
injection into the perivisceral coelom in the aboral body wall of the arms proximal to 
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the junctions with the central disk region. Here, access of asterotocin to cardiac 
stomach muscle would be limited by the compact nature of the cardiac stomach prior 
to eversion. Investigation into the in vitro pharmacological effects of asterotocin 
reveals that it causes dose-dependent relaxation of cardiac stomach preparations at 
concentrations ranging from 30 pmol l−1 to 1 µmol l−1, with a maximal efficacy at 
100 nmol l−1 (Fig. 3.16). In combination, these data suggest that asterotocin may 
mediate neural control of cardiac stomach eversion during the process of feeding in 
starfish. 
It is of interest to compare the effects of asterotocin to the SALMFamides S1 
and S2 in causing cardiac stomach relaxation in vitro and eversion in vivo. In vitro, 
the maximal effect of asterotocin was observed at 100 nmol l−1 compared to the 
maximal effects of the SALMFamides S1 and S2 at 10 µmol l−1 (Melarange et al., 
1999). Moreover, asterotocin caused cardiac stomach relaxation at 30 pmol l-1 
compared to the SALMFamides S1 at 10 nmol l-1 and S2 at 1 nmol l-1 respectively 
(Melarange et al., 1999). In vivo, asterotocin triggered cardiac stomach eversion 
upon injection of 10 µl of 10 µmol l−1 peptide compared to injection of 100 µl of 
1 mmol l−1 S1 and S2 (Melarange et al., 1999). However, it is important to note that 
such a comparison between asterotocin and the SALMFamides S1 and S2 may not 
be physiologically relevant. Both S1 and S2 in A. rubens are derived from distinct 
precursor proteins that comprise six and seven other putative SALMFamides, 
respectively (see chapter 2.3.1). It would therefore be necessary to compare the 
effect of asterotocin with “cocktails” of S1 and S2 precursor-derived SALMFamides. 
It appears that there may be redundancy of function with respect to neuropeptidergic 
control of cardiac stomach eversion during starfish feeding, with both asterotocin and 
the SALMFamides S1 and S2 implicated in the process (Melarange et al., 1999). 
Such redundancy of function could be in part due to the utilisation of distinct 
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peptidergic systems in different contexts of the feeding process. 
In combination with the effects of asterotocin in vivo and in vitro, the 
expression profile of asterotocin mRNA provides further evidence for the role of 
asterotocin in mediating neural control of cardiac stomach eversion. Importantly, 
asterotocin mRNA is expressed in the cardiac stomach of the starfish A. rubens, with 
cell bodies concentrated in the basiepithelial nerve plexus, with fewer cell bodies 
associated with the mucosal layer and visceral muscle layer (Fig. 3.11). This 
expression profile suggests that asterotocin may mediate cardiac stomach eversion by 
two potential mechanisms. Firstly, asterotocin may be released from processes of 
asterotocin-expressing cells located in the basiepithelial nerve plexus and diffuses 
across a thin connective tissue layer to reach the visceral muscle layer (Fig. 3.10). 
Alternatively, processes of asterotocin-expressing cells may project across the 
connective tissue layer to reach the visceral muscle layer directly. In this regard, 
developing antibodies to asterotocin and performing immunocytochemistry (ICC) 
will be crucial in providing insights into the functional mechanism of the peptide. 
Interestingly, it should be noted that cell bodies appear to be more densely 
concentrated in the aboral region as opposed to the oral region of the cardiac 
stomach, which is densely packed with granular secretory cells (Fig. 3.11). It should 
also be noted that asterotocin mRNA was also detected in the pyloric stomach and 
pyloric ducts, with cell bodies sparsely located in the basiepithelial nerve plexus and 
mucosal layer but absent from the visceral muscle layer (Fig. 3.12). These results are 
consistent with immunoreactivity of the SALMFamide S1 in both the cardiac and 
pyloric stomach (Moore and Thorndyke, 1993). However, S1 expression is also 
associated with other parts of the digestive system including the mouth, oesophagus 
and pyloric caecae (Moore and Thorndyke, 1993). Taken together, the expression 
profile of asterotocin mRNA throughout the digestive system reinforces the role of 
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asterotocin in regulating cardiac stomach eversion as opposed to digestive processes.  
It will be important to determine where asterotocin and, upon 
pharmacological characterisation, the candidate asterotocin receptor (Fig. 3.4; Fig. 
A5L; Fig. S4) are expressed in relation to one another in the context of the starfish 
body plan to further explore the role of asterotocin in cardiac stomach eversion. In 
addition to utilising mRNA ISH, it will also be important to develop antibodies to 
asterotocin and the candidate asterotocin receptor to perform ICC, which will help to 
distinguish the specific cell types that asterotocin is expressed in with regards to the 
mucosal layer of the gut, which includes ciliated epithelial cells (which propel food 
particles from the cardiac stomach through to the pyloric stomach) in addition to 
mucous goblet cells and granular secretory cells (Moore and Thorndyke, 1993). It 
will also be important to determine the signalling cascades that are involved in 
eliciting the cardiac stomach eversion response in order to provide insights into 
asterotocins mode of action. The expression of asterotocin mRNA in the cardiac 
stomach (and absence from retractor strands) suggests that asterotocin may exert its 
effects on the cardiac stomach either directly or indirectly (via cell bodies in the 
basiepithelial nerve plexus) by binding to its candidate receptor, which may lead to 
changes in secondary messenger levels or ion channel conductance (Elphick and 
Melarange, 2001). However, there remains the possibility that asterotocin acts 
indirectly by promoting the release of NO from neurons that innervate the visceral 
muscle layer (Elphick and Melarange, 2001). Previous studies have shown the 
gaseous neuronal signalling molecule NO is also involved in the process of cardiac 
stomach relaxation through the cyclic guanosine monophosphate (cGMP)-generating 
enzyme soluble guanylyl cyclase (Elphick and Melarange, 1998). However, 
experiments utilising 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), a soluble 
guanylyl cyclase inhibitor, on S2-induced relaxation of the cardiac stomach showed 
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that S2 does not function via the release of NO from neuronal cells in the cardiac 
stomach (Melarange et al., 1999). However, the VP/OT-type neuropeptide signalling 
system is coupled to the Gq/11-phospholipase-C (PLC) signalling transduction 
pathway, with calcium (Ca2+) release able to trigger activation of neuronal and 
endothelial isoforms of NOS (Stoop, 2012). It would therefore be of interest to 
determine whether asterotocin may in fact function through the release of NO. 
 
3.4.4. VP/OT-type neuropeptides: an evolutionarily ancient role in feeding 
behaviour? 
In vertebrates and other mammals, the physiological roles of VP and OT have been 
extensively studied. VP has a well-established role in regulating vasoconstriction and 
osmoregulation (Henderson and Byron, 2007; McCormick and Bradshaw, 2006), 
whilst OT has a well-established role in regulating reproductive processes and 
behaviour (Gimpl and Fahrenholz, 2001). However, in addition to their roles on 
peripheral target tissues, both VP and OT have also been implicated in regulating 
various central neuromodulatory functions including maternal-infant bonding and 
aggression (Broad et al., 2006; Caldwell et al., 2008; Donaldson and Young, 2008) 
and pair bonding and attachment (Carter, 2014; Carter et al., 1995; Cho et al., 1999; 
Donaldson and Young, 2008; Insel and Young, 2001; Winslow et al., 1993; Young 
and Wang, 2004). Interestingly, a number of functional studies in phyla and species 
outside of the vertebrates have revealed that the osmoregulatory, metabolic and 
reproductive roles of VP/OT-type peptides may be evolutionarily conserved.  
The discovery that asterotocin is involved in the process of cardiac stomach 
eversion in A. rubens provides the first supporting evidence from a deuterostomian 
invertebrate species for an evolutionarily ancient role of VP/OT-type peptides in 
feeding behaviour. Previous functional studies have revealed that VP/OT-type 
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peptides are involved in regulating metabolic function in the mollusc L. stagnalis 
through the regulation of glycogen metabolism (Geraerts, 1992; van Kesteren et al., 
1995) and in the nematode C. elegans through the neuromodulation of experience 
driven salt chemotaxis, a form of gustatory associative learning (Beets et al., 2012; 
Beets et al., 2013). Therefore, the role of VP/OT-type peptides as regulators of 
feeding behaviour can be traced back to the common ancestor of the Bilateria, with 
supporting data from both the deuterostomes (e.g. A. rubens) and the protostomes 
(e.g. L. stagnalis and C. elegans). However, it will be crucial to continue to 
investigate the roles of VP/OT-type peptides across a wider range of phyla (e.g. the 
cephalochordates and hemichordates) before drawing definitive conclusions on the 
potential evolutionarily ancient roles of the VP/OT-type neuropeptide family.  
 
3.4.5. VP/OT-type neuropeptides: an evolutionarily ancient role in 
osmoregulation and reproduction? 
 
The discovery of asterotocin has opened up the possibility to investigate the range of 
functions that the peptide may cover in the starfish A. rubens. Previous functional 
studies on phyla and species across the animal kingdom have revealed that VP/OT-
type peptides may have an evolutionarily ancient role in both osmoregulation and 
reproduction, mirroring the roles of vertebrate VP and OT respectively.  
In regards to the osmoregulatory role of VP, this can be observed for VP/OT-
type peptides in the urochordate S. plicata through contraction of inhalant and 
exhalant siphon preparations (Ukena et al., 2008), in the echinoderm species E. 
esculentus through contraction of tube foot preparations (Elphick and Rowe, 2009), 
in the annelid W. pigra through changes body weight as a measure of water balance 
(Fujino et al., 1999; Oumi et al., 1996) and in the arthropod T. castaneum through the 
control of diuretic activity acting indirectly on Malpighian tubules (Aikins et al., 
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2008). In support of an osmoregulatory role for asterotocin, asterotocin mRNA was 
detected in the nerve plexus of the adhesive region of the tube feet and was also 
present in marginal nerve, which innervate the outer row of tube feet in the starfish 
A. rubens (Fig. 3.9). Further evidence for the role of asterotocin in tube foot activity 
comes from the observation that injection of asterotocin into the perivisceral coelom 
to elicit cardiac stomach eversion leads to the elongation of tube feet in some animals 
(Fig. 3.15). Interestingly, however, initial functional studies on in vitro tube foot 
preparations have revealed that asterotocin has no effect on tube foot myoactivity 
(Martynuk and Elphick, unpublished data).  
In regards to the reproductive role of OT, this can be observed for VP/OT-
type peptides in the mollusc L. stagnalis through the contraction of male copulatory 
organs (Geraerts, 1992; van Kesteren et al., 1995), in the annelid W. pigra through 
the induction of egg-laying-like behaviours (Fujino et al., 1999; Oumi et al., 1996) 
and in the nematode C. elegans through the neuromodulation of male mating circuits 
(Beets et al., 2012; Beets et al., 2013). In the starfish species A. pectinifera, the 
neuropeptide GSS has been shown to induce oocyte maturation and ovulation (Mita 
et al., 2009). However, functional studies have also revealed that the SALMFamide 
S1 is involved in oocyte maturation and regulates GSS secretion from the radial 
nerves of the starfish species A. pectinifera (Mita et al., 2004). It would therefore be 
of interest to develop functional assays to determine whether asterotocin, like S1, has 
a role in regulating reproductive functions in the starfish A. rubens. 
 
3.4.6. Asterotocin: a VP/OT-type peptide that causes muscle relaxation 
 
The relaxing-type effect of asterotocin contrasts with previously reported contractile-
type effects of VP/OT-type peptides in other animals found throughout the animal 
kingdom. For example, in other deuterostomian invertebrates, SOP causes 
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contraction of in vitro inhalant and exhalant siphon preparations from the sea squirt 
S. plicata (Ukena et al., 2008) whilst echinotocin causes contraction of in vitro tube 
foot and oesophagus preparations from the sea urchin species E. esculentus (Elphick 
and Rowe, 2009). However, the effect of asterotocin on cardiac stomach retraction is 
not the only relaxing-type effect of the peptide in the starfish A. rubens. Initial 
functional studies have revealed that asterotocin also causes relaxation of in vitro 
apical muscle preparations from A. rubens (Martynyuk and Elphick, unpublished 
data). However, asterotocin mRNA was not detected in the apical muscle, which 
suggests that it may exert its effects on apical muscle relaxation indirectly. 
It is possible, however, that asterotocin may also have contractile-like effects 
in the starfish A. rubens. In this regard, injection of asterotocin into the perivisceral 
coelom to elicit cardiac stomach eversion also induced a number of postural changes 
including the thinning and curling of arms in some animals (Fig. 3.15). In support of 
a role in these contractile-like activities, asterotocin mRNA was detected in cell 
bodies in the epidermal layer of the body wall (Fig. 3.13A). It will therefore be 
important to determine if asterotocin causes contraction of in vitro body wall 
preparations. Moreover, asterotocin mRNA was also detected in cell bodies in the 
epidermal layer of the pedicellariae, which line both inside and outside of the jaw 
(Fig. 3.13B). It will therefore also be of interest to determine whether asterotocin has 
either a relaxing or contractile-like role on pedicellariae activity in the starfish A. 
rubens. 
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4. Discovery and functional characterisation of a novel neurophysin-associated 
neuropeptide (“NGFFYamide”) in the starfish A. rubens 
 
4.1. Introduction 
           
Neurophysins are highly conserved pro-hormone derived polypeptides required for 
sorting the neurohypophyseal hormones vasopressin (VP) and oxytocin (OT) into the 
regulated secretory pathway (RSP) (Cool et al., 2008; de Bree, 2000; de Bree and 
Burbach, 1998). The importance of the neurophysin domain can be highlighted 
through the disease familial neurohypophyseal diabetes insipidus (FNDI), a water 
homeostasis disorder characterised by polyuria (the excretion of large volumes of 
diluted urine) and polydipsia (increased fluid intake). FNDI is caused by mutations 
in the neurophysin domain of human VP, leading to an impairment of VP 
biosynthesis (Babey et al., 2011). However, in addition to vertebrate VP and OT, 
neurophysins are associated with VP/OT-type neuropeptide precursors across the 
animal kingdom and thus the neurophysin domain has an ancestry that dates back to 
at least as far as the common ancestor of the Bilateria (Jekely, 2013; Mirabeau and 
Joly, 2013; Stafflinger et al., 2008; van Kesteren et al., 1995). Until recently, 
neurophysins were thought to be uniquely associated with VP/OT-type neuropeptide 
precursors. However, the discovery of a neuropeptide precursor in the sea urchin 
Strongylocentrotus purpuratus comprising myoactive peptides unrelated to VP/OT-
type peptides has changed this textbook perspective (Elphick and Rowe, 2009). This 
neuropeptide precursor gives rise to two copies of the neuropeptide NGFFFamide, 
which belongs to a family of neuropeptides called the NG peptides (Elphick, 2010). 
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4.1.1. The NG peptide family  
 
The NG peptides are a novel family of neuropeptides characterised by an asparagine-
glycine (NG) motif that have recently been identified across the deuterostomian 
invertebrates (Fig. 4.1) (Elphick, 2010). The first NG peptide precursor to be 
discovered was the NGFFFamide precursor in the sea urchin S. purpuratus, which 
comprises two copies of the myoactive peptide NGFFFamide associated with a C-
terminal neurophysin domain (Elphick and Rowe, 2009). Subsequently, NG peptide 
precursors have been identified in a number of other deuterostomian invertebrates. 
These include the SFRNGVamide precursor in the cephalochordate Branchiostoma 
floridae (Elphick, 2010), the NGFWNamide/NGFYNamide precursor in the 
hemichordate Saccoglossus kowalevskii (Elphick, 2010) and the NGIWYamide 
precursor in the sea cucumber Apostichopus japonicus (Elphick, 2012). Interestingly, 
however, the NGIWYamide precursor in the sea cucumber A. japonicus is derived 
from a precursor protein that lacks a neurophysin domain, which is likely to have 
been lost in the holothurian lineage (Elphick, 2012).  
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Fig. 4.1. The NG peptide family. (A) Schematic depicting the structural 
organisation of NG peptide precursors in the deuterostomian invertebrates. Signal 
peptides are represented in blue, putative neuropeptides are represented in red, 
dibasic cleavage sites are represented in green and C-terminal neurophysin domains 
are represented in purple. (B) Alignments of putative neuropeptides derived from NG 
peptide precursors. Conserved NG motifs highlighted in yellow and the number of 
copies of each peptide is represented in parentheses. A.jap, Apostichopus japonicus; 
B.flo, Branchiostoma floridae; S.kow, Saccoglossus kowalevskii; S.pur, 
Strongylocentrotus purpuratus. 
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4.1.2. Functional roles of the NG peptides  
 
Sequencing of the sea urchin genome (Sodergren et al., 2006) led to the discovery of 
the first NG peptide precursor in the deuterostomian invertebrates – the 
NGFFFamide precursor (Elphick and Rowe, 2009). Subsequently, functional studies 
have revealed that NGFFFamide causes contraction of in vitro tube foot and 
oesophagus preparations from the sea urchin species Echinus esculentus (Elphick 
and Rowe, 2009). However, the first NG peptide to be identified biochemically was 
NGIWYamide in the sea cucumber A. japonicus (Iwakoshi et al., 1995). 
NGIWYamide was identified through a bioassay utilising radial longitudinal muscle 
(RLM) and intestinal muscle preparations to screen for myoactive peptides in A. 
japonicus (Iwakoshi et al., 1995; Ohtani et al., 1999). Two SALMFamide 
neuropeptides were identified as muscle relaxants on intestinal muscle preparations – 
GYSPFMFamide and FKSPFMFamide (Iwakoshi et al., 1995; Ohtani et al., 1999). 
Moreover, one neuropeptide that causes muscle contraction in RLM and intestinal 
muscle preparations was also identified – this was NGIWYamide (Iwakoshi et al., 
1995; Ohtani et al., 1999). Subsequently, NGIWYamide has been shown to control 
the stiffness of connective tissue in the body wall dermis (Birenheide et al., 1998) 
and cause contraction of tentacle preparations and inhibition of the rhythmic 
contractile activity of intestine preparations (Inoue et al., 1999). Accordingly, 
immunocytochemical studies have revealed that NGIWYamide has a widespread 
distribution in neurons innervating the tube feet, tentacles, intestine and body wall 
dermis, consistent with its effects in vitro (Inoue et al., 1999). Recently, it has also 
been shown that NGIWYamide induces oocyte maturation and gamete spawning in 
the sea cucumber A. japonicus (Kato et al., 2009). Interestingly, NGIWYamide has 
also been shown to cause contraction of in vitro tube foot preparations from the 
starfish species Asterina pectinifera (Saha et al., 2006). Accordingly, 
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immunocytochemical studies have detected NGIWYamide-like immunoreactivity in 
neurons innervating the tube feet (Saha et al., 2006). However, until now, the identity 
of the NGIWYamide-like peptide in A. pectinifera was unknown. The discovery of 
an NG peptide (“NGFFYamide”) in the starfish A. rubens (see chapter 2.3.2.2) has 
therefore provided further opportunities to investigate the function of the NG 
peptides in an echinoderm species. 
 
4.1.3. Investigating the NG peptides in A. rubens 
Functional studies have revealed that the processes of cardiac stomach eversion and 
cardiac stomach retraction in the common European starfish Asterias rubens is at 
least in part controlled by a number of neuropeptidergic and non-peptidergic 
mediators. Cardiac stomach relaxation and eversion is triggered by the gaseous 
signalling molecule nitric oxide (NO) (Elphick and Melarange, 1998), the 
SALMFamides S1 and S2 (Elphick et al., 1995; Melarange et al., 1999) and a 
VP/OT-type peptide (“asterotocin”) (see chapter 3). On the other hand, it has been 
hypothesised that cardiac stomach retraction is controlled by the neurotransmitter 
acetylcholine (ACh), which has been shown to cause contraction of in vitro cardiac 
stomach preparations from the starfish A. rubens (Elphick et al., 1995). Therefore, 
with both neuropeptidergic (S1, S2 and asterotocin) and non-peptidergic (NO) 
control of cardiac stomach eversion, it is likely that there are also neuropeptidergic 
mediators acting in parallel with ACh to mediate the process of cardiac stomach 
retraction in the starfish A. rubens. To date, functional studies in the sea cucumber A. 
japonicus (Kato et al., 2009) and the sea urchin species E. esculentus (Elphick and 
Rowe, 2009) have revealed that the NG peptides act as muscle contractants in the 
echinoderms. Therefore, the discovery of NGFFYamide (see chapter 2.3.2.2) has 
provided an opportunity to investigate a potential role of this neuropeptide as a 
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mediator of cardiac stomach contraction in the starfish A. rubens. 
 
4.1.4. Aims and objectives  
 
Herein, the analysis of neural transcriptome data from the starfish A. rubens has led 
to the discovery of a precursor protein that gives rise to two copies of the putative 
neuropeptide NGFFYamide (see chapter 2.3.2.2). This discovery of NGFFYamide 
has provided an opportunity to: 
 
(1) Confirm the sequence of the NGFFYamide precursor by cDNA cloning and 
sequencing. 
(2) Determine the structure of the NGFFYamide peptide through the use of mass 
spectrometric methods. 
(3) Investigate the expression of the NGFFYamide precursor in the starfish A. rubens 
using mRNA in situ hybridisation (mRNA ISH). 
(4) Investigate the physiological functions of NGFFYamide in the starfish A. rubens 
using in vitro and in vivo pharmacological techniques. 
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4.2. Methods 
 
4.2.1. Bioinformatic identification of the NGFFYamide precursor in A. rubens 
 
To search for a transcript encoding an NG peptide precursor in the starfish A. rubens, 
the sea urchin S. purpuratus NG peptide precursor (“NGFFFamide” precursor) 
protein sequence (Elphick and Rowe, 2009) was submitted as a query in a tBLASTn 
search of the A. rubens neural transcriptome using SequenceServer software 
(http://www.sequenceserver.com/) (Priyam et al., in prep). The protein sequence 
encoded by the top-hit (expected (e)-value) transcript was then analysed for the 
presence of an N-terminal signal peptide as predicted by SignalP 3.0 (Bendtsen et al., 
2004), putative NG peptides flanked by dibasic cleavage sites and a C-terminal 
neurophysin domain, which is characterised by the presence of fourteen cysteine (C) 
residues (Elphick, 2010; Elphick and Rowe, 2009). Subsequently, the protein 
sequence was submitted in a tBLASTn search of The National Centre for 
Biotechnology Information (NCBI) database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
to determine sequence similarity to known neuropeptide or peptide hormone 
precursors. 
 
4.2.2. Cloning and sequencing of NGFFYamide precursor  
Total RNA generated from the same specimen of A. rubens used for Illumina Hi-Seq 
(see chapter 2.2.2) was used to generate cDNA using the Quantitect Reverse 
Transcription Kit (QIAgen). NGFFYamide precursor cDNA containing the entire 
coding region was amplified by PCR using Phusion High-Fidelity PCR Master Mix 
(NEB) and the oligos:  5’-AGACCTTATAGGCTTAGAG-3’ and 5’- 
GTCATCACGATAACACTC-3’. The PCR product was gel-extracted and purified 
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using the QIAquick Gel Extraction Kit (QIAgen) before being blunt-end cloned into 
a pBluescript SKII (+) vector (Agilent Technologies) cut with the EcoRV-HF (NEB) 
restriction endonuclease. Three clones were sequenced from both the T3 and T7 
sequencing primer sites for sequence confirmation (Eurofins). A plasmid maxiprep 
was subsequently performed using the QIAgen Plasmid Maxi Kit (QIAgen). 
 
4.2.3. Mass spectrometric confirmation of NGFFYamide 
 
Radial nerve cords were dissected from five adult specimens of A. rubens using a 
method described previously (Chaet, 1964). Neuropeptides were then extracted in 1 
ml of 80 % acetone on ice (Elphick et al., 1991a). Acetone was subsequently 
removed by evaporation using nitrogen, with the aqueous fraction centrifuged at 
11,300 g in a MiniSpin® microcentrifuge (Eppendorf) for 10 minutes and the 
remaining supernatant stored at −80 °C. Prior to mass spectrometry (MS), the extract 
was thawed and filtered through a 0.22 µm Costar® Spin-X® centrifuge tube filter 
(Sigma-Aldrich) to remove particulates. The extract was then analysed by nanoflow 
liquid chromatography (LC) with electrospray ionisation (ESI) quadrupole time-of-
flight tandem MS (nano LC-ESI-MS/MS) using a nanoAcquity ultra performance LC 
(UPLC) system coupled to a Q-TOF Ultima Global Mass SpectrometerTM (Waters 
Corporation) and MassLynx v.4.0 software (Waters Corporation). The mobile phases 
used for the chromatographic separation were 0.1 % aqueous formic acid (termed 
mobile phase A) and 0.1 % formic acid in acetonitrile (termed mobile phase B). An 
aliquot containing 5 µl of the A. rubens radial nerve cord extract was applied to a 
Symmetry C18® trapping column (180 µm x 20 mm, 5 µm particle size, 100 Å pore 
size) (Waters Corporation) using 99.9 % mobile phase A at a flow rate of 15 µl min−1 
for 1 minute, after which the fluidic flow path included the HSS T3 analytical 
capillary column (75 µm x 150 mm, 1.8 µm particle size, 100 Å pore size) (Waters 
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Corporation). A linear gradient of 5–40 % mobile phase B over 45 minutes was 
utilised with a total run time of 60 minutes. The nanoflow ESI source conditions 
utilised a 3.5 kV capillary voltage, 25 V sample cone voltage and an 80 °C source 
temperature. A data-dependent acquisition was performed that would trigger a 
MS/MS scan on any singly charged peptide having a mass/charge (m/z) ratio of 
646.2989, or a doubly charged peptide of m/z of 323.6534, with a tolerance of 150 
mDa allowed on the precursor m/z. MS/MS spectra, obtained from data-dependent 
acquisition, was processed using MassLynx v.4.0 software (Waters Corporation). 
Spectra were combined and processed using the MaxEnt 3 algorithm to generate 
singly charged, monoisotopic spectra for interpretation and manual validation. 
 
4.2.4. Localisation of the NGFFYamide precursor in A. rubens using mRNA in 
situ hybridisation (mRNA ISH) 
The mRNA in situ hybridisation (mRNA ISH) methodology (probe synthesis, tissue 
fixation, tissue sectioning, probe hybridisation and immunodetection) was performed 
in accordance to the methodology utilised for the asterotocin precursor (see chapter 
3.2.4). 
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4.2.5. Analysis of the in vitro effects of NGFFYamide on cardiac stomach 
preparations from A. rubens 
 
Cardiac stomachs were dissected from specimens of A. rubens and set up in a 20 ml 
organ bath maintained at 11 °C, as described previously (Fig. 3.2) (Elphick et al., 
1995; Melarange et al., 1999). However, unlike for analysis of the in vitro effects of 
synthetic asterotocin (see chapter 3.2.6), the organ bath contained artificial seawater 
that was not supplemented with 30 mM potassium chloride (KCl). Stock solutions of 
synthetic NGFFYamide (NGFFY-NH2) or NGFFFamide (NGFFF-NH2) (Peptide 
Protein Research Ltd.) were prepared in autoclaved water and then added 
individually to the organ bath to achieve final concentrations ranging from 
30 pmol l–1 to 1 µmol l−1 upon the cardiac stomach maintaining a stabilised state. 
Cardiac stomach contraction was recorded using an isotonic transducer (Harvard 
Apparatus) linked to a Goerz SE 120 chart recorder (Recorderlab). The preparation 
was subsequently washed with artificial seawater between different concentrations to 
allow the cardiac stomach preparation to return to a stabilised state. 
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4.2.6. Analysis of the in vivo effects of NGFFYamide in A. rubens 
 
Informed by the pharmacological effect of synthetic NGFFYamide on cardiac 
stomach preparations in vitro, experiments were performed to investigate if 
NGFFYamide triggers cardiac stomach retraction in vivo. A total of ten specimens of 
A. rubens withheld from a food supply (mussels) for 1 week were placed in a glass 
tank containing 2 % magnesium chloride (MgCl2) dissolved in artificial seawater. 
MgCl2 acts as a muscle relaxant in marine invertebrates (Mayer, 1909) and 
reproducibly causes eversion of the cardiac stomach in A. rubens, typically within a 
period of approximately 15-30 minutes (Elphick, unpublished observations). 
Hamilton 75N 5 µl syringes (Sigma-Aldrich) were used to inject synthetic 
NGFFYamide (NGFFY-NH2) (Peptide Protein Research Ltd.) into the perivisceral 
coelom of animals at two sites in the aboral body wall of the arms proximal to the 
junctions with the central disk region. Animals were first injected with 10 µl 
autoclaved water (control) and video recorded for 220 seconds. The same animals 
were then injected with 10 µl of 100 nmol l−1 synthetic NGFFYamide (concentration 
selected based on results from in vitro pharmacology) and video recorded for 4 
minutes. Care was taken to inject test agents into the perivisceral coelom and not into 
the cardiac stomach. Static images from video recordings were captured at 20-second 
intervals from the time of injection. Then the two-dimensional area of everted 
cardiac stomach was measured from the images using ImageJ software 
(http://rsb.info.nih.gov/ij/) and normalised as a percentage of the area of cardiac 
stomach everted at the time of injection. 
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4.3. Results 
 
 
4.3.1. Bioinformatic identification and cloning of the NGFFYamide precursor in 
A. rubens 
 
In BLAST analysis of the A. rubens neural transcriptome data using the sea urchin S. 
purpuratus NGFFFamide precursor as a query, the top-hit (e-value: 2e-15) was contig 
1104160 (1268 bp), which encodes a 239-residue protein termed the NGFFYamide 
precursor. The sequence of the NGFFYamide precursor has been confirmed by 
cDNA cloning and sequencing (Fig. 4.2). The precursor protein comprises a 23-
residue N-terminal signal peptide (residues 1-23), two tandem copies of a putative 
NG peptide (NGFFYG) (residues 124-129 and residues 132-137), with C-terminal 
glycine (G) residues predicted to be subject to amidation (NGFFYamide; NGFFY-
NH2). The NGFFYamide precursor also has an 80-residue C-terminal neurophysin 
domain comprising fourteen conserved cysteine (C) residues, hitherto characteristic 
of VP/OT-type precursors (residues 153-232). The sequence of the 1268 bp 
NGFFYamide precursor transcript has been deposited in the GenBank database and 
assigned accession number KC977457. !
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1                                                              ag 
3    accttataggcttagagaggaccatcgagaagagcttgagttactttacctggcgctcag 
63   gtgggaattcattttctatcagcaagaacactccttagtttacaatcaattacaagtgga 
123  atatcgctcatttggaaacatcaacaagattttgacgaactaggaggggtgtcggtggga 
183  cgtgggggatctaagctggatatgaccatgggcagcaggtcgttattagtgacaattgtg 
                           M  T  M  G  S  R  S  L  L  V  T  I  V   13  
243  atcacagtagtcatacccagcatctgggcaggtgcaatagctggggctcaaacacaaaag 
      I  T  V  V  I  P  S  I  W  A  G  A  I  A  G  A  Q  T  Q  K   33  
303  attcgtcgtgaaagtcgagaatctggcaagtactggccaaactccgtgggtatctcagac 
      I  R  R  E  S  R  E  S  G  K  Y  W  P  N  S  V  G  I  S  D   53  
363  caacagctacggcaactcctagcacactctctggcggactcgtacagtacgtcaggggca 
      Q  Q  L  R  Q  L  L  A  H  S  L  A  D  S  Y  S  T  S  G  A   73  
423  agtcacatacggggaggagacggggatgcagggtatatatacgatagtcgagatcaggtc 
      S  H  I  R  G  G  D  G  D  A  G  Y  I  Y  D  S  R  D  Q  V   93  
483  gatgacacggggacgaacgaggaggaaggggaacgcgtaatcgggagcgaggttacatcg 
      D  D  T  G  T  N  E  E  E  G  E  R  V  I  G  S  E  V  T  S  113  
543  agagactcgaaccccggtacaagcaagagaaatgggttcttctatggcaaaagaaatggg 
      R  D  S  N  P  G  T  S  K  R  N  G  F  F  Y  G  K  R  N  G  133  
603  ttcttttatggaaagagatcagcgtcaacccctggcaatgcaaatgaagtaactcaatgc 
      F  F  Y  G  K  R  S  A  S  T  P  G  N  A  N  E  V  T  Q  C  153  
663  atcccgtgtgggcctcaaaacaacggccagtgcgtcatgtttggtacatgttgcagctat 
      I  P  C  G  P  Q  N  N  G  Q  C  V  M  F  G  T  C  C  S  Y  173  
723  gaactaggtggctgctttttcctgacagaggaggcccttccctgtgtgacgtcaaaatcg 
     E  L  G  G  C  F  F  L  T  E  E  A  L  P  C  V  T  S  K  S   193  
783  tcatcattatgtgagctgagcggattgccgtgcggtgacgagggatatggaaggtgcgtg 
     S  S  L  C  E  L  S  G  L  P  C  G  D  E  G  Y  G  R  C  V   213  
843  gcagactctgtctgttgtctgccgcaagagggctcttgtcatattaacgcagaatgtgga 
     A  D  S  V  C  C  L  P  Q  E  G  S  C  H  I  N  A  E  C  G   233  
901  ggcaagatgacatttcaataggacttgcattatgcggactttaaattatttataaaggga 
     G  K  M  T  F  Q  *                                          239  
963  taggaaaaggtggttaatatctgtattttgaaaagggtaataaaatttaaggttgtttga 
1023 gaaaagggacacgaatgttattttgacctcaatgtgtaaatttaaacaattttagcgatt 
1083 acttatttttagaccactacgaattaactgttttatgttctttacgacgggaaagaaatg 
1143 aaatcttttgagagattcgaatgtacaaagagtgttatcgtgatgac 
!
 
Fig. 4.2. A. rubens NGFFYamide precursor cDNA sequence. The nucleotide 
sequence (lowercase, 1189 bases) encoding the precursor protein (uppercase, 239 
amino acid residues) is shown. Primers used for cloning the NGFFYamide precursor 
cDNA are represented in bold and underlined text. The predicted signal peptide is 
represented in blue, two tandem copies of the putative NGFFYamide peptide are 
represented in red, C-terminal glycine (G) residues that are putative substrates for 
amidation are represented in orange and putative dibasic cleavage sites (KR) are 
represented in green. The C-terminal region of the precursor comprises a 
neurophysin domain (with fourteen characteristic cysteine (C) residues underlined), 
which is represented in purple. The asterisk shows the position of the stop codon. 
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4.3.2. Mass spectrometric confirmation of NGFFYamide 
 
In order to perform both in vitro and in vivo functional studies, it was important to 
confirm the sequence and structure of the putative NGFFYamide peptide. Cloning 
and sequencing of the NGFFYamide precursor confirmed the presence of two copies 
of an NG peptide (“NGFFYamide”) with the sequence NGFFYG (Fig. 4.2). 
However, it is also important to confirm whether the C-terminal glycine (G) residue 
is converted to an amide group. Nano LC-ESI-MS/MS using synthetic NGFFYamide 
as a standard was first implemented, resulting in the peptide eluting at a retention 
time of 30.3 minutes with the singly charged species observed at a m/z of 646.3 (Fig. 
4.3A). Subsequent analysis of the A. rubens radial nerve cord extract under identical 
conditions revealed that a single charged peptide with an m/z of 646.3 eluted at the 
same retention time to synthetic NGFFYamide (Fig. 4.3B). Both peptides were 
subjected to MS/MS during the experiment and the resulting deconvoluted, singly 
charged, monoisotopic spectra were compared, confirming the presence of 
NGFFYamide in the radial nerve cord extract (Fig. 4.3A-B). 
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(A) 
 
(B) 
 
 
Fig. 4.3. Mass spectrometric confirmation that NGFFYamide is present in the 
radial nerve cord of A. rubens. (A) MS/MS spectrum of synthetic NGFFYamide 
peptide. (B) MS/MS spectrum of NGFFYamide in an acetone extract of radial nerve 
cords of A. rubens. The deconvoluted, monoisotopic, singly charged spectrum 
derived from MS/MS data is shown, with the b-series of fragment ions annotated 
(b2, b3 and b4). Also labelled are two fragment ions from the y-series (y1 and y2), 
immonium ions from phenylalanine (F) and tyrosine (Y) residues and the 
NGFFYamide peptide ion (646.31).  
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4.3.3. Expression profile of NGFFYamide mRNA in A. rubens 
 
Serial sections were taken through the central disk and one arm of the starfish A. 
rubens to allow visualisation of the expression of NGFFYamide precursor mRNA 
(or “NGFFYamide mRNA” for brevity) (Fig. 3.6). Expression of NGFFYamide 
mRNA was observed in the radial nerve cord, circumoral nerve ring, marginal nerve, 
tube feet, cardiac stomach, pyloric stomach, pyloric ducts, the apical muscle and the 
coelomic epithelium, which will be discussed on a one-by-one basis. Note that 
expression of NGFFYamide mRNA was not detected in control experiments utilising 
a NGFFYamide mRNA sense probe to detect non-specific binding (an example is 
provided in Fig. 4.4). 
 
4.3.3.1. Radial nerve cord and circumoral nerve ring 
 
In transverse sections of the arm, expression of NGFFYamide mRNA was observed 
in the ectoneural region of the radial nerve cord but not in the hyponeural region 
(Fig. 4.5A-B). The labelled cell bodies were, largely, laterally concentrated at the 
periphery of the radial nerve cord in the epithelium of the ectoneural nerve plexus 
(Fig. 4.5A-B). NGFFYamide mRNA expression was also present in cell bodies 
located in the lateral branches of the ectoneural region of the radial nerve cord (Fig. 
4.5D). In sections through the central disk, expression of NGFFYamide mRNA was 
also observed in the ectoneural region of the circumoral nerve ring (Fig. 4.5C), 
consistent with the expression pattern observed in the ectoneural region of the radial 
nerve cord. 
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Fig. 4.4. Control experiment for NGFFYamide mRNA expression in the radial 
nerve cord in A. rubens. Transverse section through an arm of A. rubens displaying 
the radial nerve cord. NGFFYamide mRNA expression was not detected in the radial 
nerve cord utilising a NGFFYamide mRNA sense probe to detect non-specific 
binding. ec = ectoneural; hy = hyponeural. !
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Fig. 4.5. NGFFYamide mRNA expression in the radial nerve cord, lateral 
branches of the radial nerve cord and circumoral nerve ring in A. rubens. (A-B) 
Transverse section through an arm of A. rubens displaying the radial nerve cord at 
two magnifications. NGFFYamide mRNA expression was detected in the epithelium 
of the ectoneural nerve plexus of the radial nerve cord. (C) Transverse section 
through the central disk of A. rubens displaying the circumoral nerve ring.  
NGFFYamide mRNA expression was detected in the ectoneural region of the 
circumoral nerve ring. (D) Transverse section through an arm of A. rubens displaying 
the lateral branches of the radial nerve cord. NGFFYamide mRNA expression was 
detected in the ectoneural region of the lateral branches of the radial nerve cord. 
CONR = circumoral nerve ring; ec = ectoneural; hy = hyponeural; lat = lateral 
branch of radial nerve cord; RNC = radial nerve cord.  
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4.3.3.2. Tube feet and marginal nerve 
 
In transverse sections through the arm and central disk, expression of NGFFYamide 
mRNA was observed in cells located in the adhesive region of tube feet suckers (Fig 
4.6A-B). Moreover, expression of NGFFYamide mRNA was also observed in the 
basal nerve ring (Fig. 4.6A-B). However, expression of NGFFYamide mRNA was 
not observed in the sub-epithelial nerve plexus. NGFFYamide mRNA expression 
was also present in the marginal nerve, which innervates the outer row of tube feet 
(Fig. 4.6C-D).  
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Fig. 4.6. NGFFYamide mRNA expression in the tube feet and marginal nerve in 
A. rubens. (A-B) Transverse section through an arm of A. rubens displaying tube 
feet at two magnifications. NGFFYamide mRNA expression was detected in the 
nerve plexus in the adhesive region of the tube foot sucker and in the basal nerve 
ring. (C-D) Transverse section through an arm of A. rubens displaying a marginal 
nerve supplying innervation to a tube foot at two magnifications. NGFFYamide 
mRNA expression was detected in the marginal nerve. ad = adhesive region of tube 
foot; BNR = basal nerve ring; MN marginal nerve; TF = tube foot.  
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4.3.3.3. Digestive system 
 
In sections through the central disk, expression of NGFFYamide mRNA was 
observed in the cardiac stomach (Fig. 4.7) with sparser expression detected in the 
pyloric stomach and very sparse expression detected in the pyloric ducts (Fig. 4.8A-
B and Fig. 4.8D). However, expression of NGFFYamide mRNA was not observed in 
the peristomial membrane, oesophagus, pyloric caecae (Fig. 4.8C), intestine, rectal 
caecae (Fig. 4.8A) or retractor strands. Labelled cell bodies appear to be more 
densely concentrated in the aboral region as opposed to the oral region of the cardiac 
stomach, which is densely packed with granular secretory cells (Fig. 4.7). In both the 
aboral and oral regions of the cardiac stomach, however, labelled cells bodies are 
largely concentrated in the basiepithelial nerve plexus (Fig 4.7). Labelled cell bodies 
are also located in the mucosal layer, with very sparse expression in the visceral 
muscle layer (Fig. 4.7). In the pyloric stomach, labelled cell bodies are sparsely 
located in the basiepithelial nerve plexus but are absent from the mucosal and 
visceral muscle layers (Fig. 4.8A-B). In the pyloric ducts, cell bodies are sparsely 
located in the basiepithelial nerve plexus and the mucosal layer but are absent from 
the visceral muscle layer (Fig. 4.8D). 
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Fig. 4.7. NGFFYamide mRNA expression in the cardiac stomach of A. rubens. 
(A) Transverse section through the central disk of A. rubens displaying the oral and 
aboral regions of the cardiac stomach. (B) Transverse section through the central 
disk of A. rubens displaying the aboral region of the cardiac stomach. NGFFYamide 
mRNA expression was detected in the basiepithelial nerve plexus, with sparse 
expression in the mucosal and visceral muscle layers. (C) Transverse section through 
the central disk of A. rubens displaying an oral region of the cardiac stomach. 
NGFFYamide mRNA expression was detected in the basiepithelial nerve plexus, 
with sparse expression in the mucosal layer. (D) Transverse section through the 
central disk of A. rubens displaying the aboral region of the cardiac stomach. 
NGFFYamide mRNA expression was detected in the basiepithelial nerve plexus, 
with sparse expression in the mucosal layer.  ab = aboral cardiac stomach; BNP = 
basiepithelial nerve plexus; mu = mucosal layer; or = oral cardiac stomach; VML = 
visceral muscle layer.  
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Fig. 4.8. NGFFYamide mRNA expression in regions of the digestive system in A. 
rubens. (A) Transverse section through the central disk of A. rubens displaying the 
pyloric stomach and rectal caecae. NGFFYamide mRNA expression was detected in 
the basiepithelial nerve plexus and mucosal layer of the pyloric stomach. Note that 
NGFFYamide mRNA expression can also be seen in the apical muscle. (B) 
Transverse section through the central disk of A. rubens displaying the pyloric 
stomach. NGFFYamide mRNA expression was detected in the basiepithelial nerve 
plexus and mucosal layer of the pyloric stomach.  (C) Transverse section through the 
central disk of A. rubens displaying pyloric caecae. NGFFYamide mRNA expression 
was not detected in the pyloric caecae. (D) Transverse section through the central 
disk of A. rubens displaying a pyloric duct. NGFFYamide mRNA expression was 
detected in the basiepithelial nerve plexus and mucosal layer of the pyloric duct. AM 
= apical muscle; BNP = basiepithelial nerve plexus; CS = cardiac stomach; mu = 
mucosal layer; PC = pyloric caecae; PD = pyloric duct; PS = pyloric stomach; RC = 
rectal caecae; VML = visceral muscle layer.  
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4.3.3.4. Apical muscle and coelomic epithelium  
 
The apical muscle of the starfish A. rubens is a muscular thickening located on the 
inside of the dorsal body wall (Moore and Thorndyke, 1993). The apical muscle is 
bound to a thin band of circular sub-epidermal muscle at the junction between the 
arm and central disk, which has been termed the aboral autotomy plane (Moore and 
Thorndyke, 1993). The apical muscle is also bound to a ciliated coelomic epithelial 
layer and an overlying nerve plexus, which is continuous with innervation of the gut 
(Moore and Thorndyke, 1993). The expression of NGFFYamide mRNA was 
observed in cell bodies in the coelomic epithelial layer lining the apical muscle, 
which forms the coelomic lining of the apical muscle (Fig. 4.9A). The expression of 
NGFFYamide was also observed in cell bodies in the coelomic epithelium, located at 
the junction between the central disk and arm, which separates the body wall from 
the coelomic cavity (Fig. 4.9B). 
 
 
 
 
 
 
 
 
 
 
 
                   
            
! 249 
            
 
Fig. 4.9. NGFFYamide mRNA expression in the apical muscle and coelomic 
epithelium of A. rubens. (A) Transverse section through the central disk of A. 
rubens displaying the apical muscle. NGFFYamide mRNA expression was detected 
in the coelomic epithelial layer lining the apical muscle. (B) Transverse section 
through the central disk of A. rubens displaying the coelomic epithelium. 
NGFFYamide mRNA expression was detected in the coelomic epithelium. AM = 
apical muscle; CE = coelomic epithelium.  
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4.3.4. NGFFYamide causes cardiac stomach contraction in vitro 
 
In order to determine whether synthetic NGFFYamide (NGFFY-NH2) has an effect 
on cardiac stomach activity, an in vitro assay previously used to show that the 
SALMFamides S1 and S2 cause cardiac stomach relaxation was implemented (Fig. 
3.2) (Elphick and Melarange, 1998; Elphick et al., 1995; Melarange et al., 1999). In 
the in vitro assay, the addition of NGFFYamide to cardiac stomach preparations 
revealed that it caused dose-dependent contraction at concentrations ranging from 
30 pmol l–1 to 1 µmol l−1 (Fig. 4.10). A total of eight adult specimens were analysed, 
with the maximal efficacy of NGFFYamide observed at 100 nmol l−1 (Fig. 4.10). It 
should also be noted that synthetic NGFFFamide (NGFFF-NH2) also caused dose-
dependent contraction at concentrations ranging from 1 nmol l−1 to 1 µmol l−1, with 
the maximal efficacy of NGFFFamide observed at 100 nmol l−1 (Fig. 4.10B). 
Comparison of the effects of NGFFYamide and NGFFFamide on cardiac stomach 
contraction using a random intercept linear mixed effects model (Bates and Sarkar, 
2007) revealed a significant difference between both peptides on cardiac stomach 
contraction, irrespective of the concentration used (P ≤ 0.001). 
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Fig. 4.10. NGFFYamide is a potent stimulator cardiac stomach contraction in A. 
rubens. (A) Representative recordings from a single cardiac stomach preparation 
showing the dose-dependent effect of synthetic NGFFYamide (30 pmol l–1 to 
1 µmol l−1). The application of NGFFYamide (upward-pointing arrowheads) causes 
cardiac stomach contraction in a typical time-frame of 1-2 minutes, whilst the effect 
of NGFFYamide is reversed by washing (downward-pointing arrowheads). (B) 
Graph showing the dose-dependent effects of synthetic NGFFYamide (circles) and 
NGFFFamide (squares). The effects of both peptides are normalised to the maximal 
effect observed with NGFFYamide in each experiment, with mean values (± s.e.m.) 
from eight experiments shown. 
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4.3.5. NGFFYamide causes cardiac stomach retraction in vivo 
 
In order to determine whether the effect of synthetic NGFFYamide (NGFFY-NH2) 
on cardiac stomach contraction in vitro (Fig. 4.10) correlates with an effect on 
cardiac stomach contraction in vivo, cardiac stomach eversion was induced by 
placing starfish in a tank containing 2 % MgCl2 (Mayer, 1909). In the in vivo assay, 
injection of NGFFYamide (10 µl of 100 nmol l−1) into the perivisceral coelom 
triggered retraction of the cardiac stomach (Fig. 4.11). Informed by this initial 
observation, injection experiments were performed in a total of ten specimens in 
order to determine whether the effect of NGFFYamide (10 µl of 100 nmol l−1) on 
cardiac stomach retraction was repeatable. NGFFYamide triggered cardiac stomach 
retraction in 10/10 experiments with variability in the rate and extent of retraction. 
Fig. 4.11B shows data from ten experiments, with the mean area of cardiac stomach 
everted at 20-second intervals during a 220 second recording period following 
peptide injection at time 0 (T0) expressed as a percentage of the area everted at T0. 
Importantly, in control experiments in which starfish were first injected with 
autoclaved water, no eversion of the cardiac stomach was observed.  
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Fig. 4.11. NGFFYamide triggers cardiac stomach retraction in A. rubens. 
(A) Photographs from a representative experiment showing that injection of synthetic 
NGFFYamide (10 µl of 100 nmol l−1) causes cardiac stomach retraction. At time 0 
(T0), the fully everted cardiac stomach can be seen. At 60 seconds, 120 seconds and 
180 seconds after injection of NGFFYamide, cardiac stomach retraction is observed 
(outline of cardiac stomach marked by white dots). (B) Graph showing that injection 
of synthetic NGFFYamide (10 µl of 100 nmol l−1) (squares) causes cardiac stomach 
retraction compared to injection of autoclaved water (10 µl) (circles). The area of 
cardiac stomach everted (in 2D) at each time point (0-220 seconds) is normalised to 
the area of the cardiac stomach everted at T0, with means (± s.e.m.) from ten 
experiments shown. 
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4.4. Discussion 
 
4.4.1. Discovery of NGFFYamide, an NG peptide in A. rubens 
The NGFFYamide precursor in the starfish A. rubens is the first NG peptide 
precursor to be discovered in a starfish species. The NGFFYamide precursor 
contains an N-terminal signal peptide, two tandem copies of the sequence NGFFYG 
flanked by dibasic cleavage sites (KR) and a C-terminal neurophysin domain (Fig. 
4.2). Importantly, mass spectrometry has confirmed that the C-terminal glycine (G) 
residue of the putative NG peptide is converted to an amide group (NGFFY-NH2) 
(Fig. 4.3). In addition to the presence of a C-terminal amide group, comparison of 
the NGFFYamide precursor with other NG peptide precursors across the 
deuterostomian invertebrates reveals interesting similarities and differences. 
NGFFYamide, as with all known members of the NG peptide family, has a 
conserved asparagine-glycine (NG) motif. However, the position of the motif is 
variable. In NGFFYamide and other putative NG peptides in the echinoderms and 
hemichordates, the NG motif is found at the N-terminus of the putative peptide (e.g. 
NGFFYamide).  However, in the cephalochordate B. floridae, the NG motif is not 
found at the N-terminus of the putative peptide (SFRNGVamide). The number of 
copies of putative NG peptides is also variable. For example, there are six copies of 
putative NG peptides in the hemichordate S. kowalevskii, five copies in the sea 
cucumber A. japonicus and two copies in the sea urchin S. purpuratus and the 
starfish A. rubens. Interestingly, comparison of spacer peptide sequences following 
copies of NGFWNamide and NGFYNamide in the NGFWNamide/NGFYNamide 
precursor in the hemichordate S. kowalevskii reveals sequence similarity indicative 
of an intragenic duplication (Elphick, 2010). However, whether the presence of 
multiple copies of putative NG peptides derived from the same precursor is 
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functionally significant remains open to investigation. Finally, the presence of a C-
terminal neurophysin domain hitherto thought to be unique to VP/OT-type 
neuropeptide precursors appears to be a conserved feature of NG peptide precursors. 
Interestingly, however, the neurophysin domain is not present in the NGIWYamide 
precursor in the sea cucumber A. japonicus, indicating that it may have been lost in 
the holothurian lineage (Elphick, 2012).  
 
4.4.2. NGFFYamide: a regulator of cardiac stomach contraction  
 
Investigation into the in vitro pharmacological effects of NGFFYamide reveals that it 
causes dose-dependent relaxation of cardiac stomach preparations at concentrations 
ranging from 30 pmol l−1 to 1 µmol l−1, with a maximal efficacy at 100 nmol l−1 (Fig. 
4.10).  Investigation into the in vivo effects of NGFFYamide revealed that it triggers 
cardiac stomach retraction in the starfish A. rubens (Fig. 4.11). Despite variability in 
the rate and extent of retraction, NGFFYamide triggered cardiac stomach retraction 
in 10/10 experiments. In combination, these data suggest that NGFFYamide may 
mediate neural control of cardiac stomach retraction during the process of feeding in 
starfish. Interestingly, NGFFYamide is the first neuropeptidergic mediator of cardiac 
stomach retraction to be discovered in the starfish A. rubens. However, the 
neurotransmitter ACh has previously been shown to cause in vitro biphasic 
contraction of the cardiac stomach in A. rubens, which suggests it may also cause 
cardiac stomach contraction in vivo (Elphick et al., 1995).  
However, it is of interest to compare the effects of NGFFYamide to other 
neuropeptidergic mediators of the feeding process both in vitro and in vivo. In vitro, 
the maximal effect of NGFFYamide was observed at 100 nmol l−1 compared to the 
maximal effects of asterotocin at 100 nmol l−1 (Fig. 3.16) and the SALMFamides S1 
and S2 at 10 µmol l−1 (Melarange et al., 1999). In vitro, NGFFYamide caused 
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cardiac stomach contraction at 30 pmol l−1 compared to asterotocin causing cardiac 
stomach relaxation at 30 pmol l−1 (Fig. 3.16) and the SALMFamides S1 at 10 nmol l-
1 and S2 at 1 nmol l-1 respectively (Melarange et al., 1999). In vivo, NGFFYamide 
triggered cardiac stomach retraction upon injection of 10 µl of 100 nmol l−1 peptide 
compared to the injection of 10 µl of 10 µmol l−1 asterotocin (Fig. 3.14) and 100 µl 
of 1 mmol l−1 S1 and S2 in triggering cardiac stomach eversion (Melarange et al., 
1999). The differences in the concentration of peptide required to elicit a response on 
myoactivity could be in part due to the relative nature of access of the peptide to 
muscles in the cardiac stomach. In this regard, NGFFYamide is injected when the 
cardiac stomach is already fully everted whilst asterotocin is injected when access to 
the cardiac stomach muscle is limited by the compact nature of the cardiac stomach 
in the central disk prior to eversion. 
In combination with the effects of NGFFYamide in vitro and in vivo, the 
expression profile of NGFFYamide mRNA provides further evidence for the role of 
NGFFYamide in mediating neural control of cardiac stomach retraction. Importantly, 
NGFFYamide mRNA is expressed in the cardiac stomach of the starfish A. rubens, 
with cell bodies concentrated in the basiepithelial nerve plexus, with fewer cell 
bodies associated with the and the mucosal layer and visceral muscle layer (Fig. 4.7). 
This expression profile suggests that NGFFYamide may mediate cardiac stomach 
retraction by two potential mechanisms. Firstly, NGFFYamide may be released from 
processes of NGFFYamide-expressing cells located in the basiepithelial nerve plexus 
and diffuses across a thin connective tissue layer to reach the visceral muscle layer 
(Fig. 3.10). Alternatively, processes of NGFFYamide-expressing cells may project 
across the connective tissue layer to reach the visceral muscle layer directly. In this 
regard, developing antibodies to NGFFYamide and performing 
immunocytochemistry (ICC) will be crucial in providing insights into the functional 
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mechanism of the peptide. 
Interestingly, it should be noted that cell bodies appear to be more densely 
concentrated in the aboral region as opposed to the oral region of the cardiac 
stomach, which is densely packed with granular secretory cells (Fig. 4.7). It should 
also be noted that NGFFYamide mRNA was also detected in the pyloric stomach 
and pyloric ducts, with cell bodies sparsely located in the basiepithelial nerve plexus 
and mucosal layer but absent from the visceral muscle layer (Fig. 4.8). Similarly to 
the mRNA expression profile for asterotocin (see chapter 3.3.3), the mRNA 
expression profile of NGFFYamide throughout the digestive system reinforces the 
role of NGFFYamide in regulating cardiac stomach retraction as opposed to 
digestive processes. 
It will be important to first determine where NGFFYamide and, upon 
pharmacological characterisation, the candidate NGFFYamide receptor(s) are 
expressed in relation to one another in the context of the starfish body plan to further 
explore the role of NGFFYamide in cardiac stomach retraction. In addition to 
utilising mRNA ISH, it will also be important to develop antibodies to NGFFYamide 
and the candidate NGFFYamide receptor to perform ICC, which will help to 
distinguish the specific cell types that NGFFYamide is expressed in with regards to 
the mucosal layer of the gut, which includes ciliated epithelial cells (which propel 
food particles from the cardiac stomach through to the pyloric stomach) in addition 
to mucous goblet cells and granular secretory cells (Moore and Thorndyke, 1993). 
The expression of NGFFYamide mRNA in the cardiac stomach (and absence from 
retractor strands) suggests that NGFFYamide may exert its effects on the cardiac 
stomach either directly or indirectly (via cell bodies in the basiepithelial nerve 
plexus) by binding to its candidate receptor(s), which may lead to changes in 
secondary messenger levels or ion channel conductance (Elphick and Melarange, 
! 260 
2001). However, there remains the possibility that NGFFYamide may act indirectly 
to innervate the visceral muscle layer.  It will therefore be crucial to determine the 
signalling cascades that are involved in eliciting the cardiac stomach retraction 
response in order to provide insights into the peptide’s mode of action. In this regard, 
determining the receptor type that the NG peptide family activate and the signal 
transduction pathways that the peptides couple to will be key (see chapter 5). 
 
4.4.3. The NG peptides: a conserved role in muscle myoactivity? 
 
The discovery of NGFFYamide has opened up the possibility to investigate the range 
of functions that the peptide may cover in the starfish A. rubens. Previous functional 
studies in the echinoderms, although limited, have revealed that the NG peptides may 
have a conserved role in regulating a range of physiological functions associated 
with contractile activity. 
In the sea urchin species E. esculentus, NGFFFamide has been shown to 
cause contraction of in vitro tube foot and oesophagus preparations (Elphick and 
Rowe, 2009). However, NGFFFamide is a more potent contractant of oesophagus 
preparations as opposed to tube feet preparations (Elphick and Rowe, 2009). In the 
sea cucumber A. japonicus, NGIWYamide has been shown to have a variety of 
contractile effects. NGIWYamide has been shown to cause contraction of RLM and 
intestinal muscle preparations (Iwakoshi et al., 1995; Ohtani et al., 1999), tentacle 
preparations (Inoue et al., 1999) and control the stiffness of connective tissue in the 
body wall dermis (Birenheide et al., 1998). More recently, it has also been shown 
that NGIWYamide induces oocyte maturation and gamete spawning in the sea 
cucumber A. japonicus (Kato et al., 2009). Combined with functional data in the sea 
urchin species E. esculentus and the starfish A. rubens, the NG peptides appear to 
regulate a range of physiological functions associated with contractile activity. 
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Interestingly, the contractile effect of NGFFFamide on oesophagus preparations from 
the sea urchin species E. esculentus (Elphick and Rowe, 2009) mirrors the contractile 
role of NGFFYamide on cardiac stomach preparations from A. rubens, which is 
suggestive of a role for the NG peptides in the feeding process in the echinoderms. 
However, it will important to determine whether NGFFYamide acts as a general 
muscle contractant on a range of preparations from A. rubens before drawing any 
hypotheses on a conserved role for the NG peptides.  
In support of a general myoactive role for NGFFYamide, NGFFYamide 
mRNA was detected in the nerve plexus in the adhesive region of the tube feet, in the 
basal nerve ring and was also present in marginal nerve, which innervates the outer 
row of tube feet in the starfish A. rubens (Fig. 4.6). These findings are consistent in 
part with NGIWYamide immunoreactivity in the starfish species A. pectifinera, in 
which expression was also observed in the basal nerve ring, marginal nerve and the 
nerve plexus of the adhesive region of the tube foot (Saha et al., 2006). The 
expression of NGFFYamide mRNA was observed in cell bodies in the coelomic 
epithelial layer lining the apical muscle and the coelomic epithelium separating the 
body wall from the coelomic cavity (Fig. 4.9). Interestingly, initial functional studies 
on in vitro tube feet and apical muscle preparations reveal that NGFFYamide causes 
dose-dependent relaxation of both preparations (Dane and Elphick, unpublished 
data). These data are the first in an echinoderm species that show that an NG peptide 
can cause relaxing effects as opposed to solely contractile-type effects. Once more, it 
will be crucial to determine the receptor(s) that the NG peptide family activate to 
determine the signal transduction pathways that lead to both the contractile and 
relaxing-type effects of NGFFYamide. 
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4.4.4. The NG peptides: neurophysin-associated neuropeptides 
 
Neurophysins are highly conserved pro-hormone derived polypeptides required for 
sorting the neurohypophyseal hormones VP and OT into the RSP (Cool et al., 2008; 
de Bree, 2000; de Bree and Burbach, 1998). The importance of the neurophysin 
domain can be highlighted through the disease FNDI, which is caused by mutations 
in the neurophysin domain of human VP, leading to an impairment of VP 
biosynthesis (Babey et al., 2011). 
The presence of a neurophysin domain was previously thought to be unique 
to VP/OT-type neuropeptide precursors. However, the discovery that NG peptide 
precursors have a C-terminal neurophysin domain has opened up the possibility to 
investigate the function of the neurophysin domain in NG peptide biosynthesis. 
However, there remains the possibility that the neurophysin domain is not required 
for NG peptide biosynthesis, which may explain why the neurophysin domain has 
been lost in the NGIWYamide precursor in the sea cucumber A. japonicus (Elphick, 
2012). 
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5. Discovery of the NGFFFamide receptor in the sea urchin S. purpuratus unites 
a bilaterian neuropeptide family 
 
5.1. Introduction 
 
Neuropeptides can be found in highly conserved families and can therefore be 
readily identified in evolutionary distant animals within the animal kingdom. 
However, such high sequence conservation is relatively uncommon and therefore 
establishing evolutionary relationships between neuropeptides in evolutionarily 
distant phyla has historically proved difficult. Recently, with advances in 
comparative genomics/transcriptomics, a number of neuropeptide signalling systems 
have been shown to be of an ancestral bilaterian origin (Jekely, 2013; Mirabeau and 
Joly, 2013). In many cases, these associations have only been made possible by 
investigating neuropeptide signalling systems in a range of phyla across the animal 
kingdom. Importantly, a vast number of these evolutionary insights have been made 
possible on the basis on receptor orthology.  
 
5.1.1. Neuropeptide-S (NPS) 
 
The sequencing of the human genome led to the identification of a vast number of 
genes encoding G-protein coupled receptors (GPCRs) with unknown endogenous 
ligands – these GPCRs were coined “orphan receptors”. One of the first receptors to 
be deorphanised through identification of its endogenous ligand was GPR154. The 
receptor was identified as being closely related to vasopressin/oxytocin (VP/OT)-
type receptors and was therefore referred to as VP receptor-related receptor 1 
(VRR1), mapping to chromosome 7p14-15 and displaying selective expression in the 
hypothalamus and retina (Gupte et al., 2004). However, through subsequent 
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pharmacological characterisation, it was found that VP/OT-type peptides do not act 
as ligands at VRR1. Instead, it was found that the endogenous ligand for VRR1 is a 
20-residue neuropeptide (SFRNGVGTGMKKTSFQRAKS) termed neuropeptide-S 
(NPS) on account of its N-terminal serine (S) residue (Xu et al., 2004). Interestingly, 
despite activating a VP/OT-type receptor, NPS does not share any sequence 
similarity with VP/OT-type peptides. 
NPS was first discovered in mammals and has subsequently been identified 
as belonging to a highly conserved family of neuropeptides in tetrapod vertebrates 
(Reinscheid, 2007). NPS modulates arousal and anxiolytic-like behaviour in rodents 
(Xu et al., 2004), with polymorphisms in the NPS receptor (NPSR) also associated 
with panic disorders in humans (Domschke et al., 2011; Okamura et al., 2007). 
Taken together, these findings indicate that NPS is an endogenous regulator of 
anxiety in tetrapod vertebrates. 
 
5.1.2. Crustacean cardioactive peptide (CCAP) 
 
Investigation into the phylogenetic distribution of NPSR-like proteins reveals that 
orthologues of the NPSR are not only found in tetrapod vertebrates but also are 
present in a number of invertebrate species including annelids, molluscs, insects and 
crustaceans (Jekely, 2013; Mirabeau and Joly, 2013). The endogenous ligand found 
to activate an NPSR-like protein in Drosophila was found to be a 9-residue amidated 
neuropeptide (PFCNAFTGC-NH2) termed crustacean cardioactive peptide (CCAP) 
(Cazzamali et al., 2003; Park et al., 2002). Interestingly, despite activating an NPSR-
like protein, CCAP does not share any sequence similarity with NPS-type peptides. 
 CCAP was first discovered in the crustacean Carcinus maenas (Stangier et 
al., 1987) and has subsequently been identified as belonging to a highly conserved 
family of neuropeptides in protostomian invertebrates (Jekely, 2013; Mirabeau and 
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Joly, 2013). CCAP was initially discovered as controlling cardioacceleration in the 
crustacean C. maenas (Stangier et al., 1987) and has subsequently found to have a 
key role in  neural control of ecdysis behaviour in crustaceans (Chung and Webster, 
2004; Phlippen et al., 2000) and insects (Arakane et al., 2008; Belmont et al., 2006; 
Ewer et al., 1998; Gammie and Truman, 1997; Kim et al., 2006; Park et al., 2003). 
It has been proposed that CCAP shares superficial sequence similarity with 
VP/OT-type peptides in the form of two cysteine (C) residues forming a disulphide 
bridge identified as being crucial for bioactivity (Arakane et al., 2008; Stangier et al., 
1987). However, CCAP precursor proteins do not have a C-terminal neurophysin 
domain characteristic of VP/OT-type precursor proteins (Loi et al., 2001). 
Interestingly, CCAP receptors are paralogous to VP/OT-type receptors, suggesting 
that CCAP and VP/OT-type peptides may have evolved from a common ancestral 
neuropeptide system (Mirabeau and Joly, 2013). However, despite paralogous 
receptors, what remains unclear is the relationship between NPS and VP/OT-type 
peptides and CCAP, with NPS sharing no apparent sequence or structural similarity 
with either VP/OT-type peptides or CCAP.  
 
5.1.3. The NG peptides 
 
Recent advances in comparative genomics/transcriptomics have transformed our 
understanding of neuropeptide diversity across the animal kingdom. A strategy to 
bridge the gap of understanding between neuropeptide signalling systems in 
vertebrates and classic model protostomian invertebrates (e.g. Drosophila and 
Caenorhabditis elegans) is to investigate genomic/transcriptomic data from the 
deuterostomian invertebrates (e.g. cephalochordates, hemichordates and 
echinoderms). Investigation into the phylogenetic distribution of NPSR-like proteins 
in deuterostomian invertebrate genome data reveals that orthologues of NPS/CCAP-
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type receptors are also present in the cephalochordates, hemichordates and 
echinoderms (Mirabeau and Joly, 2013; Pitti and Manoj, 2012; Valsalan and Manoj, 
2014). 
The NG peptides are a novel family of neuropeptides characterised by an 
asparagine-glycine (NG) motif that have recently been identified in deuterostomian 
invertebrates (Elphick, 2010). The first NG peptide precursor to be discovered was 
the NGFFFamide precursor in the sea urchin S. purpuratus, which has two tandem 
copies of the neuropeptide NGFFFamide (Elphick and Rowe, 2009). Subsequently, 
NG peptide precursors have been identified in a number of other echinoderm species 
(see chapter 4), the hemichordate Saccoglossus kowalevskii and the cephalochordate 
Branchiostoma floridae (Elphick, 2010). Interestingly, the NG peptide precursor in 
B. floridae has two copies of the putative NG peptide SFRNGVamide that shares 
sequence identity with the N-terminal region of NPS 
(SFRNGVGTGMKKTSFQRAKS), which is crucial for its bioactivity (Roth et al., 
2006); this is indicative of a common evolutionary origin (Elphick, 2010). 
Interestingly, NG peptide precursors have a C-terminal neurophysin domain, which 
was previously believed to be uniquely associated with VP/OT-type precursors (de 
Bree, 2000; de Bree and Burbach, 1998). Thus, with NPS and VP/OT-type peptides 
acting as ligands for orthologous receptors, the discovery of the neurophysin-
associated NG peptides has provided a link between NPS and VP/OT-type peptides.  
 
 
 
 
 
! 267 
5.1.4. NPS-type peptides, NG peptides and CCAP-type peptides: a bilaterian 
neuropeptide family? 
 
Taken together, it appears that structural features characteristic of the VP/OT-type 
neuropeptide signalling system have been differentially retained in the protostomian 
and deuterostomian invertebrates. In protostomian invertebrates, it is the presence of 
a disulphide bridge between two cysteine (C) residues in CCAP that is characteristic 
of VP/OT-type peptides. In deuterostomian invertebrates, despite sharing no 
sequence similarity with VP/OT-type peptides, it is the presence of a C-terminal 
neurophysin domain in the NG peptide precursors that is characteristic of VP/OT-
type precursors. Finally, despite NPS precursors not containing a C-terminal 
neurophysin domain, it is sequence similarity shared between the N-terminal region 
of NPS and SFRNGVamide in the cephalochordate B. floridae that is indicative of a 
common evolutionary origin (Elphick, 2010). Therefore, it can be deduced that the 
neurophysin domain was lost in an NG peptide-type precursor that gave rise to NPS 
precursors in the tetrapod vertebrates. 
Collectively, these observations indicate that duplication of a VP/OT-type 
neuropeptide precursor gene may have occurred in the common ancestor of the 
Bilateria. Here, one copy was retained giving rise to the VP/OT-type neuropeptide 
precursors found throughout extant bilaterians. The second copy diverged and took 
different courses during evolution in the protostomian and deuterostomian 
invertebrates. Moreover, the remaining gene copy diverged throughout bilaterian 
evolution giving rise to the CCAP system in protostomes and the NG peptide and 
NPS systems in deuterostomes respectively.  
Importantly, evidence in support of this model of neuropeptide evolution has 
been obtained through analysis of gene contiguity in the genomes of the 
deuterostomian invertebrates S. purpuratus and B. floridae. In the echinoderm S. 
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purpuratus, a gene encoding a VP/OT-type receptor (SPU_021290) is located 
adjacent to a gene encoding a candidate NPS/CCAP-type receptor (SPU_021291) 
(Fig. 5.1). In the cephalochordate B. floridae, a gene encoding a VP/OT-type 
precursor (Brafl1-84802) is located adjacent to a gene encoding the SFRNGVamide 
precursor (Brafl1-84803) (Mirabeau and Joly, 2013). However, to date, such gene 
contiguities have not been identified in other species, potentially reflecting gene 
rearrangement within these species.  
 
 
Fig. 5.1. Gene contiguity in the sea urchin S. purpuratus. Diagram showing that a 
VP/OT-type (“echinotocin”) receptor gene (Sp-Echtcnr) (SPU_021290) is located 
adjacent to a NPS/CCAP-type receptor gene (Sp-Ccap/NpSLr) (SPU_021291) on 
scaffold 114 of the S. purpuratus genome. Exons are represented by red rectangles 
and introns are represented by grey rectangles. The diagram was generated as an 
output from the S. purpuratus genome browser 
(http://www.echinobase.org/Echinobase/Spbase) utilising the JBrowse Genome 
Browser v.1.10.9 (http://jbrowse.org). 
 
 
 
 
 
 
 
 
 
! 269 
5.1.5. Aims and objectives 
 
The primary aim of the work reported in this chapter is to clone, sequence and 
pharmacologically characterise the receptor for the NG peptide NGFFFamide in the 
sea urchin S. purpuratus. The candidate NGFFFamide receptor is orthologous to 
NPS-type receptors in the tetrapod vertebrates and CCAP-type receptors in the 
protostomian invertebrates. Thus, characterisation of the NGFFFamide receptor will 
unify a bilaterian neuropeptide family that includes NPS-type peptides in tetrapod 
vertebrates, NG peptides in deuterostomian invertebrates and CCAP-type peptides in 
protostomian invertebrates. 
The secondary aim of this chapter is to identify NG peptide precursors and 
candidate NPS/CCAP-type receptors utilising recently available 
genome/transcriptome data from a number of echinoderm species. In combination, 
these data will provide an important foundation to pharmacologically characterise 
NG peptide receptors across the echinoderms. 
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5.2. Methods 
 
5.2.1. Bioinformatic identification of an NPS/CCAP-type receptor in the sea 
urchin S. purpuratus 
 
A candidate neuropeptide receptor (SPU_021291) was identified through the sea 
urchin genome project (Burke et al., 2006; Sodergren et al., 2006) and has 
subsequently been identified as an NPS/CCAP-type receptor on account of sequence 
similarity with NPS/CCAP-type receptors in both the protostomian and 
deuterostomian invertebrates (Mirabeau and Joly, 2013; Valsalan and Manoj, 2014). 
 
5.2.2. Cloning and sequencing of an NPS/CCAP-type receptor in the sea urchin 
S. purpuratus 
 
S. purpuratus cDNA (72-hour embryonic) generated using an iScriptTM cDNA 
Synthesis Kit (Bio-Rad) was kindly provided by Dr. Paola Oliveri (UCL). 
NPS/CCAP-type receptor cDNA containing the entire coding region was amplified 
by PCR using Phusion High-Fidelity PCR Master Mix (NEB) and the oligos: 5’-
CCGACATAGAAAGTCATAG-3’ and 5’-GTCAGATCAGATATAGCAGT-3’. 
The PCR product was gel-extracted and purified using the QIAquick Gel Extraction 
Kit (QIAgen) before being blunt-end cloned into a pBluescript SKII (+) vector 
(Agilent Technologies) and cut with the EcoRV-HF restriction endonuclease (NEB). 
Upon sequencing a clone from both the T3 and T7 sequencing primer sites for 
sequence confirmation (Eurofins), the full-length cDNA of the S. purpuratus 
NPS/CCAP-type receptor was sub-cloned into the eukaryotic expression vector 
pcDNA 3.1+ (Invitrogen) cut with BamHI and ApaI restriction endonucleases (NEB) 
using the oligos: 5’-cgggatccCACCATGGCGACACAAGTGA-3’ and 5’-
atcgggcccCTACATCGGACTAGTAGTC-3’. The partial Kozak sequence (CACC) 
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was incorporated immediately preceding the start codon to optimise initiation of 
translation. The clone was then sequenced from the T7 and pCR3.1-BGH-rev 
sequencing primer sites (Eurofins). A plasmid maxiprep was subsequently performed 
using the QIAgen Plasmid Maxi Kit (QIAgen). 
 
5.2.3. Pharmacological characterisation of heterologously expressed candidate 
NGFFFamide receptor 
 
Chinese hamster ovary (CHO) K1 (CHO-K1) cells stably overexpressing the 
mitochondrially targeted apo-aequorin and the promiscuous human Gα16 protein 
were used as a heterologous expression system for an in vitro Ca2+ mobilisation 
assay as has been employed previously for identification of neuropeptide receptors in 
the nematode C. elegans (Janssen et al., 2008). CHO-K1 cells were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM)/F12-Ham (Sigma-Aldrich) 
supplemented with 10 % fetal bovine serum (FBS) (Sigma-Aldrich), 100 U/ml of 
penicillin/streptomycin (Invitrogen), 250 µg/ml zeocin (Invitrogen) and 2.5 µg/ml 
amphotericin B (Sigma-Aldrich), in a humidified atmosphere of 5 % carbon dioxide 
(CO2) at 37 °C. CHO-K1 cells were transiently transfected with the pcDNA 3.1+ 
eukaryotic expression vector containing the NPS/CCAP-type receptor from the sea 
urchin S. purpuratus using Lipofectamine® LTX with Plus reagentTM (Invitrogen) 
according to the manufacturer’s instructions. CHO-K1 cells for negative control 
experiments were transfected with an empty pcDNA 3.1+ eukaryotic expression 
vector (Invitrogen). Two days post-transfection, cells were challenged with the 
synthetic NG peptides NGFFFamide (NGFFF-NH2) (S. purpuratus), NGFFYamide 
(NGFFY-NH2) (Asterias rubens) and NGIWYamide (NGIWY-NH2) (A. japonicus) 
within the concentration ranges 10-17 M to 2.5 x 10-4 M. Potential activation of the 
NPS/CCAP-type receptor at each peptide concentration was monitored by measuring 
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Ca2+ levels for 30 seconds using a Mithras LB 940 luminometer (Berthold 
Technologies). Ca2+ responses were normalised to the total Ca2+ response monitored 
after addition of Triton X-100 (0.1 %), and measured in triplicate in at least two 
independent experiments. Dose-response data were determined as relative (%) to the 
highest value (100 % activation). Half maximal effective concentrations (EC50 
values) were calculated from dose-response curves, constructed with non-linear 
regression analysis using a sigmoidal dose-response equation on SigmaPlot v.12.0 
(Systat Software Inc.). 
 
5.2.4. Bioinformatic identification of novel NG peptide-type precursors and 
candidate NG peptide receptors in the echinoderms 
To search for transcripts encoding NG peptide precursors and NPS/CCAP-type 
receptors that have not previously not identified in the echinoderms, the 
NGFFFamide precursor protein sequence (Elphick and Rowe, 2009) and the 
NPS/CCAP-type receptor protein sequence (Mirabeau and Joly, 2013; Valsalan and 
Manoj, 2014) from the sea urchin S. purpuratus (or the NGIWYamide precursor 
from the sea cucumber species A. japonicus for Parastichopus parvimensis due to 
loss of a C-terminal neurophysin domain) were submitted as queries in a tBLASTn 
search of a number of genome/transcriptome datasets: the publically available 
genome of the sea urchin species Lytechinus variegatus 
(http://www.echinobase.org/Echinobase/Blast/LvBlast/blast.php); transcriptomes of 
the sea cucumber species A. japonicus (Du et al., 2012) and P. parvimensis 
(http://www.echinobase.org/Echinobase/PBase); the transcriptome of the starfish 
species A. rubens (see chapter 2) and the publically available genome of P. miniata 
(http://www.echinobase.org/Echinobase/pm); transcriptomes of the brittle star 
species Ophionotus victoriae (Elphick et al., 2015) and Amphiura filiformis (access 
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to this transcriptome dataset was provided by Dr. Paola Oliveri, UCL); 
transcriptomes of the feather star species Antedon mediterranea (Elphick et al., 
2015) and Florometra serratissima (access to this transcriptome dataset was 
provided by Dr. Christopher Lowe, Stanford University). 
In the NG peptide precursor queries, the top-hits (expected (e)-value) for each 
species were as follows: L. variegatus (scaffold 1378; 96196 base pairs; e-value: 1e-
53) encoding a 265-residue protein; P. parvimensis (contig 177728; 1825 base pairs; 
e-value: 2e-165) encoding a 239-residue protein; P. miniata (contig 387981; 3147 base 
pairs; e-value: 4e-16) encoding a 239-residue protein; O. victoriae (contig 2050454; 
1597 base pairs; e-value: 6e-21) encoding a 248-residue protein; A. filiformis (contig 
3155347; 610 base pairs; e-value: 8e-31) encoding a partial 182-residue protein. 
These proteins were analysed for N-terminal signal peptides using SignalP 3.0 
(Bendtsen et al., 2004), putative NG peptides flanked by dibasic cleavage sites and a 
C-terminal neurophysin domain, which is characterised by the presence of fourteen 
cysteine (C) residues (Elphick, 2010; Elphick and Rowe, 2009). Subsequently, 
protein sequences were submitted as tBLASTn searches of The National Centre for 
Biotechnology Information (NCBI) database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
to determine sequence similarity to known neuropeptide or peptide hormone 
precursors.  
In NPS/CCAP-type receptor queries, the top-hits (e-value) for each species 
were as follows: L. variegatus (scaffold 255; 274595 base pairs; e-value: 4e-33) 
encoding a 440-residue protein; A. japonicus (isotig14190; 1646 base pairs; e-value: 
2e-113) encoding a 423-residue protein; P. parvimensis (contig 183467; 2956 base 
pairs; e-value: 8e-109) encoding a 423-residue protein; A. rubens (contig 1116923; 
1994 base pairs; e-value: 2e-118) encoding a 449-residue protein; P. miniata (scaffold 
44; 185723 base pairs; e-value: 3e-22) encoding a 439-residue protein; A. 
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mediterranea (contig 1796804; 1746 base pairs; e-value: 7e-98) encoding a 394-
residue protein; F. serratissima (contig 26548l; 2182 base pairs; e-value: 1e-95) 
encoding a 332-residue protein. These proteins were analysed for seven 
transmembrane domains characteristic of GPCRs using GPCRHMM 
(http://gpcrhmm.sbc.su.se).! Subsequently, protein sequences were submitted as 
tBLASTn searches of The National Centre for Biotechnology Information (NCBI) 
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to determine sequence similarity to 
known neuropeptide or peptide hormone receptors. !
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5.3. Results 
 
5.3.1. Cloning and sequencing of an NPS/CCAP-type receptor in the sea urchin 
S. purpuratus  
 
An NPS/CCAP-type receptor identified in the genome of the sea urchin S. 
purpuratus has been reported previously (Burke et al., 2006; Mirabeau and Joly, 
2013; Valsalan and Manoj, 2014) and its sequence has subsequently been confirmed 
through transcriptome sequencing (Tu et al., 2012). However, in order to test the 
hypothesis that NGFFFamide is the endogenous ligand for an NPS/CCAP-type 
receptor in the sea urchin S. purpuratus, the 444-residue sequence was cloned and 
sequenced (Fig. 5.2). The cloned and sequenced receptor contained a number of 
polymorphisms at the nucleotide level, but was identical at the protein level to 
previously reported genome (Burke et al., 2006) and transcriptome (Tu et al., 2012) 
data. 
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1                                                              cc 
3    gacatagaaagtcatagttctactcgcattatggcgacacaagtgaactttgaccctggg 
                                    M  A  T  Q  V  N  F  D  P  G   10  
63   gtcacgacgacagagggcttcgattatacagagcctgggtcaaacaatggcaccagtaac 
      V  T  T  T  E  G  F  D  Y  T  E  P  G  S  N  N  G  T  S  N   30  
123  ggcattgtcgacaggtggtcgcttgacaaacacatccagcttgccgtcctctgggttctc 
      G  I  V  D  R  W  S  L  D  K  H  I  Q  L  A  V  L  W  V  L   50  
183  ttcaccctcatcatagtagggaacggcatcgtcctcatcgcaatatggctcgtccgccac 
      F  T  L  I  I  V  G  N  G  I  V  L  I  A  I  W  L  V  R  H   70  
243  aagaaatccagactcaacttcttcatcacaaatctcgccgttgcggatatctgtgtgggt 
      K  K  S  R  L  N  F  F  I  T  N  L  A  V  A  D  I  C  V  G   90  
303  ttattcagcgtgggttttgatattcttgatcgccagacaccggaatttataggcggtgac 
      L  F  S  V  G  F  D  I  L  D  R  Q  T  P  E  F  I  G  G  D  110  
363  atagcctgcaaactatatcgatatgtccaagcttatgttgtgttggcttcatcgtaccag 
      I  A  C  K  L  Y  R  Y  V  Q  A  Y  V  V  L  A  S  S  Y  Q  130  
423  cttgtagcattgagttttgatcgattctttgctatagtttacccgatggatttcacaggc 
      L  V  A  L  S  F  D  R  F  F  A  I  V  Y  P  M  D  F  T  G  150  
483  aatggtaagcggtcgacgatgctggcagcgggcggttggatattaccagcggtgctaggt 
      N  G  K  R  S  T  M  L  A  A  G  G  W  I  L  P  A  V  L  G  170  
543  attacttcacccgtcgtttttcaagtcgatcccctagcttcaccagacgggacacaaatg 
      I  T  S  P  V  V  F  Q  V  D  P  L  A  S  P  D  G  T  Q  M  190  
603  gtgatgtcatgctggcctgctgcactctacagcaatcgatcgtggatactcaaggtttac 
      V  M  S  C  W  P  A  A  L  Y  S  N  R  S  W  I  L  K  V  Y  210  
663  gcgatgtacgtcacctcctcgttcttctacattcctctgatactcatcaccttttgttac 
      A  M  Y  V  T  S  S  F  F  Y  I  P  L  I  L  I  T  F  C  Y  230  
723  gtcacaatcatcgtaaccatctggacgagagcgaagaagatgggcggaccccaaaaggtc 
      V  T  I  I  V  T  I  W  T  R  A  K  K  M  G  G  P  Q  K  V  250  
783  aagaagtcgaaaaacgcaaacagagatgtcgcctacgaaggattgtcaaaagacagcaac 
      K  K  S  K  N  A  N  R  D  V  A  Y  E  G  L  S  K  D  S  N  270  
843  tccacaatgcctaaacatcgagccagttcacgaggcctaatcccaagggctaagattaag 
      S  T  M  P  K  H  R  A  S  S  R  G  L  I  P  R  A  K  I  K  290  
903  accatcaaaatgaccatctgtatcgtctgtgcttacatatgttgcttcatgccgttctct 
      T  I  K  M  T  I  C  I  V  C  A  Y  I  C  C  F  M  P  F  S  310  
963  ctcttctacacgctggaggcattcggatgcatagacacctccagccaagcggtcctcttg 
      L  F  Y  T  L  E  A  F  G  C  I  D  T  S  S  Q  A  V  L  L  330  
1023 gccacacccgttctccaaaacctcccatccctcaacagcgccaccaaccctttcatttat 
      A  T  P  V  L  Q  N  L  P  S  L  N  S  A  T  N  P  F  I  Y  350  
1083 ggcattttcagcaccaatgtctgcaaagaattgagacggatacccgccatcaactggata 
      G  I  F  S  T  N  V  C  K  E  L  R  R  I  P  A  I  N  W  I  370  
1143 gccgacaaggtgccgtgctgcagcgcttggaaaccgctccgattcggccgtcccacctac 
      A  D  K  V  P  C  C  S  A  W  K  P  L  R  F  G  R  P  T  Y  390  
1203 cagaccaacacacacacgacggaattcaacaacttctccgacggccatacgggctcaaga 
      Q  T  N  T  H  T  T  E  F  N  N  F  S  D  G  H  T  G  S  R  410  
1263 gggcgcaacatcgtcagcatgagcgggaaggtggtcgatggcccttcccgggacgatagt 
      G  R  N  I  V  S  M  S  G  K  V  V  D  G  P  S  R  D  D  S  430  
1323 cgttccagggacgatagccgaaattcgactactagtccgatgtagtacggtgtcgtccgc 
      R  S  R  D  D  S  R  N  S  T  T  S  P  M  *                 444 
1383 aatgtcatcaacgacggtttatcctacacgatgtcggtggatggtatttggaccattatc 
1443 caattattgtagcatttttctttttacaacagggtagactttcgtttgtggaactgctat 
1503 atctgatctgac !
Fig. 5.2. S. purpuratus NPS/CCAP-type receptor. The nucleotide sequence 
(lowercase, 1514 bases) encoding the receptor protein (uppercase, 444 amino acid 
residues) confirmed by cloning and sequencing is shown, with primer sites shown by 
highlighting bases in bold. The positions of introns in the gene are shown by 
highlighting the pairs of bases (bold and underline) in the sequence that are 
interrupted by an intron. The asterisk shows the position of the stop codon. Predicted 
transmembrane domains are highlighted in grey. 
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5.3.2. NGFFFamide is a potent ligand for an NPS/CCAP-type receptor in the 
sea urchin S. purpuratus  
 
In order to test the hypothesis that the endogenous ligand for an NPS/CCAP-type 
receptor in the sea urchin S. purpuratus is the NG peptide NGFFFamide, an 
approach that has been successfully used to deorphanise a number of GPCRs in the 
nematode C. elegans was implemented (Janssen et al., 2008). The cloned and 
sequenced NPS/CCAP-type receptor was expressed in a CHO-K1 cell line stably 
overexpressing the human Gα16 protein (directing intracellular signalling via the 
phospholipase-C (PLC) and inositol triphosphate (IP3) pathway of Ca2+ release 
regardless of endogenous G-protein coupling) and the mitochondrially-targeted apo-
aequorin (to monitor the subsequent intracellular Ca2+ elevation). The NPS/CCAP-
type receptor was activated in a dose-dependent manner by synthetic NGFFFamide 
(NGFFF-NH2) with an EC50 of 0.4 nM (Fig. 5.3). In order to characterise structure-
activity relationships of the NPS/CCAP-type receptor, synthetic NGFFYamide 
(NGFFY-NH2) (A. rubens; see chapter 4) and synthetic NGIWYamide (NGIWY-
NH2) (A. japonicas; Iwakoshi et al., 1995; Elphick, 2012) were also investigated as 
potential ligands for the receptor. The NPS/CCAP-type receptor was activated by 
synthetic NGFFYamide and NGIWYamide with an EC50 of 5.7 nM and 367 nM 
respectively (Fig. 5.3). It is noteworthy that there is over a ten-fold difference in 
potency between NGFFFamide and NGFFYamide despite differing by only one 
amino acid and more specifically a single hydroxyl group on the C-terminal tyrosine 
(Y) residue of NGFFYamide. It is also noteworthy that the additional fold difference 
in potency between NGFFYamide and NGIWYamide is likely due to differences in 
the side chain structures of the isoleucine-tryptophan (IW) dipeptide as opposed to 
the phenylalanine-phenylalanine (FF) dipeptide present in NGFFFamide and 
NGFFYamide. 
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Fig. 5.3. The S. purpuratus NPS/CCAP-type receptor is activated by the NG 
peptides NGFFFamide, NGFFYamide and NGIWYamide. CHO-K1 cells 
expressing the S. purpuratus NPS/CCAP-type receptor were challenged with the 
synthetic NG peptides NGFFFamide (NGFFF-NH2) (S. purpuratus), NGFFYamide 
(NGFFY-NH2) (A. rubens) and NGIWYamide (NGIWY-NH2) (A. japonicus) and 
Ca2+ response measured. Each point (± s.e.m) represents mean values from at least 
two independent experiments performed at least in triplicate. Dose-response data are 
shown as relative (%) to the highest value (100 % activation) after normalisation to 
the maximum Ca2+ response. The log EC50 values (± s.e.m) are NGFFFamide - 9.38 
± 0.09; NGFFYamide: - 8.25 ± 0.04; NGIWYamide: - 6.44 ± 0.04.  
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5.3.3. Sequences of novel NG peptide precursors and candidate receptors in the 
echinoderms 
 
Upon determining that NGFFFamide is the endogenous ligand for an NPS/CCAP-
type receptor in the sea urchin S. purpuratus, NG peptide precursors and candidate 
NPS/CCAP-type receptors across the echinoderms were identified through both the 
generation and analysis of transcriptome data and from publicly available 
transcriptome/genome data. The purpose for the identification of NG peptide 
precursors and candidate NPS/CCAP-type receptors in the echinoderms is two-fold. 
Firstly, it enables reconstruction of the evolution of the NG peptide signalling system 
in deuterostomian invertebrates. Secondly, it enables prediction of the endogenous 
ligands for NPS/CCAP-type receptors identified in these species.  
To date, a number of NG peptide precursors and NPS/CCAP-type receptors 
in deuterostomian invertebrates have been reported (Table 6). These include the 
SFRNGVamide precursor in the cephalochordate B. floridae (Elphick, 2010), the 
NGFWNamide/NGFYNamide precursor in the hemichordate S. kowalevskii 
(Elphick, 2010), the NGIWYamide precursor in the sea cucumber A. japonicus 
(Elphick, 2012) and the NGFFYamide precursor in the starfish A. rubens (see 
chapter 4). Consistent with the finding that NGFFFamide is the endogenous ligand 
for an NPS/CCAP-type receptor in the sea urchin S. purpuratus, NPS/CCAP-type 
receptors are also found in species that contain an NG peptide-type precursor 
(Mirabeau and Joly, 2013; Pitti and Manoj, 2012; Valsalan and Manoj, 2014). 
Interestingly, however, to date, NG peptide precursors and NPS/CCAP-type 
receptors have not been identified in the urochordates, including the tunicates Ciona 
intestinalis (http://genome.jgi-psf.org/Cioin2/Cioin2.home.html) and Oikopleura 
dioica (http://www.genoscope.cns.fr/externe/GenomeBrowser/Oikopleura/). This 
finding suggests that the loss of a gene encoding an NG peptide precursor is 
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associated with a loss of an NPS/CCAP-type precursor or vice versa, providing 
further evidence that the NG peptides are the endogenous ligands for NPS/CCAP-
type receptors. 
The recent availability of echinoderm genome/transcriptome data has enabled 
identification of NG peptide precursors and candidate NPS/CCAP-type receptors in 
each of the extant classes of echinoderms (Fig. 5.4). The echinoderms comprise five 
classes – the echinoids, the holothurians, the asteroids, the ophiuroids and the 
crinoids (Fig. 1.4). The echinoids and holothurians form the echinozoan clade, the 
asteroids and ophiuroids form the asterozoan clade whilst the crinoids are basal to 
the echinozoan and asterozoan clades (O'Hara et al., 2014; Telford et al., 2014).  
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Species NG peptide(s) Ref(s) NPS/CCAP-type 
receptor 
Ref(s) 
B. floridae SFRNGV-NH2 
(x1 copy) 
 
a 
 
✓ 
 
d 
S. kowalevskii NGFYN-NH2 
(x1 copy) 
NGFWN-NH2 
(x5 copies) 
 
a 
 
✓ 
 
d 
A. japonicus NGIWY-NH2 
(x5 copies) 
 
b 
 
✓ 
 
e 
A. rubens NGFFY-NH2 
(x2 copies) 
 
c 
 
- 
 
- 
 
Table 6. NG peptides and candidate NPS/CCAP-type receptors previously 
reported in invertebrate deuterostomes. NG peptide precursors and NPS/CCAP-
type receptors have been identified in the cephalochordate B. floridae, the 
hemichordate S. kowalevskii and the echinoderm species A. japonicus and A. rubens. 
a) Elphick, 2010; b) Elphick, 2012; c) chapter 4; d) Pitti and Manoj, 2012; e) Rowe 
et al., 2014. 
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5.3.3.1. NG peptide signalling system in the Echinoidea 
 
In the echinoids, beyond the characterisation of the NG peptide signalling system in 
the sea urchin S. purpuratus, an NG peptide precursor and NPS/CCAP-type receptor 
were identified in the genome of the sea urchin species L. variegatus 
(http://www.echinobase.org/Echinobase/Blast/LvBlast/blast.php). In comparison 
with the S. purpuratus precursor, the L. variegatus precursor also comprises two 
copies of the NG peptide NGFFFamide in tandem flanked by dibasic cleavage sites 
(Fig. 5.5A; Fig. S69). The L. variegatus precursor and the S. purpuratus precursor 
both have a similar gene structure comprising three exons. In the L. variegatus 
precursor, the first exon encodes the N-terminal signal peptide and 10 amino acid 
residues separating the signal peptide from the NGFFFamide coding region. The 
second exon encodes two copies of NGFFFamide flanked by dibasic cleavage sites 
and a 26 amino acid sequence separating NGFFFamide from the C-terminal 
neurophysin domain. The third exon encodes the C-terminal neurophysin domain 
followed by a stop codon. Similarly, the L. variegatus NPS/CCAP-type receptor and 
the S. purpuratus NGFFFamide receptor also have a similar gene structure 
comprising nine exons (Fig. 5.6A; Fig. S74). This conservation of gene exon/intron 
structure provides further evidence of orthology. 
 
5.3.3.2. NG peptide signalling system in the Holothurians 
 
The holothurians (e.g. sea cucumbers) form a sister class to the echinoids (e.g. sea 
urchins) and together comprise the echinozoan clade (O'Hara et al., 2014; Telford et 
al., 2014). Previous investigation into the transcriptome of the sea cucumber A. 
japonicus (Du et al., 2012) has led to the identification of an NG peptide precursor 
comprising five copies of the NG peptide NGIWYamide (Elphick, 2012) and an 
NPS/CCAP-type receptor (Rowe et al., 2014). Interestingly, however, the A. 
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japonicus precursor does not have a C-terminal neurophysin domain, which 
presumably reflects loss in the holothurian lineage (Elphick, 2012). Extending 
analysis to the transcriptome of the sea cucumber species P. parvimensis reveals a 
precursor protein comprising four copies of the NG peptide NGIWYamide and one 
copy of the NG peptide NGVWYamide, differing by a single amino acid residue – a 
valine (V) as opposed to an isoleucine (I) (Fig. 5.5B; Fig. S70). The P. parvimensis 
precursor does not have a C-terminal neurophysin domain, which provides further 
evidence of loss of this domain in the holothurian lineage. Furthermore, an 
NPS/CCAP-type receptor was also identified in this species (Fig. 5.6B; Fig. S75). 
 
5.3.3.3. NG peptide signalling system in the Asteroidea 
The asteroids (e.g. starfish) form a sister clade to the ophiuroids (e.g. brittle stars) 
and together comprise the asterozoan clade (O'Hara et al., 2014; Telford et al., 2014). 
Analysis of transcriptome of the starfish A. rubens resulted in identification of an NG 
peptide precursor comprising two copies of the NG peptide NGFFYamide (Fig. 2.4; 
Fig. S5) and an NPS/CCAP-type receptor (Fig. 5.6C; Fig. S6). Analysis was 
extended to the genome of the starfish species P. miniata, which also has an NG 
peptide precursor comprising two copies of the NG peptide NGFFYamide (Fig. 
5.5C; Fig. S71) and an NPS/CCAP-type receptor (Fig. 5.6D; Fig. S76). 
 
5.3.3.4. NG peptide signalling system in the Ophiuroidea 
The ophiuroids (e.g. brittle stars) form the sister clade to the asteroids (e.g. starfish) 
comprising the asterozoan clade (O'Hara et al., 2014; Telford et al., 2014). To date, 
NG peptide precursors and NPS/CCAP-type receptors have not been reported for any 
species of ophiuroid. In this regard, a transcriptome dataset has been generated from 
the brittle star O. victoriae (Elphick et al., 2015) and a transcriptome dataset has been 
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analysed from the brittle star species A. filiformis leading to the identification of NG 
peptide precursors in both species. The O. victoriae precursor contains one copy of 
the NG peptide NGFFFamide and one copy of the NG peptide NGFFYamide in 
tandem (Fig. 5.5D; Fig. S72). The A. filiformis precursor contains two copies of the 
NG peptide NGFFFamide in tandem (Fig. 5.5E; Fig. S73). Interestingly, however, 
an NPS/CCAP-type receptor was not identified in either species. 
 
5.3.3.5. NG peptide signalling system in the Crinoidea 
The crinoids (e.g. feather stars and sea lilies) are basal to the echinozoan and 
asterozoan clades (O'Hara et al., 2014; Telford et al., 2014). To date, NG peptide 
precursors and NPS/CCAP-type receptors have not been reported for any species of 
crinoid. In this regard, a transcriptome dataset has been generated from the feather 
star A. mediterranea (Elphick et al., 2015) and a transcriptome dataset has been 
analysed from the feather star species F. serratissima (access to transcriptome 
dataset was provided by Dr. Christopher Lowe, Stanford University). Interestingly, 
through BLAST analysis, NG peptide precursors were not identified in either 
species. However, NPS/CCAP-type receptors were identified for both species (Fig. 
5.6E-F; Fig. S77-78). The absence of NG peptide precursors in the crinoids could 
represent sequence divergence in the peptide region and/or represent the loss of the 
C-terminal neurophysin domain. 
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Fig. 5.4. The NPS/NG peptide precursors and receptors in the deuterostomes. 
(A) Schematic depicting the structural organisation of NPS/NG peptide precursors in 
the deuterostomes. Signal peptides are represented in blue, putative neuropeptides 
are represented in red, dibasic cleavage sites are represented in green and C-terminal 
neurophysin domains are represented in purple. (B). Neighbour joining (NJ) tree 
(including bootstrap values out of 1000) of NPS/CCAP-type receptors in the 
deuterostomes. The hypothetical position of a candidate NPS/CCAP-type receptor in 
the brittle star O. victoriae is depicted by a dashed line. (C) Alignments of putative 
neuropeptides derived from NPS/NG peptide precursors. Conserved NG motifs are 
highlighted in yellow and the number of copies of each peptide is represented in 
parentheses. A.jap, Apostichopus japonicus; A.med, Antedon mediterranea; A.rub, 
Asterias rubens; B.flo, Branchiostoma floridae; H.sap, Homo sapiens; O.vic, 
Ophionotus victoriae; S.kow, Saccoglossus kowalevskii; S.pur, Strongylocentrotus 
purpuratus. 
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(A) L. variegatus NGFFFamide precursor 
MGYERRILRTLLSISIVLASFVTVYGERDNNFMQQKQFRNIVPSPLIQKWRENQMGP
SEEKISNEEWKDELLSNLRNVLRKHNPSSRSRDRTDITAYGLQEPLPQLPADVSADQ
LFILEGASPNSPLGNYEAETPIDEDKRNGFFFGKRNGFFFGKRSGSEVSATKVDDDR
LSKFESSGSFDKCRPCGPRSQGRCVMVGTCCSPQFGCYLFTPEAAACMTEDVSPCQL
NAPSCGLEGQCVANGICCSAAEGACHLDPTCTSMSLK 
 
(B) P. parvimensis NGIWY/NGVWYamide precursor 
MAVEAKIVSCLVCIWLTSTVYSQSNTGRTHDYGELSKAVDTFLDILMDEENFDDVNN
IESWETVLKEDINPKLRILAHVMRSLSSRQDTSSLRQQVLPNDYISRYLQEFLTDEQ
PFWDESSPKLPSLQTPELDQIKASADERNNFWSDNPSHRPPEGIPFSAGEESKRNGI
WYGKRKSSLQDGEAVKRNGVWYGKRSSPPVDDKRNGIWYGKRNGIWYGKRNGIWYGK
RDDSLYSEEMM 
 
(C) P. miniata NGFFYamide precursor 
MGGRSVSLIGVVIVVVTILVAFTWAETANGSLSQKVKIRREGRESDKYWSKDVGLTD
QQLRQLLANSLTNSYSTGEGESQTRPAKPGYRLYGNRLSDTNLGIDGNEEDEVETEV
TPRGSSLRTSKRNGFFYGKRNGFFYGKRSGSTLENANQCTQCGPQNSGQCVMFGTCC
SYAAGGCFFMTEEALPCVTSKTSSICQLQGAPCGSDGYGRCVADSVCCSPQEGACHV
DVACSSKPTYQ 
 
(D) O. victoriae NGFFF/NGFFYamide precursor 
MAVGIRNVILHLILVLYVARTILGEIDTYKVRRYTDGSPVNSNHWTQSDNINELRKE
IFASLPADLPGIIHKSKTHDSRSGRHSDELSNLEQLGNVAGKDGANDAKDKLALYNF
MSKQATRNNLGDELDKRNGFFFGKRNGFFYGKRDVEAVNNEDSCVRCGPENRGQCVM
FGTCCSPQFGCYLMTKESEACMSNHIGTGCRNLDMAPQCGSTGVCVAKGVCCSPQDG
ACHIDVTSCLSDNTTIDKSL 
 
(E) Partial (5’) A. filiformis NGFFFamide precursor 
DIPAILLNPQTQENKEDTPQDLTALEQVERVATGQTIDTDARDNLYNFLSRQSARNN
YQAGLESKRNGFFFGKRNGFFFGKRDTEAVKSDLCTSCGPQNIGQCVMFGTCCSPQF
GCYFMTQEATACTKHHIDNACWNQDLMPSCGRRGICAADALCCSPKDGACRIDLSCS
SPQKKNYDFND 
 
Fig. 5.5. NG peptide precursors identified in echinoderm species. (A) L. 
variegatus NGFFFamide precursor. (B) P. parvimensis NGIWY/NGVWYamide 
precursor. (C) P. miniata NGFFYamide precursor. (D) O. victoriae 
NGFFF/NGFFYamide precursor.  (E) Partial (5’) A. filiformis NGFFFamide 
precursor. N-terminal signal peptides are represented in blue, putative NG peptides 
are represented in red, C-terminal glycine (G) residues are represented in orange and 
dibasic cleavage sites are represented in green. Neurophysin domains characteristic 
of NG peptide precursors are represented purple, with the characteristic fourteen 
cysteine (C) residues underlined. 
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(A) L. variegatus NPS/CCAP-type receptor 
MTTQLNFDPEVMTTEALNFTDSWPENDTGNGIVDRWSLDKHIQLAILWILFTLIIVG
NGIVLIALWLVRHKKSRLNFFITNLAVADICVGLFSVGLDIIDRQTPEFTGGDIACK
LYRYVQAYVVLASSYQLVALSFDRFFAIVFPMDFTGNHAGKRSTLLAAGGWLLPSVL
CITSAVVFQVDLLDSPDRKSKVMSCWPAPLYGDQAWKLKVYSMYVISSFFYIPLILI
TFCYVTIIVTIWKRAKKMGGPQVIKKSKNSNRDVAYEGLSKDSNCTMPKHRASSRGL
IPKAKVKTIKMTICIVLAYICCFLPFSLFYTLEAFGCINPQSTAVLMATPVLQNLPS
LNSATNPFIYGIFSTNVCKELRRIPAINWIADKVPCCTAWKPLRFGRTTYQTNTHTT
EFNNFSDGHTGSRGRNIVSMSGKVVDGPSRDDSRNSTTSPM 
 
(B) P. parvimensis NPS/CCAP-type receptor 
MADEPAVLSTLGTELQRTSENTFTTIGSHEHDNRLAVESELQLAILWTMYILIVVGN
GLVLLALFSVRHKKSRLNFFVKHLAIADVCVGLLNVLPEIIHRYRGAFYAGMFLCKI
KSYGQAFVIYASIYQMVALSLDRFFAIVFPMDFMASRKRSTFMAAGAWILPGMLATP
SLAIFVTVDLHGQTQCAPIAILQDKLKYQLYSLYIVSITFLIPLMILCVCYGTMISV
IWRRGKAMAPPVKSDKNANSGGVKYTGLQKKAKQDENNFKHRSSSRGLIPRAKIKTV
KMTICIVIAYILCWLPTSLYFTLEAFKVVKPSADPQHAIYWVSVIMQNLVYLNSATN
PFIYGFFSSNICKELRRYYIIRQLLKWMPCCKVTEPGYGRSTAGTVMTEFHSHTAAI
SDNHRFNHNASSNDEKSVRETSHI 
 
(C) A. rubens NPS/CCAP-type receptor 
MATIPAYDHLVTDSVMAGYSLNDTASTVMVPTGLPSTLEGAPNATTSVTYFSDGENR
LSFYGGFQLIVLWVLFGLTVIGNSTVLLAVYVIRHKKSRLNFFVAHLAASDLLVGIV
NNGYEVLYRYLGEFYGGMVFCKIIRFSQAYVINASSFQLVALSLDRFFAIVFPMDFS
GSGKRANLMAVTAWIAPLFASIPSAIVFEAAVDSWGKTHCIPPPLVPGSWQYKVYTL
YVVSGFFYIPLIIISTCYIFMVISIWRRSKYMMGQKPEKVKGKAAKNASKEKEPMKH
RASSRGLIPKAKIKTLKMTVSIIVAFIVCWCPFSVFYTLDAFGVIFIDEANLNTAFR
ASAFIQNLPFLNSAINPFIYGMFSTNICQELRRFSVINWMATKLRCCKSWRPSRYGR
STTLRTDTNLTDMSEGASGTHRGHTRPLYVYTPGRTSNSDHSRDLSNSAM 
 
(D) P. miniata NPS/CCAP-type receptor 
MTSLATSTSYERLMNYSSGGGVSVMANPAGVDLSTEGALNASTTENPFADGENRISF
YGDLQLIVLWVLVALTVVGNSTVLLAVFVIRHKKSRLNFFVAHLAAADLLVGVINAG
YEIIYKYMGEFYGGTVFCKIIRYLQAYVINASSFQLVALSLDRFFAIVFPMDFSGSG
KRANLMAGTAWIAPFFASIPSAIVFEAKMDGWGTTHCYPPPLQPGSWQYKVYTLYVV
SGFFYIPLIVISTCYIFMVVSIWRRSKYMMGQKPDKVKGKAASKEMKHRASSRGLIP
KAKIKTLKMTVCIIVAFILCWCPFSIFYTLDAFRVIVIDEATLNTAFRASAFIQNLP
YLSSAINPFIYGLFSTNICQELRRFRVINWMATKLRCCKSWRPSRYGRSTLRTDTNL
TDMSEGASGTHRGHSRPMYVYTPARTSNSDNSREMPNSAM 
 
(E) A. mediterranea NPS/CCAP-type receptor 
MDYNMDNYTDFWTEMTPTTKEVSRIVLYRDLQLIVLWSLFISILIGNGAVLFALYTV
RHKKSRMNFFVMNLAISDIIVGFFEVLVQLIHRGYTGTWETGNIACKLVKYIQAASL
TASSCQLVALSVDRYLAIIYPMNFSGRSRRAHMMAAAAWITPFITSITSLHIFEIRE
HGEGTQCWMVLENENLKLKLYTIYVMCILFFIPLVVILFCYCSIIITIWKKSKMMGP
NIKPASNKKGNNYDNLKADEGSRSHRASSRGLIPKAKVKTIYITLSIVIAFVLCWSP
FIFTYLLAAFQVIQPSAKLMAVIANLPAINSAVNPLIYGIFSTNLCRELKRIPVINW
FAGVLPCCTARKKAEPGFTRAMYTRTENTNMDYSVTTCEQDSERIKLGQTSK!
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(F) F. serratissima NPS/CCAP-type receptor 
MDDMDNTTEFWSEMTPTLEVSRIVLHRDLQLVVLWSLFVSIFIGNGAVLLALYSVRH
KKSRMNFFVMNLAISDILVGIFEVLVQLIHRGYTGTWRTGNISCKIVKYIQAASMSA
SSFQLVALSVDRYLAIIYPMNFSGRSRRAHIMAAAAWIAPFITSITSLHIFEIREFP
EGPQCWMTLEGGGWKSKLYTVFVCCILFFIPLIVILFCYCSIIITIWQKSKMMGPKI
KSTNNKKGNYDNLKADEGSRSHRASSRGLIPKAKIKTIYITLSIVIAFVLCWSPFIF
YYLLMAFKVIVPDPKVMAVIANLPAINSAVNPLIYGIFSTNLCRELK 
 
Fig. 5.6. NPS/CCAP-type receptors identified in echinoderm species. (A) L. 
variegatus NPS/CCAP-type receptor. (B) P. parvimensis NPS/CCAP-type receptor. 
(C) A. rubens NPS/CCAP-type receptor. (D) P. miniata NPS/CCAP-type receptor.  
(E) A. mediterranea NPS/CCAP-type receptor. (F) F. serratissima NPS/CCAP-type 
receptor. Predicted transmembrane domains are highlighted in grey. 
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5.4. Discussion 
 
The finding that the NG peptide NGFFFamide activates an NPS/CCAP-type receptor 
in the sea urchin S. purpuratus, which to date is the first echinoderm neuropeptide 
GPCR to be deorphanised, has unified a bilaterian family of neuropeptides that 
encompasses NPS-type peptides in tetrapod vertebrates, NG peptides in 
deuterostomian invertebrates and CCAP-type peptides in protostomian invertebrates. 
This finding, along with the identification of novel NG peptide precursors and/or 
NPS/CCAP-type receptors across each of the five extant echinoderm classes 
(echinoids, holothurians, asteroids, ophiuroids and crinoids), has allowed 
reconstruction of the evolution of the NPS/NG peptide/CCAP-type neuropeptide 
signalling system. 
 
5.4.1. An ancient duplication of a VP/OT-type neuropeptide signalling system 
gave rise to the NPS/NG/CCAP-type signalling systems 
In Fig. 5.7, an evolutionary hypothesis is presented in which an ancient duplication 
of a VP/OT-type precursor and receptor in the common ancestor of the Bilateria gave 
rise to the VP/OT-type neuropeptide signalling system, the NPS-type system in 
tetrapod vertebrates, the NG peptide system in deuterostomian invertebrates and the 
CCAP-type system in protostomian invertebrates. In the common ancestor of the 
Bilateria, one copy was retained giving rise to the highly conserved VP/OT-type 
precursors found throughout the extant bilaterians, comprising a single VP/OT-type 
peptide with a disulphide bridge and a C-terminal neurophysin domain. The second 
copy diverged but this took different courses during the evolution of protostomes, 
deuterostomian invertebrates and vertebrates. In this regard, comparison of the 
sequences of NPS-type peptides, NG peptides and CCAP-type peptides with each 
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other and with the sequences of VP/OT-type peptides show the differential retention 
of a number of structural characteristics, which reflect the common evolutionary 
origins of these neuropeptides. 
In the deuterostomian branch of the animal kingdom, the second copy lost the 
disulphide bridge characteristic of VP/OT-type peptides but differentially retained 
the C-terminal neurophysin domain. In the deuterostomian invertebrates, the NG 
peptide family retained the C-terminal neurophysin domain, with the exception of the 
holothurian lineage (e.g. sea cucumbers). However, in the vertebrate lineage that 
gave rise to NPS-type precursors in tetrapod vertebrates, the C-terminal neurophysin 
domain was lost. To date, NPS-type precursors have not been identified in the 
teleosts and basal vertebrate classes including the Chondrichthyes (e.g. cartilaginous 
fish) and Agnathans (e.g. jawless fish) (Reinscheid, 2007). This indicates that there 
has been independent loss of NPS-type precursor genes in multiple vertebrate 
lineages whilst there has also been loss in the urochordates.  
In the protostomian branch of the animal kingdom, the second copy retained 
the disulphide bridge characteristic of VP/OT-type peptides. Interestingly, however, 
comparison with the NG peptides and NPS-type peptides reveals that the NG motif is 
also a feature of CCAP-type peptides in molluscs (e.g. Conus villepinii; [GI: 
325529921] and Aplysia californica; [GI: 524893759]). It is therefore possible that 
the NG motif may be a unifying characteristic of this bilaterian peptide family. 
However, CCAP-type precursors did not retain the C-terminal neurophysin domain 
characteristic of VP/OT-type precursors suggesting that this domain was lost during 
the evolutionary history of CCAP-type precursor genes. 
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Fig. 5.7. Evolution of the VP/OT-type and the NPS/NG/CCAP-type 
neuropeptide signalling systems in the Bilateria. (A) Schematic depicting an 
ancient duplication of a VP/OT-type precursor in the common ancestor of the 
Bilateria that gave rise to the highly conserved VP/OT-type precursors in extant 
bilaterian animals and the divergent NPS, NG peptide and CCAP-type precursors in 
tetrapod vertebrates, deuterostomian invertebrates and protostomian invertebrates 
respectively. Signal peptides are represented in blue, putative neuropeptides are 
represented in red, dibasic cleavage sites are represented in green and C-terminal 
neurophysin domains are represented in purple. (B) Schematic depicting an ancient 
duplication of a VP/OT-type receptor in the common ancestor of the Bilateria that 
gave rise to NPS/NG/CCAP-type receptors. Receptors for which the cognate ligand 
has been proven are highlighted in black whilst receptors for which the cognate 
ligand has yet to be proven are highlighted in grey. Multiple isoforms of receptors 
are represented by n = x. (C) Alignment of NPS/NG/CCAP-type peptides and 
VP/OT-type peptides derived from precursors shown in (A) that are proven or 
candidate ligands for the receptors shown in (B). NG motifs are highlighted in 
yellow and pairs of cysteine (C) residues that form disulphide bridges in VP/OT-type 
and CCAP-type precursors are underlined. A TG motif and two phenylalanine (F) 
residues, which are conserved in some peptides, are highlighted in purple. B.flo, 
Branchiostoma floridae; C.ele, Caenorhabditis elegans; C.tel, Capitella teleta; 
H.sap, Homo sapiens; L.gig, Lottia gigantea; L.sta, Lymnaea stagnalis; S.kow, 
Saccoglossus kowalevskii; S.pur, Strongylocentrotus purpuratus; T.cas, Tribolium 
castaneum. 1, Xu et al., 2004; 2, this chapter; 3, Stafflinger et al., 2008; 4, 
Birnbaumer et al., 1992; Sugimoto et al., 1994; Thibonnier et al., 1994; 5, Kimura et 
al., 1992; 6, van Kesteren et al., 1995; 7, Li et al., 2011; 8, Beets et al., 2012; 
Garrison et al., 2012.  
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Importantly, in addition to identifying NGFFFamide as the endogenous 
ligand for the NPS/CCAP-type receptor in the sea urchin S. purpuratus, there are 
additional pieces of evidence to support this evolutionary hypothesis including gene 
contiguity in the genomes of the deuterostomian invertebrates S. purpuratus and B. 
floridae. In the echinoderm S. purpuratus, a gene encoding a VP/OT-type receptor 
(SPU_021290) is located adjacent to a gene encoding a candidate NPS/CCAP-type 
receptor (SPU_021291) (Fig. 5.1); in the cephalochordate B. floridae, a gene 
encoding a VP/OT-type neuropeptide precursor (Brafl1-84802) is located adjacent to 
a gene encoding the SFRNGVamide neuropeptide precursor (Brafl1-84803) 
(Mirabeau and Joly, 2013). The gene contiguity in the genomes of S. purpuratus and 
B. floridae presumably reflects conservation of the adjacent positioning of genes 
generated by a tandem gene duplication event that occurred in the common ancestor 
of the Bilateria. 
 
 
5.4.2. Characteristics of an ancestral neuropeptide precursor protein 
 
It is important to recognise that alternative evolutionary scenarios of this bilaterian 
neuropeptide family have also been postulated with regards to the nature of the 
ancestral neuropeptide precursor that gave rise to NPS-type peptides in tetrapod 
vertebrates, NG peptides in the deuterostomian invertebrates and CCAP-type 
peptides in the protostomian invertebrates (Mirabeau and Joly, 2013; Valsalan and 
Manoj, 2014). It has been proposed that the ancestral precursor comprised both an 
NPS-type and VP/OT-type peptide associated with a C-terminal neurophysin domain 
before duplication in the common ancestor of the bilaterians (Mirabeau and Joly, 
2013; Valsalan and Manoj, 2014) (Fig. 5.8). 
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Fig. 5.8. Characteristics of a common ancestral neuropeptide precursor protein. 
Mirabeau and Joly, 2013 propose that the ancestral precursor protein comprised both 
a VP/OT-type and an NPS/NG/CCAP-type peptide before subsequent duplication 
giving rise to VP/OT-type precursors in extant bilaterians and the divergence of the 
second copy into the NPS/NG/CCAP-type neuropeptide signalling systems. Signal 
peptides are represented in blue, putative neuropeptides are represented in red, 
dibasic cleavage sites are represented in green and C-terminal neurophysin domains 
are represented in purple. An asterisk denotes a VP/OT-type peptide whilst a double 
asterisk denotes an NPS/NG/CCAP-type peptide in the ancestral precursor. Figure 
adapted from Mirabeau and Joly, 2013. 
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However, a scenario in which the ancestral precursor encoded a single 
VP/OT-type peptide before duplication in the common ancestor of the Bilateria and 
subsequent divergence of the second copy to give rise to NPS in tetrapod vertebrates, 
NG peptides in deuterostomian invertebrates and CCAP-type peptides in 
protostomian invertebrates seems more likely. This evolutionary scenario differs 
from previously reported evolutionary hypotheses on the basis of two factors. The 
first is that VP/OT-type peptides are highly conserved in extant animals throughout 
the animal kingdom as opposed to NPS-type peptides, NG peptides and CCAP-type 
peptides; this alludes to the VP/OT-type peptides reflecting the ancestral state. The 
second factor is the interactive stoichiometry between VP/OT-type peptides and the 
neurophysin domain, which has been shown to be 1:1 (de Bree, 2000; de Bree and 
Burbach, 1998). However, the NPS/NG peptide/CCAP-type precursors are highly 
divergent in terms of the number of neuropeptide copies and the presence of a C-
terminal neurophysin domain. For example, the neurophysin domain has been lost in 
NPS-type and CCAP-type precursors whilst NG peptide precursors in 
deuterostomian invertebrates comprise two to six NG peptides. Therefore, with the 
1:1 interactive stoichiometry of VP/OT-type peptides with the neurophysin domain, 
a hypothesis in which the ancestral precursor comprised a single VP/OT-type peptide 
is favoured over the alternative model where the ancestral precursor comprised a 
VP/OT-type and a NPS/NG peptide/CCAP-type peptide (Fig. 5.8) (Mirabeau and 
Joly, 2013; Valsalan and Manoj, 2014).  
An interesting question that remains unanswered is the significance of 
neurophysin domain retention in some, but not all, NG peptide precursors in the 
deuterostomian invertebrates, with the neurophysin domain appearing to be lost in 
the holothurian lineage. It remains unclear whether the neurophysin domain is 
required for biosynthesis of the NG peptides as is observed for VP/OT-type peptides 
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(Cool et al., 2008; de Bree, 2000; de Bree and Burbach, 1998). If it is required, what 
is the interactive stoichiometry? If it is not required, what is the function of the 
neurophysin domain? Investigation into the functional roles of the neurophysin 
domain in NG peptide precursors will shed further light on the evolutionary origins 
of the NG peptide family and the composition of an ancestral precursor in the 
common ancestor of the Bilateria. 
 
5.4.3. An evolutionarily ancient role for the NPS/NG/CCAP-type neuropeptide 
signalling system? 
 
The finding that the NG peptide NGFFFamide activates an NPS/CCAP-type receptor 
in the sea urchin S. purpuratus provides a foundation for investigating the 
physiological roles of NG peptides in deuterostomian invertebrates and has the 
potential to shed light on the evolution of the physiological functions of NPS/NG 
peptide/CCAP-type neuropeptides in the Bilateria. To date, investigations into the 
NG peptides in the deuterostomian invertebrates have focused on the echinoderms. 
For example, the NG peptide NGIWYamide in the sea cucumber A. japonicus has 
been shown to be involved in reproduction inducing in vitro germinal vesicle 
breakdown and oocyte ovulation (Kato et al., 2009), whilst the NG peptide 
NGFFYamide in the starfish A. rubens has been shown to be involved in cardiac 
stomach contraction and retraction (see chapter 4). However, to date, the roles of 
NG peptides in the cephalochordates (e.g. B. floridae) and the hemichordates (e.g. S. 
kowalevskii) remain unknown. NPS stimulates arousal and inhibits anxiolytic-like 
behaviour in rodents (Xu et al., 2004), with polymorphisms in the NPSR also 
associated with panic disorders in humans (Domschke et al., 2011; Okamura et al., 
2007). CCAP, on the other hand, has been shown to stimulate cardiac activity 
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(Stangier et al., 1987) and trigger the motor programme that enables shedding of the 
exoskeleton during ecdysis (Park et al., 2003) in arthropods.  
Based upon the known physiological functions of NPS-type, NG peptides and 
CCAP-type peptides to date, it appears that this newly unified family of peptides 
may have an important role in triggering behaviours associated with heightened 
states of arousal. It will be interesting to continue investigations into the 
physiological roles of these peptides in a range of phyla across the animal kingdom 
to begin to reconstruct how this highly divergent peptide family acquired distinct 
physiological roles following ancient gene duplication from a VP/OT-type peptide in 
the common ancestor of the Bilateria.  
 
5.4.4. Future directions 
 
The use of genome/transcriptome data from an echinoderm species in the unification 
of a bilaterian neuropeptide family highlights the general importance of the 
deuterostomian invertebrates, and the echinoderms in particular, in bridging the gap 
of evolutionary understanding between neuropeptide signalling systems in 
vertebrates and classic model protostomian invertebrates (e.g. Drosophila and C. 
elegans). Moreover, the characterisation of the NGFFFamide receptor could 
potentially lead to synergistic exchange between research in the fields of NPS-type 
peptides, the NG peptides and CCAP-type peptides. For example, research in the 
field of the NG peptides and CCAP-type peptides may inform the pharmaceutical 
development of synthetic NPS receptor agonists that could be used as anxiolytics. 
Conversely, NPS receptor antagonists may inform the pharmaceutical development 
of CCAP antagonists that could be used for pest control through the inhibition of 
ecdysis. 
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6. General discussion 
 
Neuropeptides are evolutionarily ancient mediators of neuronal signalling that 
regulate a diverse range of physiological processes and behaviours across the animal 
kingdom. Recent advances in comparative genomics/transcriptomics has provided 
new opportunities to analyse neuropeptide systems in a wider range of phyla – from 
model protostomian invertebrates including Drosophila melanogaster (Hewes and 
Taghert, 2001) and Caenorhabditis elegans (Nathoo et al., 2001) to deuterostomes 
including the urochordate Ciona intestinalis (Kamesh et al., 2008) and the 
cephalochordate Branchiostoma floridae (Nordstrom et al., 2008). It has therefore 
become possible, in many cases, to trace the evolutionarily origins of neuropeptide 
signalling systems back to the common ancestor of the Bilateria (Jekely, 2013; 
Mirabeau and Joly, 2013). 
 
6.1. A. rubens: providing novel insights into neuropeptide evolution 
 
The echinoderms are of particular interest from an evolutionary perspective because 
as deuterostomian invertebrates they occupy an intermediate position in animal 
phylogeny, bridging from model protostomian invertebrates (e.g. Drosophila and C. 
elegans) to the vertebrates. The generation and analysis of genome/transcriptome 
data from the sea urchin Strongylocentrotus purpuratus (Burke et al., 2006; Rowe 
and Elphick, 2012), the sea cucumber Apostichopus japonicus (Rowe et al., 2014) 
and the starfish species Patiria miniata (Elphick et al., 2013) have provided 
important insights into neuropeptide diversity and its functional significance across 
the animal kingdom.  
The common European starfish Asterias rubens has been used as a model 
system for neuropeptide research for over twenty five years, with the SALMFamides 
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S1 and S2 the first neuropeptides to be identified in an echinoderm species (Elphick 
et al., 1991a; Elphick et al., 1991b). However, with no genome or transcriptome data 
available, the sequencing of a neural transcriptome of the starfish A. rubens has 
provided an opportunity to identify novel neuropeptide signalling systems in the 
species and has provided a foundation to investigate neuropeptide diversity and its 
functional significance across the animal kingdom. 
The analysis of the neural transcriptome of A. rubens has revealed the 
presence of thirty-five novel neuropeptide precursors and a number of candidate 
receptors (see chapter 2). Interestingly, precursors of two kisspeptin (KP)-type 
peptides (the first to be identified in a non-chordate species), a melanin-concentrating 
hormone (MCH)-type peptide (the first to be identified outside of the vertebrates) 
and two tachykinin (TK)-type peptides (the first to be identified in an ambulacrarian 
species) have been identified. However, before undertaking functional studies on 
these novel neuropeptides, it will be important to confirm predicted peptide 
sequences and potential post-translational modifications through mass spectrometry.  
 
6.2. A. rubens: providing novel insights into neuropeptide function  
 
The utilisation of the A. rubens neural transcriptome and subsequent sequence 
confirmation through mass spectrometry has allowed for functional studies on two 
novel neuropeptides – a vasopressin/oxytocin (VP/OT)-type peptide (“asterotocin”) 
(see chapter 3) and an NG peptide (“NGFFYamide”) (see chapter 4). Investigation 
into the physiological functions of asterotocin and NGFFYamide has revealed that 
asterotocin causes cardiac stomach eversion in vivo and cardiac stomach relaxation 
in vitro whilst the NG peptide NGFFYamide causes cardiac stomach retraction in 
vivo and cardiac stomach contraction in vitro. 
 The discovery that asterotocin and NGFFYamide are involved in the 
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processes of cardiac stomach eversion and retraction respectively, crucial to the 
extraoral feeding process in the starfish A. rubens (see chapter 1.3.2.3), has provided 
insights into the evolutionarily conserved roles of the VP/OT-type and NG peptide 
signalling systems (see chapter 5). However, understanding the function of 
neuropeptides that control feeding in starfish will also have both economic and 
environmental implications. For example, some starfish species, including A. rubens, 
feed on economically important shellfish (Agüera et al., 2012; Dare, 1982; Dolmer, 
1998; Magnesen and Redmond, 2012), whilst other starfish species including the 
crown-of-thorns starfish Acanthaster planci feed on reef-building corals and cause 
destruction of Pacific reef tracts (De'ath et al., 2012; Kayal et al., 2012; Timmers et 
al., 2012). Thus, the identification of neuropeptides that regulate cardiac stomach 
eversion (asterotocin) or retraction (NGFFYamide) may provide a basis for 
development of non-peptidic small molecule agonists and antagonists that mimic or 
block the effects of these endogenous neuropeptides; this could have implications for 
the chemical control of starfish feeding.  
 
6.3. The echinoderms: providing novel insights on neuropeptide evolution 
 
The sequencing of a neural transcriptome of the starfish A. rubens has provided 
further novel insights into the evolutionary origins of a number of neuropeptide 
signalling systems (see chapter 2). However, the genome of the sea urchin S. 
purpuratus has also proved an invaluable tool in understanding the evolution of 
neuropeptide signalling systems. The identification of the receptor for the NG 
peptide NGFFFamide – a neuropeptide-S/crustacean cardioactive peptide 
(NPS/CCAP)-type receptor – has unified a bilaterian neuropeptide family that 
includes NPS-type peptides in tetrapod vertebrates, NG peptides in deuterostomian 
invertebrates and CCAP-type peptides in protostomian invertebrates (see chapter 5).  
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The utilisation of genome data from the sea urchin S. purpuratus and 
genome/transcriptome data from a number of other echinoderm species has also 
provided a foundation to characterise candidate NG peptide receptors across the 
echinoderms (see chapter 5). This could be particularly important for the NG 
peptide signalling system in the sea cucumber A. japonicus; the NG peptide 
NGIWYamide induces oocyte maturation and gamete spawning (Kato et al., 2009) 
and could therefore have implications for sea cucumber aquaculture (Anderson et al., 
2011). 
 
6.4. Future directions: a platform for neuropeptide research 
The sequencing of a neural transcriptome of the starfish A. rubens has provided 
important insights into the neuropeptide diversity and its functional significance 
across the animal kingdom – the use of this transcriptome data can be highlighted by 
functional studies on asterotocin (see chapter 3) and NGFFYamide (see chapter 4). 
The identification of a total of thirty-five neuropeptide precursors have also provided 
a foundation to investigate the function of other neuropeptide signalling systems in 
the starfish A. rubens.  
However, perhaps one of the most interesting discoveries is the identification 
of a neuropeptide precursor that comprises two KP-type peptides – the first KP-type 
peptides to be identified in a non-chordate species (see chapter 2.3.2.10). In 
mammals, KP has a key role in regulating reproductive functions in the 
hypothalamic-pituitary axis (Oakley et al., 2009) through the regulation of 
gonadotropin-releasing hormone (GnRH) neurons both directly (Colledge, 2009) and 
indirectly (Pielecka-Fortuna et al., 2008; Zhang et al., 2008). Accordingly, mutations 
in the KP receptor (GPR54) have been shown to cause delayed puberty in humans 
(Seminara et al., 2003), GPR54-knockout mice (Funes et al., 2003) and KP-knockout 
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mice (d'Anglemont de Tassigny et al., 2007). Investigating KP-type neuropeptide 
signalling systems outside of the vertebrates could therefore be of interest both from 
an evolutionarily perspective and from a clinical perspective. For example, salmon 
calcitonin (CT) (Niall et al., 1969) is more potent in humans than human CT and has 
been used for the treatment of hypercalcemia and osteoporosis (Torres-Lugo and 
Peppas, 2000). 
Informed by mRNA in situ hybridisation (ISH) and immunocytochemical 
(ICC) studies, the potential physiological roles of KP-type peptides as an 
evolutionarily ancient regulator of GnRH release and reproductive processes could 
then be investigated. In the starfish A. rubens, gonadal growth occurs through the 
autumn and winter, with gonadal size and oocyte diameter peaking in early spring 
prior to spawning (Barker and Nichols, 1983). It will be of interest to determine if 
there are seasonal changes in KP expression (and subsequent GnRH expression) 
through the employment of radioimmunoassays (RIA) and the quantitative 
polymerase chain reaction (qPCR) to determine if expression levels correlate with an 
increase in gonadal size. It will also be of interest to employ pharmacological 
techniques to investigate KP-type peptide function in A. rubens; for example, 
injection of KP-type peptides could be used to determine whether KP triggers 
gonadal growth and maturation in starfish. 
The function of KP-type peptides (in addition to other novel neuropeptides) 
could also be investigated through the development of loss-of-function assays that 
allow the targeted knockout of genes in starfish. To date, although there is no 
genome available for the starfish species A. rubens, there is genome data available 
for the starfish species P. miniata (http://www.echinobase.org/Echinobase/pm). 
Nuclease-based genome-engineering technologies including zinc-finger nucleases 
(ZFNs), transcription activator-like effector nucleases (TALENs) and clustered 
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regularly interspaced short palindromic repeats (CRISPR) have been utilised across a 
number of model systems including in the echinoderms. For example, ZFNs and 
TALENs have been used to investigate gene function in the embryo of the sea urchin 
Hemicentrotus pulcherrimus (Hosoi et al., 2014; Ochiai et al., 2010). However, with 
the sea urchin embryo a well-established tool in developmental biology, gene 
knockout approaches in the starfish A. rubens would have to be developed for the 
larval stage in order to allow delivery to the starfish germ line. The development of 
targeted gene knockouts will be crucial to furthering our understanding of 
neuropeptide function in non-model organisms, which do not possess the genetic 
toolbox available for classic model organisms including Drosophila (Mohr et al., 
2014) and C. elegans (Boulin and Hobert, 2012). 
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9. Appendices 
!
Fig. A1. Phylogenetic analysis of secretin-type receptors. Neighbour joining (NJ) 
tree (with bootstrap values out of 1000 represented in decimal format) of candidate 
secretin-type receptors for selected neuropeptides/peptide hormones identified in the 
starfish A. rubens. Calcitonin (CT)-like receptors are highlighted in yellow, 
corticotropin hormone (CRH)-like receptors are highlighted in pink and pigment 
dispersing hormone (PDF)-like receptors are highlighted in blue. Representative H. 
sapiens rhodopsin β-type neuropeptide receptors have been used as an outgroup. Ar, 
Asterias rubens; Bf, Branchiostoma floridae; Ce, Caenorhabditis elegans; Ct, 
Capitella teleta; Dm, Drosophila melanogaster; Hs, Homo sapiens; Lg, Lottia 
gigantea; Sk, Saccoglossus kowalevskii; Sp, Strongylocentrotus purpuratus. Note 
that sequences used for phylogenetic analysis can be found in Mirabeau and Joly, 
2013.  
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Fig. A2. Phylogenetic analysis of rhodopsin β-type receptors. Neighbour joining 
(NJ) tree (with bootstrap values out of 1000 represented in decimal format) of 
candidate rhodopsin β-type receptors for selected neuropeptides/peptide hormones 
identified in the starfish A. rubens. Gonadotropin-releasing hormone (GnRH)-type 
receptors are highlighted in yellow, vasopressin/oxytocin (VP/OT)-type receptors are 
highlighted in pink, neuropeptide-S (NPS)/crustacean cardioactive peptide (CCAP)-
type receptors are highlighted in light blue, luqin (LQ)-like receptors are highlighted 
in grey, tachykinin (TK)-like receptors are highlighted in green, cholecystokinin 
(CCK)-like receptors are highlighted in red and orexin (OX)-like receptors are 
highlighted in dark blue. Representative H. sapiens secretin-type neuropeptide 
receptors have been used as an outgroup. Ar, Asterias rubens; Bf, Branchiostoma 
floridae; Ce, Caenorhabditis elegans; Ct, Capitella teleta; Dm, Drosophila 
melanogaster; Hs, Homo sapiens; Lg, Lottia gigantea; Sk, Saccoglossus kowalevskii; 
Sp, Strongylocentrotus purpuratus. Note that sequences used for phylogenetic 
analysis can be found in Mirabeau and Joly, 2013. 
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Fig. A3. Phylogenetic analysis of rhodopsin γ-type receptors. Neighbour joining 
(NJ) tree (with bootstrap values out of 1000 represented in decimal format) of 
candidate rhodopsin γ-type receptors for selected neuropeptides/peptide hormones 
identified in the starfish A. rubens. Somatostatin (SMS)-like receptors are 
highlighted in yellow, melanin concentrating hormone (MCH)-like receptors are 
highlighted in pink and kisspeptin (KP)-like receptors are highlighted in blue. 
Representative H. sapiens secretin-type neuropeptide receptors have been used as an 
outgroup. Ar, Asterias rubens; Bf, Branchiostoma floridae; Ca, Carassius auratus; 
Ce, Caenorhabditis elegans; Ct, Capitella teleta; Dm, Drosophila melanogaster; Dr, 
Danio rerio; Gg, Gallus gallus; Hs, Homo sapiens; Lg, Lottia gigantea; Po, 
Panaeolus olivaceus; Sk, Saccoglossus kowalevskii; Sp, Strongylocentrotus 
purpuratus; Xt, Xenopus tropicalis. Note that sequences used for phylogenetic 
analysis can be found in Jekely, 2013 and Mirabeau and Joly, 2013. 
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A. Partial (5’) CT-like receptor (Ar_CTLR) 
RFTPRGDHTSIYKKPVHTWLILVLVVLLNAGVISGDKMDTQTPQQRERHINESVLCE
YRMRTELPPDDEYVYCNMTFDTWDCWNYTRAGSTIVQPCPEWIPDSNPNKTASKICM
PNGQWFRHPETDDTWTNYTSCNYRVKEDLDSNVHIVYYFGYGLSVISLCIASFIFFY
FRSLGCPRVTIHKNLFISFILCGIVWLQWFALVTQNPALIADNPAFCKILLVLGNYF
NTCNYFWMLSEGLYLHTVIVVAVFSENHRLHLYYIIGWVLPMIPVTIYTSFMLVYHQ
GVCWLAESEYEWCVASFIILVLFVNLILLLNIVRVLVTKLRATPASGSNTYTRAVRA
TLILLPLLGLHYILFPVKPKGNKVAETFYNYFIAVLLSFQGFFVACIFCFFNGEV 
B. CRH-like receptor 1 (Ar_CRHLR1) 
MATHVLTVWITRTTYSLVLILLLASFSCTYGQANNTTTAIPTNTTDFLPPITSTEDT
NMSFTFIARTNASASPALPPEPQQYCNASIMDGLQQQFNREYMDYHKLTEISDEDTC
NLRKSVDEYLVDYCSPASAVYCDSYFDTIMCWPPSPVGLNSRPCPEELNGVSYDTSD
NVTRYCNLDGTWANGNKSNYSLCSPRNLPEMTGHDAVLKIMVYIGYSLSMGALLGAF
CIFLFFRSLRCVRNYIHWNLVSSFLLLYICFFTTTAATNTYSEKPGLHWLCRLSFTM
MMYIMMTNFFWMFVEGVYLYTLVVRALTVRKNRFWLYCIFGWGGPLPFVITFVILKL
FNSKDCWVDDAPEVYLIVAPIICVILVNLYFLVHIMCILFTKLRASHSLETQQYRKG
VKGTLFLLPLLGVTYLLFLLGPISVQVPQRPPSFYVYQYLNTILSSIQGFLVAIIYV
FLNQEVQNVIKRKIRRWREENTLPTRIVSRRGSNQRNSIGNIFVGRRSVNCNTMADD
DTNVSAFKLPACNRSPDVYSNGSKVPPFIRLDEIQPLTPASETHASPQTLYSSLGSN
GADSGDMQQVNLEEKEADASCNVTNGSTDTDCNELPLLAVNACGAQSPNSSPDQSTG
EELDRVIRKESQIATEKDQDLPYRTVDNNGLSNGNHNNNNSLSPRLARPKTSPFTGG
RTRVTFAEDPVQENLKRPACCDLGKNNEGLARSPTRKVEEPIARGHVEGDESLEGGY
SSKQDPHRSPLIPCIRKKPWATKPNGTIAFPKAPEGTPV 
C. Partial (5’) CRH-like receptor 2 (Ar_CRHLR2) 
DPLLLVWLLAFIMNLGATGAGAQDEMNQEYYERVIHERAMDCVRRYQNVTVPGVDPN
FSCQFFFDGVLCWPPSAPDTKVEQICPLDRYEVALVQRTCFSNATWEQASPQSLYLS
DSCRCVHCLSLAVLNNLGYALSLAACAVAFLIFLCSRTLHCTRNRIHWHLISSFMLK
YLVYFAQIALFNTKELHLTRILDTLLFYFEQTNYFWMFVEGMYLHTLVVFALRIDAD
KIMFWVYCIIGWGLPMVFVGSWAIVSVALYPDSQFINMSQDAVIVHEYVCIIGPILL
VLVINCFFLLNIVRLLMSKLRMQGNRTSDIQHYRRAARATLVLVVLLGVGYILFICL
SFLPTDLPPLGNLILKYVNVLLASTQGLAVSVIYVFLNTE 
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D. PDF-like receptor 1 (Ar_PDFLR1) 
MTTSEKECDFLKSMQTESEDACPIEYDKTMCWPETPLNTTAYQLCPDIFPQLDPTKF
AQAFCREDGTWGLFDYLPCFRKETEELDELRLNISDEKLEFTKDVIYGAKAMEIAGL
FLSFFCLVFALCVFSCFRSLQCHRTKIHKHLFAAYIARLFIEIILGVNQIYKLTQAD
VGFAPSVISSAPALCVILEVLREYTRLCTFAWMFIEGMYLNSLLSSAVFGKPKFLVF
YIVGWVVGIPLTITWGLVMHFINGSDRCWYDNITSGNCLLIIEIPRNAFLAMNLLFL
INILRVLVTKLRESNTSETKQVRKAIKATFVLLPLLGVANLIWLIPQAEASDSRAWL
IIYYYGILFLDAYQGFFVAVLYCFMNAEVGSVLRRKWSTWRTYHNPNRRGQNMVVTT
ATDVCTTEHAQFS 
E. PDF-like receptor 2 (Ar_PDFLR2) 
MVRSEDECDGIYQQFYAEERDALMCEPNWDTTLCWPATSANSTVTVRCPNFFWFNPD
NSLTRYCSPNATWETGGTYQDCFTEGAKSTINGNESFGNVTTEQIEFYIEVLEGANF
MRLIGVCLSWVALVVALLIFSSFRSLNCNRIKIHKHFFAAFLIRMTLEVILVADKRH
RDQSTMYNGVNDVKSIHLTPVLCELFETIREYGRLCAFFWMFIEGLYLTFLVSANVF
SKPRFRIYYCIGWLIPLPTVMAWAIAMYLTSKERCWKDHAVSNYYLIIEIPRNGALI
INVLFLVNIVRVLVTKLRESNSSETKQIRKAAKGAVLLIPLLGVANLVWFIPSPNVT
DSRASIVLYNYLFLFLDAYQGFFLCVMYCFLNHEVRMTIHRKWSTLRYYRDPYPFLR
RTSVLTSTSDMMSTTRAAYKPSQKMNGTAGGEYLKMAAIDEMSSTHA 
Fig. A4. Secretin-type receptors identified in A. rubens. (A) Partial (5’) calcitonin 
(CT)-like receptor (Ar_CTLR). (B) Corticotropin releasing hormone (CRH)-like 
receptor 1 (Ar_CRHLR1). (C) Partial (5’) CRH-like receptor 2 (Ar_CRHLR2). (D) 
Pigment dispersing factor (PDF)-like receptor 1 (Ar_PDFLR1). (E) PDF-like 
receptor 2 (Ar_PDFLR2). Note that transmembrane domains were not predicted for 
partial G-protein coupled receptors (GPCRs); predictions on GPCRHMM 
(http://gpcrhmm.sbc.su.se) are restricted to a GPCR model and hence contain seven 
transmembrane domains (Wistrand et al., 2006). 
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A. CCK-like receptor (Ar_CCKLR) 
MATATTAYPYSLIDSSLPPVNSTFLVTSIVDVNSTNSSLITEDFDDDRNRGVRIGFG
LNIYLTATLYGIVFVLAIVGNILVLVTLAQDKRMRTVTNMFLLSLAFSDLLFGIFCM
PFTVVGNMLGRFVFGAVICKIVPYIQGISVTVSVWTMVVISLERYHAICNPLSSRVW
QTKAHAYKAIVGVWMVALFLNLPAVIFSKLFSFNSGTVFRCDEIWPATLYRTIYRMC
LFVILMVAPLFTMLTAYGLIIRELRRGMKLEQCGADNEKRENGIAMKNMGDEASCSL
NEKKTKKSDKKPAQATMRSTSTSGAKKRVVKMLIVIVALFFVCWTPSWVGNIWIMIS
EKSASEHFGRAEVTIFKLMTYASACVNPIVYCFMNKRFRQGFLNAFSCGRRGRAGDR
ATASGDVSRFQSTRRTNVPRPSPTNYTNVSSDSSV 
B. GnRH-like receptor 1 (Ar_GnRHLR1) 
MATTSVNPTLITYIYETVEVNDTYSNFTKAGPTSDGNGTDYHSGISIYDDYLIRLIL
YVIIFVVSTIGNTAVLCSLIKGRRRKSRVNLLIMHLTVADLMITFFNIPTYFIWLIT
YQWYGGDIMCRSVMYIAMVGTYASPFILIVISLDRFASIVFPLSVRQADMRCKIMLR
VAWAACIIASIPQLLIHQVMSPKSDPDFTQCVDYGFRKNFPVFWNLYHWFVMAATYF
IPLTLIIGCYTSIVIKIFGNSTIRSYSGNNGNRMTLRRSGVDTLPKARVRALKMTGA
IVTAFIVCWTPTCIEGTITHANPALGEATPIWLNHIMLAFGFSNVCIDPIVYGMFTV
DFRRHFPGCFDCWGGRNILRGRRSGRSTTSSNNYPPVTYASSTRCGTTTGVSGNYHV
MELDSRHGTAEKCV 
C. GnRH-like receptor 2 (Ar_GnRHLR2) 
MSVQYTSDESEFALCDLLSSATECDENTTIALPEFTPFTAFKVGVLALMIVFSTVGN
CIAIAVTCKIRGRRKSTVTTLILNLAVSDLIVTYCHMLVHMIWYSTDAWLGGEALCK
IAKFFSNFGLFASSFITVDVGLDRCLAVLRPLGHRQRPFHIKMMIITSYMVAFLFSI
PQLIVFRLEHWPFDPEIDFWQCVTNVGIPNVYIAVYTTLVVLAQFVAPLGIMMVAYG
LIFMKVRQKIVMKETSENLSEMRQARSKLFLRAQRRTVRMAVAIFIVFAINWLPYAI
FGLWYVWFPGQTYNMYVFEVAFMFGLSNSCFNPLIYGACNVRYCHKICACFGIRSKP
GMDTSHSDRSNKTTMYSVRWQSSKGGNNTHKNNNKDNSWTKGTAAVPPERQQMITTT
T 
D. LQ-like receptor 1 (Ar_LQLR1) 
MNISYSNDSSGGYSDVCVEYYREPVWLQVLFGIIFGLITVFGIGGNAIVCYIVLGHR
RMRTVTNYFVVNLAVSDQLMAVMCVNFTFYSTLYMTWPFGPVMCKAVSFFQSVSVSV
SIFTLVAISMERYMAIIHPLRPRLGSTGTLLVIGFIWISSGALGLPTAIYTSVYVEN
GITYCSEEWDQRGNYSFATMVLQYFLPLAVLAMAYSRIGIRIWARKTPGEMEANRDR
RMTESKIRLVKMFAVVVFLFAICYLPIHTFNIVQDVYQYVLCYQYIRIIYVTVVAVA
MSNCMYNPFIYCWMNSKFRDGFKNVVRCLPGVRRYRDRQQANQSGSFRGLKRTSTLN
THMQS 
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E. LQ-like receptor 2 (Ar_LQLR2) 
MSGLTISNFSETINSSDSSDYDYPTYEYYEEPVWIQAIFIFLYGTVSVIGIFGNGIV
CYIVLGHPRMRTVTNYFIVNLAIGDLLMAAMCVNFTVYATLYNQWPFGELMCKLVSF
SQTISVSVSIYTLVAIGVDRYFAIIHPLRPRMGSKETLFVIGVIWVISIALALPAAL
FTTLESQGGSTFCTDGAWEDSLVYSLICMVLQYFLPLAVLMGAYIRIGKRIWGRRTP
GEVEAERDKKMSESKARLVKMFATIVLLFALCYMPIQIYTIMQDSNRSILSFYYIKI
VYLCCLLSAMSNCVYNPFIYCWMNIKFRNGFRSVFRFLPCVNYQGDWNGFTGLRRAN
TAQTQTETMSMGSRNDRGRWWTQDQAKIAKNGRASNSDGETRTSFM 
F. NPS/CCAP-type receptor (“NGFFYamide” receptor) (Ar_NPSLR) 
MATIPAYDHLVTDSVMAGYSLNDTASTVMVPTGLPSTLEGAPNATTSVTYFSDGENR
LSFYGGFQLIVLWVLFGLTVIGNSTVLLAVYVIRHKKSRLNFFVAHLAASDLLVGIV
NNGYEVLYRYLGEFYGGMVFCKIIRFSQAYVINASSFQLVALSLDRFFAIVFPMDFS
GSGKRANLMAVTAWIAPLFASIPSAIVFEAAVDSWGKTHCIPPPLVPGSWQYKVYTL
YVVSGFFYIPLIIISTCYIFMVISIWRRSKYMMGQKPEKVKGKAAKNASKEKEPMKH
RASSRGLIPKAKIKTLKMTVSIIVAFIVCWCPFSVFYTLDAFGVIFIDEANLNTAFR
ASAFIQNLPFLNSAINPFIYGMFSTNICQELRRFSVINWMATKLRCCKSWRPSRYGR
STTLRTDTNLTDMSEGASGTHRGHTRPLYVYTPGRTSNSDHSRDLSNSAM 
G. OX-like receptor 1 (Ar_OXLR1) 
MEPEMDMENPAFNSTLYSSMQLDSEYNQYILDFLKTKVFPAPYEYLIIAIYGLVFLL
AIIGNTLVCIAVLRNEHMRTVTNYYIVNLAVADILVSLVCLPVTVVVDVSETWFFGG
VLCLIIPYIQNTSVCVSVFTLTMIAVDRFLAICYPLKFQSSARRTIISVIVIWCVSL
AITLANPLTMEVTSQQWMDGANPVWLSKCVEKKWDKTEGRKAYYVVMLVFTYIIPLY
IIGLAYMMVCVRLWSGIPSDETSCQGKKAGNNNSGHAKGKRVMNKSAEAQLQSRRKV
ARMLIVVVVIFAVCYLPIRVLNVLSAFGAFSQANVDMMAHSANLGVAYLIAHMMAFI
NSAINPLIYNFMSAKFRQAFKMTFNCCGSDSKRHSRYTQRYTKCQSFNQSSAISDSR
ANTNTECFSMANRPNSIVHTTEA 
H. Partial (5’) OX-like receptor 2 (Ar_OXLR2) 
PPRWDEFAPSALNPTGPPETDDYVDYIYDFIKGMVYPDAHEWFLIAAYVVIFVTGVI
GNFLVCFAVLRNEHMRTVTNYYIVNLALSDILVVLVCLPPNVMVDATETWFFGDLAC
HIVPYIQEVCLSVSVYTLAAIAVDRYLAICRPLKFHIRASRTLFIVAAIWVTSFTIM
APQPVFTRSEPSSHAGYIGKPIWLMKCYEKAWKGTIWQKVYHISKVVVSYVIPLLIM
AVAYARVCLRLWSGIPTDESHRPALGGRSAGQTKPTMNKSTETQLESRRKVARMLIV
VVVMFAICKLPTHVLNTIRYMDGFNNMKASENTESSGRVALHVSFLIAHFMAYLNNV
INPVIYNFLSARFRKEFRHVFSCCPCVTAPDREGKRPDSTSYHRCRDFAARSSNNGV
TSQSDFRSHDHNTEYLQLSKLGKSSGTNNNSNIVINTKPLAPNPES 
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I. OX-like receptor 3 (Ar_OXLR3) 
METTTLTSVLYPNYTASVFPNSDYIMDGSDADVNGTSIQPVLTPGVLAVTTIAYGII
FFFGVTGNALVAIVIWQNADMRSSTNYFLVNLSIADLMVILVCLPPSMLELYFPDWM
LGKFMCYLVTILDSATAHASILTLLAIAVERYYVICMPFKANYTCTSKRTLIICCLV
WLIAFISSVPLALTVVYSNTEAGCVCGSFANTTLKEAYVGGIAVGFFLLPCAFMAII
YCVIANTLRKHDNYMASIRNKESLGPASGTPVYREGRLVELATMPRKNSGDSMVENN
YVPLKNHVTSNSTNEEHEPTVAFIENEANHEAAMRPSNQSSSNSTCQNLANAATRQA
HRRVVLMMASVVAVFFLCWFPMRTVILWQIFAPKESIRAWLGANMHTFQVMIAIFRI
LVYINSAINPILYNLISSKFRVAFRSVIRCENARRARSKRSISTRSFTSTSSLRIHS
RTTDYHG 
J. TK-like receptor 1 (Ar_TKLR1) 
MVDYKDINSLNFTFVHNLDQESRILWSVFCSIIMAVAAGGNLIVIWIVATNPRMRTV
TNYFLLNLAVADALIATLSMPFMFSYIVTQNWALGIGMCKVVRFFGLVSTSASVLSL
VAISIDRYRAIVHPLLPRLSKSYIVCMIIFIWGGSSIFASPLLVYSTVLTFMYNDGV
IKNQCFIKWPDGIYRRIDFTYNVASFAVLYCLPLTVLAGCYTVIGVKLWRGDVLGEY
IPNRARQLKAKRKVVKMIIVVIAVFAICWFPLHVYQFLGYLHEEVYTQSYAVHIYST
IWTLAMSSSMYNPFIYCWLNDRFRAGFKRVFHCLIPGSKKQRDNKGIDRRTPLTSTT
SNANSLMTASTTGMHRQVPNGKPAILCRTSLIGISVVDSSEDIF 
K. Partial (5’) TK-like receptor 2 (Ar_TKLR2) 
TVSTVASVLSLVAISIDRYRAIVHPLLPRLSKTCIVCMIIFIWIGAISFASPQFFYS
QLITFGYSDGDITQCYIIWPDGIQREYEFWYNVTSFIVVYCVPLSVLAMCYTVIGVK
LWRSGVLGEYIPNRAKHIKAKRKVVKMIIVVIAVFATCWLPLHIYQFLSFMSYSVYQ
KSYSLHIYLSVWTLAMSSSMYNPFIYCWLNDRFRAGFKRVFRCSQGTSDTRHSQRQS
GTPMSPTSRMTSSTGYQRTTNGKQELGCKNSLLSASVVDSMEDTC 
L. VP/OT-type receptor (“asterotocin” receptor) (Ar_VP/OTLR) 
MTPSQVLTTRVPVVATDTKESNISQEGAATYGLMTTSTPYHPTRDNQLAIVEILITA
SIFVLAIVGNTIVIAVLWRRRKSLSRMHYFIIHLCVADLTVAFLYTLPQMLWDITYK
FYAPDVVCRLVKYFQLFPVYLSTYILVMTAIDRYLAICHPLMGLRRNQTFRMRVMVL
IAWGIAVVCSLPQLAVFKLKNRTPNSHQEWMDCRANFQNSAGVKAYITFFTMAIYVI
PSLILAAMYGMICLTVWKNMGKNYKSSDTKTPQQPAPQKENNNWEDDETDKLNPDHV
EMQQPTVTKKESSQKTQVQYRRHGAAGKVSRAKIKTVKMTLTIVTVYVVTWAPFFVA
QMLSVWTTVQFDSLFFAIALLLTSLTSCINPWIYFAFSSNAGRDIKQTFGCLKVSRQ
DNGLASDKTHHDETSSRFVSTTGTASAHM 
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Fig. A5. Rhodopsin β-type receptors identified in A. rubens. (A) Cholecystokinin 
(CCK)-like receptor (Ar_CCKLR). (B) Gonadotropin-releasing hormone (GnRH)-
like receptor 1 (Ar_GnRHLR1). (C) GnRH-like receptor 2 (Ar_GnRHLR2). (D) 
Luqin (LQ)-like receptor 1 (Ar_LQLR1). (E) LQ-like receptor 2 (Ar_LQLR2). (F) 
Neuropeptide-S/crustacean cardioactive peptide (NPS/CCAP)-type receptor 
(“NGFFYamide” receptor) (Ar_NPSLR). (G) Orexin (OX)-like receptor 1 
(Ar_OXLR1). (H) Partial (5’) OX-like receptor 2 (Ar_OXLR2). (I) OX-like receptor 
3 (Ar_OXLR3). (J) Tachykinin (TK)-like receptor 1 (Ar_TKLR1). (K) Partial (5’) 
TK-like receptor 2 (Ar_TKLR2). (L) Vasopressin/oxytocin (VP/OT)-type receptor 
(“asterotocin” receptor) (Ar_VP/OTLR). Note that transmembrane domains were not 
predicted for partial G-protein coupled receptors (GPCRs); predictions on 
GPCRHMM (http://gpcrhmm.sbc.su.se) are restricted to a GPCR model and hence 
contain seven transmembrane domains (Wistrand et al., 2006). 
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A. Partial (3’) KP-like receptor 1 (Ar_KPLR1) 
MTSYEVDITGVLNDTSSKSWLDQAMEPGPETVFVPVVWSLIIAVGVTTNAVVVYVVM
LHMKMTTVTNYYIVNLALTDISYLLFCTPFTTLTFTLYGYLTEGMCRVISYVQQASV
HATCMTLTIMSADRYFAIVYPIKSMKYRTRRLSFLINLSVWILSYIMAIPAPIFVEA
ESHFYYTGEKYFCFEAFSTPTKQAVYYTYVLVFTYILPLIVICACYSLLLRTTWTRH
HPSAQNSHRTRQNLLQKRRMTRMVLVVVCL 
B. KP-like receptor 2 (Ar_KPLR2) 
MTTSITQTIGFLVNSSECCHESIAFTTKTLFGETTTTSSIPTITTDEAAVVQATAGQ
AAWLIPVIFGLITVCGVVGNFLVIYVIVRHGHMKTVTNYYIVNLAVTDISFLLCCAP
FTATLFVSPNWLFGRFMCKFVFYMMQVTGQCTCLTLTAMSVDRYQAIVHPIKSLKSR
TTRVACIVNMCIWIGSLLISVPVAIFFDLSLYINLLVCSEMWPLDIMFPGYAVFSFI
LLYVIPIFTISVCYSLMLRKLWSRVSPGEDNNSHLNNARQKRKVTRMVLVVVLVFAI
CWLPTYIINLWIRLDPYFPKTNATYIFKMAAHTLSYANSSVNPFVYAFMGENYRRYF
KKAFPVCFRQRVRRPTDFTTSRTDPTGNFNGGTAGIGGRTVETVALD 
C. Partial (5’) KP-like receptor 3 (Ar_KPLR3) 
VPRRKYSKMSTPAGLLNVTTAIPNVTEASMDDGGASVYTKLVPALIGIITLVGLVGN
SIVVYVIVCQGHLKTVTNYYIVNLAITDIFFLVFCAPFTASIYATPSWLFGRFMCKF
VFYMMQATAQATCATLTAMSIDRYYAITDPLKALKTRTPRVAIVVSVGIWTFSAVLA
IPVAVFFDIDVVQFQNQTYDICDEMWPLKIVNQGYGVYCFVMLYLIPLTIIVVCYSI
VLNRLWKAVSPTEETHAPVHLRMLIQKRRITRMILAVIVAFAACWIGTHIMSLWRRL
DVNFPRTSTSALVFQTIAHLLMYFNSCVNPFVYAFMGGNFRKQMARAFPFLAGKKSA
MTEGPTGSLIKSKSTQV 
D. KP-like receptor 4 (Ar_KPLR4) 
MTTTVATIFPLSTLGTNNDSVGNETFYQQPADLKPPHHALLMPILFGILMVVGIVGN
TLVIFVILKMRQFKTVTNYYVVNLAVADILFLCICAPSTAAQYGSPSFLGGRFMCKM
VYYMQSVSAQVTCLFLVAMSIDRFQAIVRPLKSLKTRTLHNAATISIVIWLFAVTVY
IPLLVFFDTVDIPYNGGIILLCKEFWSKTWSELFSIWIFLFTYTLPLVVISICYSMM
ILNLWQRVVPTDALSGPANDRNLRQKRKITWMVLTVVIVFAVCWLPVHVIQIWMEFD
VNFPYTMATLDFKAAGHALIYINSCANPFIYTFLGENFQKNFKKTFHCCFKKVRPTR
EGAGHVANTGTQQGSSSEQAGTRRKTGGGRTQMSTLTSSNVEAKGIEQIDNNHC 
E. KP-like receptor 5 (Ar_KPLR5) 
MMSTADHQLGLLHQIQISNLSTSIMEDFEVENYYDSNNTSDYVFDISVSIFNATSRI
LVPTTFFLLALMGLVGNCSVMFIICRHTDMQTVTNYFIANLAITDVATVLFCILPTA
LQNSGIIPMSTGVCKGVNYIQFVTVQATCCTLTAMSIDRYFLIVHAVRSRRSRTTNK
VLIINVTIWAVSFMMHSPVAVVSKVTSYNYCETVFGTVRGERVFQTFATLSMYVVPL
IINLVCYISILLQVWTRTARGTESAQAQERAVRRKRKITRMVFVVVLLFAVCWAPKH
FFRMWIAFDYVEFHMTSNRHYVLMGSLQFVALCLAYGNSCVNPFVYAFTTTSFKKYF
KKVFKPCCRFEDRQARTSVNQSRVSKVITGEESLV 
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F. KP-like receptor 6 (Ar_KPLR6) 
MTDSQAFVTDIATTMVEVYGPTNLTSLFDSTSSYISGPCTEGNSSLGDGVTPSGMTP
GLQFPDSFLNPIRIVMPIIMAIISIIGLVGNGTVLCIIFKYREMQNITNYFIANLAL
TDVAMLGICAIPTAAGLAGMKMEEGLCKGVNYMQFVAVQATCCTLTAMSIDRYLLIV
HAVKSRKTRTTTRAIIVNVAVWIASFIVHSPVAIFYQLTDQGCELNIGKDGNGAKYY
YLGAFLSMYVIPLMIILMCYAKILIIVWRKTSAGTESAQAHERSIRQKRKITRMVFI
VVLLFAVCWAPIHCILLWEQFKTEDITNLSTAMAFACLRLFALCLAYANSLTNPFIY
AFTTASFKKHFKKVLSCSTPTESKEQKTMGPTSTYKKIGKYVNEYSSVNTCDTKV 
G. KP-like receptor 7 (Ar_KPLR7) 
MEGTCGNCSSDVGGDVDPITGIIFPVLMVLIAAVGITGNSLVLHIIFRHRDMRTVTN
SFVASLALSDIAMLTMCVIPTATVAITETWKLGDFLCKAASYTSFVTVQATCLTLTA
MTVDRYYLIVHAVKSRNTRTVMKAVVINVAIWIFSSLIHLATPVFTAVDSDSNCANT
FPNPDVDAKIYGVYAFLGMYIIPLMLIMFCYAKILIQIWQKTSGGTESAQAHTRALK
RKRKITRMVLIVVVLFAFCWAPLQIFIIWTNFNYAQVSEMRKDVFLFLRGSFQCMAY
ANSCVNPFVYAFTTTSFRKYFRKMFATCRGNVYKDRTSISISMTTKTERLAAEEDSS
I 
H. KP-like receptor 8 (Ar_KPLR8) 
MSSGDFLSDSYSMYYNDNATVEAASLGPSAVLVPLTLGIIAVLAVVGNALVIYIVLR
YRNMRSSVTNFYIMNVAISDIVFVVICVPLTSVSYGMTYWPFGQFFCKLNAYMQCVS
VQATCTTLTAMTVDRYYVIMSPLASRRTRTICRAGMVCASIWIFSAVVHIPVAVFFK
IEVINWFGEINEYCKFTLHKPAALSGYFIYLSLSTFLLPLTIIAVCYSLILSHLWSL
SRVGRCREPTSTAGYDPLSQQSRSGALPPAQSSARTASKTWKTTRIVLCVVMLFAVC
WAPLQAFNVWNAIDPEHHSSSVHVNNLRVFCLCLAYANSCINPIVYALAGTSYRHHL
HQMVSGSNKSGRINSRFSPTGGRNSSYRSVRRMSRTEATSVSTCV 
I. KP-like receptor 9 (Ar_KPLR9) 
MEYPDVSYSYSYSSFYYSSNSNFTNGFEGETGVHAILVPIIFGIITVVGLIGNGCVV
IVIARNRCMRTVTNFFIMNNAITDMVFVVICAPVTASQFILTDWIFGDFICKLVVFM
QYVSVQASCSTIMAMTIDRYMVILHPMRSLHARTIRRTTCINIVIWLTSFLLHVPVA
IYYEQVSEPNNGYFCGTNFVNITASKIYHFYAVIVLYVFPFLVMTFCYLRILRKVWS
KYLIVTSSTQTQRKRRWKITRMTLLVVILFGICWGPIHAVHLVALFKTATSATEIDW
SYYNFSIFCLCISYSNSAINPFVYAFSGRSYRSLLLSCLKRKPGKNPVSRMCSSRTK
AGSAQYSLEMNNLIRTNGQNGRSPKTRYTNQYIGGGRHIVRAVPE 
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J. MCH-like receptor 1 (Ar_MCHLR1) 
MEGNLHSDLSTQVSSAKMYSLTTQHPVYQGENNTDYWDNSSSDAISNATENIQSVLF
QRFLAPLIFGCISIVGIVANGLVIIVLLKYANMRTIPNVYILSLALMDFMFVLSLPM
VGYQFCTNNWPFGYFMCKLVPGIDGFNQFGSVNIMTMMSADRYVAVVYPLSSMRYRT
KKTARIVCGVVFLISFILCTPSWYFMELKDGGYGLTYCIAKGPSWDKEGTLYTLYYA
CFGFLIPLAIIIVCYSTLLFKILGSKLRIRSDGTGTAQRASKRVFILTVSVIVVFVV
CWLPYNVVQLFHQFTTAEVSHAFSIAYAVSSLWCYTNSCFNPIVYTFIGENFKKNVM
HLCPFCTSPDDTKLDRYRSNRESSTYIRGGTLRLHSVQHEAPASPPAMTTNATAITD
ATSFTEAPANTQTYTFSNNNTHNSCGKE 
K. MCH-like receptor 2 (Ar_MCHLR2) 
MDKSTSIMLTTAGYSDILTPMFCANCTTPAGHPQDNSFLMSLQQISFIVTCILGTVG
LLCNGFIILILMRFPNMKTLANYFILNLALADFLFMISFLFLGHQLRVNHWVFGKFM
CRLIVPYDAMTQFLVIYFVMIMSIDRYFAICLPIKSMNFRTLRNGKIVCAMIWGVAI
LTTLPLWIYTEHTCVNGWCTCLARVSSNDEDDPRWWIIYTIIIGFCVPLTIVCICYL
LILQNLLTSNMQDSKNTLRRAARRVAILVICIIIVFILCFLPFYVFQLVYSTIDAEE
DASNALILIYIITWTLMYSHSIINPIVYALVGENFRKNITFMFCKRSSRHVMYTRQS
SMRTSSFRRTRNSLKSCNSNDPNGMRPHNGYYVHLDTGQHRGAREDPV 
L. Partial (3’) SMS-like receptor 1 (Ar_SMSLR1) 
MDCMDTASDSFSTNCSLENCTEEETTKSVTQIRDWVAGIFLLIVCITGLIGNSMVIF
VVLRYAKMKTVTNLYILNLAIADDLFMIALVFLSIATLAGNNWIFGPVLCHVVFAID
GLNQFTSVFCLTAMSMDRYVAVCHARRVRGYRTLRLAICVNFGVWFLALAAASPMNI
VTRYTVYNGTPLCYFNFESVFGKDAVVITQKLFMIYTTLMGLVIPLVIISVCYSSIV
VRLKKLGTRTGKMKKSRKVNRLVFFVVLAFFMCWWPFYVWRTIVVFVPCLGQ 
M. Partial (5’) SMS-like receptor 2 (Ar_SMSLR2) 
EEEEEEGNFSDIQLAGTIIGSLYMIITIVGILGNGTVIYVVLRFAKMKTVTNCYILN
LAVADAVFVTFLTLMAVSNFMETYWIFGAFLCKVYFGIDMFNMVISVWCLTAMSVDR
YVAVCHAMKSRSFRNLPIATAINASTWLLSILAAIPFVYFAKLEPGSGNYDVCYLYF
EPDRVKTSSQIMAMCVFIFNFVIPLTVIIVCYASITMRLRDMNKKTGKPEKSRKVNR
LVLIVVITFVICWAPFYIVKILFVFVDTFRRWNKTWILSDITMSLTYINSCANPFLY
AFFSDNFRKSFRKAWLCHSRNQAEVSQTSYASRWKFGKSGGKGKFNKKGKRFRLHDD
EGDDTNVSGYNNQYPLTATAVTSVVSESSYPRNGEMSQVNLDKQAVAKA 
N. SMS-like receptor 3 (Ar_SMSLR3) 
MASVGNSTEEPFADLYGDSDWIYSVTGSFSYIVCVIGLLANTWVICVLLCKLGLKTA
GNMYILNLAIADDLFLAGLALQAAYQITEVWHFGEFLCRAALAFDGLNMYASAFFVT
ALSIERYMAVSRSSRARLHRKRRQAAAVSVIIWVISILAAIPTLLASYYITNTREDY
ICITTFSNFGEPGVEFWNQAFITYNFVLGLCVPLLVSCLCYGMLIVQMRQVSMRNDA
GADVKRVTRIVTGVVVVFFLCWAPFYLVRMILVYNPSLMYWSGKPFVFELSLCFTYI
NSCVNPFIYALISEKFRENLPCLALRGRGYISGKRTAVCDRNSTALTDIHRNSVITN
NDSS 
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Fig. A6. Rhodopsin γ-type receptors identified in A. rubens. (A) Partial (3’) 
kisspeptin (KP)-like receptor 1 (Ar_KPLR1). (B) KP-like receptor 2 (Ar_KPLR2). 
(C) Partial (5’) KP-like receptor 3 (Ar_KPLR3). (D) KP-like receptor 4 
(Ar_KPLR4). (E) KP-like receptor 5 (Ar_KPLR5). (F) KP-like receptor 6 
(Ar_KPLR6). (G) KP-like receptor 7 (Ar_KPLR7). (H) KP-like receptor 8 
(Ar_KPLR8). (I) KP-like receptor 9 (Ar_KPLR9). (J) Melanin concentrating 
hormone (MCH)-like receptor 1 (Ar_MCHLR1). (K) MCH-like receptor 2 
(Ar_MCHLR2). (L) Partial (3’) somatostatin (SMS)-like receptor 1 (Ar_SMSLR1). 
(M) Partial (5’) SMS-like receptor 2 (Ar_SMSLR2). (N) SMS-like receptor 3 
(Ar_SMSLR3). Note that transmembrane domains were not predicted for partial G-
protein coupled receptors (GPCRs); predictions on GPCRHMM 
(http://gpcrhmm.sbc.su.se) are restricted to a GPCR model and hence contain seven 
transmembrane domains (Wistrand et al., 2006). 
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A. Partial (5’) GPA2/5-type receptor  
PPLFRFQSISTAKLHYFSHCCAFYYNTTENTHMAKMHNITEAVEDVDCPTSTSQPVR
SASPFEFLDNREASIPRGSREILDEYIQSAVVPPNKESSMGHSFFIPVNNESLMAVT
GEPFIGPFGADDTSDMGFREEVVDPHVTHVIYGSTCHDIVPKNYSKVNCSPLPDPFN
PCSDVMGYPFLRVIVWFIASTAMIGNLVVMVVLIAYRHKMTVPKFLMCNLAFADFCM
GIYLLMVAAVDVHTLGAYFNYAIDWQFGAGCKIAGFISVFSSELSVFTLTVLTIERW
YTIIYAIDLNKRIRLRQAGRILLGGWFFAIVIASLPFLGVAGYGVTSMCLPFYVRKT
DSAAAVAYVIFILLFNALAFIVICACYIKMYVTVRNPHSAMQRKDSKVAKRMAVLIF
TDLACWAPIAINGLSSIFNGKNALLTTDQTKVFIVLFYPINSCANPFLYAIFTRAFR
RDLFLLLAKHGMCEKRAMKYRPTYTSSPRSMSQVNSTTMRDVCPKGSSHRGSSASVM
TQITSDARPSMVSFDKESPDNSPKMNIELQFVVTPGSSLQSQIPEDTSISNQLEVSH
SPNTGSKAGGTKKLNEYSYILDGLPPVPEEHNSDRPEPSSKPFQTELDDNLNPCRPG
NPLIIEHCVSDNFVDMEPVNRESSSLLSYVAGNGDVDAALTNGNRTDIGIQSVTPND
HEVNSKLIQMNLTKADDVETTL 
 
B. Partial (3’) bursicon-type receptor  
MELILMLFWAAVYGVMLPVFPATPTKFNCHRNSSLCSSVCCCYRPKNPNGGSVDIIA
VDCTRRNLTEVPLDLPANTVEINLSFNNLTALPADAFSHVTRLRHLKLVGNRIRTLN
EDVFRGLKELHSLDLQLNIFQKLPSKAFHPDLANLRTLNLNSNYIEDFPGHALLNLH
SLRHLYVEGNRLNRIPTEAISLVPELTVLLLSSNAITMVQDHAFQNNTKLIELSLNN
NSIQVISTHAFSGLYNLKGLDFRYNYHRIKNIKQGAFRNLTNLNALAISDVDNLSEF
PDLSGTTSLERLTIDRCSLTAIPTTFCDGMHHLKELDLHNNKIESIPSFSNCSQLQY
LNLGLNKLSSLESTPFQGLNQLSHLYLGENNIERIRADSFEGLSAAYELDLGNNDII
EIDEKAFLPLKQLETLRLNGNRFPDFPTAGLERLLNIYTFDNIHLESFPKPSELPKI
IIIISSYAYHCCSYISLNEVNSVKNTPEIKEIYTWTLSSSTYDYNGGNGSSSDWAEE 
WYDSTWEPQYNLSGVPIQIHSNISCSPVPGPFLPCVDLFGSWFLRIGVYFVFLLAVI
GNAIVIFVILVSHTKMDVPRFLICNLAFADFFLGVYLGFLAGVDTSTLGVFHKYGAQ
WQLSPGCSLAGFLAVFSSEFSIYTLSVITLERFYAIKHALHLEKRMKLPHAVAVMAF
GWIFAVVVAIMPLVHISSYYKFPVCLPLDITTTIGKVYGSSILLLNVTAFVIIMLCY
ANIYMAIQGSHAWNCNDSRVARRMSLLVFTDFACWAPIAFFSLTSAFGLQLISMEGA
KVLTIFVLPLNSCANPFLYTILTKQFKKDCQMILRSLRNQVLRPRKSTNPSLGRHPS
MRSTQAHQISQLPWRTNGSISQDITGDGCMVSSFKTENGEPSSNVYTMSTMAETHTP
QQNGSCSNDHSHSDSSAMLDPMLLTNSDLDDLRRGSTSPLLDLMTQVTSKDPEAKPK
SKVRRKFSIPFPFFSTRSPTKEPTHSSSANTSIRRSPTPQRQKRSHSITEGLLHKMN
RKRPLTSMKSAPGISSPISRSSEKLDQGINGISIGICITVPDKQNQNKNVKQTEADE
KVYSIDVPKEPPKPPLSNFPIDQAGMETQTLLEIGASNNYFSENRSPHDTDSPGMLA
AHENPVRDQLSSATSSPQLHRPEKLVLVDSVVPADKDVPDNDSGLGTASSPLPDSTE
SMRFLPVSLETPEVVCNSELDDHSSRVTSQPSVLGGLFGH 
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Fig. A7. Glycoprotein hormone-type receptors. (A) Partial (5’) glycoprotein α-
2/β-5 (GPA2/5)-type receptor. (B) Partial (3’) bursicon-type receptor. Note that 
candidate GPA2/5 and bursicon receptors belong to the rhodopsin-δ family of 
receptors (Fredriksson et al., 2003) so were not included in neighbour joining (NJ) 
trees. Note that transmembrane domains were not predicted for partial G-protein 
coupled receptors (GPCRs); predictions on GPCRHMM (http://gpcrhmm.sbc.su.se) 
are restricted to a GPCR model and hence contain seven transmembrane domains 
(Wistrand et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
